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Synergy	  between	  materno-­‐foetal	  infection	  and	  hypoxic-­‐ischemic	  insult	  around	  the	  time	  
of	   birth	   is	   a	   known	   contributing	   factor	   to	   perinatal	   brain	   damage.	   This	   is	   a	   common	  
precursor	  to	  cerebral	  palsy	  and	  other	  neurological	  deficits,	  affecting	  2	  to	  5	  per	  1000	  live	  
births.	   Endotoxin	   up-­‐regulates	   several	   molecules,	   including	   the	   TNF	   cluster	   of	   pro-­‐
inflammatory	  cytokines.	  Our	  group	  has	  explored	  the	  role	  of	  this	  cluster	  and	  shown	  that	  
its	  deletion	  abolishes	  LPS	  sensitization	  to	  neonatal	  hypoxic-­‐ischemic	  insult.	  
	  
In	   this	   study	   we	   wanted	   to	   first	   investigate	   the	   effects	   of	   LPS-­‐mediated	   sensitization	  
across	  multiple	  wild	   type	   strains	   (C57BL/5,	   129SVJ,	   BALB/c,	   CD1	   and	   FVB)	   in	   order	   to	  
then	  further	  characterize	  the	  TNF	  cluster,	  by	  studying	  the	  individual	  effects	  of	  TNFα,	  LTα	  
and	   LTβ	   members	   of	   this	   cluster,	   using	   either	   global	   gene	   deletion,	   or	   peripheral	  
myeloid/macrophage-­‐specific	  deletion	  of	  the	  floxed	  TNFα	  allele	  with	  MLys::Cre	  (MLys+).	  
Additionally,	  we	  decided	  to	  also	  look	  at	  the	  acquired	  cellular	  immune	  system,	  using	  the	  
athymic	  nude	  mouse	  model	  of	  T	  cell	  deficiency	  (nu).	  	  
	  
At	  P7,	  littermates	  for	  each	  of	  the	  wild	  type	  strains,	  wild-­‐type	  and	  homozygous	  knock-­‐out	  
offspring	   of	   heterozygous	   animals	   listed	   above	   underwent	   hypoxic-­‐ischemic	   insult,	  
consisting	  of	  unilateral	  carotid	  occlusion	  followed	  2	  hours	  recovery	  before	  being	  placed	  
in	  a	  hypoxic	   chamber	   for	  30min	  with	   continuous	  8%	  oxygen	  exposure.	  12	  hours	  prior,	  
animals	  received	  a	  single	  intraperitoneal	   injection	  of	  0.6µg/g	  LPS	  or	  saline	  as	  a	  control.	  
1/3	   of	   animals	   in	   the	  wild	   type	   strains	   group	   underwent	   hypoxia-­‐ischemia	   alone	   as	   a	  
control	  for	  saline	  treatment.	  
	  
LPS	   pre-­‐treatment	   resulted	   in	   substantial	   increase	   inflammation,	   neuronal	   injury	   and	  
infarct	  in	  all	  wild	  type	  strains,	  as	  well	  as	  in	  the	  phenotypically	  wild	  type	  littermates	  of	  the	  
homozygous	  mutant	  animals.	  Mice	  lacking	  both	  copies	  of	  the	  LTα	  gene	  revealed	  a	  clear	  
reduction	   in	   LPS-­‐mediated	   sensitization.	   In	   reverse,	   global	   deletion	   of	   LTβ	   had	   a	  
detrimental	   effect,	  with	   significant	   increase	   in	   brain	   damage.	   Global	   deletion	   of	   TNFα	  
showed	  a	  trend	  towards	  greater	  damage,	  but	  deletion	   just	   in	  MLys+	  macrophages	  was	  
strongly	   protective,	   pointing	   to	   a	   dual	   role	   for	   the	   TNFα	   gene	   depending	   on	   in	  which	  
cell-­‐type	  it	  is	  expressed.	  Finally,	  nude	  animals	  (nu/nu)	  demonstrated	  a	  complete	  lack	  of	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LPS-­‐mediated	   sensitization	   to	   subsequent	   hypoxic-­‐ischemic	   insult,	   suggesting	   that	   LPS	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  synthase	  
CNS	   	   Central	  nervous	  system	  
COX	   	   Cytochrome	  oxidase	  
CP	   	   Cerebral	  palsy	  
CROC	   	   Carotid	  occlusion	  
CSF	   	   Cerebrospinal	  fluid	  
CTX	   	   Dorsoparietal	  cortex	  
DAB	   	   Diaminobenzidine	  
ddH2O	   	   Double	  distilled	  water	  
DNA	   	   Deoxyribonucleic	  acid	  
dUTP	   	   Deoxyuridine	  triphosphate	  
EAA	   	   Excitotoxic	  amino	  acid	  
EAE	   	   Experimental	  autoimmune	  encephalomyelitis	  
EDTA	   	   Ethylenediaminetetraacetic	  acid	  
EEG	   	   Electroencephalography	  
eNOS	   	   Endothelial	  nitric	  oxide	  synthase	  
EPO	   	   Erythropoietin	  
EtOH	   	   Ethanol	  
EXC	   	   External	  capsule	  
FA	   	   Formaldehyde	  
GFAP	   	   Glial	  fibrillary	  acidic	  protein	  
HI	   	   Hypoxia-­‐ischemia	  
HIE	   	   Hypoxic-­‐ischemic	  encephalopathy	  
HIP	   	   Hippocampus	  	  
IgG	   	   Immunoglobulin	  G	  
IGR	   	   Intrauterine	  growth	  restriction	  
IL	   	   Interleukin	  
iNOS	   	   Inducible	  nitric	  oxide	  synthase	  
IUGR	   	   Intrauterine	  growth	  restriction	  
KO	   	   Knockout	  
LPS	   	   Lipopolysaccharide	  
LTα	   	   Lymphotoxin	  alpha	  
LTβ	   	   Lymphotoxin	  beta	  
MAP	   	   Mitogen-­‐activated	  protein	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MHC	   	   Major	  Histocompatibility	  complex	  
MRA	   	   Magnetic	  resonance	  angiography	  
MRI	   	   Magnetic	  resonance	  imaging	  
MS	   	   Multiple	  sclerosis	  
MyD88	  	   Myeloid	  differentiation	  primary	  response	  protein	  88	  
NAC	   	   N-­‐Acetylcysteine	  
NE	   	   Neonatal	  encephalopathy	  
NF-­‐kB	   	   Nuclear	  factor	  kappa	  B	  
NMDA	  	   N-­‐methyl-­‐D-­‐aspartate	  
nNOS	   	   Neuronal	  nitric	  oxide	  synthase	  
NO	   	   Nitric	  oxide	  
NOS	   	   Nitric	  oxide	  synthase	  
OCT	   	   Optimal	  cutting	  temperature	  compound	  
O/N	   	   Overnight	  
PARP	   	   Poly	  (ADP-­‐ribose)	  polymerase	  
PB	   	   Phosphate	  buffer	  
PB/BSA	   Bovine	  serum	  albumin	  in	  0.1M	  PB	  
PCR	   	   Polymerase	  chain	  reaction	  
PFA	   	   Paraformaldehyde	  
PVL	   	   Periventricular	  leukomalacia	  
PYR	   	   Pyriform	  cortex	  
Rag1	   	   Recombination	  activating	  gene	  
RNA	   	   Ribonucleic	  acid	  
RT	   	   Room	  temperature	  
SD	   	   Standard	  deviation	  
SEM	   	   Standard	  error	  of	  the	  mean	  
SGA	   	   Small	  for	  gestational	  age	  
STR	   	   Striatum	  
TdT	   	   Terminal	  deoxynucleotidyl	  transferase	  
THL	   	   Thalamus	  
TLR	   	   Toll-­‐like	  receptor	  	  
TNF	   	   Tumour	  necrosis	  factor	  
TNFα	   	   Tumour	  necrosis	  factor	  alpha	  
TUNEL	   	   Terminal	  deoxynucleotidyl	  transferase	  dUTP	  nick	  end	  labelling	  
WM	   	   White	  matter	  
WMI	   	   White	  matte	  injury	  
WS	   	   Watershed	  





CHAPTER	  1:	  GENERAL	  INTRODUCTION	  
	  
William	   Little,	   an	   English	   Orthopaedic	   Surgeon,	   was	   the	   first	   to	   identify	   and	  
describe	   a	   pattern	   of	   disabilities	   characterized	   by	   deformities	   of	   the	   human	  
frame	  now	  known	  as	  spastic	  diplegia,	  a	   form	  of	  Cerebral	  Palsy	   (CP).	  Nowadays,	  
cerebral	   palsy	   is	   applied	   as	   an	   umbrella	   term	   that	   designates	   a	   group	   of	  
permanent	  non-­‐progressive,	   non-­‐contagious	  disorders	   affecting	  movement	   and	  
posture.	  These	  disturbances	  are	  generally	  attributed	  to	  catalystic	  events	  around	  
the	   time	  of	   birth	   or	   to	   abnormal	   brain	   development.	   Furthermore,	   the	   human	  
developing	   brain	   is	   highly	   susceptible	   to	   various	   prenatal,	   perinatal	   and	   early	  
postnatal	  stresses.	  Neonatal	  brain	  injury	  is	  not	  only	  a	  major	  contributor	  to	  infant	  
morbidity	   and	  mortality	  but	   is	   also	  one	  of	   the	   leading	   causes	  of	   cerebral	   palsy	  
and	   other	   neurological	   disabilities,	   such	   as	   cognitive	   impairment,	   epilepsy	   and	  
autism	  (Bax	  et	  al.,	  2005).	  
	  
Epidemiology	  
Perinatal	  brain	  damage	  remains	  one	  of	  the	  main	  precursors	  to	  cerebral	  palsy.	  For	  
the	  last	  20	  years,	  cerebral	  palsy	  has	  had	  a	  continual	  incidence	  of	  2-­‐5	  in	  1000	  live	  
term	  births	   (Vannucci	   and	  Vannucci,	   1997;	   Robertson	   et	   al.,	   2007),	  whereas	   in	  
low	   birth	   weight	   (<1500	   grams)	   premature	   newborn	   infants,	   the	   incidence	   is	  
significantly	   increased	  to	  60%.	  When	  asphyxia	   is	   involved,	  there	   is	  an	   increased	  
fatality	  of	  around	  25-­‐50%	  for	  hypoxic-­‐ischaemic	  babies	  still	  within	  the	  neonatal	  
period,	  mostly	  due	  to	  multiple	  organ	  failure	  (Liu	  et	  al.,	  2006).	  Of	  the	  remaining	  
survivors,	   up	   to	   25%	  will	   display	   lifelong	   neurological	   sequelae	   in	   the	   form	   of	  
cerebral	   palsy	   or	   other	   neurological	   deficits,	   with	   an	   additional	   25-­‐50%	  
either/also	   suffering	   from	   mental	   retardation,	   cognitive	   impairment,	   epilepsy,	  
schizophrenia	  and	  autism	  (Vannucci	  and	  Vannucci,	  1997;	  Lindström	  et	  al.,	  2008;	  




Lindström	  et	   al.,	   2006,	   conducted	   a	   population	   based	   study	   in	   Sweden,	  where	  
moderate	  neonatal	  encephalopathy	  had	  a	  prevalence	  of	  0.06%.	  Of	  the	  surviving	  
infants,	   30%	   developed	   moderate	   cerebral	   palsy.	   71%	   of	   the	   children	   not	  
affected	   by	   cerebral	   palsy	   demonstrated	   cognitive	   impairment	   and	   18%	   had	  
hearing	   impairment.	   Furthermore,	   only	   8%	   of	   individuals	   diagnosed	   with	  
neonatal	   encephalopathy	   but	  without	   cerebral	   palsy	   had	   no	   impairment	  when	  
tested	   at	   15-­‐19	   years	   of	   age.	   Prevalence	   data	   from	   the	   United	   States	   indicate	  
that	  8000	  babies	  are	  born	  every	  year	  with	  cerebral	  palsy	  (Winter	  et	  al.,	  2002).	  In	  
Germany,	   approximately	   1000	   children	   suffer	   from	   perinatal	   brain	   damage	  
annually,	   with	   a	   considerable	   proportion	   of	   these	   children	   later	   developing	  
cerebral	  palsy	  as	  well	  (Bumke	  and	  Foerster,	  1936).	  
	  
Clinical	  manifestation	  and	  recognition	  
Perinatal	   brain	   injury	   is	   typically	   diagnosed	   based	   on	   signs	   of	   encephalopathy,	  
which	  evolve	   from	   lethargy	   to	  hyperexcitability	   to	   stupor	  during	   the	   first	   three	  
days	  of	  life	  (Sarnat	  and	  Sarnat,	  1976).	  Difficulties	  with	  initiating	  and	  maintaining	  
respiration,	   subnormal	   level	   of	   consciousness,	   seizures	   and	   depression	   of	   tone	  
and	  reflexes	  characterise	  those	  affected	  (Nelson	  and	  Leviton,	  1991).	  	  
	  
However,	   in	   cases	   of	   prematurity	   and	   low	   birth	   weight,	   perinatal	   brain	   injury	  
often	  eludes	  diagnosis,	  as	  obvious	  signs	  of	  injury	  are	  not	  present,	  possibly	  due	  to	  
misinterpretation	  by	  attribution	  of	  symptoms	  as	  consequential	  to	  developmental	  
immaturity	   (Mercuri	   et	   al.,	   2003).	   Furthermore,	   subclinical	   symptoms	  will	   also	  
lead	   to	   a	   delay	   in	   diagnosis	   of	   cerebral	   palsy,	   cognitive	   impairment	   as	  well	   as	  
other	  complex	  behavioral	  disorders	  which	  are	  only	  noticeable	  at	  a	  later	  stage	  in	  
childhood	  (Mercuri	  et	  al.,	  2004).	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Outcomes	  of	  perinatal	  brain	  damage	  
	  
Cerebral	  palsy	  
Cerebral	   palsy	   is	   the	  most	   common	   disability	   in	   childhood.	   This	   condition	   is	   a	  
manifestation	   of	   injuries	   to	   the	   brain	   parts	   responsible	   for	   controlling	   body	  
movement	   and	   persists	   through	   life.	   As	   aforementioned,	   insults	   leading	   to	  
cerebral	  palsy	  may	  occur	  in	  the	  antenatal,	  perinatal	  and	  early	  postnatal	  periods	  
of	   life.	   There	   is	   significant	   evidence	   from	   clinical	   cases	   that	   relate	   severity	   of	  
neonatal	   encephalopathy	   to	   long-­‐term	  neurodisabilities.	  Overall,	   cerebral	   palsy	  
in	   its	   mild	   form	   accounts	   for	   only	   2%	   death	   risk	   (Collins	   and	   Panneth,	   2002),	  
whereas	  a	  more	  severe	  form	  of	  cerebral	  palsy	  the	  risk	  of	  mortality	   increases	  to	  
85%	  (see	  table	  1.1).	  Multiple	  organ	  dysfunction	  is	  considered	  the	  major	  cause	  of	  
death	  in	  infant	  sufferers	  (Cowan	  et	  al.,	  2003).	  
	  
Severity	  of	  CP	   Characteristics	  
Mild	   No	  increased	  risk	  of	  motor	  or	  cognitive	  impairment	  
Moderate	   Significant	   motor	   deficits,	   fine	   motor	   disability,	   memory	  
impairment,	   visual	   or	   visuomotor	   dysfunction,	   increased	  
hyperactivity	  and	  delayed	  school	  readiness	  
Severe	   High	  death	  risk	  (up	  to	  85%);	  	  
Increased	  risk	  of	  mental	  retardation	  
Table	  1.1:	  Types	  of	  cerebral	  palsy.	  Abbreviations:	  CP	  –	  cerebral	  palsy.	  
	  
Furthermore,	  depending	  on	  the	  type	  of	   insult	  and	  which	  areas	  of	   the	  brain	  are	  
affected,	  cerebral	  palsy	  will	  present	  itself	  in	  different	  forms.	  These	  subtypes	  can	  
be	   classified	   as	   being	   spastic	   (80%	   of	   cases),	   dyskinetic	   (10%),	   or	   ataxic	   (10%)	  
(Paneth,	   2008),	   and	   will	   have	   different	   onsets,	   thus	   affecting	   the	   sufferer	  
differently	  (Volpe,	  2009)	  (see	  table	  1.2).	  Spastic	  cerebral	  palsy	  is	  associated	  with	  
damage	   to	   the	   brain	   cortico-­‐motor	   and	   underlying	   white	  matter	   areas,	   and	   is	  
characterized	  by	  hypertonia,	  i.e.	  decreased	  range	  of	  muscular	  motility,	  and	  may	  
affect	   many	   areas	   of	   the	   body,	   and	   in	   some	   cases,	   even	   affect	   speech	   and	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continence	   (Blair	   and	   Stanley,	   1997).	   In	   cases	   of	   dyskinetic/dystonic,	   normally	  
the	   basal	   ganglia	   area	   of	   the	   brain	   is	   damaged	   and	   sufferers	   experience	  
uncontrolled	  muscle	  contraction,	  which	  can	  be	  either	  sustained	  or	  intermittent.	  
This	   type	   of	   cerebral	   palsy	   can	   affect	   all	   four	   limbs,	   thus	   making	   difficult	  
maintaining	   an	   upright	   position.	   Additionally,	   speech	  may	   be	   impaired	   due	   to	  
difficulty	   in	   breathing	   and	   controlling	   the	   tongue	   (Hou	   et	   al.,	   2006).	   Ataxia	  
cerebral	   palsy	   occurs	   when	   the	   cerebellar	   part	   of	   the	   brain	   is	   affected	   and	   is	  
associated	   with	   difficulty	   in	   coordinating	   muscle	   function	   and	   balance,	   with	  
possible	  additional	  poor	  spatial	  awareness	  (Cheney,	  1997).	  
	  
Subtypes	  of	  CP	   Characteristics	   Onset	  
Quadriplegia/dyskinetic	   Involvement	  of	  all	  4	  limbs	   Perinatal	  HI	  
Hemiplegia	   One	   side	   of	   the	   body	   –	  
more	   commonly	   arm	   than	  
leg	  
Term	  infants,	  stroke-­‐like	  
vascular	  incident	  
Spastic	   Both	   sides	   –	   more	   arms	  
than	  legs	  
Preterm	   or	   growth	  
restricted	  infants	  




Observational	   studies	   of	   children	   with	   both	   severe	   and	   moderate	   neonatal	  
encephalopathy	  have	  demonstrated	  visible	  memory	  impairment,	  visual-­‐motor	  or	  
-­‐perceptive	   dysfunction	   and	   hyperactivity,	   the	   later	   not	   being	   limited	   to	   the	  
presence	  of	  mental	  retardation.	  Marlow	  et	  al.,	  2005,	  studied	  65	  children	  having	  
suffered	  neonatal	   encephalopathy;	   they	  were	   followed	  up	   to	   the	   age	  of	   7	   and	  
assessed	  for	  neurocognitive	  and	  behavioral	  outcomes.	  In	  50%	  of	  severe	  neonatal	  
encephalopathy	   cases,	   affected	   children	   had	   severe	   cognitive	   impairment	  
(IQ<55).	   Despite	   75%	  of	   observed	   children	   not	   having	   cerebral	   palsy,	   cognitive	  
scores	   were	   still	   low	   for	   the	   severe	   group,	   but	   in	   the	   moderate	   group	   the	  
difference	  in	  scores	  was	  relatively	  small	  in	  comparison	  to	  classmates.	  Moreover,	  
both	  groups	  showed	  a	  higher	  need	  for	  special	  educational	  needs	  than	  unaffected	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children	   (Marlow	   et	   al.,	   2005).	   A	   Swedish	   population-­‐based	   cohort	   study	  
following	   children	   born	   suffering	   from	  moderate	   encephalopathy	   also	   showed	  
that	  children	  born	  at	   term	  with	  moderate	  neonatal	  encephalopathy	  had	  a	  high	  
rate	   of	   cognitive	   impairment,	  which	   occurred	  with	   or	  without	   the	   presence	   of	  
cerebral	  palsy	  (Lindström	  et	  al.,	  2008).	  A	  review	  by	  van	  Handel	  et	  al.,	  has	  shown	  
that	  in	  terms	  of	  academic	  achievement,	  children	  with	  mild	  encephalopathy	  fared	  
well,	   whereas	   sufferers	   with	  moderate	   encephalopathy	   had	   lower	   scores	   than	  
children	  with	  mild	   encephalopathy,	   still	   these	   results	  were	  with	   normal	   range.	  
However,	  children	  with	  severe	  encephalopathy	  consistently	  demonstrated	  lower	  
IQ	   and	   performed	   worse	   at	   school,	   particularly	   in	   subjects	   such	   as	  
arithmetic/mathematics	   and	   reading	   and	   spelling,	   when	   compared	   to	   age-­‐
matched	  peers	  (van	  Handel	  et	  al.,	  2007).	  
	  
Autism	  
Badawi	  et	  al.	  performed	  a	  population-­‐based	  case-­‐control	   study	  using	  276	   term	  
newborn	   infants	  with	   identified	  moderate	   or	   severe	   neonatal	   encephalopathy,	  
and	   another	   564	   term	   infants	   were	   randomly	   selected	   as	   controls.	   This	   study	  
revealed	  a	  correlation	  between	  neonatal	  encephalopathy	  and	  autism.	  From	  the	  
neonatal	  encephalopathy	  group,	  around	  13%	  died	  by	  the	  age	  of	  5	  years.	  Of	  the	  
remaining	  survivors,	  12	  (5%)	  were	  diagnosed	  with	  an	  autism	  spectrum	  disorder.	  
Of	  these,	  10	  sufferers	  met	  the	  full	  criteria	  for	  autism,	  1	  had	  Asperger	  syndrome	  
and	  one	  had	  pervasive	  developmental	  disorder	  (Badawi	  et	  al.,	  2006).	  
	  
Causes	  and	  risk	  factors	  of	  cerebral	  palsy	  
Birth	  asphyxia	  was	  considered	  to	  be	  the	  main	  cause	  of	  neonatal	  encephalopathy	  
and	   cerebral	   palsy;	   however,	   epidemiological	   studies	   have	   now	   consistently	  
shown	   the	   origin	   of	   cerebral	   palsy	   as	   being	   multifactorial.	   Even	   though	   some	  
cases	  still	  have	  unidentified	  origins	  (Bax	  et	  al.,	  2005),	  other	  universally	  accepted	  
causes	   include	   infection/inflammation	   during	   pregnancy	   and	   labor,	   genetic	  	  	  
metabolic	   defects,	   such	   homozygous	   mutation	   of	   the	   gene	   encoding	   for	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glutamate	  decarboxylase-­‐1	  enzyme	  (McHale	  et	  al.,	  1999;	  Lynex	  et	  al.,	  2004),	  as	  
well	   as	   maternal	   exposure	   to	   toxins	   such	   as	   methyl	   mercury	   (Harada,	   1978).	  
Furthermore,	   these	   factors	   have	   been	   shown	   to	   act	   either	   alone	   or	   in	   a	  
synergistic	  manner	  (Blair	  and	  Stanley,	  1993;	  Badawi	  et	  al.,	  1998;	  Hagberg	  et	  al.,	  
2002).	   Nonetheless,	   hypoxia-­‐ischaemia	   remains	   the	   most	   debilitating	   factor	  
preceding	  cerebral	  palsy,	  with	  significant	  morbidity	  and	  a	  high	  mortality	  rate	  of	  
30%	   (Vannucci,	   1990;	   Vannucci	   and	   Vannucci,	   1997;	   Nelson	   et	   al.,	   1998;	  
Vannucci	   and	   Hagberg,	   2004).	   Despite	   advances	   in	   neonatal	   care,	   neonatal	  
encephalopathy	   still	   has	   an	   incidence	   of	   2-­‐4	   per	   1000	   live	   births	   (Peebles	   and	  
Wyatt,	   2002),	   and	   as	   a	   result,	   this	   condition	   has	   long-­‐lasting	   devastating	  
consequences	   not	   only	   to	   sufferers,	   but	   also	   to	   carers,	   as	  well	   as	   an	   immense	  
cost	  to	  society,	  making	  understanding	  of	  the	  mechanisms	  involved	  imperative,	  as	  
a	  means	   to	   help	   improve	  management	   of	  mothers	   and	   babies	   and	   reduce	   the	  
risk	  of	  long-­‐term	  brain	  damage.	  	  
	  
A	  population-­‐based	  cohort	  study	  of	  neonatal	  encephalopathy	  cases	  revealed	  that	  
69%	   originated	   from	   antepartum	   risk	   factors	   alone,	   25%	   had	   antepartum	   and	  
intrapartum	   origin,	   4%	   intrapartum	   hypoxia	   alone,	   with	   a	   further	   2%	   being	  
contributed	   to	   unidentifiable	   factors	   (Badawi	   et	   al.,	   1998).	   The	   majority	   of	  
antepartum	   risks	   associated	  with	   cerebral	   palsy	   include	  maternal	   risks	   such	   as	  
maternal	   neurological	   disorder,	   infertility	   treatment,	  maternal	   thyroid	   disease,	  
preeclampsia	  and	  intrauterine	  growth	  restriction	  (IUGR)	  (Wu	  et	  al.,	  2004).	  Some	  
cases	   have	   demonstrated	   both	   ante	   and	   intrapartum	   factors,	   whereas	   only	   a	  
minor	  number	  of	   incidents	  are	  considered	  to	  be	   the	  result	  of	   intrapartum	  risks	  
alone	   such	   as	   maternal	   fever,	   emergency	   caesarean,	   placental	   abruption	   and	  
uterine	   rupture,	  however,	   the	   later	  was	  shown	  to	   increase	   the	  risk	  of	  neonatal	  





Figure	  1.1:	  Diagram	  representation	  of	  the	  aetiology	  of	  cerebral	  palsy	  (adapted	  from	  Badawi	  et	  al.,	  
1998).	  
	  
Low	  Birth	  weight	  
Approximately	  1.2%	  of	  all	  live	  born	  infants	  have	  low	  birth	  weight.	  Studies	  on	  the	  
prevalence	   of	   cerebral	   palsy	   have	   consistently	   shown	   that	   low	   birth	   weight	  
infants	   (<2500	   grams)	   are	   at	   a	   risk	   of	   developing	   cerebral	   palsy.	   This	   risk	  
increases	   exponentially	   in	   very	   small	   babies	   (<1500	   grams).	   Colver	   et	   al.	  
investigated	  epidemiological	  changes	   in	  cerebral	  palsy	   in	  England	  over	  a	  period	  
of	   30	   years	   (1964-­‐1993).	   His	   findings	   demonstrated	   a	   reduction	   in	   perinatal	  
mortality	  throughout	  the	  examined	  period,	  and	  babies	  born	  with	  a	  weight	  above	  
2500	  grams	  demonstrated	  no	  significant	  increase	  in	  perinatal	  brain	  damage	  and	  
cerebral	  palsy.	  However,	   infants	  with	   low	  birth	  weight	   (<2500	  grams)	   the	  most	  
severe	   forms	   of	   cerebral	   palsy	   were	   present	   (Colver	   et	   al.,	   2000).	   Similarly,	  
Pharoah	  et	  al.	  looked	  at	  cases	  of	  cerebral	  palsy	  covering	  Scotland	  and	  6	  counties	  
of	  England.	  This	  study	  found	  that	  the	  prevalence	  of	  cerebral	  palsy	  was	  of	  1.1	  per	  
1000	   live	   births	   where	   the	   birth	   weight	   was	   ≥2500	   grams.	   This	   prevalence	  
increased	  to	  78.1	  per	  1000	  live	  births	  in	  babies	  with	  ≤1000	  grams	  (Pharoah	  et	  al.,	  
1998).	   Additionally,	   25-­‐50%	   of	   low	   birth	   weight	   survivors	   will	   also	   exhibit	  
cognitive	  and	  behavioral	   impediments	  affecting	  school	  performance	  (Skranes	  et	  
al.,	  1997).	  	  
	  
Prematurity	  
Advancements	   in	   neonatal	   care	   have	   led	   to	   an	   increase	   in	   preterm	   infant	  
survival;	  however,	   this	  does	  not	   translate	   to	  reduction	   in	  morbidity	   (D’Angio	  et	  
Antepartum	  risk	  only	  (69%)	  
Antepartum	  +	  Intrapartum	  risks	  (25%)	  
Intrapartum	  risk	  only	  (4%)	  
Unidengﬁed	  risks	  (2%)	  
25	  
	  
al.,	  2002;	  Marlow,	  2005).	  Additionally,	  the	  cost	  of	  care	  for	  preterm	  children	  over	  
the	   first	   10	   years	   of	   life	   is	   443	   times	   greater	   than	   that	   of	   a	   term	   infant	   also	  
suffering	   from	   perinatal	   brain	   damage	   (Petrou,	   2005).	   Greenwood	   et	   al.	  
conducted	   a	   population-­‐based	   study	   of	   two	   health	   districts	   in	   England.	   Of	   the	  
235	  cases	  of	  cerebral	  palsy	   identified,	  31%	  were	  born	  at	  ≤32	  weeks,	  15%	  were	  
born	  between	  33	  and	  36	  weeks,	  and	  54%	  ≥	  37	  weeks	  of	  gestation.	  Compilation	  of	  
these	  findings	  with	  population	  data	  revealed	  that	  cerebral	  palsy	  occurred	   in	  42	  
per	  1000	  live	  births	  at	  ≤	  32	  weeks,	  6	  per	  1000	  live	  births	  in	  33-­‐36	  weeks	  and	  only	  
1	  per	  1000	  births	  after	  37	  weeks	  of	  gestation	  (Greenwood	  et	  al.,	  2005).	  	  	  
	  
Multiple	  pregnancies	  and	  assisted	  pregnancies	  
Multiple	   births	   have	   demonstrated	   to	   increase	   the	   probability	   of	   acquiring	  
cerebral	  palsy.	  	  A	  study	  performed	  in	  Sweden	  revealed	  that	  2.9%	  of	  babies	  born	  
are	   twins	   and	   incidence	   of	   cerebral	   palsy	   amongst	   the	   survivors	   is	   of	   1.3%.	   In	  
case	  of	  triplets	  (0.11%	  of	  babies),	  this	  incidence	  increases	  to	  4.5%.	  This	  leads	  to	  
4.33	  per	  10,000	  infants	  suffering	  from	  cerebral	  palsy	  being	  attributed	  to	  multiple	  
pregnancies	  (Pharoah	  and	  Cooke,	  1996).	  A	  commonly	  accepted	  cause	  for	  this	   is	  
the	  fact	  that	  children	  born	  from	  multiple	  pregnancies	  are	  often	  preterm	  and/or	  
with	   low	   birth	   weight.	   A	   considerable	   percentage	   of	   multiple	   pregnancies	   are	  
result	   of	   assisted	   reproductive	   technology	   (ART)	   treatments.	   Infertility	  
treatments	   increase	   the	   likelihood	   of	   prematurity	   in	   birth	   or	   multiple	  
pregnancies	  (Bergh	  et	  al.,	  1999).	  
	  
Intrauterine	  growth	  restriction	  (IGR)	  
Intrauterine	   growth	   restriction	   is	   associated	  with	   an	   increased	   risk	   of	   perinatal	  
brain	   damaged	   resulting	   in	   mortality	   and	   morbidity.	   This	   risk	   is	   further	  
augmented	  in	  cases	  of	  prematurity	  at	  birth.	  A	  Swedish	  population	  study	  revealed	  
an	  incidence	  of	  1.6%	  infants	  born	  small	  for	  gestational	  age	  (SGA).	  Despite	  some	  
SGA	  babies	  being	  simply	  genetically	  small	  but	  healthy,	  a	  good	  proportion	  of	  cases	  
are	   a	   result	   of	   either	   malformation	   or	   hypoxic-­‐ischaemic	   insult	   (Wennergren,	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1992).	   In	   western	   societies,	   these	   HI	   events	   are	   attributed	   to	   uteroplacental	  
insufficiency	  associated	  with	  maternal	  conditions	  such	  as	  chronic	  hypertension,	  
diabetes	   mellitus,	   preeclampsia	   and	   infections,	   as	   well	   as	   maternal	   substance	  
abuse	   (Bernstein	  and	  Divon,	  1997).	   Furthermore,	   several	   studies	  have	   shown	  a	  
correlation	   between	   IGR	   and	   mild	   neurological	   deficits	   associated	   with	   poor	  
school	  performance	  (Harvey	  et	  al.,	  1982;	  Ley	  et	  al.,	  1996).	  
	  
Infection/Inflammation	  
Feto-­‐placental	   infections	   are	   highly	   associated	   with	   prematurity	   in	   birth,	   as	  
studies	  have	   shown	  genital	   tract	   infections	   such	  as	  bacterial	   vaginosis,	   syphilis,	  
and	   gonorrhea	   as	   increasing	   the	   risk	   of	   preterm	   birth	   (Mc	  Gregor	   and	   French,	  
1997).	   Another	   infection-­‐associated	   cause	   of	   prematurity	   is	   the	   intrauterine	  
infection	  chorioamnionitis	  (Gomez	  et	  al.,	  1997).	  TORCH	  –	  toxoplasmosis,	  rubella,	  
cytomegalovirus	  (CMV)	  or	  herpes	  simplex	  virus	  are	  also	  associated	  with	  4-­‐10000	  
cases	  of	  children	  suffering	  neurological	  brain	  damage	  (Rudd	  and	  Peckam,	  1988).	  
Additionally,	  maternal	  pyrexia	  has	  been	  known	  to	  also	  cause	  cerebral	  palsy.	  As	  
infectious	   agents	   have	   become	   increasingly	   associated	   with	   perinatal	   brain	  
damage	  and	  subsequent	  cerebral	  palsy,	  it	  is	  believed	  that	  these	  infectious	  agents	  
act	  through	  up-­‐regulation	  in	  the	  production	  of	  pro-­‐inflammatory	  cytokines,	  such	  
as	  IL-­‐1,	  IL-­‐6	  and	  TNFα,	  which	  can	  be	  detected	  both	  in	  the	  blood	  and	  brain	  of	  the	  
fetus,	   thus	   leading	   to	   inflammation-­‐mediated	  brain	  damage	   (Yoon	  et	   al.,	   1997;	  
Hagberg	  and	  Mallard,	  2000).	  
	  
Maternal	  conditions	  
Mothers	   with	   hypothyroidism	   during	   pregnancy	   (Klein	   and	   Mitchell,	   2002),	  
intellectual	   disability,	   or	   seizures	   have	   been	   linked	   to	   a	   slightly	   higher	   risk	   of	  
having	   a	   child	   with	   cerebral	   palsy	   and/or	   mental	   retardation.	   Maternal	   poor	  
lifestyle,	   including	   smoking	   and	   alcohol	   intake	   has	   also	   demonstrated	   a	  
correlation	  with	   fetal	  growth	  restriction,	  perinatal	  brain	  damage,	  cerebral	  palsy	  




Prematurity	  and	  perinatal	  brain	  damage	  
There	  is	  an	  increasing	  body	  of	  evidence	  suggesting	  that	  preterm	  labor	  may	  be	  a	  
sign	   of	   antenatal	   insults	   such	   as	   malformation,	   intrauterine	   growth	   restriction	  
and	   intrauterine	   infection.	   The	   latter	   has	   gained	   recent	   wide	   acceptance	   as	  
genital	  tract	  infections	  such	  as	  bacterial	  vaginosis	  and	  gonorrhea	  have	  shown	  to	  
increase	  the	  risk	  of	  preterm	  birth	  (McGregor	  and	  French,	  1997).	  The	  presence	  of	  
chorioamnionitis	  has	  also	  demonstrated	  a	  strong	  correlation	  with	  preterm	  birth	  
(Gomez	  et	  al.,	  1997).	  Premature	  infants	  are	  prone	  to	  white	  matter	  injury	  (WMI)	  
with	  devastating	  consequences	  to	  their	  neurobiological	  development,	  leading	  to	  
subsequent	   chronic	   neurological	   disorders	   such	   as	   cerebral	   palsy,	   cognitive	  
impairment,	  epilepsy	  and	  neurosensory	   impairments.	  Studies	  characterizing	  the	  
vulnerability	  of	  oligodendrocyte	  precursor	  cells	  to	  hypoxic-­‐ischaemic	  insult	  have	  
shown	  that	  injury	  to	  these	  cells,	  with	  subsequent	  hypomyelination	  form	  the	  basis	  
of	  white	  matter	  injury	  (Levine	  et	  al.,	  2001;	  Volpe,	  2009).	  	  
	  
Patterns	  of	  preterm	  brain	  injury	  
Clinical	  studies,	  together	  with	  several	  experimental	  animal	  research	  models	  into	  
the	   pathophysiology	   of	   perinatal	   brain	   injury	   have	   concluded	   that	   neurologic	  
dysfunction	  resultant	  from	  perinatal	  injury	  depends	  on	  the	  developmental	  stage.	  
The	  varying	  pattern	  of	  injury	  in	  neonatal	  encephalopathy	  is	  related	  to	  maturation	  
dependent	   susceptibility	   to	   adverse	   stimuli	   (Cowan	   et	   al.,	   2003;	   Thibeault-­‐
Eybalin	   et	   al.,	   2009).	   The	   type,	   severity,	   and	   duration	   of	   insult	   also	   play	   an	  
important	   role	   in	   disease	   outcome.	   Therefore,	   basic	   mechanisms	   of	   normal	  
cerebral	   development	   and	   homeostasis	   form	   the	   background	   for	   the	  
interpretation	   of	   subsequent	   injury	   (Ferriero,	   2004).	   Advances	   in	   magnetic	  
resonance	  imaging	  (MRI)	  have	  revealed	  two	  main	  patterns	  of	  brain	  injury,	  one	  of	  





Premature	   infants	   are	   at	   a	   high	   risk	   of	   developing	   brain	   injury	   most	  
predominantly	  associated	  with	  watershed	  (WS)	  damage	  and	  white	  matter	  injury	  
(WMI)	   (Vope,	   2001;	   Rezaie	   and	   Dean,	   2002).	   	  White	  matter	   injury	   is	   a	   known	  
contributing	   factor	   to	   spastic	   cerebral	   palsy	   and	   reduction	   in	   cognitive	   and	  
learning	   capacities	   (Volpe,	   2009).	   This	   pattern	   of	   injury	   was	   first	   described	   in	  
1867	   by	   Rudolph	   Virchow	   as	   congenital	   encephalomyelitis.	   Virchow’s	   post-­‐
mortem	  examination	   of	   the	   neonatal	   brain	   revealed	  macroscopic	   areas	   of	   soft	  
and	   pale	   degenerated	   tissue	   in	   the	   periventricular	   brain	   region.	   Post-­‐mortem	  
microscopic	  examinations	  by	  Banker	  and	  Larroche	  (1962),	   revealed	  microscopic	  
lesions	   of	   coagulative	   necrosis	   within	   areas	   of	   liquefaction	   and	   surrounded	   by	  
highly	   vascularized	   periphery	   which	   were	   then	   termed	   periventricular	  
leukomalacia	   (PVL).	   These	   lesions	   were	   particularly	   present	   in	   the	   subcallosal	  
white	  matter	  superior	  fronto-­‐occipital	  and	  longitudinal	  fascicule	  and	  the	  external	  
and	  internal	  sagittal	  strata	  of	  the	  lateral	  ventricles’	  temporal	  and	  occipital	  horns.	  
To	   a	   lesser	   extent,	   the	   corona	   radiate	   also	   appeared	   affected.	   The	   particular	  
localization	   of	   these	   focal	   necrotic	   lesions	   at	   the	   end	   zones	   of	   the	   anterior,	  
middle	   and	   posterior	   cerebral	   arteries	   provide	   strong	   evidence	   of	   hypoxia-­‐
ischaemia	   being	   causal	   to	   white	   matter	   injury	   (Banker	   and	   Larroche,	   1962;	  
Reuck,	  1971;	  Takashima,	  1982).	  	  
	  
Ultrasound,	  and	  more	  recently,	  MRI	  scans	  of	  the	  brains	  of	  preterm	  infants	  have	  
markedly	   improved	   understanding	   and	   visualization	   of	   periventricular	  
leukomalacia,	  what	  has	  now	  become	  known	  as	   the	  predominant	   form	  of	  white	  
matter	   injury	  of	  these	  patterns	  of	  brain	   injury.	  These	  advances	   in	   imaging	  have	  
demonstrated	  not	  only	  microscopic	  lesions	  consisting	  of	  focal	  (Volpe,	  2001),	  but	  
also	   diffuse	   areas	   of	   coagulated	   necrotic	   tissue	   containing	   axons,	  
oligodendrocytes	   and	   astrocytes,	   within	   the	   areas	   of	   liquefaction	   and	   highly	  
vascularized	  periphery.	  Thinning	  of	  the	  corpus	  callosum	  is	  also	  a	  characteristic	  of	  
white	  matter	  brain	  injury	  (Leviton	  and	  Gilles,	  1996;	  Volpe,	  2001;	  Hagberg	  et	  al.,	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2002;	   Volpe,	   2012).	   Furthermore,	  magnetic	   resonance	   techniques	   have	   shown	  
that	  diffuse	  white	  matter	  injury	  are	  in	  fact	  more	  predominant	  in	  preterm	  infants.	  
Another	  study	  following	  119	  infants	  born	  between	  22	  and	  30	  weeks,	  revealed	  an	  
even	  greater	  presence	  of	  diffuse	  white	  matter	  injury,	  where	  80%	  of	  these	  infants	  
were	  affected	  (Dyet	  et	  al,	  2006).	  From	  a	  clinical	  perspective,	  diffuse	  white	  matter	  
injury	  is	  thought	  to	  be	  causal	  to	  cognitive	  and	  behavioral	  impairments	  commonly	  
seen	  in	  premature	  birth,	  whereas	  focal,	  or	  cystic	  periventricular	   leukomalacia	  is	  
highly	   associated	   with	   spastic	   diplegia,	   as	   a	   result	   of	   disruption	   to	   the	  
corticospinal	  tracts	  within	  the	  posterior	  limb	  if	  the	  external	  capsule	  (Volpe,	  2001;	  
Marlow	  et	   al.,	   2005).	   Similarly,	   another	   review	  comprising	  12	   studies	   assessing	  
272	  infants	  with	  periventricular	   leukomalacia	  demonstrated	  through	  ultrasound	  
scan	   showed	   that	   58%	   of	   these	   infants	   developed	   severe	  motor	   and	   cognitive	  
impairments.	   In	   contrast,	   only	   2.6%	   of	   the	   655	   infants	   with	   normal	   head	  
ultrasound	  scan	  developed	  cerebral	  palsy	  (Holling	  and	  Leviton,	  1999).	  	  
	  
Periventricular	   leukomalacia	   has	   two	   main	   pathological	   features;	   focal	  
periventricular	   necrosis	   and	   diffuse	   cerebral	   white	   matter	   injury.	   Focal	  
periventricular	  necrosis	  is	  the	  result	  of	  focal	  necrotic	  lesions	  occurring	  mainly	  in	  
the	   areas	   supplied	   by	   deep	   penetration	   arteries.	   These	   sites	   of	   coagulative	  
necrosis,	   as	  well	   as	   loss	   of	   cellular	   elements,	   are	   visible	   in	   the	   first	   6-­‐12	  hours	  
following	   hypoxia-­‐ischaemia.	   Cranial	   ultrasonography	   1-­‐3	   weeks	   post-­‐insult	  
reveals	   tissue	   dissolution	   and	   cavity	   formations	   (≥2-­‐3	   mm).	   Studies	   involving	  
larger	   number	   of	   infants	   surviving	   the	   postnatal	   period	   have	   shown	   a	   more	  
diffuse	  cerebral	  white	  matter	  injury	  pattern.	  These	  lesion	  patterns	  are	  harder	  to	  
be	  identified	  through	  ultrasonography	  as	  they	  rarely	  undergo	  cystic	  changes,	  and	  
consist	   instead	  of	   acute	   glia	   damage	   (Hope	  et	   al.,	   1988;	  Dambska	   et	   al.,	   1989;	  
Paneth	  et	  al.,	  1990).	  
	  
Epidemiological	  studies	  have	  identified	  risk	  factors	  other	  than	  cerebral	  hypoxia-­‐
ischaemia,	   which	   also	   contribute	   to	   the	   development	   of	   periventricular	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leukomalacia.	   Hypocarbia,	   a	   decrease	   of	   CO2	   in	   blood,	   caused	   by	   mechanical	  
ventilation	   management,	   has	   shown	   a	   strong	   association	   with	   periventricular	  
leukomalacia,	  possibly	  due	  to	  hypocarbia	  mediated	  vasoconstriction,	  resulting	  in	  
reduced	  cerebral	  blood	  flow	  (Saliba	  and	  Marret,	  2001).	  Intrauterine	  infection	  has	  
a	  strong	  correlation	  with	  white	  matter	  injury,	  and	  its	  dual	  role	  as	  both	  inducer	  of	  
preterm	  labor	  and	  perinatal	  brain	  injury	  has	  been	  increasingly	  studied	  in	  recent	  
years	   (Yoon	   at	   al.,	   1996;	   Damman	   and	   Leviton,	   1997;	   Rezaie	   and	   Dean,	   2002;	  
Kendall	  and	  Peebles,	  2005).	  
	  
Other	   hallmarks	   of	   periventricular	   leukomalacia	   include	   maternal	   intrauterine	  
infection	   resulting	   in	   inflammation,	   cytokine	   release	   and	   excitotoxicity.	  
Neuropathological,	   epidemiological	   and	   experimental	   studies	   by	   Gilles	   and	   co-­‐
workers	   were	   the	   first	   to	   establish	   the	   connection	   between	   maternal/fetal	  
infection	  and	  periventricular	  leukomalacia	  (Gilles	  et	  al.,	  1976;	  Gilles	  et	  al.,	  1977;	  
Leviton	   and	  Gilles,	   1984).	   Further	   studies	   have	   shown	   increase	   in	   incidence	   of	  
periventricular	   leukomalacia	   and/or	   development	   of	   cerebral	   palsy	   in	   the	  
presence	  of	  maternal/placental/fetal	  infection	  (Zupan	  et	  al.,	  1996;	  O’Shea	  et	  al.,	  
1998),	   rise	   in	   levels	   of	   pro-­‐inflammatory	   cytokine	   interleukin-­‐6	   (IL-­‐6)	   in	   cord	  
blood	  (Yeon	  et	  al.,	  1990),	  and	  increase	  in	  levels	  of	  interleukin-­‐1	  (IL-­‐1)	  and	  IL-­‐6	  in	  
amniotic	   fluid	   (Yoo	   et	   al.,	   1997a).	   Furthermore,	   both	   IL-­‐6	   and	   tumor	   necrosis	  
factor-­‐alpha	   (TNFα)	   have	   been	   shown	   within	   areas	   of	   periventricular	  
leukomalacia	   damage	   (Deguchi	   et	   al.,	   1996;	   Deguchi	   et	   al.,	   1997;	   Yoon	   et	   al.,	  
1997b).	  
	  
Animal	   studies	  using	  hypoxia-­‐ischaemia,	   infection	  and	  excitotoxic	   insults	   alone,	  
or	  in	  combination,	  have	  been	  able	  to	  successfully	  reproduce	  white	  matter	  injury,	  
thus	  allowing	   further	  understanding	   the	  neuropathology	  of	   this	  disease	   (Volpe,	  
2009).	   During	   this	   developmental	   stage	   (≤32	   weeks),	   the	   subcortical	   white	  
matter	  of	  the	  immature	  brain	  is	  still	  unmyelinated	  and	  predominantly	  populated	  
by	   oligodendrocyte	   precursor	   cells.	   These	   are	   highly	   susceptible	   to	   exogenous	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free	  radicals	  due	  to	  a	  lack	  of	  antioxidants	  such	  as	  superoxide	  dismutase	  (Volpe,	  
2001;	   Deng,	   2010;	   Hristova	   et	   al.,	   2010;	   Kinney	   and	   Volpe,	   2012).	   Subplate	  
neurons	  are	  also	  affected	   in	  the	  presence	  of	  hypoxia-­‐ischaemia.	  These	  neurons	  
appear	  only	  transiently	  during	  development	  of	  the	  brain	  cerebral	  cortex	  and	  are	  
vital	  in	  the	  formation	  of	  connections	  between	  the	  visual	  cortex	  and	  the	  thalamus	  
(Kanold	   et	   al.,	   2003).	   Despite	   the	   immature	   cerebral	   cortex	   being	   highly	  
vascularized,	  and	  thus	  more	  resistant	  to	  hypoxia-­‐ischaemia	  (Ferriero,	  2004),	  grey	  
matter	   regions	   like	   basal	   ganglia,	   cerebral	   cortex	   and	   thalamus	   may	   also	  
occasionally	  be	  directly	  affected	  by	   the	  hypoxic-­‐ischaemic	   insult,	  or	   secondarily	  
affected	   due	   to	   the	   presence	   of	   white	   matter	   lesion,	   as	   cystic	   periventricular	  
leukomalacia	  can	  lead	  to	  subsequent	  significant	  reduction	  in	  cortical	  grey	  matter	  
volume	  at	  term	  (Inder	  et	  al.,	  1999).	  
	  
Neonatal	  encephalopathy	  
Hypoxia-­‐ischaemia-­‐induced	   severe	   brain	   damage	   in	   term	   infants	   can	   lead	   to	  
neonatal	  encephalopathy	  within	  12-­‐36	  hours,	  this	  is	  known	  as	  hypoxia-­‐ischaemia	  
encephalopathy	  (HIE).	  Neonatal	  encephalopathy	  occurs	  in	  1-­‐6	  per	  1000	  live	  term	  
births,	  with	  20%	  of	  mortality.	  Of	   the	   survivors,	  25%	  will	   develop	   some	   form	  of	  
permanent	   neurological	   disorder,	   and	   is	   therefore	   a	   major	   predictor	   of	  
neurodevelopmental	   impairment	   (Volpe	   2001).	   Hypoxia-­‐ischaemia	  
encephalopathy	   and	   term	   asphyxia	   were	   thought	   to	   be	   the	   only	   causes	   of	  
neonatal	   encephalopathy;	   however,	   some	   cases	   of	   neonatal	   encephalopathy	  
have	  no	  demonstrable	  hypoxia-­‐ischaemia	  or	   asphyxia	   in	   their	   aetiology	   (Wu	  et	  
al.,	  2004).	  Studies	  into	  the	  risk	  factors	  of	  neonatal	  encephalopathy	  have	  revealed	  
that	   other	   cases	   associated	   with	   antepartum	   events	   include	   maternal	  
hypotension,	   assisted	   reproductive	   treatments	   or	   thyroid	   disease.	   Intrapartum	  
risks	   such	   as	  maternal	   fever,	   abruption	  of	   the	  placenta,	   prolapsed	  of	   the	   cord,	  
forceps	   delivery	   and	   breech	   extraction	   are	   also	   present	   (Badawi	   et	   al.,	   1998).	  
Combined	   antepartum/intrapartum	   risks	   are	   also	   known	   causes	   of	   neonatal	  
encephalopathy,	  and	   finally,	  postnatal	   complications	   such	  as	   sepsis,	   respiratory	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failure	   and	   shock	   occur	   in	   less	   than	   10%	   of	   neonatal	   encephalopathy	   cases	  
(Cowan	  et	  al.,	  2003).	  
	  
Development	  and	  manifestation	  
Infants	  with	  neonatal	  encephalopathy	  exhibit	  in	  the	  first	  hours	  of	  life	  a	  reduced	  
level	  of	  consciousness.	  This	  is	  generally	  accompanied	  by	  periodic	  breathing	  with	  
apnea	  or	  bradycardia.	  Nonetheless,	   in	   cases	  where	   injury	   is	  not	   severe,	   cranial	  
nerve	  response	  may	  be	  spared,	  with	  intact	  papillary	  responses	  and	  spontaneous	  
eye	  movement.	  It	  is	  not	  uncommon	  for	  a	  transient	  recovery	  in	  levels	  of	  alertness	  
within	   the	   first	   week	   of	   life	   (Shah	   and	   Perlman,	   2009);	   however,	   this	   is	   not	  
associated	   with	   signs	   of	   neurological	   function	   improvement.	   Furthermore,	  
jitteriness,	   episodes	   of	   refractory	   seizures	   alongside	   with	   apnea	   and	   shrill	   cry	  
may	  be	  seen	  during	  this	  period.	  Symptoms	  persisting	  for	  the	  first	  months	  include	  
hypotonia	  and	  weakness	  in	  the	  face	  and	  proximal	  limbs,	  as	  well	  as	  exaggeration	  
of	   Moro’s	   and	   muscle-­‐stretch	   reflexes.	   These	   symptoms	   are	   more	   easily	  
identifiable	   as	   associated	   with	   neonatal	   encephalopathy,	   as	   term	   infants	   have	  
higher	   muscle	   tone	   than	   preterm	   babies,	   thus	   making	   a	   proper	   assessment	  
difficult	  (Miller	  et	  al.,	  2004).	  In	  cases	  of	  severe	  injury,	  respiratory	  arrest	  and	  other	  
signs	   of	   brain	   dysfunction	   may	   precede	   the	   initial	   depression	   in	   the	   level	   of	  
consciousness.	  
	  
Seizures	   occurring	   due	   to	   neonatal	   encephalopathy	   represent	   a	   sign	   of	  
malformation,	   reversible	   metabolic	   disorders	   and	   structural	   injury.	   Neonatal	  
seizure	  may	  be	  subtle	  in	  nature	  with	  only	  horizontal	  tonic	  deviation	  of	  the	  eye,	  or	  
sustained	   blinking	   or	   eye	   opening.	   Stronger	   manifestations	   include	   oro-­‐lingual	  
movements	   such	   as	   tongue	   or	   lip	   smacking	   and	   sucking,	   rowing	   or	   bicycling	  
movements	   of	   the	   extremities,	   or	   recurrent	   apnea.	   Neurological	   examinations	  
permitting	   recognition	   of	   seizures	   include	   the	   use	   of	   amplitude-­‐integrated	  
electroencephalography	  to	  assess	  brain-­‐wave	  activity	   (Rennie	  et	  al.,	  2004).	  MRI	  
allows	  distinction	  between	  neonatal	  seizures	  resulting	  from	  metabolic	  disorders	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such	   as	   congenital	   deficiency	   of	   sulphite	   oxidase	   and	   from	   that	   resultant	   from	  
hypoxia-­‐ischaemia	   (Barkovich,	   1997).	   MRI	   can	   also	   be	   used	   in	   conjunction	   to	  
regular	   laboratory	   test	   to	   identify	   other	   risk	   factors	   such	   as	   infection,	   physical	  
traumas	   (skull	   fracture),	   hypoglycaemia,	   hypocalcemia,	   hyponatreima,	  
hypoxemia	  and	  acidosis	  (Ferriero,	  2004).	  Another	  method	  of	  diagnosing	  genetic	  
disorders	   is	   lumbar	   puncture,	   which	   can	   detect	   pediatric	   neurotransmitter	  
diseases	   and	   glucose-­‐transport	   defects	   (Hyland	   K,	   2003).	   Although	   difficult	   to	  
treat,	   neonatal	   seizures	   do	   not	   always	   result	   in	   reduced	   neurodevelopmental	  
disability	  (Painter	  et	  al.,	  1999).	  
	  
	  
Neonatal	  encephalopathy	  score	  
Variable	   Score=0	   Score=1	  
Feeding	   Normal	   Gavage,	   gastronomy	   or	   intolerance	  
of	  oral	  feeding	  
Alertness	   Alert	   Irritable,	  poor	  response	  or	  comatose	  
Muscle	  tone	   Normal	   Hypotonia	  or	  hypertonia	  
Respiratory	  status	   Normal	   Respiratory	  distress	  
Reflexes	  	   Normal	   Absent,	   hyporreflexia	   or	  
hyperreflexia	  
Seizures	   None	   Suspected	   to	   confirmed	   clinical	  
seizure	  
Table	  1.3:	  Assessment	  of	  neonatal	  encephalopathy	  (adapted	  from	  Miller	  et	  al.,	  2004).	  
	  
Patterns	  of	  neonatal	  encephalopathy	  brain	  injury	  
	  
Basal	  Ganglia	  Thalamus	  (BGT)	  
Despite	   hypoxic-­‐ischaemic	   encephalopathy	   not	   being	   the	   main	   cause	   of	   term	  
perinatal	   brain	   damage,	   it	   is	   still	   the	  major	   cause	   of	  morbidity	   in	   infants	   born	  
after	   37	   weeks	   of	   gestation.	   Pathological	   assessment	   of	   term	   babies	   suffering	  
from	   hypoxic-­‐ischaemic	   insult	   as	   well	   as	   MRI	   scans	   have	   revealed	   deep	   gray	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matter	   injury,	   with	   the	   hippocampal,	   lateral	   geniculate	   nuclei,	   putamen,	  
ventrolateral	   thalami	   and	   dorsal	   mesencephalon	   and	   peri-­‐rolandic	   cerebral	  
cortex	  areas	  particularly	  affected	  (Barkovich	  et	  al.,	  1995;	  Folkerth,	  2005).	  
	  
Hypoxia	   results	  most	   commonly	   in	   selective	   neuronal	   necrosis,	   as	   neurons	   are	  
more	   sensitive	   to	   hypoxia-­‐ischaemia	   insult	   at	   term	   in	   comparison	   to	   preterm	  
(Terrie	  and	  Volpe,	  2002).	  Also,	  white	  matter	  susceptibility	  is	  greatly	  decreased	  in	  
term	   infants,	   as	   mature	   myelin	   basic	   protein-­‐expressing	   oligodendrocytes	   are	  
more	   resistant,	   due	   partially	   to	   the	   now	  presence	   of	   antioxidant	   enzymes	   and	  
proteins	  (Deng,	  2010).	  As	  a	  result,	  basal	  ganglia	  thalamus	  (BGT)	  most	  commonly	  
shows	  damage	  in	  affected	  term	  babies.	  Population	  specific	  neurons	  in	  the	  deep	  
grey	   nuclei	   and	   periolandic	   cortex	   are	   more	   likely	   injured	   via	   a	   failure	   of	  
mitochondrial	  oxidative	  phosphorylation.	  The	  BGT	  pattern	  of	  injury	  involves	  the	  
central	   grey	   nuclei,	   the	   cortex	   around	   the	   grey	   sulcus	   and	   the	   hippocampal	  
pyramidal	   cell	   layers,	   particularly	   the	  CA1-­‐3	  hippocampal	   regions	   (Berger	   et	   a.,	  
1992;	  Johnston	  et	  al.,	  2001;	  Volpe,	  2012).	  
	  
Mitochondrial	  swelling	  leads	  to	  cytoplasmic	  vacuolation	  in	  the	  neurons	  within	  5-­‐
30	   minutes	   after	   the	   onset	   of	   hypoxic-­‐ischaemic	   insult	   (Brown	   and	   Brierley,	  
1973;	   Kim,	   1975).	   Neurons	   most	   frequently	   affected	   by	   hypoxia-­‐ischaemia	  
encephalopathy	  include	  neurons	  present	  in	  the	  CA1	  region	  of	  the	  hippocampus,	  
deeper	   layer	  of	  the	  cerebral	  cortex,	  putamen,	  thalamus	  and	  cerebellar	  Purkinje	  
cells	  (Rivkin,	  1997).	  Neuronal	  cell	  death	  is	  most	  prominent	  in	  the	  cerebral	  cortex	  
and	  in	  the	  depths	  of	  the	  sulci	  watershed	  brain	  regions.	  The	  cerebral	  cortex	  and	  
subcortical	  white	  matter	  of	  the	  parasagittal	  and	  superomedial	  are	  also	  frequently	  
affected.	   When	   BGT	   is	   injured	   there	   is	   initial	   neuronal	   loss,	   gliosis	   and	  
hypermyelination.	   This	   is	   apparent	   from	   8	   months	   after	   term	   birth	   and	   is	  
categorized	  by	  marbled	  appearance	  of	  the	  basal	  ganglia	  (Inder	  and	  Volpe,	  2000).	  
Focal	   and	   multifocal	   necrosis	   is	   also	   present	   in	   neonatal	   encephalopathyas	   a	  




Fetal	  sheep	  studies	  where	  only	  hypoxia	  insult	  alone	  was	  investigated	  have	  shown	  
different	   selective	   patterns	   of	   injury	   depending	   on	   type	   and	   severity	   of	   insult.	  
Fetal	   sheep	   exposed	   to	   a	   single	   30	   minutes	   exposure	   to	   ischaemic	   insult	   had	  
strong	   neuronal	   cell	   loss	   in	   both	   parasagittal	   cortex	   and	   hippocampal	   brain	  
regions	   (Williams	   et	   al.,	   1992).	   Another	   study	   revealed	   severe	   neuronal	   loss	   in	  
the	  striatum	  with	  only	  a	   reduced	   loss	  of	  neurons	  within	   the	  cortex,	  when	   fetal	  
sheep	  were	  exposed	  to	  3	  repeated	  events	  of	  10	  minutes	  ischaemia	  at	  1	  hour	  and	  
5	  hours	  intervals	  (Mallard	  et	  al.,	  1993).	  Repeated	  occlusion	  of	  the	  umbilical	  cord	  
also	  resulted	  in	  predominant	  striatum	  damage	  (Mallard	  et	  al.,	  1995a).	  However,	  
single	  10	  minutes	  occlusion	  resulted	  in	  hippocampal	  rather	  than	  striatal	  neuronal	  
damage	  (Mallard	  et	  al.,	  1992).	  
	  
More	   recently,	   a	   large	   number	   of	   studies	   using	   different	   animal	   models	   of	  
hypoxia-­‐ischaemia	   have	   been	   able	   to	   reproduce	   a	   predominant	   gray	   matter	  
infarction	  with	  substantial	  neuronal	   loss	  seen	  in	  human	  infants	  (Johnston	  et	  al.,	  
2005).	   Neonatal	   models	   of	   rat	   hypoxia-­‐ischaemia	   have	   demonstrated	   similar	  
injury	  to	  what	  is	  seen	  in	  MRI	  of	  infants	  in	  the	  basal	  ganglia	  and	  cerebral	  cortex,	  
where	   unilateral	   carotid	   occlusion	   followed	   by	   transient	   hypoxia	   results	   in	  
predominant	  injury	  to	  the	  ipsilateral	  brain	  hemisphere	  and	  reduced	  injury	  to	  the	  
contralateral	  side	  (Rice	  et	  al.,	  1981;	  Nakajima	  et	  al.,	  2000;	  Kendall	  et	  al.,	  2011a).	  
In	  the	  mouse	  model	  of	  hypoxia-­‐ischaemia,	  P7	  mice	  had	  visible	   ipsilateral	  dorsal	  
cortex,	   hippocampus,	   striatum	   and	   thalamus	   brain	   regions	   severely	   affected	  
(Kendall	  et	  al.,	  2011a).	  	  
	  
Hypoxic-­‐ischaemic	  insult	  
Despite	  universal	  acknowledgement	  that	  hypoxia-­‐ischaemia	  (HI)	  insult	  during	  the	  
neonatal	   period	   is	   not	   the	   only	   cause	   of	   cerebral	   palsy	   and	   other	   neurological	  
debilities;	  it	  still	  remains	  a	  major	  cause	  of	  perinatal	  brain	  damage,	  and	  the	  main	  
precursor	  to	  these	  neurological	  impairments,	  with	  an	  incidence	  of	  2	  per	  1000	  live	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births	  as	  well	  as	  a	  mortality	  rate	  of	  30%	  (Nelson,	  1988;	  Vannucci,	  1990;	  Vannucci	  
and	  Vannucci,	  1997;	  Vannucci	  and	  Hagberb,	  2004).	  	  
	  
The	  neuropathological	   characteristics	  of	  hypoxia-­‐ischaemia	  encephalopathy	  are	  
determined	   by	   type,	   duration	   and	   severity	   of	   insult,	   as	  well	   as	   gestational	   age	  
and	  metabolic	  status	  of	  the	  infant	  (Terrie	  and	  Volpe,	  2000).	  There	  are	  three	  main	  
different	   onsets	   of	   hypoxia-­‐ischaemia.	   Maternal	   origin	   is	   associated	   with	  
impaired	   or	   inadequate	   perfusion	   of	   maternal	   placenta.	   Placental	   abruption,	  
cord	   prolapse	   and	   uterine	   rupture	   are	   also	   associated	   with	   hypoxia-­‐ischaemia	  
(Peebles	   and	  Wyatt,	   2002).	  Additionally,	   ischaemic	   insults	  may	  originate	   in	   the	  
fetus	   itself	   through	   impaired	   fetal	   oxygenation/perfusion	   (fetomaternal	  
haemorrhage,	   fetal	   thrombosis)	   (Higgins	   and	   Shankaran,	   2009;	   Vincer	   et	   al.,	  
2006).	   Intrauterine	   asphyxia	   is	   the	   most	   common	   antecedent	   to	   neonatal	  
hypoxia	  ischaemia	  encephalopathy	  (Hill	  and	  Volpe,	  1981).	  Furthermore,	  neonatal	  
patterns	   of	   injury	   also	   differ	   depending	   on	   maturation,	   as	   the	   developmental	  
stage	  of	  preterm	  children	  differs	   from	   that	  of	   term	  babies,	  which	   in	   turn	  gives	  
rise	  to	  different	  selective	  vulnerability	  of	  the	  different	  cell	  populations	  (Cowan	  et	  
al.,	   2003).	   It	   is	   important	   to	   note	   that	   prognosis	   for	   both	   infants	   and	   children	  
suffering	   from	   movement	   debilities	   after	   hypoxic-­‐ischaemic	   insult	   is	   not	   only	  
different	  between	  preterm	  and	   term	  birth,	   but	   it	   is	   also	  different	   from	   that	   of	  
adults	  (Jiménez	  et	  al.,	  1997).	  In	  the	  case	  of	  neonatal	  hypoxia-­‐ischaemia,	  there	  is	  
generally	   a	   longer	  delay	  before	   the	  development	  of	   the	  disorder	  with	  a	  higher	  
possibility	  of	  generalization	  (Vannucci,	  1993),	  whereas	  in	  the	  adult	  the	  reduction	  
in	  mobility	   will	   appear	   from	   the	   onset	   of	   injury	   and	   as	   strength	   improves	   the	  
disorder	   has	   a	   tendency	   to	   stay	   localized.	   This	   difference	   in	   response	  
demonstrates	  again	  a	  relation	  between	  age-­‐related	  changes	  in	  neuroplasticity	  or	  





Oxygen	   is	   a	   fundamental	   requirement	   for	   human	   survival	   as	   it	   is	   essential	   to	  
maintain	   respiration,	   and	   allows	   regulation	   of	   cellular	   energetic,	   growth	   and	  
differentiation	  processes.	  The	  human	  central	  nervous	  system	  (CNS)	  is	  a	  complex	  
structure,	   which	   requires	   a	   constant	   supply	   of	   blood	   and	   oxygen	   in	   order	   to	  
function.	   This	   high	   oxygen	   demand	   allows	   the	   brain	   to	   maintain	   homeostasis	  
(King	  and	  Parer,	  2000)	  with	  only	  a	  minimal	  capability	  for	  anaerobic	  metabolism	  
(Hossman,	   1994).	   In	   the	   event	   of	   absence	   or	   reduced	   oxygen	   availability	   the	  
fetus	   is	   able	   to	   maintain	   a	   temporary	   degree	   of	   homeostasis	   through	   either	  
reduction	   of	   non-­‐obligatory	   energy	   consumption,	   including	   in	   cases	   of	   severe	  
insult,	   suppression	   of	   neuronal	   activity	   (avoiding	   neuronal	   depolarisation)	  
through	  mediation	  of	  inhibitory	  neuromodulators,	  such	  as	  adenosine	  (Hunter	  et	  
al.,	  2003;	  Hossmann,	  2006).	  Secondly,	  cells	  can	  maintain	  anaerobic	  metabolism	  
in	  order	  to	  maintain	  high-­‐end	  production	  of	  metabolites,	  albeit	  only	  for	  a	  short	  
time,	  as	  theoretically,	  anaerobic	  glycolysis	  produces	  lactate	  and	  only	  2	  molecules	  
of	  ATP,	  whereas	  aerobic	  glycolysis	  produces	  38	  ATP	  molecules.	  This	  reduced	  ATP	  
production	  eventually	   leads	  to	  rapid	  consumption	  of	  glucose	  reserves,	  followed	  
by	  severe	  metabolic	  acidosis	  caused	  by	  lactic	  acid	  accumulation	  (Locatelli	  et	  al.,	  
2008),	   leading	   vascular	   tone	   and	   cardiac	   contractility,	   in	   an	   attempt	   to	   reduce	  
blood	   acidity.	   In	   fact,	   a	   study	   by	   Graham	   et	   al.,	   showed	   that	   neurological	  
mortality	  and	  morbidity	  of	   term	   infants	  with	  cord	  pH<7.0	  was	  25%	  (Graham	  et	  
al.,	   2008).	   Under	   conditions	   where	   both	   oxygen	   and	   tissue	   blood	   flow	   are	  
reduced,	   depletion	   of	   high	   energy	  metabolites	   occurs	   rapidly	   and	  with	   greater	  
consequences.	  However,	  due	   to	   the	   speed	  with	  which	   the	   insult	   is	  developing,	  
this	  may	   actually	   represent	   less	  metabolic	   acidosis	   as	   there	   is	   reduced	   glucose	  
availability	  for	  metabolism	  to	  lactate	  (Gunn	  and	  Bennet,	  2009).	  
	  
If	   this	   period	   of	   reduced	   oxygen	   and	   glucose	   availability	   is	   sustained	   for	   a	  
prolonged	  period	  of	  time,	  then	  injury	  to	  the	  cells	  of	  the	  developing	  brain	  starts	  
occurring.	  Both	  clinical	  and	  experimental	  studies	  of	  cell	  death	  following	  hypoxia-­‐
ischaemia	   have	   originated	   the	   seminal	   concept	   that	   brain	   cell	   death	   does	   not	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necessarily	   occur	   during	   the	   hypoxic-­‐ischaemic	   insult	   but	   rather,	   as	   an	  
evolutionary	  event	  that	  precipitates	  a	  cascade	  of	  biochemical	  processes,	  which	  in	  
turn	   lead	  to	  delayed	  neuronal	  cell	  death	  days	  to	  weeks	  after	  hypoxic-­‐ischaemic	  
event.	  Experimental	  studies	  using	  animal	  models	  such	  as	   the	   immature	  rodent,	  
piglet	  and	  fetal	  sheep	  attempting	  to	  replicate	  hypoxia-­‐ischaemia	  encephalopathy	  
have	  shown	  the	  presence	  of	  a	  primary	  energy	  failure	  phase	  occurring	  during	  the	  
hypoxic-­‐ischaemic	  insult,	  followed	  by	  a	  recovery	  phase,	  known	  as	  “latent	  phase”,	  
followed	  by	  a	  secondary	  energy	  failure	  (Williams	  et	  al.,	  1991;	  Lorek	  et	  al.,	  1994;	  
Blumberg	  et	  al.,	  1997).	  These	  finding	  are	  similar	  to	  various	  human	  cases	  where	  a	  
secondary	  energy	  failure	  occurs	  after	  transient	  recovery	  and	  within	  6	  to	  15	  hours	  
after	  birth.	  This	  secondary	  phase	  is	  directly	  associated	  with	  neurodevelopmental	  
impairments	   seen	   during	   childhood	   (Roth	   et	   al.,	   1997;	   Azzopardi	   et	   al.,	   1989).	  
Additionally,	   experimental	   studies	   in	   the	   fetal	   sheep	   have	   shown	   that	   a	   single	  
short	   insult	   leading	   to	   reduced	   or	   no	   neural	   injury	   may	   lead	   to	   increased	  
vulnerability	   to	   later	   insults	   repeated	   in	   a	   similar	   window	   frame	   ,	   leading	   to	  
intrauterine	  death	  or	  exacerbation	  of	  striatal	  brain	  damage	  (Mallard	  et	  al.,	  1993;	  
Mallard	  et	  al.,	  1995b).	  
	  
Fetal	  models	  of	  hypoxic-­‐ischaemic	  encephalopathy	  have	  demonstrated	  the	  fetus	  
ability	   to	   survive	   without	   injury	   mild	   to	   moderate	   reductions	   in	   oxygen	  
availability,	   from	  values	  above	  20mmHg	  down	   to	  10-­‐12mmHg	   (Giusssani	  et	  al.,	  
1994;	  Jensen	  et	  al.,	  1999).	  During	  late	  gestation,	  the	  fetal	  sheep	  goes	  through	  an	  
initial	   phase	   of	   moderate	   bradycardia	   followed	   by	   tachycardia	   and	   increased	  
blood	  pressure,	  sometimes	  accompanied	  by	  increase	  in	  lactate	  circulation.	  These	  
events	  are	  followed	  by	  rapid	  vasoconstriction	  within	  the	  periphery,	  thus	  reducing	  
blood	   flow	   to	   peripheral	   organs	   in	   favor	   of	   the	   heart,	   brain	   and	   adrenal	   gland	  
(Jensen	  et	  al.,	  1999).	  This	  redirected	  increase	  in	  blood	  flow	  to	  the	  brain	  enables	  
restoration	   of	   oxygen	   delivery	   and	   extraction,	   and	   transfer	   to	   lower	   frequency	  
EEG	  states	  resulting	  in	  20%	  reduction	  in	  oxygen	  consumption	  whilst	  maintaining	  
normal	   brain	   oxygen	   consumption	   (Lee	   et	   al.,	   2009).	   In	   cases	   where	   hypoxic	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insult	   is	  maintained,	   the	  sheep	   fetus	  can	  potentially	  adapt	   indefinitely	   to	   these	  
conditions.	  Normalization	  of	  heart	  rate	  and	  blood	  pressure	  are	  achieved	  as	  well	  
as	   return	   of	   normal	   sleep	   cycle.	   However,	   this	   requires	  maintenance	   of	   blood	  
flow	  redistribution,	  which	  will	  result	  in	  reduced	  somatic	  growth	  (Richardson	  and	  
Bocking,	  1998;	  Danielson	  et	  al.,	  2005).	  	  
	  
Mechanisms	  of	  hypoxic-­‐ischaemic	  brain	  injury	  
Hypoxia-­‐ischaemia	   is	   not	   a	   single	   event	   leading	   to	   immediate	   neuronal	   cell	  
death,	   but	   rather	   an	   evolving	   process	   where	   a	   cascade	   of	   biochemical	   events	  
lead	  to	  delayed	  cell	  death	  hours	  after	  insult.	  In	  fact,	  hypoxia-­‐ischaemia-­‐mediated	  
cell	  death	  can	  evolve	  for	  days,	  possibly	  even	  weeks	  after	  resuscitation	  (McKinstry	  
et	   al.,	   2002).	   This	   continuous	   progression	   of	   hypoxia-­‐ischaemia	   injury	   is	  
described	  below:	  	  
	  
Acute	  energy	  breakdown	  and	  cell	  depolarization	  
In	   the	   presence	   of	   cerebral	   asphyxia,	   there	   is	   a	   decrease	   in	   cerebral	   oxidative	  
metabolism	  leading	  to	  diminished	  cardiac	  output.	  This	  is	  followed	  by	  reduction	  in	  
high-­‐energy	  phosphate	  metabolism,	   instigating	   various	   injury	  mechanisms	   such	  
as	   cerebral	   lactic	   acidosis	   and	   cell	   membrane	   ionic	   transport	   failure.	   As	   the	  
Na+/K+	  pumps	  stop	  functioning,	  accumulation	  of	  Na+,	  Ca2+	  and	  Cl-­‐	  within	  the	  cell	  
occurs.	   This	   calcium	   overload	   causes	   activation	   of	   lipases,	   proteases	   and	  
endonucleases	   leading	  to	  the	  destruction	  of	  the	  cellular	  skeleton	  (Jensen	  et	  al.,	  
2003).	  Rat	  models	  of	  neonatal	  hypoxia-­‐ischaemia	  have	  shown	  that	  this	  reduction	  
in	  ATP	   followed	  by	   failure	  of	  Na+/K+	  pumps	  and	  cell	  depolarization	   is	   the	   initial	  
step	  occurring	  during	  hypoxic-­‐ischaemic	  damage	  which	  will	   lead	   to	  cytoplasmic	  
accumulation	  of	  calcium	  and	  severe	  cell	  swelling,	  causing	  necrosis	  and	  eventual	  
activation	   of	  multiple	   cascading	   events	   leading	   to	   further	   cell	   death	   at	   a	   later	  





This	  change	  in	  neuronal	  membrane	  voltage	  leads	  to	  depolarization	  and	  excessive	  
pre-­‐synaptic	   release	   of	   the	   excitatory	   neurotransmitter	   glutamate.	   This	  
neurotransmitter	   is	   used	   in	  most	   synapses	  within	   the	  brain	   and	   is	   removed	  by	  
perisynaptic	   glial	   glutamate	   reuptake	   pumps.	   However,	   severe	   hypoxia-­‐
ischaemia	  models	  have	  demonstrated	  raised	  levels	  of	  glutamate,	  as	  well	  as	  other	  
neurotransmitters	   in	   the	   brain	   and	   cerebrospinal	   fluid	   (CSF)	   (Johnston	   et	   al.,	  
2002).	   Anaerobic	   metabolism	   of	   glucose	   is	   required	   to	   provide	   the	   energy	  
required	   for	   the	   perisynaptic	   glial	   uptake	   pumps	   to	   remove	   glutamate	  
(Magistretti	  et	  al.,	  1999).	  As	   ischaemia	  reduces	  glucose	  availability,	   reuptake	  of	  
glutamate	  is	  severely	  depleted	  leading	  to	  an	  overactivation	  of	  the	  receptors.	  This	  
excitotoxicity	   is	   present	   in	   multiple	   brain	   regions,	   including	   the	   periolandic	  
cerebral	   cortex,	   thalamus	  and	  putamen	   (Sie	  et	  al.,	   2000;	   Johnston	  et	  al.,	   2001.	  
Neurons	  and	  oligodendrocyte	  progenitor	  cells	  are	  among	   the	  cells	   that	  express	  
glutamate	   receptors,	   including	   N-­‐methyl-­‐D-­‐aspartate	   (NMDA),	   which	   functions	  
as	   a	   transmembrane	   calcium	   channel.	   Other	   glutamate	   receptors	   include	   α-­‐
amino-­‐3-­‐hydroxy-­‐5-­‐methyl-­‐4-­‐isoxazole	   (AMPA)	   and	   kainate	   receptors	   (Biagas,	  
1990;	  Ferriero,	  2004;	  Volpe,	  2012),	  which	  during	  	  membrane	  depolarization	  open	  
voltage-­‐dependent	   calcium	   channels	   (Choi,	   1988).	   Additionally,	   glutamate	   also	  
activates	   metabotropic	   receptors,	   known	   regulators	   of	   intracellular	   G-­‐protein	  
signal	  cascades	  (Jensen	  et	  al.,	  2003).	  Overstimulation	  of	  these	  receptors	  leads	  to	  
a	   substantial	   increase	   of	   calcium	   influx	   into	   neurons	   causing	   mitochondrial	  
dysfunction	   (Kristian	   and	   Siesjo,	   1996;	   Johnston	   et	   al.,	   2002).	   The	   relevance	  of	  
NMDA	   and	   AMPA	   receptors	   in	   hypoxic-­‐ischaemic	   injury	   has	   been	   further	  
evidenced	   in	   studies	   where	   blockage	   of	   these	   receptors	   led	   to	   significant	  
reduction	   in	   brain	   injury	   following	   hypoxic-­‐ischaemic	   injury	   in	   the	   neonatal	   rat	  




Inhibition	  of	  protein	  synthesis	  
Acute	   disruption	   in	   energy	   metabolism	   can	   hinder	   protein	   synthesis.	   Animal	  
studies	   looking	   at	  monkey	   brain	   resuscitation	   after	   1	   hour	   of	   global	   ischaemia	  
showed	   that	   protein	   synthesis	   is	   not	   only	   reduced	  during	   the	   ischaemic	   insult,	  
but	   also	   during	   the	   early	   post-­‐ischaemic	   phase	   in	   both	   vulnerable	   and	   non-­‐
vulnerable	  brain	  regions	  (Kleihues	  et	  al.,	  1975).	  	  Non-­‐vulnerable	  brain	  regions	  are	  
capable	   of	   returning	   to	   pre-­‐ischaemic	   levels	   of	   protein	   synthesis,	   however,	   in	  
vulnerable	   brain	   regions	   this	   inhibition	   remains	   (Bodsch	   et	   al.,	   1985).	  
Biochemical	   studies	   together	   with	   electron	   microscopy	   have	   shown	   that	  
continuous	   post-­‐ischaemic	   inhibition	   of	   protein	   synthesis	   is	   associated	   with	  
disaggregation	   of	   polyribosomes	   from	   the	   mRNA	  molecule.	   This	   occurs	   in	   the	  
post-­‐ischaemic	   period,	   as	   during	   the	   ischaemic	   phase	   disaggregation	   is	   not	  
possible	   due	   to	   energy	   metabolism	   breakdown	   affecting	   all	   stages	   of	   protein	  
synthesis	   (Kleyhues	   et	   al.,	   1975).	   Therefore,	   during	   the	   early	   post-­‐ischaemic	  
period,	   reestablished	   energy	   metabolism	   is	   only	   capable	   of	   reinitiating	   the	  
elongation	   and	   termination	   phases	   of	   protein	   synthesis,	   thus	   leading	   to	  
disaggregation	  of	  polyribosomes	  and	  continuation	  of	  protein	  synthesis	  inhibition	  
(Hossmann	   et	   al.,	   1992).	   Prolonged	   inhibition	   is	   therefore	   not	   only	   an	   early	  
indicator	  of	  cell	  damage,	  but	  it	  may	  also	  be	  one	  of	  its	  contributors.	  	  
	  
Secondary/delayed	  neuronal	  cell	  death	  
When	  short	   in	  duration,	  “primary	  energy	   failure	  phase”	   is	   rapidly	  compensated	  
during	   the	   latent	   phase	   by	   cerebroprotective	   mechanisms,	   which	   allow	  
redistribution	  and	   increase	  of	  brain,	  heart	  and	  adrenal	  glands	  mediated	  cardiac	  
output	  (Vannucci,	  1990;	  Jensen	  and	  Berger,	  1991;	  Gunn	  et	  al.,	  1998).	  However,	  
when	   reduction	   in	   blood	   gas	   exchange	   is	   prolonged,	   or	   following	   cerebral	  
reperfusion	  and	  successful	  resuscitation,	  a	  secondary	  injury	  phase	  may	  occur	  (8-­‐
24	   hours	   later),	   with	   a	   substantial	   increase	   in	   depletion	   of	   cellular	   energy	  
reserves	   (ATP)	   associated	  with	   a	   rise	   in	   lactate,	   pH	   fluctuation	   and	   increase	   in	  
oxidative	  stress	   (Hope	  et	  al.,	  1984;	  Penrice	  et	  al.,	  1997).	  These	  are	   followed	  by	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epileptogenic	   activity,	   which	   can	   be	   supervised	   through	   EEG.	   Several	   different	  
animal	  studies	  have	  demonstrated	  not	  only	  this	  biphasic	  evolution	  in	  injury,	  but	  
also	  that	  it	  is	  during	  the	  second	  failure	  phase	  that	  the	  majority	  of	  cellular	  death	  
occurs	  (Williams	  et	  al.,	  1991;	  Lorek	  et	  al.,	  1994;	  Blumberg	  et	  al.,	  1997),	  together	  
with	  abnormal	  neurodevelopmental	  outcome	  and	  suboptimal	  head	  growth	  (Roth	  
et	  al.,	  1992;	  Kendall	  et	  al.,	  2011a).	  This	  is	  likely	  to	  be	  a	  result	  of	  the	  presence	  of	  
oxygen	  radicals,	  nitric	  oxide,	   inflammatory	  response	  and	  excitatory	  amino	  acids	  
such	  as	  glutamate.	  	  
	  
Oxygen	  radicals	  
Whereas	  production	  and	  release	  of	  free	  radicals	  has	  been	  shown	  to	  occur	  during	  
the	  hypoxic-­‐ischaemic	  event,	  it	  is	  in	  fact	  during	  the	  reperfusion	  period	  that	  most	  
of	   these	  oxidative	   stress	  markers	   are	   generated.	  As	  previously	  mentioned,	   it	   is	  
known	   that	   the	   brain	   has	   a	   high	   requirement	   for	   aerobic	   respiration,	   which	  
signifies	  a	  higher	  rate	  of	  mitochondrial	  respiratory	  activity,	  thus	  potentiating	  the	  
risk	   of	   free	   radical	   release	   from	   this	   organelle.	   Additional	   sources	   of	   reactive	  
oxygen	   species	   include	   nitric	   oxide	   synthase	   (NOS),	   several	   steps	   in	   the	  
metabolism	   of	   arachidonic	   acid,	   as	   well	   as	   compromise	   in	   pathways	   involving	  
xanthine	   and	   superoxide	   dismutase.	   Furthermore,	   hypoxia-­‐ischemia-­‐mediated	  
decrease	   in	   intracellular	   pH	   may	   alter	   binding	   of	   metals,	   such	   as	   iron,	   thus	  
increasing	  this	  molecule’s	  catalytic	  activity	   in	  the	  Haber-­‐Weiss	  reaction	  (Kehrer,	  
2000).	   Brain	   lipids	   are	   highly	   enriched	   in	   polyunsaturated	   fatty	   acids	   (PUFAs);	  
also	  many	  brain	  regions	  contain	  a	  high	  concentration	  of	  iron	  (e.g.	  striatum).	  This	  
causes	   the	   brain	   to	   be	   highly	   susceptible	   to	   lipid	   peroxidation,	   destruction	   of	  
cellular	  membrane,	  as	  well	  as	  DNA	  damage,	  degradation	  of	  protein	  structure	  and	  
tissue	  deterioration	  (Davies	  and	  Goldberg,	  1987;	  Helfaer	  et	  al.,	  1994;	  Shah	  et	  al.,	  
2014).	  
	  	  
In	   correlation	   to	   these	   findings,	   a	   neonatal	   rat	   model	   of	   perinatal	   hypoxia-­‐
ischaemia	  has	  demonstrated	  that	  use	  of	  allopurinol,	  a	  xanthine	  oxidase	  inhibitor	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prevented	  severe	  neuronal	  cell	   loss,	  an	   indication	  of	   the	  significance	  of	  oxygen	  
radicals	   in	   the	  development	  of	  secondary/delayed	  neuronal	  cell	   loss	   (Palmer	  et	  
al.,	  1993).	  Additionally,	  a	  study	   looking	  at	  permanent	   focal	   ischemia	   in	  rats	  has	  
shown	  an	   immediate	   transient	   increase	   in	   iron	   levels	  within	   the	  hypoxic	   tissue.	  
Furthermore,	   this	   same	   study	   has	   also	   shown	   that	   iron	   chelation	   resulted	   in	  




Nitric	   oxide	   (NO)	   is	   synthesised	   within	   the	   brain	   from	   arginine,	   NADPH	   and	  
oxygen	  by	  NO	  synthase	  (NOs).	  This	  production	  is	  initiated	  by	  excessive	  glutamate	  
release	   which	   causes	   coupling	   and	   activation	   of	   the	   NMDA	   receptor,	   allowing	  
calcium	   uptake	   into	   the	   cells	   of	   the	   brain,	   including	   the	   thalamus	   and	   basal	  
ganglia	   regions.	   Excessive	   intracellular	   calcium	   causes	   activation	   of	  NOs,	  which	  
then	   produces	   NO,	  water	   and	   citrulline.	   Oxidative	   stress	   leads	   to	   an	   excessive	  
production	   of	   NO	   within	   different	   brain	   regions.	   NO	   then	   combines	   with	  
superoxide	   radicals	   to	   produce	  peroxynitrite	   (Beckman,	   1991),	  which	   is	   quickly	  
decomposed	  to	  form	  NO2+,	  nitrogen	  dioxide	  and	  hydroxyl	  radicals.	  This	  results	  in	  
mitochondrial	   dysfunction	   and	   permeabilization,	   accompanied	   by	   failure	   of	  
oxidative	  phosphorylation	  (Bal-­‐Price	  and	  Brown,	  2001;	  Rousset	  et	  al.,	  2012).	  This	  
NO-­‐induced	  neuronal	  toxicity	  has	  been	  demonstrated	  in	  neonatal	  rodent	  models	  
of	  hypoxia-­‐ischaemia	  where	  both	  inhibition	  of	  NOs	  1.5h	  before	  insult	  in	  a	  rat,	  as	  
well	   as	   neuronal	   NOs	   (nNOs)	   deficient	   mice	   demonstrated	   a	   highly	  
neuroprotective	  effect,	  particularly	  in	  the	  hippocampal	  and	  cortex	  brain	  regions	  
(Hamada	   et	   al.,	   1994;	   Ferriero	   et	   al.,	   1996).	   Furthermore,	   nNOs	   and	   inducible	  
NOs	   (iNOs)	   inhibition	   also	   improves	   long-­‐term	   outcomes	   in	   the	   neonatal	   rat	  





A	   study	   by	  Gluckmant	   et	   al.	   has	   shown	   that	   development	   of	   epileptic	   seizures	  
occurs	   within	   hours	   after	   hypoxic-­‐ischaemic	   insult,	   and	   is	   associated	   with	  
aggravation	  of	  brain	  injury.	  Mature	  sheep	  fetuses	  showed	  epileptogenic	  activity	  
8	  hours	  post	  30	  minutes	   cerebral	   ischaemia,	  with	  a	  peak	  10	  hours	  after	   insult.	  
These	  seizures	  were	  completely	   inhibited	  by	  using	  a	  glutamate	  antagonist	   (MK-­‐
801),	  and	  this	  was	  associated	  with	  visible	  reduction	  in	  brain	  damage	  (Williams	  et	  
al.,	   1991;	   Tan	   et	   al.,	   1992).	   Therefore,	   it	   is	   suggested	   that	   excessive	   release	  of	  
glutamate	   as	   well	   as	   imbalance	   between	   inhibitory	   and	   excitatory	  
neurotransmitters	   after	   cerebral	   reperfusion	   may	   cause	   neurons	   to	   fire	   in	   an	  
abnormal	  manner	  leading	  to	  impairment	  of	  energy	  metabolism	  and	  subsequent	  
lead	  to	  delayed/secondary	  neuronal	  cell	  loss	  (Jensen	  et	  al.,	  2003).	  
	  
Necrosis	  
Necrosis	  form	  of	  cell	  death	  following	  severe	  hypoxic-­‐ischaemic	  insult	  occurs	  as	  a	  
result	   of	   extensive	   damage	   caused	   to	   organelles	   such	   as	  mitochondria.	   In	   this	  
process,	  loss	  of	  membrane	  integrity	  combined	  with	  extravasation	  of	  cytoplasmic	  
contents	  into	  the	  extracellular	  matrix	  (Jensen	  et	  al.,	  2003).	  
	  
Apoptosis	  
Despite	   necrotic	   cell	   death	   being	   the	   prominent	   form	   of	   cellular	   degeneration	  
immediately	   after	   severe	   cerebral	   insults	   due	   to	   rapid	   loss	   of	   mitochondrial	  
function	   and	   cessation	   of	   ATP	   production,	   animal	   studies	   have	   demonstrated	  
that	  apoptosis	  is	  in	  fact,	  the	  predominant	  mode	  of	  cell	  death	  during	  the	  delayed	  
phase	  of	  injury,	  where	  release	  of	  cytochrome	  c	  activates	  proteases	  and	  caspases	  
causing	   DNA	   fragmentation	   (Chung	   et	   al.,	   1998;	   Northington	   et	   al.,	   2001b;	  
Ferriero,	  2004).	  The	  apoptotic	  process	  is	  a	  programmed	  form	  of	  cell	  death	  which	  
requires	  time,	  energy	  and	  transcription	  and	  translation	  of	  new	  genes.	  One	  of	  the	  
ways	   in	   which	   apoptotic	   programmed	   cell	   death	   occurs	   following	   hypoxia-­‐
ischaemia,	  is	  the	  intrinsic	  pathway	  where	  mitochondrial	  cytochrome	  c	  is	  released	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through	   the	  permeability	   transition	  pore	   controlled	  by	   the	   anti-­‐apoptotic	   Bcl-­‐2	  
proteins.	  Cytochrome	  c	   forms	  a	  complex	  with	  Apaf-­‐1	  and	  caspases-­‐9	   in	  the	  cell	  
cytosol,	   leading	   to	  activation	  of	   caspases-­‐9	  between	  3	   to	  24	  hours	  after	   insult,	  
which	   is	   then	   followed	   by	   activation	   of	   caspase-­‐3	   6	   to	   48	   hours	   after	   injury	  
(Nakajima	   et	   al.,	   2000;	   Gill	   et	   al.,	   2002).	   Caspase-­‐3	   is	   a	   protease	   and	   cleaves	  
critical	   proteins	   as	   well	   as	   triggering	   apoptotic	   execution	   by	   activating	  
downstream	   caspases	   and	   endonucleases	   (Taylor	   and	   Colgan,	   1999).	   Cell	  
fragments	   are	   then	   ‘shrink/wrapped’	  within	   the	   contracting	  plasma	  membrane	  
becoming	   apoptotic	   bodies,	   which	   in	   turn	   are	   phagocytosed	   by	   surrounding	  
health	   cells	   (Tominaga	  et	   al.,	   1993).	  A	   rat	   study	  of	   neonatal	   hypoxia-­‐ischaemia	  
has	  shown	  that	  blockade	  of	  caspases	  provides	  significant	  neuroprotection	  in	  this	  
particular	  form	  of	  injury	  (Cheng	  et	  al.,	  1998).	  
	  
Cytokine	  stimulation	  is	  part	  of	  the	  inflammatory	  response	  to	  hypoxia-­‐ischaemia	  
and	   is	   causal	   to	   activation	   of	   cell	   death	   signaling	   programs	   (Blomgren	   et	   al.,	  
2007).	   Cell	   surface	   receptors	   including	   the	   tumor	   necrosis	   factor	   receptor	  
superfamily	   (TNFRS)	   belong	   to	   this	   group	   of	   cytokine-­‐responsive	   receptors	  
(Collette	  et	  al.,	  2003).	  TNFα	  is	  a	  major	  extrinsic	  mediator	  of	  apoptosis,	  where	  the	  
binding	   of	   TNFα	   to	   its	   receptor	   TNFR1	   leads	   to	   caspases	   activation	   via	   Fas-­‐
associated	   death	   domain	   protein	   (FADD)	   and	   TNF	   receptor	   associated	   death	  
domain	   (TRADD).	   Fas	   death	   receptor,	   a	   TNFRS	   member	   regulates	   apoptosis	  
involving	  activation	  of	  caspases-­‐8	  and	  subsequent	  caspase-­‐3	  activation	  (Le	  et	  al.,	  
2002).	   Additionally,	   a	   neonatal	   mouse	   model	   of	   caspase-­‐3-­‐deficiency	   has	  
demonstrated	   hypoxia-­‐ischaemia-­‐mediated	   activation	   of	   Fas	   death	   receptor	  
(Northington	  et	  al.,	  2001a).	  
	  
Non-­‐caspase-­‐associated	   cell	   death	   is	   also	   present	   in	   neonatal	   encephalopathy.	  
The	   nuclear	   enzyme	   poly	   (ADP-­‐ribose)	   polymerase	   (PARP-­‐1)	   functions	   by	  
transferring	   the	   ADP	   ribose	   groups	   from	   NAD+	   to	   nuclear	   proteins,	   thus	  
facilitating	   DNA	   repair	   (Fatemi	   et	   al.,	   2009).	   This	   enzyme	   is	   over-­‐activated	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following	   adult	   hypoxic-­‐ischaemic	   insult	   and	   contributes	   to	   neuronal	   death	   by	  
nuclear	   translocation	   of	   apoptosis	   inducing	   factor,	   causing	   large-­‐scale	   DNA	  
fragmentation	   (Andrabi	   et	   al.,	   2008).	   A	   neonatal	   mouse	   study	   of	   hypoxia-­‐
ischaemia,	   where	   Parp-­‐1	   gene	   was	   deleted	   showed	   through	   histological	  
assessment	  10	  days	  after	   injury	  that	  knockout	  male	  animals	  had	  moderate,	  but	  
significant	   protection,	   however	   this	  was	   gender-­‐related,	   female	   knockout	  mice	  




Autophagy	   is	   characterized	  by	  degradation	  of	   cellular	   organelles	   by	   lysosomes,	  
thus	   allowing	   the	   cell	   to	   degrade	   and	   recycle	   its	   own	   cytoplasmic	   contents	  
(Kionsky	   and	   Emr,	   2000).	   Adult	   mouse	   studies	   have	   shown	   an	   association	  
between	   autophagy	   and	   hypoxia-­‐ischaemia.	   Deletion	   of	   the	   autophagy-­‐related	  
protein	  7	  (atg7)	  gene	  in	  mice	  has	  resulted	  in	  near	  complete	  protection	  in	  these	  
mice	   from	   hypoxic-­‐ischaemic	   insult	   (Koike	   et	   al.,	   2008).	   However,	   induction	   of	  
autophagy	   in	   neonates	   has	   been	   shown	   to	   have	   some	   endogenous	  
neuroprotective	  effect	   (Carloni	  et	  al.,	   2008).	  Rapamycin	  administration	  prior	   to	  
hypoxic-­‐ischaemic	  insult	  has	  shown	  to	  augment	  the	  expression	  of	  beclin	  1,	  a	  Bcl-­‐
2-­‐interacting	   protein	   required	   for	   autophagy.	   This	   up-­‐regulation	   has	   led	   to	  
















Mechanisms	  of	  HI	  injury	  
Primary	  Energy	  Failure	  
• Decline	  in	  CBF,	  O2	  substrates	  and	  high-­‐energy	  phosphate	  compounds	  
• Initiation	  of	  neurotoxic	  cascade	  
• Reduction	   of	   membrane	   homeostasis	   leading	   to	   calcium	   influx,	  
mitochondrial	  dysfunction,	  brain	  acidosis,	  apoptosis	  and	  necrosis	  
Latent	  phase	  
• Normalization	  of	  oxidative	  metabolism	  
Secondary	  Energy	  Failure	  
• Continuation	  of	  neurotoxic	  cascade	  
• Inflammatory	  response	  (microglia)	  
• Caspase	  activation	  
• Decrease	  in	  levels	  of	  protein	  synthesis	  and	  growth	  factors	  
• Continuation	  of	  apoptosis	  and	  necrosis	  
Table	   1.4:	   Summary	   of	   pathophysiological	   cascading	   mechanisms	   involved	   in	   HI	   injury	   to	   the	  
immature	  brain	  (adapted	  from	  Shankaran,	  2012).	  
	  
Infection/inflammation	  
Although	   infection/inflammatory	   signals	   can	   affect	   the	   neonatal	   brain	   directly,	  
recent	  research	  and	  clinical	  evidence	  have	  demonstrated	  that	  prenatal	  maternal	  
pyrexia	  and/or	  intrauterine	  infections	  (including	  sub-­‐clinical),	  are	  not	  only	  causal	  
to	  cerebral	  palsy,	  but	  may	  also	  triple	  its	  risk.	  Congenital	  infections	  are	  considered	  
to	  be	  a	  result	  of	  toxicity	  to	  the	  fetal	  brain	  caused	  by	  cytokine	  production	  as	  part	  
of	   the	   inflammatory	   response	   (Peebles	   and	   Wyatt,	   2002).	   Maternal	   to	   fetal	  
infection	   are	   transmitted	   either	   across	   the	   placenta	   during	   fetal	   development	  
(preterm),	   or	   during	   labor	   and	   passage	   through	   the	   birth	   canal	   (perinatal).	  
Bacterial	   infection	  of	   both	  maternal	   and	   fetal	   origin	   leads	   to	   activation	  of	   pro-­‐
inflammatory	  cytokines,	  which	  play	  a	  critical	  role	   in	   inducing	  preterm	  labor	  and	  
neonatal	  encephalopathy	  (Duggann	  et	  al.,	  2001).	  Despite	  only	  a	  small	  percentage	  
of	   fetuses	   having	   demonstrable	   infection	   caused	   by	   chorioamnionitis,	   it	   is	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associated	  with	   initiating	   labor	   of	   over	   a	   third	   of	   preterm	  births.	   Furthermore,	  
chorioamnionitis	  has	   a	   risk	   factor	   for	   cystic	  periventricular	   leukomalacia,	   and	  a	  




Lipopolysaccharide	   (LPS)	   endotoxin	   is	   a	   major	   component	   of	   Gram-­‐negative	  
bacteria	   outer	   membrane,	   and	   has	   been	   used	   extensively	   in	   different	   animal	  
models	   as	   a	  means	   of	   inducing	   a	   robust	   inflammatory	   response	   via	   circulating	  
monocytes/neutrophils	   and	   tissue	   macrophages,	   triggering	   secretion	   of	  
cytokines	   through	   a	   cascading	   series	   of	   mechanisms	   (Hagberg	   and	   Mallard,	  
2005).	  The	  initial	  inflammatory	  response	  to	  LPS	  occurs	  upon	  its	  binding	  with	  the	  
serum	   proteins	   LPS-­‐binding	   protein	   (LBP)	   or	   septins.	   This	   complex	   results	   in	  
activation	  of	  different	  cell	  populations	  by	  binding	  to	  its	  receptor	  complex	  CD14,	  
toll-­‐like	   receptor	  4	   (TLR4)	  and	   the	  extracellular	  adaptor	  protein	  MD-­‐2	   (Hagberg	  
and	  Mallard,	  2005).	  The	  TLR4	  receptor	  has	  now	  being	  recognized	  as	  the	  signal-­‐
transducing	   receptor	   for	   LPS	   (Calvano	  et	   al.,	   2003).	   Transduction	   through	  TLR4	  
induces	   an	   intracellular	   cascading	   event,	   including	   mitogen-­‐activated	   protein	  
(MAP)	   kinase	   activation,	   together	  with	   translocation	   of	   nuclear	   factor-­‐Κb	   (NF-­‐
ΚB),	   followed	   by	   transcription	   of	   inflammatory	   genes,	   numerous	   pro-­‐
inflammatory	   cytokines	   including	   IL1,	   IL6	   and	   TNFα,	   and	   anti-­‐inflammatory	  
cytokines	  such	  as	  IL10	  and	  TGFβ1.	  TLR4-­‐mediated	  LPS	  signal	  induction	  occurs	  via	  
two	   distinct	   signaling	   cascading	   pathways,	   the	  myeloid	   differentiation	   primary	  
response	   protein	   88	   (MyD88)-­‐dependent	   and	   MyD88-­‐independent	   pathways.	  
Classical	   induction	  of	   inflammatory	   cytokines	   such	  as	  TNFα	  and	   IL-­‐1,	   as	  well	   as	  
chemokines	  and	  cell	  adhesion	  molecules	  such	  as	  E-­‐Selectin,	  P-­‐Selectin	  and	  ICAM-­‐
1	   are	   thought	   to	   occur	   via	   the	   MyD88-­‐dependent	   pathway	   following	   NF-­‐kB	  
translocation	   to	   the	   cellular	   nucleus	   (Lehnardt	   et	   al.,	   2003;	   Yamamoto	   et	   al.,	  
2003;	  Hagberg	  and	  Mallard,	  2005;	  Wang	  et	  al.,	  2008;	  Dean	  et	  al.,	  2010;	  Kendall	  
et	   al.,	   2011b),	   whereas	   the	   MyD88-­‐independent	   pathway	   is	   considered	   to	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regulate	  IFN-­‐inducible	  genes	  including	  IP-­‐10	  (Yamamoto	  et	  al.,	  2003;	  Dean	  et	  al.,	  
2010).	  	  
	  
Animal	  studies	  using	  LPS	  exposure	  study	  have	  reproduced	  focal	  and	  diffuse	  white	  
matter	   injury,	   which	   closely	   resembles	   the	   clinical	   injury	   pattern	   of	   preterm	  
infants	  (Hagberg	  et	  al.,	  2002;	  Mallard	  et	  al.,	  2003;	  van	  de	  Looij	  et	  al.,	  2012).	  Both	  
LPS	  administration	  intraperitoneally	  in	  immature	  animal	  models	  and	  in	  maternal	  
infection	   models	   have	   consistently	   induced	   up-­‐regulation	   of	   pro-­‐inflammatory	  
cytokines.	  In	  the	  latter	  model,	  LPS	  crosses	  the	  placenta	  and	  prompts	  activation	  of	  
pro-­‐inflammatory	  cytokines	  in	  the	  neonatal	  brain	  (P8)	  white	  matter.	  Additionally,	  
maternal	   LPS	   administration	   decreases	   myelin	   basic	   protein,	   alters	   microglial	  
immunoreactivity	   and	   increases	   glial	   fibrillary	   acidic	   protein	   (GFAP)-­‐positive	  
astrocytes	  (Cai	  et	  al.,	  2000).	  Other	  animal	  studies	  have	  also	  been	  able	  to	  recreate	  
patterns	  of	   injury	  more	   resembling	   the	  damage	   seen	  on	   term	  babes,	   including	  
high	   levels	   of	   damage	   to	   the	   cortex,	   hippocampus,	   striatum	   and	   thalamus	  
(Kendal	  et	  al.,	  2011b).	  
	  
Synergy	  	  
Continuous	   study	   of	   the	   cerebral	   palsy	   aetiology	   has	   led	   to	   the	   now	   widely	  
accepted	   suggestion	   of	   a	   synergistic	   interaction	   between	   infection	   and	  
inflammation	   and	   other	   types	   of	   damage	   such	   as	   trauma,	   neurodegenerative	  
disease	  and	  hypoxic-­‐ischaemic	  insult	  as	  one	  of	  the	  causal	  to	  perinatal	  brain	  injury	  
(Peebles	  and	  Wyatt,	  2002).	  Furthermore,	  the	  combined	  exposure	  of	  the	  neonatal	  
brain	  to	  infection	  and	  hypoxia-­‐ischaemia	  dramatically	  increases	  the	  risk	  of	  spastic	  
and	  spastic	  quadriplegic	  cerebral	  palsy	  (Grether	  and	  Nelson,	  1997).	  Additionally,	  
a	   case	   study	   has	   specifically	   demonstrated	   that	   both	   chorioamnionitis	   and	  
hypoxia-­‐ischaemia	   brain	   injury	   had	   been	   present	   in	   children	   suffering	   from	  
cerebral	   palsy	   (Wu	   et	   al.,	   2003).	   Also,	   increased	   cytokine	   expression	   has	   been	  
found	   in	   cerebrospinal	   fluid	   of	   patients	   with	   neonatal	   encephalopathy,	   and	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therefore,	  it	  is	  possible	  that	  these	  cytokines	  may	  have	  had	  a	  role	  in	  the	  aetiology	  
of	  cerebral	  palsy	  (Aly	  et	  al.,	  2006).	  
	  
Experimental	   animal	   models	   have	   consistently	   been	   used	   to	   assist	   in	  
understanding	   the	   mechanisms	   involved	   in	   perinatal	   brain	   damage,	   and	  
subsequently	  cerebral	  palsy.	  Different	  animal	  models	  where	  LPS	  is	  administered	  
either	   systemically	   (Eklind	   et	   al.,	   2001;	   Yang	   et	   al.,	   2004)	   or	   intracisternally	  
(Coumans	  et	  al.,	  2003)	  before	  unilateral	  carotid	  occlusion	  and	  hypoxic	  induction	  
directed	  an	  exacerbation	  of	  inflammation	  and	  tissue	  loss	  in	  comparison	  to	  either	  
LPS	  or	  hypoxic-­‐ischaemic	  insult	  alone	  (Eklind	  et	  al.,	  2001;	  Kendall	  et	  al.,	  2011b).	  
Interestingly,	  both	  endotoxin	  sensitization	  and	  hypoxia-­‐ischaemia	  are	  capable	  of	  
raising	   the	   concentration	   levels	   of	   pro-­‐inflammatory	   cytokines	   IL-­‐1,	   IL-­‐6	   and	  
TNFα	  alone,	  which	  have	  been	   implicated	   in	  numerous	  studies	  to	  be	  part	  of	  the	  
pathway	   causal	   to	   neonatal	   encephalopathy.	   Therefore,	   it	   is	   possible	   that	   this	  
shared	  inflammatory	  mechanism	  may	  be	  partially	  explanatory	  to	  this	  synergistic	  
effect	   (Peebles	   and	   Wyatt,	   2002).	   However,	   the	   mechanism	   by	   which	   this	  
synergistic	  interaction	  occurs	  still	  remains	  largely	  unknown.	  	  
	  
A	   study	   by	   Clancy	   et	   al.	   using	   histological	   and	   functional	   multivariate	   analysis	  
from	   multiple	   brain	   regions	   across	   different	   mammalian	   species	   has	   enabled	  
comparison	   to	   human	   early	   postnatal	   brain	   development,	   thus	   giving	   credit	   to	  
the	   continual	   use	   of	   the	   P7	   rodent	   model	   of	   hypoxia-­‐ischaemia	   as	   a	  
representative	   of	   the	   human	   neonate	   at	   term	   (Clancy	   et	   al.,	   2001).	   Carotid	  
occlusion	   followed	   by	   timed	   continuous	   hypoxia	   leads	   to	   90%	   of	   animals	  
demonstrating	   visible	   brain	   injury,	   with	   56%	   also	   showing	   infarct	   (Ride	   et	   al.,	  
1981).	   Observation	   of	   the	   mouse	   brain	   neuroanatomy	   reveals	   damage	   to	   the	  
ipsilateral	  cerebral	  cortex,	  hippocampus,	  striatum,	  thalamus	  and	  subcortical	  and	  
periventricular	  white	  matter	  (Roohey	  et	  al.,	  1997).	  Mild	  combination	  of	  hypoxic-­‐
ischaemic	   insult	   with	   LPS	   bacterial	   endotoxin	   has	   demonstrated	   a	   significant	  




Figure	   1.2:	   Demonstrative	   graph	   of	   the	  
possible	   relationship	   between	   infection	   and	  
hypoxia-­‐ischaemia.	   Fetus	   A	   can	   withstand	  
substantial	   hypoxic-­‐ischaemic	   stress	   before	  
sustaining	  brain	  damage;	  fetus	  B	  will	  develop	  
perinatal	  brain	  damage	  following	  antepartum	  
inflammatory	   event,	   despite	   reduced	  
intrapartum	   stress;	   Fetus	   C	   is	   vulnerable	   to	  
hypoxic-­‐ischaemic	   stress,	   however	   may	   not	  
develop	   brain	   damage	   if	   hypoxic-­‐ischaemic	  
stress	   is	   not	   increased,	   nor	   risk	   of	  
infection/inflammation	   (From	   Peebles	   and	  
Wyatt,	  2002,	  reproduced	  with	  permission).	  
	  
	  
Mechanisms	  of	  inflammation	  in	  the	  brain	  
Inflammation	   is	   considered	   both	   a	   protective	   and	   detrimental	   response	   to	   the	  
aforementioned	  types	  of	  insult,	  with	  acute	  inflammation	  being	  an	  integral	  part	  of	  
the	  immune	  response.	  Furthermore,	  injury	  to	  neurons	  leads	  to	  a	  rapid	  change	  in	  
their	  gene	  expression	  with	  stimulation	  of	  astrocytes	  and	  microglia	  activation	  and	  
aggregation	   for	   survival	   support	   (Raivich	  et	  al.,	  1999).	  Neuroglial	  activation	   is	  a	  
graded	   response	   accompanied	   by	   production	   of	   pro-­‐inflammatory	   cytokines,	  
activation	  of	  vascular	  endothelial	  cells	  and	  recruitment	  of	  peripheral	  cells	  of	  the	  
immune	  system	  into	  the	  damaged	  brain.	  This	  response	  has	  been	  clearly	  observed	  
in	  hypoxia-­‐ischaemia,	   infection,	   autoimmune	  disorders,	   neurodegenerative	   and	  
cardiovascular	  diseases	  (Norenberg,	  1994;	  Kreutzberg,	  1996;	  Raivich	  et	  al.,	  1996).	  	  
In	   the	   immature	   brain,	   astrocytes	   and	   microglia	   are	   involved	   in	   regulation	   of	  
viability,	   function	   and	   differentiation	   of	   progenitor	   cells.	   However,	   when	  
activated	  under	  pathological	  conditions,	  these	  glial	  cells	  also	  mediate	  a	  cytotoxic	  
effect	  on	  oligodendrocytes,	  by	  production	  of	  pro-­‐inflammatory	   cytokines	   (Pang	  
et	  al.,	  2000).	  	  
	  
Blood-­‐brain	  barrier	  
The	  blood-­‐brain	  barrier	  (BBB)	  is	  an	  integral	  part	  of	  the	  neurovascular	  unit,	  and	  is	  
formed	   by	   non-­‐fenestrated	   capillary	   endothelial	   cells	   connected	   by	   tight	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junctions,	   The	   tight	   junctions	   are	   formed	   at	   an	   early	   stage	   during	   fetal	   brain	  
development	   (Baburamani	  et	  al.,	  2012).	  The	  endothelial	   cells	   regulate	  diffusion	  
of	  molecules	  into	  the	  CNS	  by	  both	  restricting	  hydrophilic	  molecules	  and	  allowing	  
diffusion	   of	   hydrophobic	   molecules.	   Additionally,	   metabolic	   products	   such	   as	  
glucose	  can	  be	  actively	  transported	  across	  the	  BBB.	  The	  BBB	  is	  surrounded	  by	  a	  
basal	   membrane,	   pericytes	   and	   astrocyte	   foot	   processes	   (Ahmad	   et	   al.,	   2012;	  
McAdams	   and	   Juul,	   2012).	   Astrocyte	   cells	   surrounding	   the	   BBB	   epithelial	   cells	  
play	  an	  important	  role	  in	  providing	  biochemical	  support	  to	  these	  cells,	  ensuring	  a	  
cellular	   link	  to	  neurons	  as	  well	  as	  participating	   in	  signal	   transduction	  pathways,	  
tight	   junction	   formation	  and	  BBB	   regulation	   (McAdams	  and	   Juul,	   2012).	  As	   the	  
BBB	   is	   selectively	  permeable,	   it	   plays	   a	   significant	   role	   in	   separating	   circulating	  
blood	  from	  the	  brain	  and	  maintaining	  CNS	  homeostasis.	  
	  
Additionally,	   the	   neonatal	   BBB	  has	   different	   properties	  when	   compared	   to	   the	  
adult,	   as	   the	   developing	   brain	   has	   different	   requirements.	   During	   neonatal	  
development	   there	   is	   an	   additional	   ependymal	   barrier	   (Fossan	   et	   al.,	   1985),	   a	  
higher	  transport	  influx	  of	  glucose	  (Cornford	  and	  Cornford,	  1986)	  and	  amino	  acids	  
(Braun	   et	   al.,	   1980;	   Tuor	   et	   al.,	   1992)	   as	   well	   as	   reduced	   entry	   of	   many	  
compounds	  such	  as	  drugs	  and	  toxins	  through	  active	  efflux	  (Ek	  et	  al.,	  2010).	  	  
	  
However,	   in	   the	   presence	   of	   environmental	   and	   physiological	   insults	   such	   as	  
hypoxia-­‐ischaemia	   and	   inflammation	   there	   is	   an	   increase	   in	   expression	   of	  
cytokines,	   chemokines,	   adhesion	  molecules	   and	   other	   inflammatory	  mediators	  
such	  as	  NO	  (Iadecola	  and	  Alexander,	  2001).	  This	  inflammatory	  response	  leads	  to	  
transmigration	  of	   leykocytes	   into	  the	  brain	  parenchyma.	  Additionally,	  microglial	  
activation	   leads	   to	  production	  of	  pro-­‐	  and	  anti-­‐inflammatory	  cytokines,	  antigen	  
presentation	   and	   release	   of	  matrix	  metalloproteinase	   (MMP),	   resulting	   in	   BBB	  
breakdown	  and	  further	  infiltration	  of	  peripheral	  immune	  cells	  into	  the	  brain,	  and	  





Microglial	  cells	  are	   the	  resident	  macrophages	  of	   the	  CNS,	   form	  10-­‐20%	  of	   total	  
glial	  population	  and	  are	  responsible	  for	  the	  CNS	  immune	  response.	  In	  the	  normal	  
brain	   they	   are	   present	   in	   a	   resting	   state	   with	   highly	   ramified	   and	   motile	  
processes.	  Microglial	  receptors	  sense	  the	  presence	  of	  environmental	  changes	  to	  
the	   brain,	   inducing	   rapid	   activation	   (Raivich	   et	   al.,	   1999;	   Raivich,	   2005).	  
Morphologically,	  microglial	  activation	  happens	  through	  several	  sequential	  steps,	  
starting	   with	   retraction	   of	   microglial	   processes	   and	   increase	   in	   cell	   body	   size.	  
Further	   activation	   into	   phagocytic	   microglia	   and	   subsequent	   migration	   to	   the	  
injured	   site	   is	   dependent	   on	   the	   extent	   of	   damage	   induced	   to	   the	   brain	  
(Kreutzberg,	  1996).	  	  
	  
Immediately	   following	   ischaemia,	  microglial	   cells	  become	  activated.	  This	  allows	  
them	   to	   become	   phagocytic,	   produce	   pro-­‐,	   anti-­‐inflammatory	   cytokines	   and	  
present	   antigen.	   Microglia	   are	   also	   capable	   of	   releasing	   matrix	  
metalloproteinases	   (MMPs),	   leading	   to	   breakdown	   of	   the	   blood-­‐brain	   barrier	  
(Iadecola	   and	   Anrather,	   2011).	   This	   allows	   influx	   of	   leukocytes	   into	   the	   brain,	  
which	   further	   exacerbates	   inflammation	   and	   subsequently,	   brain	   damage.	  	  
Retrospective	   clinical	   studies	   on	   postmortem	  neonatal	   brains	   have	   shown	   that	  
microglial	   activation	   and	   aggregation	   is	   a	   hallmark	   of	   hypoxia-­‐ischaemia	  
encephalopathy.	   These	   studies	   have	   shown	   a	   dense	   infiltration	   of	  microglia	   in	  
the	  dentate	  gyrus	  of	  the	  hippocampus	  which	  was	  not	  seen	  in	  infants	  which	  had	  
died	  of	  other	  causes	  such	  as	  trauma	  or	  sepsis.	  (Del	  Bigio	  and	  Becker,	  1994).	  TLR4,	  
the	  main	   LPS	   receptor,	   highly	   expressed	   in	  microglia,	   and	  mediate	   endothelial	  
activation	   and	   leukocyte	   recruitment	   to	   the	   brain	   (Zhou	   et	   al.,	   2006),	   thus	  
suggesting	   that	   microglia/macrophages	   activation	   is	   a	   major	   source	   of	  
inflammation	  (Lehnardt	  et	  al.,	  2002;	  Zhou	  et	  al.,	  2006).	  This	  activation	  is	  widely	  
considered	   as	   highly	   detrimental	   to	   the	   brain,	   however,	   contrasting	   data	   also	  
suggests	   that	  microglial	   activation	   inhibition	  does	  not	   improve	  outcome	   to	   the	  
immature	   brain	   (Dean	   et	   al,	   2010).	   Furthermore,	   there	   is	   an	   abundance	   of	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microglia	  in	  the	  periventricular	  white	  matter,	  and	  prominent	  parts	  of	  the	  internal	  
and	  external	   capsule.	  These	  are	  white	  matter	   tracts	   that	  are	  primarily	  affected	  
areas	   in	   many	   cases	   of	   cerebral	   palsy,	   where	   these	   glial	   cells	   are	   thought	   to	  
generate	  free	  radicals,	  secrete	  cytokines	  and	  enhance	  excitotoxicity	  (Hristova	  et	  
al.,	  2010;	  Hagberg	  et	  al.,	  2012).	  
	  
Astrocytes	  
Astrocytes,	  the	  predominant	  glial	  cells	  in	  the	  CNS,	  are	  characteristic	  star-­‐shaped	  
glial	   cells	   that	   provide	   structural	   support	   and	   homeostasis	   to	   the	   CNS.	   In	   the	  
presence	   of	   injury,	   such	   as	   CNS	   trauma,	   hypoxia-­‐ischaemia,	   infection,	  
autoimmune	   and	   neurodegenerative	   disease,	   astroglia	   are	   responsible	   for	   the	  
formation	  of	  scar	  tissue	  surrounding	  the	  areas	  of	  CNS	  tissue	  loss,	  and	  in	  severe	  
cases,	   inhibit	   neuronal	   axonal	   regeneration	   (Noremberg,	   1996;	   Raivich,	   1999).	  
Astrocytes	  are	  thought	  to	  be	  activated	  within	  minutes	  after	  injury	  due	  as	  a	  result	  
of	   pro-­‐inflammatory	   cytokines	   and	   reactive	   oxygen	   species	   being	   released	   by	  
injured	  neurons	  and	  glia	  (Tuttolomondo	  et	  al.,	  2008).	  Astroglial	  role	  in	  neuronal	  
repair	   after	   an	   ischaemic	   event	   include	   release	   of	   superoxide	   dismutase	   (SOD)	  
(Swanson	  et	  al.,	  2004)	  and	  glutathione	   (Sims	  et	  al.,	  2004),	  as	  well	  as	  enhanced	  
extra-­‐synaptic	   glutamate	   uptake	   (Anderson	   and	   Swanson,	   2000)	   and	  
maintenance	   of	   ion	   gradients,	   including	   potassium	   (Walz,	   2000).	   Conversely,	  
astrocytes	   can	   also	   increase	   brain	   damage	   through	   production	   of	   pro-­‐
inflammatory	  cytokines,	  such	  as	  IL-­‐1,	  IL-­‐6	  and	  TNFα	  (Tuttolomondo	  et	  al.,	  2008),	  
which	  leads	  to	  exacerbation	  of	  brain	  ischaemic	  injury,	  as	  rapid	  increase	  of	  these	  
pro-­‐inflammatory	   cytokines	   lead	   to	   neuronal	   apoptosis	   (Stoll	   et	   al.,	   1998),	  
increase	  of	  nitric	  oxide	  levels	  and	  inhibition	  of	  neurogenesis	  (Monje	  et	  al.,	  2003).	  
Chemokines	   are	   also	   secreted	   by	   astrocyte,	  which	   in	   turn,	   attract	  migration	   of	  
immune	  cells	  into	  the	  brain	  (Kim,	  1996).	  
	  
A	  clinical	  study	  on	  autopsies	  performed	  on	  hypoxic-­‐ischaemic	  neonates	  showed	  
the	  presence	  of	  white	  matter	  injury,	  including	  periventricular	  leucomalacia,	  with	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a	  prevalence	  of	  astrogliosis	  of	  15-­‐40%	  within	  the	  white	  matter	  (Rezaie	  and	  Dean,	  
2002).	  Nonetheless,	  it	  still	  remains	  unknown	  whether	  astrogliosis	  present	  in	  the	  
white	  matter	  is	  a	  direct	  cause	  to	  periventricular	  leucomalacia,	  or	  if	  this	  astrocyte	  
activation	  is	  a	  result	  of	  injury	  to	  neurons	  and	  oligodendrocytes	  (Sen	  and	  Levison,	  
2006).	   Animal	   models	   of	   hypoxia-­‐ischaemia	   have	   also	   shown	   astrocyte	  
activation.	   However,	   this	   appears	   to	   be	   secondary	   to	   microglial	   activation,	  
possibly	  as	  a	  response	  to	  microglial	  expression	  of	  the	  pro-­‐inflammatory	  cytokine	  
IL-­‐1	   (Ohno	   et	   al.,	   1995).	   Astrocytes	   also	   produce	   other	   pro-­‐inflammatory	  
cytokines	  (TNFα)	  and	  free	  radicals.	  An	   in	  vitro	  study	  has	  demonstrated	  that	  the	  
additional	   presence	   of	   astrocytes	   shifts	   the	   mechanism	   of	   toxicity	   in	   the	  
presence	  of	  LPS	  from	  NOs	  and	  peroxynitrite	  to	  a	  TNFα-­‐dependent	  mechanism	  (Li	  
et	   al.,	   2008).	   Conversely,	   astrocytes	   may	   also	   produce	   anti-­‐inflammatory	  
cytokines	  (TGFβ)	  in	  PVL	  regions	  (Meng	  and	  Takashima,	  1999).	  
	  
Lymphocytes	  
It	   is	   generally	   accepted	   that	   lymphocyte	   cells	   have	   a	   detrimental	   effect	   in	  
ischaemic	  brain	  damage.	  A	  study	  using	  adult	  Rag1-­‐/-­‐	  mice	  -­‐	  deficient	  in	  B	  and	  T	  
cells	   -­‐	   has	   shown	   that	   following	  middle	   cerebral	   artery	  occlusion,	  Rag1-­‐/-­‐	  mice	  
have	   reduced	  brain	   infarction	   compared	   to	  wild	   type	   controls.	   The	   same	   study	  
showed	   that	   reconstitution	   of	   splenocytes	   in	   the	  Rag1-­‐/-­‐	   animals	   removed	   the	  
protective	   effect	   seen	   following	   stroke	   insult,	   thus	   indicating	   that	   these	  
peripheral	  immune	  cells	  play	  a	  detrimental	  role	  mediating	  post-­‐ischaemic	  injury	  
(Yilmaz	  et	  al.,	  2006).	  Studies	  of	  lymphocyte	  infiltration	  to	  the	  neonatal	  brain	  have	  
shown	  that	  in	  a	  P7	  rat	  model	  of	  ischaemia,	  lymphocytes	  are	  only	  present	  for	  up	  
to	   96	   hours	   in	   the	   brain	   following	   insult	   (Benjelloun	   et	   al.,	   1999).	   This	   is	   in	  
concordance	   with	   clinical	   studies	   of	   newborns	   with	   hypoxic-­‐ischaemic	  
encephalopathy,	   showing	   that	   agranulocytes	   of	   newborns	   are	   rather	  
undifferentiated,	   with	   low	   surface	   markers	   expression	   levels	   (Wang	   and	   Lu,	  
2008).	   However,	   a	   study	   by	   Hagberg	   et	   al.	   has	   shown	   infiltration	   of	   CD4+	  
lymphocytes	   7	   days	   after	   hypoxic-­‐ischaemic	   insult.	   Furthermore,	   this	   study	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showed	   that	   these	   lymphocytes	   persisted	   in	   the	   area	   of	   damage	   for	   up	   to	   35	  
days.	  However,	  it	  is	  not	  known	  if	  this	  immune	  response	  is	  exacerbating	  damage	  
or	   enhancing	   repair	   (Bona	   et	   al.,	   1999).	   However,	   there	   are	   still	   few	   studies	  
investigating	   the	   role	   of	   lymphocytes	   in	   neonatal	   hypoxia-­‐ischaemia,	   and	   how	  
these	   cells	   may	   be	   involved	   in	   a	   more	   sever	   immune	   inflammatory	   response	  




Both	  pro	  and	  anti-­‐inflammatory	  cytokines	  and	  their	  receptors	  are	  present	  in	  the	  
brain	  and	  cerebrospinal	  fluid,	  and	  act	  as	  part	  of	  the	  CNS	  inflammatory	  response	  
to	  adverse	  stimuli	  (Huleihel	  et	  al.,	  2004).	  In	  fact,	  it	  is	  believed	  that	  cytokines	  work	  
as	  a	  final	  common	  pathway	  to	  injury	  from	  a	  number	  of	  varying	  insults,	  including	  
the	  ones	  previously	  mentioned.	  	  
	  
In	   neonatal	   encephalopathy	   and	   cerebral	   palsy	   cases,	   the	   high	   levels	   of	   pro-­‐
inflammatory	  cytokines	  in	  the	  fetal	  brain	  can	  also	  be	  originated	  peripherally,	  i.e.,	  
from	  other	  cells	  of	  immune	  lineage	  such	  as	  T	  lymphocytes	  and	  natural	  killer	  (NK)	  
cells,	   or	   even	   from	   the	   maternal	   uterus	   and	   placenta,	   following	   intrauterine	  
infection/inflammation,	  as	   the	  blood-­‐brain	  barrier	  can	  be	  permeable	   to	  cells	  of	  
the	  immune	  system.	  Elevated	  levels	  of	  IL-­‐6	  and	  TNFα	  have	  been	  found	  in	  in	  the	  
amniotic	   fluid	   of	   pregnant	   women	   with	   chorioamnionitis	   (Greig	   et	   al.,	   1993).	  
Nevertheless,	   not	   all	   cytokines	   that	   are	   present	   at	   high	   levels	   in	   the	  maternal	  
uterus	   are	   also	   upregulated	   in	   the	   fetal	   brain	   (Dammann	   and	   Levinton,	   1997;	  
Nelson	  et	  al.,	  1998;	  Saliba	  and	  Henrot,	  2001).	  
	  
The	  early-­‐response	  IL-­‐1,	  IL-­‐6	  and	  TNFα	  cytokines	  are	  believed	  to	  be	  influential	  in	  
the	   progression	   of	   injury	   in	   the	   neonatal	   brain	   via	   further	   stimulating	   the	  
synthesis	  of	  other	   cytokines	  and	  adhesion	  molecules,	   and	  prompting	   leukocyte	  
infiltration,	  the	  latter	  prompting	  recruitment	  of	  more	  immune	  cells	  to	  the	  site	  of	  
57	  
	  
inflammation,	   and	   inducing	   neuronal	   injury	   mediators	   such	   as	   NOs.	   This	  
continual	   and	   progressive	   stimulus	   has	   influencing	   modulatory	   effect	   on	   glial	  
gene	  expression,	  activating	  microglia	  and	  astrocytes.	  Depending	  on	  the	  extent	  of	  
this	   cytokine-­‐mediated	   cytotoxic	   inflammatory	   cellular	   activation,	   cell	   damage	  
and	  subsequent	  death	  occurs	   (Yoon	  et	  al.,	  1996;	  Gomez	  et	  al.,	  1998;	  Raivich	  et	  
al.,	   1999;	   Duggan	   et	   al.,	   2001;	   Volpe	   et	   al.,	   2001;	   Huleihel	   et	   al	   2004).	  
Additionally,	   IL-­‐1	  neurotoxic	  effect	   following	  hypoxic-­‐ischaemic	  encephalopathy	  
has	   been	   clearly	   shown	   in	   a	   combined	   model	   of	   maternal	   endotoxin	   and	  
neonatal	  hypoxic-­‐ischaemic	  (P1)	  encephalopathy	  study,	  where	  there	  was	  a	  clear	  
up-­‐regulation	   of	   IL-­‐1,	   particularly	   in	   the	   areas	   of	   brain	   damage	   (Girard	   et	   al.,	  
2008).	  Furthermore,	  IL-­‐1	  receptor	  antagonist	  administration	  in	  7	  day	  old	  rats	  has	  
shown	  to	  be	  neuroprotective	  following	  hypoxic-­‐ischaemic	  insult	  (Hagberg	  et	  al.,	  
1996).	   Conversely,	   the	   anti-­‐inflammatory	   IL-­‐10	   cytokine	   has	   presented	   a	  
neuroprotective	  effect	  in	  both	  stroke	  and	  head	  trauma	  injuries,	  thus	  suggesting	  
potential	  therapeutic	  effects	  for	  using	  anti-­‐inflammatory	  cytokine	  modulation	  in	  
hypoxic-­‐ischaemic	  encephalopathy	  (Saliba	  and	  Henrot,	  2001).	  
	  
TNF	  family	  of	  pro-­‐inflammatory	  cytokines	  
The	  tumor	  necrosis	   factor	   (TNF)	   family	  of	  cytokines	  contains	  over	  20	  members,	  
however,	  the	  actual	  TNF	  gene	  cluster	  is	  12kb	  long	  and	  is	  located	  inside	  the	  major	  
histocompability	  complex	  locus.	  It	  encodes	  for	  only	  three	  ligands,	  tumor	  necrosis	  
factor	  alpha	  (TNFα),	  lymphotoxin	  alpha	  (LTα),	  and	  lymphotoxin	  beta	  (LTβ).	  These	  
three	  genes	  are	  structurally	  and	  functionally	  highly	  related	  (Kuprash	  et	  al.,	  2002;	  
Giles	  et	  al.,	  2011b).	  
	  
TNFα	  was	  discovered	  due	  to	   its	  anti-­‐tumor	  properties	  seen	  in	  mice	  (Carswell	  et	  
al.,	   1975)	   and	   is	   the	  most	   widely	   studied	   TNF	   cluster	  member.	   From	   an	   early	  
period,	   studies	   have	   demonstrated	   a	   dual	   role	   for	   this	   cytokine.	   Use	   of	   anti-­‐
cachectin/TNF	   monoclonal	   antibodies	   2	   hours	   prior	   to	   bacterial	   challenge	  
prevented	  death	   in	  a	  baboon	  model	  of	   sepsis	   (Tracey	  et	  al.,	  1987).	  Conversely,	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mouse	   studies	   have	   shown	   an	   apparent	   protective	   effect	   for	   TNFα	   immune	  
response	  against	  Mycobacterium	  tuberculosis	   infection	  (Flynn	  et	  al.,	  1995;	  Bean	  
et	  al.,	  1999).	  Although	  TNFα	  is	  produced	  mainly	  by	  activated	  macrophages,	  this	  
cytokine	   has	   also	   been	   shown	   to	   be	   produced	   by	   other	   cells	   such	   as	   neurons,	  
microglia,	   astrocytes,	   lymphocytes,	   dendritic	   cells	   and	   neutrophils	   (Liu	   et	   al.,	  
1994;	   Grivennikov	   et	   al.,	   2005).	   	   TNFα	   is	   expressed	   mainly	   as	   a	   26-­‐kDa	  
transmembrane	  protein	  that	  can	  be	  cleaved	  and	  release	  a	  17-­‐kDa	  soluble	  form	  of	  
TNFα	  cytokine	  (Idriss	  and	  Naismith,	  2000).	  TNFα’s	  primary	  role	  is	  thought	  to	  be	  
regulation	   of	   immune	   cells	   and	   it	   is	   involved	   in	   cellular	   proliferation	   and	  
differentiation,	   necrosis	   and	   apoptosis	   (Locksley	   et	   al.,	   2001).	   TNFα	   has	   been	  
shown	  to	  interact	  with	  two	  different	  receptors:	  TNR	  receptor	  type	  1	  (TNFR1)	  and	  
TNFR2.	  TNFR1	  is	  expressed	  in	  most	  tissues	  and	  contains	  a	  death-­‐domain	  region	  
(Tartaria	  et	  al.,	  1993).	  
	  
Both	  LTα	  and	  LTβ	  production	  expression	  is	  limited	  to	  activated	  lymphocytes,	  NK	  
cells	   (Ware	  et	  al.,	  1992).	  LTα	   lacks	  a	  transmembrane	  and	  exists	  as	  homotrimer.	  	  
When	   bound	   to	   LTβ,	   a	   type	   II	   transmembrane	   protein,	   they	   form	   the	  
heterotrimeric	  complex	  LTαβ2,	  which	  signals	  through	  LTβ	  receptor	  (LTβR)	  (Crowe	  
et	   al.,	   1994).	   The	   binding	   of	   LTα1β2	   to	   this	   ligand	   is	   essential	   for	   the	  
development	  of	  Peyer’s	  patches	  and	   lymph	  nodes,	  organization	  of	   the	  spleen’s	  
white	   pulp	   (deTogni	   et	   al.,	   1994;	   Alimzhanov	   et	   al.,	   1997),	   expression	   of	  
lymphoid	  chemokines	  (Ngo	  et	  al.,	  1999)	  and	  recruitment	  of	  NK	  and	  dendritic	  cells	  
(Ito	  et	  al.,	  1999).	  
	  
This	   gene	  cluster	   is	   a	   known	  mediator	  of	   septic	   shock,	   and	  up-­‐regulation	  of	   its	  
members	   is	   a	   fundamental	   modulator	   of	   severe	   CNS	   damage	   associated	   with	  
neuronal	   cell	   loss	   (Raivich	   et	   al.,	   1999;	   Loddick	   and	   Rothwell,	   1999).	   These	  
molecules	   have	   consistently	   shown	   significant	   detrimental	   impact	   on	   neuronal	  
survival	   in	   the	   presence	   of	   neural	   injury	   (Raivich	   et	   al.,	   2002).	   Nelson	   et	   al.,	  
(2005)	   has	   demonstrated	   that	   single	   nucleotide	   polymorphism	   in	   LTα	   is	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associated	  with	   development	   of	   cerebral	   palsy.	   In	   a	  mouse	  model	   of	   hypoxia-­‐
ischaemia	  by	  Kendal	  et	  al.,	  deletion	  of	  the	  entire	  TNF	  gene	  cluster	  abolished	  the	  
LPS	   sensitization	   of	   neonatal	   brain	   to	   hypoxic-­‐ischaemic	   insult	   (Kendal	   et	   al.,	  
2011b).	   The	   damaging	   clinical	   effects	   seen	   by	   the	   activation	   of	   this	   pro-­‐
inflammatory	  cytokine	  cluster,	  combined	  with	  the	  scientific	  knowledge	  that	  in	  an	  
animal	  model	  its	  deletion	  removes	  such	  cytotoxic	  inflammatory	  response	  further	  
implicates	  these	  cytokines	  in	  the	  mechanism	  of	  perinatal	  brain	  damage.	  
	  
Neuroprotection	  
Current	  clinical	  therapies	  –	  hypothermia	  
Following	   initial	   resuscitation	   and	   stabilization,	   treatment	   of	   neonatal	  
encephalopathy	   is	   largely	   supportive,	   focusing	   on	   maintaining	   ventilation,	  
perfusion	   and	   careful	   fluid	   management,	   preventing	   hypoglycemia	   or	  
hyperglycemia,	  and	  avoidance/treatment	  of	  seizures	  (Shankaran,	  2002;	  Stola	  and	  
Perlman,	  2008).	  Despite	  scientific	  and	  medical	  advances,	   there	   is	  still	  very	   little	  
else	   that	   can	   be	   done	   in	   terms	   of	   therapy,	   with	   mild/moderate	   hypothermia	  
being	   the	   only	   clinically	   available	   treatment	   for	   infants	  with	   hypoxia-­‐ischaemia	  
encephalopathy	  (Azzopardi	  et	  al.,	  2008).	  
	  
Mild	  hypothermia	   is	   so	   far	   the	  most	   successful	   clinical	   treatment	  used	   in	   term	  
neonatal	  encephalopathy,	  however	  its	  success	  is	  still	  moderate	  (Gluckman	  et	  al.,	  
2005).	   Several	   experimental	   studies	   have	   shown	   the	   efficacy	   of	   therapeutic	  
hypothermia	   when	   applied	   3-­‐4°C	   below	   baseline	   temperature	   and	   initiative	  
within	   few	   hours	   –	   no	   later	   than	   6	   hours	   –	   after	   hypoxic-­‐ischaemic	   event.	  
However	   a	   therapeutic	   window	   for	   the	   use	   of	   hypothermia	   has	   not	   yet	   been	  
identified,	  with	  different	  studies	  using	  varied	  duration	  of	  hypothermia	  treatment	  
from	  as	  little	  as	  3	  hours	  and	  up	  to	  72	  hours,	  which	  have	  shown	  varying	  degrees	  
of	   successful	   reduction	   in	   brain	   damage	   (Busto	   et	   al.,	   1987;	   Colbourne	   and	  
Corbett,	   1994;	   Thoresen	   et	   al.,	   1996;	   Johnston	   et	   al.,	   2011).	   The	   exact	  
mechanisms	   by	   which	   hypothermia	   prevents	   exacerbation	   of	   neonatal	   brain	  
60	  
	  
damage	  are	  not	  yet	  fully	  understood	  (Drury	  et	  al.,	  2010),	  but	  it	  is	  widely	  accepted	  
that	  therapeutic	  hypothermia	  reduces	  brain	  metabolism,	  thus	   inhibiting	  release	  
of	  oxygen	  free	  radicals	  and	  accumulation	  of	  cytotoxic	  free	  radicals,	   inhibition	  of	  
inflammatory	   cascade,	   and	   reduction	   of	   necrosis	   and	   apoptosis	   cell	   death	  
(Shankaran,	  2012)	  (see	  table	  1.5).	  
	  
Multiple	  clinical	  trials,	  including	  CoolCap	  and	  TOBY	  looking	  at	  death	  and	  disability	  
at	   18-­‐24	   months,	   have	   also	   demonstrated	   visible	   reduction	   in	   mortality	   and	  
morbidity	  in	  babies	  treated	  with	  hypothermia	  when	  compared	  to	  normothermic	  
babies	   (Gluckman	   et	   al.,	   2005;	   Shankaran	   et	   al.,	   2005;	   Azzopardi	   et	   al.,	   2009;	  
Simbruner	  et	  al.,	  2010;	  Jacobs	  et	  al.,	  2011).	  	  
	  
Mechanisms	  of	  therapeutic	  hypothermia	  
• Reduction	  of	  brain	  metabolism	  ,	  prevention	  of	  edema	  	  
• Decrease	  of	  energy	  requirement	  
• Reduction	  of	  nitric	  oxide	  and	  cytotoxic	  amino	  acid	  accumulation	  
• Inhibition	  of	  inflammatory	  cascade	  
• Suppression	  of	  free	  radicals	  activity	  and	  lipid	  peroxidation	  
• Amelioration	  of	  secondary	  energy	  failure	  
• Reduction	  of	  necrosis	  and	  apoptosis	  
• Amelioration	  of	  brain	  damage	  
Table	  1.5:	  Summary	  of	  mechanisms	  involved	  in	  therapeutic	  hypothermia	  (adapted	  from	  
Shankaran,	  2012).	  
	  
Pre-­‐clinical	  treatments:	  future	  potential	  	  
Unfortunately,	  therapeutic	  hypothermia	  is	  not	  sufficient	  to	  treat	  babies	  at	  risk	  of	  
cerebral	  palsy	  and	  other	  neurological	  deficits,	  as	  it	  only	  provides	  a	  certain	  degree	  
of	  protection,	  with	  11%	  reduction	   in	  mortality	  and	  morbidity	   (Robertson	  et	  al.,	  
2012),	   highlighting	   the	   need	   for	   identification	   of	   other	   therapeutic	   agents	   are	  
required	   that	   can	   be	   used	   either	   alone,	   or	   in	   combination	   with	   hypothermia.	  
Furthermore,	   several	   studies	   investigate	   various	   pharmacological	   and	   non-­‐
pharmacological	  agents	  that,	  according	  to	  their	  mechanisms	  of	  action,	  could	  be	  




Primary	  neuroprotection	  –	  preventing	  damage	  
There	  are	  currently	  no	  clinically	  established	  interventions	  that	  can	  be	  given	  prior	  
to	  the	  hypoxic	  event,	  or	  prevention	  of	  its	  neurotoxic	  cascade,	  which	  could	  assist	  
in	  preventing	  or	  ameliorating	  subsequent	  brain	  damage.	  	  
	  
Allopurinol	  –	   hypoxia-­‐ischaemia	   leads	   to	   the	   damaging	   release	   of	   free	   radicals	  
such	   as	   hydroperoxide,	   hydroxyl	   radical,	   peroxynitrite	   and	   superoxide	   radical.	  
The	  enzyme	  xanthine	  oxidase	  is	  considered	  a	  primary	  source	  of	  superoxide,	  and	  
therefore,	   its	   inhibition	   could	   potentially	   provide	   a	   degree	   of	   neuroprotection.	  
Allopurinol	   has	   a	   free	   radical	   scavenger	   property	   and	   is	   a	   xanthine	   oxidase	  
inhibitor.	   When	   used	   in	   high	   concentrations,	   allopurinol	   has	   shown	   to	   also	  
scavenge	   hydroxyl	   radicals	   and	   prevent	   free	   radicals	   formation	   (Kelen	   and	  
Robertson,	   2010).	   In	   the	   neonatal	   rat,	   allopurinol	   administration	   15	   minutes	  
after	  hypoxia-­‐ischaemia	  has	  led	  to	  a	  reduction	  in	  cerebral	  oedema	  and	  long-­‐term	  
brain	  injury	  (Palmer	  et	  al.,	  1993).	  
	  
Magnesium	   –	   magnesium	   sulfate	   is	   an	   NMDA	   receptor	   antagonist,	   therefore	  
preventing	   excitotoxicity	   via	   inhibition	   of	   excessive	   calcium	   influx	   into	   the	   cell	  
(Spandou	  et	  al.,	  2007).	  Magnesium	  has	  also	  been	  associated	  with	  direct	  action	  on	  
mitochondrial	  activity,	  anticonvulsant	  properties	  and	   increase	   in	  cerebral	  blood	  
flow	  (Enomoto	  et	  al.,	  2005).	  A	  randomized,	  controlled	  trial	  of	  magnesium	  sulfate,	  
where	   the	   fetus	   of	   women	   at	   risk	   of	   preterm	   delivery	   was	   exposed	   to	  
magnesium,	  has	  shown	  a	  reduction	  in	  the	  risk	  of	  cerebral	  palsy	  among	  survivors	  
(Rouse	   et	   al.,	   2008).	   A	   second	   study	  by	  Doyle	   et	   al.,	   has	   shown	   that	   antenatal	  
magnesium	  sulfate	  administration	  to	  women	  at	  risk	  of	  preterm	  birth,	  has	  again	  





Melatonin	   –	  melatonin,	   a	   neurohormone	   secreted	   from	   the	   pineal	   gland,	   has	  
shown	  to	  significantly	  reduce	  infarct	  volume.	  This	  is	  considered	  to	  be	  a	  result	  of	  
its	  ant-­‐oxidant	  property,	  as	  melatonin	  has	  shown	  to	   reduce	   infarct	  volume	  and	  
levels	  of	  oxidative	  stress	  without	  affecting	  blood-­‐brain	  barrier	   integrity	   in	  adult	  
rat	   models	   of	   middle	   cerebral	   artery	   occlusion	   (Sinha	   et	   al.,	   2001;	   Pei	   et	   al.,	  
2003).	   In	   fetal	   rat	  models	  of	  bilateral	  utero-­‐ovarian	  artery	  occlusion,	  melatonin	  
has	   also	   shown	   a	   neuroprotective	   effect	   with	   reduction	   of	   oxidative	  
mitochondrial	  dysfunction	  within	  the	  brain	  (Wakatsuki	  et	  al.,	  2001).	  Melatonin	  is	  
also	  neuroprotective	  in	  the	  neonatal	  mouse	  (Husson	  et	  al.,	  2002),	  however,	  more	  
recent	   studies	   have	   shown	   that	   melatonin	   protection	   may	   also	   be	   due	   to	  
inhibition	   of	   inflammatory	   response	   following	   hypoxia-­‐ischaemia	   (Pei	   and	  
Cheung,	   2004).	   Sheep	   hypoxia-­‐ischaemia	   studies	   have	   shown	   the	   beneficial	  
effect	  of	  melatonin	  administration	  both	  directly	   into	   fetus	  and	   into	   the	  mother	  
(Miller	  et	  al.,	  2005;	  Welin	  AK	  et	  al.,	  2007).	  Furthermore,	  melatonin	  also	  reduced	  
brain	   injury	   in	   a	   study	   using	   LPS-­‐sensitization	   prior	   to	   hypoxia-­‐ischaemia.	   This	  
study	  showed	  that	  another	  free	  radical	  scavenging	  agent,	  N-­‐acetylcysteine	  (NAC)	  
provides	   a	   higher	   degree	   of	   neuroprotection	   in	   this	   synergistic	  mode	   of	   injury	  
(Wang	  et	  al.,	  2006).	  However,	  NAC	  has	  been	  associated	  with	  adverse	  reactions	  in	  
humans,	  thus	  limiting	  its	  use	  in	  humans	  (Heard,	  2008),	  whereas	  melatonin	  shows	  
minimal	  toxicity	  in	  humans	  (Lin	  and	  Lee,	  2009).	  
	  
Xenon	  –	  this	  is	  a	  noble	  gas	  occurring	  in	  Earth’s	  atmosphere.	  Xenon	  is	  not	  only	  a	  
safe	   anesthetic,	   but	   a	   study	   by	   Franks	   et	   al.	   has	   shown	   its	   role	   as	   a	  
neuroprotective	  agent,	  via	   inhibition	  of	  the	  excitatory	  NMDA	  receptor	  channels	  
(Franks	  et	  al.,	  1998).	  Additionally,	  recent	  studies	  have	  shown	  that	  xenon	  reduces	  
isoflurane-­‐associated	   cell	   death	   (Ma	   et	   al.,	   2007).	   A	   study	  where	   laboring	   rats	  	  
were	   exposed	   to	   xenon	   four	   hours	   prior	   to	   intrauterine	   perinatal	   asphyxia	  
revealed	   that	   the	   pups	   had	   a	   reduction	   in	   c-­‐Fos	   expression	   in	   the	   dorsal	   horn	  




Secondary	  neuroprotection	  –	  therapeutic	  window	  
Experimental	   animal	   studies	   have	   identified	   that	   hypoxia-­‐ischaemia	  
encephalopathy	   is	  a	  biphasic	  brain	  energy	  failure	  form	  of	   insult,	  where	  delayed	  
neuronal	  cell	  death	  accounts	  for	  the	  larger	  part	  of	  cell	  death	  in	  this	  type	  of	  injury.	  
Therefore,	   therapeutic	   strategies	   targeting	   this	   latent	   window	   period	   could	  
possibly	   prevent	   or	   ameliorate	   secondary	   energy	   failure.	   Hypothermia	   has	  
already	   been	   established	   as	   a	   clinical	   standard	   treatment	   used	   to	   prevent	  
secondary	   energy	   failure.	   Other	   treatment	   candidates	   include	   the	  
aforementioned	  melatonin,	  xenon	  and	  allopurinol,	  as	  well	  as	  erythropoietin.	  
	  
Erythropoietin	   –	   studies	   using	   erythropoietin	   (EPO)	   after	   hypoxic-­‐ischaemic	  
insult	   have	   demonstrated	   its	   efficacy	   as	   a	   neuroprotective	   agent.	   This	  
glycoprotein	  hormone	   is	   known	   to	  not	  only	   control	  erythropoiesis,	  but	  also,	   to	  
modulate	   inflammatory	  response,	  as	  well	  as	  having	  vasogenic	  effects	   (Gonzales	  
and	   Ferriero,	   2007).	   Administration	   of	   erythropoietin	   following	   hypoxic-­‐
ischaemic	  insult	  leads	  to	  increase	  in	  oli-­‐godendrogenesis,	  thus	  attenuating	  white	  
matter	   injury	   and	   promoting	   neurogenesis	   (Iwai	   et	   al.,	   2010).	   Erythropoietin’s’	  
neuroprotective	  effect	  is	  thought	  to	  occur	  through	  a	  decrease	  in	  susceptibility	  to	  
glutamate	   toxicity	   together	   with	   stimulation	   of	   anti-­‐apoptotic	   factors	   and	  
reduction	   in	   inflammation	   and	   NO-­‐mediated	   injury	   (Palmer	   et	   al.,	   1999).	  
Furthermore,	  a	  randomized	  controlled	  study	  using	  167	  infants	  revealed	  that	  low-­‐
dose	   erythropoietin	   administration	   (300	   or	   500	   U/Kg)	   was	   deemed	   safe	   and	  
resulted	  in	  improved	  neurological	  outcome	  in	  sufferers	  of	  moderate	  and	  severe	  
neonatal	  encephalopathy	  at	  18	  months	  of	  age	  (Zhu	  et	  al.,	  2009).	  
	  
Tertiary	  neuroprotection	  –	  post-­‐injury	  recovery	  
Despite	   prevention	   of	   perinatal	   brain	   damage	   being	   the	   most	   desired	   for	   of	  
treatment,	   promotion	   of	   plasticity	   and	   repair	   are	   also	   important	   aspects	   in	  
neuroprotection,	  as	  quite	  often	  there	  is	  an	  absence	  of	  early	  markers	  of	  perinatal	  
brain	   damage.	   Endogenous	   capacity	   in	   the	   neonatal	   brain	   is	   reduced	   following	  
64	  
	  
hypoxic-­‐ischaemic	  injury;	  however	  recent	  studies	  have	  suggested	  the	  use	  of	  stem	  
cell	   transplantation	   to	   ameliorate	   brain	   damage	   (Velthove	   et	   al.,	   2009).	  
Additionally,	  use	  of	  mesenchymal	  stem	  cells	  have	  also	  been	  suggested,	  as	  these	  
cells	   are	   able	   to	   secrete	   several	   trophic	   factors,	   including	   colony	   stimulating	  
factor-­‐1	   (CSF-­‐1),	   vascular	   endothelial	   growth	   factor	   (VEGF)	   and	   brain	   derived	  
neurotrophic	  factor	  (BDNF)	  (Rivera	  et	  al.,	  2006;	  Wei	  et	  al.,	  2009).	  
	  
Combined	  therapies	  
The	   use	   of	   adjuvant	   therapies	   to	   hypothermia	   treatment	   has	   been	   extensively	  
studied,	   with	   some	   of	   the	   most	   promising	   neuroprotective	   agents	   including	  
melatonin	   and	   xenon.	   Melatonin	   has	   been	   shown	   to	   augment	   hypothermia	  
protection	   in	  a	  piglet	  model	  of	  perinatal	  asphyxia.	  Results	  of	  this	  study	  showed	  
that	  treated	  animals	  had	  improved	  cerebral	  metabolism	  and	  reduced	  cell	  death	  
(Robertson	  et	  al,	  2013).	  Another	  piglet	  model	  of	  hypoxia-­‐ischaemia	  showed	  that,	  
50%	   xenon	   started	   2	   hours	   after	   insult	   improved	   brain	   neuroprotection	   when	  
used	   in	   conjunction	   with	   hypothermia	   (Chandrasekaran	   et	   al.,	   2010).	   In	   a	  
neonatal	  rat	  hypoxic-­‐ischaemic	  study,	  using	  both	  hypothermia	  and	  xenon	  at	  40%	  
concentration	   or	   greater,	   has	   shown	   a	   synergistic	   neuroprotective	   effect,	   with	  
improved	   neuromotor	   function	   at	   30	   days	   of	   age,	   thus	   suggesting	   a	   long-­‐term	  
protection	  role	  (Ma	  et	  al.,	  2005).	  
	  
It	   is	   important	   to	  note	   that	  most	  of	   these	   treatments	   are	  only	   considering	   the	  
hypoxic-­‐ischaemic	  spectrum,	  and	  not	  the	  added	  damage	  caused	  by	  infection.	  It	  is	  
widely	  accepted	  that	  there	  is	  a	  low	  prevalence	  of	  neonatal	  encephalopathy	  to	  a	  
higher	   occurrence	   of	   maternal	   intrapartum	   pyrexia,	   which	   in	   turns	   makes	   a	  
randomized	   controlled	   trial	   to	   determine	   a	   neuroprotective	   effect	   in	  maternal	  
cooling	  difficult	  due	   to	  high	   recruiting	  numbers	   required.	  However,	   this	  matter	  
does	  need	  to	  be	  addressed,	  as	  this	  is	  a	  relatively	  common	  obstetric	  complication	  





It	   is	   now	   evident	   that	   part	   of	   the	   multifactorial	   aetiology	   of	   neonatal	  
encephalopathy	  is	  attributed	  to	  the	  modulating	  effect	  of	  infection	  to	  subsequent	  
hypoxic-­‐ischaemic	   insult.	  Furthermore,	  different	  synergistic	  animal	  models	  have	  
been	   able	   to	   consistently	   reproduce	   the	   brain	   injury	   patterns	   associated	   with	  
term	  neonatal	  encephalopathy.	  Unfortunately,	  despite	  advances	  in	  medical	  care	  
and	   scientific	   research,	   the	   number	   of	   cerebral	   palsy	   sufferers	   has	   remained	  
constant	  throughout	  the	  last	  20	  years.	  Therapeutic	  hypothermia	  is	  so	  far	  the	  only	  
clinically	  accepted	  treatment;	  however,	  its	  success	  is	  only	  moderate.	  In	  terms	  of	  
experimental	   therapies,	   a	   lot	   of	   different	   pharmacological	   and	   non-­‐
pharmacological	   agents	   are	   being	   tested	   and	   showing	   promising	   results.	  
However,	   there	  has	  been	  a	   constant	   increase	   in	   shift	   in	   this	   research,	  where	  a	  
number	   of	   research	   groups	   acknowledging	   that	   optimizing	   hypothermia	   with	  
adjuvant	   agents	   hold	   the	   highest	   promising	   in	   preventing	   or	   ameliorating	  




















AIMS	  OF	  THE	  PROJECT	  
	  
As	   outlined,	   perinatal	   brain	   damage	   is	   one	   of	   the	  main	   precursors	   to	   cerebral	  
palsy	   and	  other	   neurological	   disorders.	   Several	   studies	   have	   demonstrated	   the	  
involvement	   of	   infection/inflammation	   in	   the	   aetiology	   of	   perinatal	   brain	  
damage.	   Furthermore,	   there	   has	   been	   growing	   evidence	   demonstrating	   the	  
synergistic	  role	  of	  infection/inflammation	  and	  hypoxia-­‐ischemia,	  where	  infection	  
appears	   to	  sensitize	   the	   immature	  brain	   to	  subsequent	  hypoxic-­‐ischemic	   insult,	  
thus	   exacerbating	   neonatal	   brain	   damage	   and	   the	   risk	   of	   developing	   cerebral	  
palsy.	  
	  
Previous	  studies	  in	  this	  laboratory	  have	  demonstrated	  that	  the	  TNF	  family	  of	  pro-­‐
inflammatory	   cytokines	   consisting	   of	   TNFα,	   LTα	   and	   LTβ	   play	   a	   role	   in	   the	  
aetiology	   of	   perinatal	   brain	   injury.	   This	   original	   study	   demonstrated	   the	   up-­‐
regulation	   of	   these	   three	   cytokines	   following	   endotoxin-­‐sensitization	   alone.	  
Moreover,	  homozygous	  deletion	  of	  the	  whole	  gene	  cluster	  led	  to	  an	  abolishment	  
in	   microglial	   activation	   and	   consequent	   inflammation	   in	   the	   murine	   model	   of	  
infection/inflammation	  and	  hypoxic-­‐ischemic	  insult	  (Kendall	  et	  al.,	  2011b).	  
	  
Therefore,	   in	   this	   project	   we	   wanted	   to	   further	   characterize	   the	   role	   of	   the	  
individual	   cytokines	  members	   of	   the	   TNF	   cluster	   and	   investigate	  which	   one	   or	  
combination	  of,	  is	  mediating	  this	  LPS	  sensitization	  of	  the	  neonatal	  brain.	  For	  this	  
purpose,	  the	  study	  was	  divided	  into	  three	  parts:	  
	  
1. Test	   LPS-­‐mediated	   sensitization	   in	   multiple	   background	   mouse	   strains	  
(C57BL/6,	  129SVJ,	  BALB/c,	  CD1	  and	  FVB).	  As	  there	  would	  be	  a	  number	  of	  
transgenic	   strains	   required	   for	   the	   study,	   and	   hypoxic-­‐ischemic	   studies	  
have	  demonstrated	   the	  variability	  of	   the	  model,	  we	  wanted	   to	   first	   test	  
the	   efficacy	   of	   the	   experimental	   design,	   and	   see	   which	   strain	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background/s	   would	   provide	   the	   optimal	   model	   of	   combined	   infection	  
and	  hypoxic-­‐ischemic	  insult.	  
	  
2. In	   the	   second	  part,	  we	  wanted	   to	   identify	  which	  of	   the	   three	   cytokines	  
TNFα,	   LTα	   or	   LTβ	   is	   responsible	   for	   the	   LPS-­‐mediated	   sensitization	   to	  
subsequent	   hypoxia-­‐ischemia	   seen	   previously.	   For	   that,	   we	   would	   use	  
global	   single	   gene	   deletion	   for	   each	   of	   the	   three	   cytokines,	   as	   well	   as	  
deletion	   of	   TNFα	   gene	   in	   myeloid	   granulocytes	   and	   macrophages	   –	  
excluding	  microglial	  cells.	  
	  
3. Originally,	   the	   third	   part	   of	   this	   study	   would	   have	   consisted	   of	  
pharmacological	  inhibition	  of	  the	  identified-­‐mediating	  cytokine.	  However,	  
results	   on	   the	   individual	   cytokines	   deletion	   were	   dissimilar	   from	   what	  
was	  observed	  in	  the	  TNF	  cluster	  deletion.	  Since	  the	  TNF	  cluster	  deletion	  
also	  produces	  a	   very	   severe	   structural	   defect	  of	   the	  peripheral	   immune	  
system,	  a	  new	  approach	  was	  made,	  where	  instead	  we	  would	  look	  at	  the	  
acquired	  cellular	  immune	  system,	  and	  specifically,	  the	  T	  cell	  component.	  
The	   aim	   is	   to	   see	   whether	   or	   not	   deleting	   a	   key	   component	   of	   the	  
immune	  system	  would	  reproduce	  the	  same	  abolishment	  of	  LPS-­‐mediated	  











CHAPTER	  2:	  GENERAL	  MATERIALS	  &	  METHODS	  
	  
Animals	  
All	   animal	   experiments	   were	   carried	   out	   in	   accordance	   with	   the	   UK	   Animals	  
(Scientific	  Procedures)	  Act	  1986	  and	  approved	  by	   the	  Home	  Office.	  All	   animals	  
used	   in	   this	   project	   were	   housed	   in	   the	   UCL	   Biological	   Services	   Unit	   following	  
approved	   husbandry	   protocols.	   Experimental	   breeding	   pairs	   were	   mated	   in-­‐
house,	  and	  kept	  under	  standard	  conditions,	   i.e.	  with	  a	  12	  hour	   light-­‐dark	  cycle,	  
constant	   temperature	   (21-­‐23°C)	   and	  humidity	   (60%±5),	  with	   access	   to	  pelleted	  
food	  and	  water	  ad	  libitum.	  Several	  lines	  of	  wild	  type	  and	  genetically	  engineered	  
mice	   were	   used	   in	   this	   study,	   and	   were	   sourced	   from	   a	   number	   of	   different	  
laboratories	  and	  are	  summarised	  in	  Table	  2.1.	  
	  
Mouse	  strain	   Background	   Source	  
C57BL/6	   C57BL/6	   Charles	  River,	  UK	  
129SVJ	   129SVJ	   Charles	  River,	  UK	  
BALB/c	   BALB/c	   Charles	  River,	  UK	  
CD1	   CD1	   Charles	  River,	  UK	  
FVB	   FVB	   Charles	  River,	  UK	  
LTα	  global	   C57BL6/129SVJ	   The	  Jackson	  Laboratory,	  USA	  
LTβ	  global	   C57BL6/129SVJ	   The	  Jackson	  Laboratory,	  USA	  
TNFα	  global	   C57BL6/129SVJ	   The	  Jackson	  Laboratory,	  USA	  
TNFα	  flox	   C57BL/6	   Dr	   Sergei	   Nedospasov,	   Bundesinstitut	   für	  
Risikobewertung,	  Berlin,	  Germany	  
MLys	  CRE	   C57BL/6	   Dr	   Sergei	   Nedospasov,	   Bundesinstitut	   für	  
Risikobewertung,	  Berlin,	  Germany	  
Nude	   BALB/c	   Charles	  River,	  UK	  
Table	  2.1:	  Summary	  of	  wild	  type	  and	  transgenic	  mice.	  
	  
3Rs:	  replacement,	  reduction	  and	  refinement	  
Due	  to	  the	  nature	  of	   this	  study,	   the	  use	  of	  animals	  defined	  as	  protected	  under	  
the	   UK	   ASPA	   was	   essential.	   Every	   effort	   was	   made	   to	   comply	   with	   the	   3Rs	  
strategy	  of	  animal	  experimentation.	   	  Animals	  were	  mated	  after	  6	  weeks	  of	  age.	  
Good	  husbandry	  is	  part	  of	  refinement	  of	  animal	  experimentation	  and	  therefore	  
important	   to	  standardise:	  Cages	  were	  monitored	  on	  a	   regular	  basis	  by	   the	  BSU	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staff	  and	  myself	  not	  only	  for	  signs	  of	  pregnancy,	  but	  also	  for	  signs	  of	  stress	  and	  
sickness.	  Breeding	  pairs	  were	  kept	  to	  a	  maximum	  of	  3	  animals	  per	  cage	  (1	  male,	  
2	  females)	  to	  avoid	  crowding,	  as	  well	  as	  stamping	  on	  the	  litters.	  Once	  the	  pups	  
were	   injected	   with	   either	   LPS	   or	   saline,	   the	   males	   were	   separated,	   and	   only	  
returned	  once	  pups	  were	  collected	  for	  perfusion,	  in	  order	  to	  avoid	  cannibalism	  of	  
the	  litters.	  Spare	  heterozygotes	  were	  kept	  at	  a	  maximum	  of	  2/3	  per	  cage,	  and	  a	  
maximum	   of	   1	   cage	   with	   males	   and	   a	   second	   cage	   with	   females	   per	   strain.	  
Additionally,	   to	   improve	   refinement	   and	  avoid	  boredom,	  all	   cages	  had	  housing	  
with	  nesting	  material,	  one	  cardboard	  tube	  and	  one	  wood	  block.	  Enrichment	  diet	  
was	  scattered	  throughout	  the	  bedding	  every	  Friday.	   	  Experimental	  groups	  were	  
kept	  at	  around	  n=10	  as	  this	  sample	  size	  was	  demonstrated	  in	  previous	  studies	  in	  
our	  group	  to	  produce	  statistically	  significant	  results.	  Furthermore,	  the	  use	  of	  LPS	  
endotoxin	  -­‐	  a	  robust	  inducer	  of	  inflammation	  -­‐	  reduced	  the	  high	  variability	  seen	  
in	   the	   neonatal	   model	   of	   hypoxia-­‐ischaemia.	   The	   only	   instance	   where	   more	  
animals	  were	  used	  was	  in	  the	  NUDE	  study,	  as	  due	  to	  difficulty	  in	  breeding	  these	  
animals	  together	  with	  the	  extra	  cost	  of	  maintaining	  such	  animals	  in	  IVC	  cages	  in	  
quarantine	  rooms,	  we	  were	  unable	  to	  keep	  spare	  animals,	  and	  an	  extra	  litter	  was	  
obtained	   from	   two	   females	   before	   the	   experiment	   was	   terminated,	   for	   safety	  
measure.	  All	  experimental	  groups	  used	  the	  already	  established	   (in	  our	   lab)	  48h	  
post-­‐insult	  time	  point,	  thus	  reducing	  the	  need	  for	  more	  data	  sets,	  as	  our	  research	  
group	  has	  shown	  that	  this	  time	  point	  gives	  reliable	  changes	  in	  response	  to	  injury	  
in	  both	  HI	   versus	  naïve,	   as	  well	   as	  HI+LPS	  versus	  HI+saline.	   For	   the	  histological	  
assessments,	  5	  sections	  10	  sections	  apart	  were	  used	  per	  stain.	  As	  50	  consecutive	  
sections	  were	  collected	  (see	  cryostat	  sectioning),	  this	  allowed	  the	  possible	  use	  of	  
10	  different	  histological/immunohistological	  markers,	  thus	  avoiding	  the	  need	  to	  
use	  extra	  animals.	  Furthermore,	  all	  markers	  used	  represented	  relevant	  questions	  
to	   be	   addressed	   in	   this	  model	   of	   perinatal	   brain	   damage,	   once	   again	   ensuring	  
avoidance	  of	  unnecessary	  using	  extra	  animals	  (Kendall	  et	  al.,	  2006;	  Kendall	  et	  al.,	  




Global	  gene	  deletion	  
TNFα	   –	   This	   mutation	   was	   developed	   by	   replacing	   part	   of	   the	   muTNFα	   gene,	  
including	   the	   ATG	   translation	   initiation	   codon	   of	   the	   first	   exon,	   with	   a	  
MC1neiopA	   cassette.	   The	   construct	   was	   electroporated	   into	   129SVJ-­‐derived	  
embryonic	  stem	  cells	  (ESCs),	  and	  the	  correctly	  targeted	  ESCs	  were	   injected	  into	  
C57BL/6	   blastocysts.	   Resultant	   chimeras	   were	   consecutively	   crossed	   with	  
C57BL/6	  mice	   to	   achieve	  a	  homozygous	   colony	   (Pasparakis	   et	   al.,	   1996).	   These	  
homozygous	   TNFα	   KO	   mice	   were	   obtained	   from	   Jackson	   Laboratory,	   USA.	  
Animals	   were	   mated	   in-­‐house	   with	   wild	   type	   C57BL/6	   (Charles	   River,	   UK)	   to	  
obtain	   a	   F1	   heterozygote	   generation	   for	   breeding	   purposes.	   Heterozygous	  
breeding	  produced	  F2	  generation	  consisting	  of	  WT	  (controls),	  heterozygote	  and	  
homozygote	  (KO)	  animals	  for	  the	  TNFα	  gene	  deletion.	  Heterozygous	  pups	  were	  
not	  employed	  in	  this	  study.	  	  
	  
LTα	   –	   Targeted	   mutation	   of	   the	   LTα	   gene	   was	   attained	   through	   partial	  
replacement	   of	   LTα	   transcripts,	   introducing	   an	   earlier	   stop	   codon,	   with	   a	  
neomycin	  resistant	  cassette.	  Similarly	  to	  the	  TNFα	  mutation,	  the	  targeting	  vector	  
was	   electroporated	   into	   129SVJ-­‐derived	   ESCs,	   and	   successfully	   targeted	   ESCs	  
were	   injected	   into	   C57BL/6	   blastocysts.	   Continuous	   crossing	  with	   C57BL6	  mice	  
resulted	  in	  LTα	  homozygote	  generation	  (de	  Togni	  et	  al.,	  1994).	  Homozygous	  LTα	  
KO	   mice	   were	   obtained	   from	   Jackson	   Laboratory,	   USA.	   As	   with	   the	   TNFα	  
mutants,	   these	   animals	   were	  mated	   in-­‐house	  with	  wild	   type	   C57BL/6	   (Charles	  
River,	   UK)	   to	   obtain	   the	   F1	   heterozygote	   generation	   required	   for	   this	   study.	  
Heterozygous	  breeding	  pairs	  produced	  F2	  generation	  consisting	  of	  WT	  (controls),	  
heterozygote	   and	  homozygote	   (KO)	   animals	   for	   the	   specific	   LTα	  gene	  deletion.	  
Heterozygous	  pups	  were	  not	  included	  in	  this	  study.	  	  
	  
LTβ	   –	   In	   order	   to	   obtain	   LTβ	   mutants,	   a	   0.7	   kb	   fragment	   of	   the	   gene,	   thus	  
truncating	   the	   coding	   sequence	   at	   codon	   153,	   was	   replaced	   with	   a	   neomycin	  
resistant	   cassette.	   The	   construct	  was	   electroporated	   into	   129SVJ-­‐derived	   ESCs,	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and	  the	  effectively	  targeted	  ESCs	  were	  injected	  into	  C57BL6	  blastocysts	  similarly	  
to	   the	   development	   of	   both	   TNFα	   and	   LTα	   mutants	   (Koni	   et	   al.,	   1997).	  
Heterozygous	  LTβ	  (+/-­‐)	  mice	  were	  obtained	  from	  Jackson	  Laboratory,	  USA.	  These	  
animals	   were	   mated	   in-­‐house	   with	   C57BL/6	   (Charles	   River,	   UK)	   to	   obtain	   F1	  
generation	   containing	   the	   heterozygote	   animals	   required	   for	   this	   study.	  
Heterozygous	   breeding	   pairs	   produced	   F2	   generation	   comprising	   of	   WT	  
(controls),	  heterozygote	  and	  homozygote	  (KO)	  animals	  for	  the	  LTβ	  gene	  deletion.	  
Heterozygous	  littermates	  were	  not	  used	  in	  this	  study.	  	  
	  
Athymic	  nude	  mouse	  –	  The	  recessive	  nude	  (nu)	  mutation	  consists	  of	  a	  single	  base	  
pair	   (bp;	   G)	   deletion	   in	   the	   hepatocyte	   nuclear	   factor	   3	   (HNF-­‐3)/forkhead	  
homolog	   11	   gene	   (Segre	   et	   al.,	   1995),	   a	   member	   of	   the	   FOX	   gene	   family	  
(Kaestner	  et	  al.,	  2000).	  This	  spontaneous	  mutation	  results	  in	  lack	  of	  thymus,	  the	  
mice	   are	   unable	   to	   produce	   T	   cells,	   and	   that	   makes	   them	   immunodeficient.	  
Therefore,	   all	   nude	   animals	   were	   kept	   in	   individually	   ventilated	   cages	   (IVCs)	  
under	   quarantine	   for	   the	   duration	   of	   this	   study.	   Due	   to	   the	   nature	   of	   the	  
mutation	   leading	   to	   the	   nude	   phenotype	   (single	   base	   pair	   deletion),	  
pyrosequencing	   technology	   would	   be	   required	   to	   maintain	   a	   heterozygous	  
breeding	   strategy.	   Considering	   that	   this	   is	   a	   recessive	   mutation	   and	   lacks	  
phenotypic	   differences	   between	   WT	   and	   heterozygote	   animals,	   heterozygous	  
(nu/+)	  females	  were	  mated	  with	  a	  homozygous	  recessive	  (nu/nu)	  male	  (Charles	  
River,	  UK).	  Female	  homozygous	  nude	  mice	  are	  not	  effective	  breeders	  and	  fail	  to	  
lactate.	   	   Experimental	   cohorts	   consisting	   of	   homozygous	  mutants	   (nu/nu)	   and	  
littermate	   controls	   (nu/+)	   were	   generated	   with	   normal	   Mendelian	   frequency	  
(50:50).	  
	  
Cell-­‐specific	  gene	  deletion	  
Cell-­‐specific	  gene	  deletion	  animals	  were	  generated	  using	  Cre-­‐Lox	  recombination.	  
Transgenic	   mice	   carrying	   floxed	   allele	   for	   the	   TNFα	   gene	   were	   crossed	   with	  
MLys::CRE	  +/-­‐	  transgenic	  animals	  expressing	  cre	  recombinase	  under	  the	  myeloid-­‐
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expressing	   granulocyte/macrophage	   promoter	   (Clausen	   et	   al.,	   1999)	   twice	   in	  
order	   to	   obtain	   littermates	   that	  were	   TNFαflox/flox	  MLys	   CRE	   -­‐/-­‐	   (controls)	   or	  
TNFαflox/flox	   MLys	   CRE	   +/-­‐	   (knockouts)	   cell-­‐specific	   deletion.	   The	   loxP	   sites	  
flanking	  the	  TNFα	  gene	  are	  recognised	  by	  MLys::CRE	  recombinase,	  which	  excises	  
TNFα	   in	   MLys-­‐expressing	   granulocyte/macrophages	   (excluding	   microglia)	   to	  
generate	  homozygous	  cell-­‐type	  specific	  deletion	  of	  TNFα	  gene.	  	  
	  
Genotyping	  
Upon	   weaning,	   all	   transgenic	   mice	   used	   for	   breeding	   or	   colony	   maintenance	  
were	  identified	  through	  ear-­‐notch,	  and	  less	  than	  0.5mm	  of	  their	  tail-­‐tip	  biopsied	  
for	   DNA	   extraction.	   Experimental	   transgenic	   pups	   had	   the	   tail-­‐tips	   biopsied	   at	  
perfusion.	  DNA	  was	  extracted	  by	  adding	  20μl	  of	  20μg/ml	  Proteinase	  K	  (Promega,	  
UK)	  and	  750μl	  of	  extraction	  buffer	   (5%	  1M	  Tris,	  20%	  0.5M	  EDTA,	  1%	  SDS,	  3.3%	  
3M	  NaCl)	  to	  each	  tail	  and	  incubating	  at	  55°C	  overnight	  (O/N)	  in	  a	  rotating	  water-­‐
bath.	   Subsequently,	   samples	   were	   briefly	   vortexed	   and	   placed	   on	   ice,	   before	  
being	   centrifuged	   at	   16900g	   for	   4min.	   600μl	   isopropanol	   was	   added	   to	   the	  
supernatant	  and	  the	  solution	  mixed	  by	  inversion.	  Samples	  were	  centrifuged	  for	  a	  
further	   1min	   (16900g)	   with	   resulting	   pellets	   washed	   with	   70%	   ethanol	   (EtOH;	  
v/v;	  VWR,	  UK)	  and	  centrifuged	  for	  further	  1min	  (16900g).	  After	  air	  drying	  for	  2h,	  
the	  DNA	  samples	  were	   re-­‐suspended	   in	  50μl	  of	  Tris-­‐EDTA	  buffer	   (TE;	  Promega,	  
UK),	  incubated	  in	  a	  rotating	  water-­‐bath	  for	  one	  hour	  at	  65°C	  and	  stored	  at	  4°C.	  	  
	  
Polymerase	  chain	  reaction	  (PCR)	  DNA	  amplification	  was	  carried	  out	  using	  a	  25µl	  
Qiagen	   PCR	  master	   mix	   (2.5μl	   10X	   buffer,	   5μl	   Q	   solution,	   0.25μl	   25mM	   dNTP	  
(Fermentas,	  UK),	  0.125μl	  of	  each	  primer	  (1nM/μl;	  Invitrogen,	  UK;	  see	  table	  2.2),	  
0.2μl	  Taq	  polymerase)	  and	  1μl	  of	  DNA	  previously	  diluted	  to	  5µg/µl	  in	  DEPC	  water	  
according	   to	   DNA	   concentration	   using	   a	   FLUOstar	   Omega	   microplate	   reader	  
(BMG	  Labtech,	  UK).	  The	  thermocycling	  conditions	   for	  each	  PCR	  were	  optimised	  




PCR	   products	   were	   separated	   using	   2%	   agarose-­‐TAE	   gel	   electrophoresis.	   1g	  
agarose	  (Eurogentec)	  was	  added	  to	  50ml	  1x	  TAE	  buffer	  (0.4M	  Tris,	  0.2M	  sodium	  
acetate,	   20mM	  EDTA,	   pH),	   boiled	   and	   ethidium	  bromide	   (EtBr;	   Invitrogen,	  UK)	  
was	  added	   to	  a	   final	   concentration	  of	  0.2μg/ml.	  PCR	   samples	  were	  mixed	  with	  
loading	  dye	  (1x	  TAE,	  50%	  glycerol,	  0.025%	  bromophenol	  blue)	  immediately	  prior	  
to	   well	   loading	   (10µl)	   and	   run	   against	   a	   100bp	   DNA	   ladder	   (5µl;	   NEB,	   UK)	   for	  
40min	   at	   a	   constant	   voltage	   of	   100V.	   Samples	  were	   then	   visualised	  with	   a	  UV	  
transilluminator	  (BioDoc-­‐It	  220	  Imaging	  system,	  UVP,	  UK).	  
	  





LTα	  WT	  Fwd	   60°C	   229bp	   5’-­‐	  CCT	  TGT	  TGG	  TAA	  ACT	  TCT	  GCC	  -­‐3’	  
LTα	  WT	  Rev	   60°C	   	   5’-­‐	  AAG	  AGA	  GCA	  CAA	  GAC	  ATT	  GGG	  -­‐
3’	  
LTα	  MU	  Fwd	   60°C	   280bp	   5’-­‐	  CTT	  GGG	  TGG	  AGA	  GGC	  TAT	  TC	  -­‐3’	  
LTα	  MU	  Rev	   60°C	   	   5’-­‐	  AGG	  TGA	  GAT	  GAC	  AGG	  AGA	  TC	  -­‐
3’	  
LTβ	  Common	   60°C	   	   5’-­‐	  CCT	  GTA	  GTC	  CAC	  CAT	  GTC	  G	  -­‐3’	  
LTβ	  WT	  Rev	   60°C	   120bp	   5’-­‐	  GAG	  ACA	  GTC	  ACA	  CCT	  GTT	  G	  -­‐3’	  
LTβ	  MU	  Rev	   60°C	   330bp	   5’-­‐	  CCT	  GTT	  CAA	  TGG	  CCG	  ATC	  C	  -­‐3’	  
TNFα	  Common	   60°C	   	   5’-­‐	  TAG	  CCA	  GGA	  GGG	  AGA	  ACA	  GA	  -­‐
3’	  
TNFα	  WT	  Rev	   60°C	   183bp	   5’-­‐	  AGT	  GCC	  TCT	  TCT	  GCC	  AGT	  TC	  -­‐3’	  
TNFα	  MU	  Rev	   60°C	   318bp	   5’-­‐	  CGT	  TGG	  CTA	  CCC	  GTG	  ATA	  TT	  -­‐3’	  
TNFαflox	  41	   60°C	   Flx	  400bp	   5’-­‐	  TGA	  GTC	  TGT	  CTT	  AAC	  TAA	  CC	  -­‐3’	  
TNFαflox	  42	   60°C	   WT	  
350bp	  
5’-­‐	  CCC	  TTC	  ATT	  CTC	  AAG	  GCA	  CA	  -­‐3’	  
MLys	  Common	   60°C	   	   5’-­‐	  CTT	  GGG	  CTG	  CCA	  GAA	  TTT	  CTC	  -­‐3’	  
MLys	  WT	  Rev	   60°C	   345bp	   5’-­‐	  TTA	  CAG	  TCG	  GCC	  AGG	  CTG	  AC	  -­‐3’	  
MLys	  MU	  Rev	   60°C	   Near	  1kb	   5’-­‐	  CCC	  AGA	  AAT	  GCC	  AGA	  TTA	  CG	  -­‐3’	  
Table	   2.2:	   PCR	   reaction	   primers,	   annealing	   temperature,	   band	   size	   and	   sequences.	  
Abbreviations:	  Fwd	  –	  forward,	  MU	  –	  mutant,	  Rev	  –	  reverse	  and	  WT	  –	  wild	  type.	  	  	  
	  
Because	  nude	  mice	  have	  a	  second	  defect,	  i.e.,	  are	  born	  with	  functional	  but	  faulty	  
hair	  growth	  follicles,	  resulting	  in	  a	  hairless	  appearance,	  their	  genotype	  could	  be	  










	  Figure	   2.1:	   Untyped	   Nude	   Mice	   are	  
macroscopically	   differentiated	   at	   P9	   prior	   to	  
perfusion.	   Mice	   heterozygous	   (nu/+)	   for	   the	  
nude	  mutation	  are	  physically	  larger	  and	  covered	  
with	   white	   fur,	   whereas	   homozygous	   (nu/nu)	  








Levine	   first	  demonstrated	   the	  need	   to	  combine	  hypoxic	  and	   ischemic	   insults	   in	  
order	   to	   cause	   significant	   lesion	   to	   the	   adult	   rat	   brain.	   Surviving	   rats	   showed	  
considerable	  histological	  damage	  to	  the	  cerebral	  cortex,	  striatum	  and	  thalamus,	  
with	   the	   hippocampus	   being	   the	  most	   severely	   affected	   region.	   However,	   the	  
corpus	   callosum	   and	   corpus	   striatum	   white	   matter	   tracts	   remained	   largely	  
unaffected	   (Levine,	   1960).	   Rice	   et	   al	   (1981)	   then	   adapted	   this	   model	   and	  
generated	  a	  neonatal	  HI	  model.	  Postnatal	  day	  7	   (P7)	   rats	  underwent	  unilateral	  
carotid	   artery	   occlusion	   by	   surgical	   ligation	   (ischaemia)	   followed	   by	   3.5h	  
exposure	  to	  8%	  oxygen	  (hypoxia).	  This	  combined	  HI	  insult	  resulted	  in	  grey	  matter	  
damage	  in	  a	  manner	  similar	  to	  the	  adult	  rat	  model,	  as	  well	  as	  substantial	  WMI	  on	  
the	   ipsilateral	   side,	   and	   occasional	   appearance	   of	   WM	   damage	   on	   the	  





Our	   laboratory	  has	  since	  been	  able	   to	  successfully	  adapt	  and	  reproduce	  this	  HI	  
model	   using	   P7	   mice,	   where	   pups	   are	   exposed	   for	   a	   total	   of	   either	   30min	  
(moderate)	  or	  60min	  (severe)	  hypoxic	  insult	  (Kendall	  et	  al.,	  2011a).	  Animals	  were	  
anaesthetised	  with	  isoflurane	  (5%	  induction,	  1.5%	  maintenance,	  1L/min;	  Abbott,	  
UK).	  Following	  a	  midline	  incision	  to	  the	  neck	  the	  left	  common	  carotid	  artery	  was	  
exposed	   and	   permanently	   occluded	   through	   ligation	   with	   8/0	   polypropylene	  
suture	   (Ethicon,	   UK).	   The	   incision	   was	   closed	   using	   tissue	   glue.	   Pups	   were	  
allowed	   to	   recover	   at	   36°C	   before	   being	   returned	   to	   their	   respective	   dams	   to	  
nurse	   for	  1.5h.	  The	  animals	  were	  then	  placed	   in	  a	  sealed	  hypoxic	  chamber	  and	  
exposed	   to	  a	   constant	   flow	  of	  humidified	  8%	  oxygen/92%	  nitrogen	   (3L/min)	   at	  
36°C	  for	  30min.	  Finally,	  after	  10min	  recovery	  at	  36°C,	  the	  mice	  were	  returned	  to	  
their	  dams	  until	  point	  of	  sacrifice.	  	  
	  
LPS	  injection	  
Our	   research	   group	   has	   effectively	   established	   a	   synergistic	   model	   of	  
infection/inflammation	  and	  HI.	  Administration	  of	  LPS	  at	  0.3µg/g	  12h	  prior	  to	  HI	  
(30min	  8%	  oxygen	  exposure)	  insult	  resulted	  in	  a	  significant	  exacerbation	  of	  tissue	  
loss	  compared	  to	  either	  HI	  or	  LPS	  alone	  (Kendall	  et	  al.,	  2011b).	  For	  the	  purposes	  
of	   this	   study,	  a	  new	  batch	  of	   LPS	  was	   titrated.	   Intraperitoneal	   (ip)	   injections	  of	  
0.3μg/g,	  0.6μg/6,	  1μg/g	  and	  10μg/g	  were	  administered	  followed	  12h	  later	  by	  HI	  
insult	  and	  48h	  survival.	  	  Animals	  that	  received	  03-­‐0.6μg/g	  were	  associated	  with	  a	  
survival	   rate	   of	   6/6,	   4/6	   at	   1μg/g	   and	   0/6	   at	   10μg/g.	   This	   gave	   optimal	  
sensitization	  dose	  of	  0.6µg	  in	  10µl/g	  BW	  administered	  intraperitoneally	  (titration	  
was	   performed	   by	   Dr	   Mariya	   Hristova	   prior	   to	   the	   commencement	   of	   this	  
project,	  see	  Figure	  2.2)	  12h	  prior	  to	  HI	   insult.	  All	  pups	  were	  randomly	  allocated	  
to	  receive	  ip	  injections	  of	  either	  LPS	  (Escherichia	  coli,	  serotype	  055:B5;	  Fluka,	  UK)	  





























Figure	  2.2:	  Comparison	  between	  
saline-­‐	   and	   LPS-­‐treated	  
(0.6µg/g)	   mice.	   Comparison	  
between	  saline-­‐	  and	  LPS-­‐treated	  
(0.6µg/g)	   mice.	   Saline	   controls	  
(n=6)	  had	  limited	  infarct	  volume	  
48h	   post	   combined	   LPS+HI	  
injury,	   whereas	   LPS	   pre-­‐treated	  
littermates	   (n=6)	   demonstrates	  
a	   significant	   increase	   in	   infarct	  
volume	   as	   demonstrated	   by	  
Nissl	   stain	   used	   for	   volume	  
measurement	   (p<0.05).	   Graph	  
reproduced	  with	  permission.	  	  
	  
Perfusion	  fixation	  
48h	  post-­‐HI	  animals	  were	  terminally	  anaesthetised	  with	  ip	  injection	  of	  10µl/g	  BW	  
pentobarbital	  sodium	  (Euthatal,	  Merial,	  UK).	  Paw	  withdrawal	  reflex	  was	  used	  to	  
determine	  extent	  of	  anaesthesia	  and	  tail-­‐tips	  collected	  for	  genotyping.	  A	  midline	  
incision	  was	  made	  under	  the	  xiphoid	  process,	  exposing	  the	  peritoneal	  cavity.	  The	  
diaphragm	  was	   incised	   at	   the	   nearest	   its	   junction	  with	   the	   anterior	   abdominal	  
wall.	   The	   ribcage	   was	   cut	   laterally	   and	   lifted	   exposing	   the	   heart.	   A	   26-­‐gauge	  
needle	  attached	  to	  a	  peristaltic	  pump	  (Gilson,	  UK)	  was	  inserted	  at	  the	  base	  of	  the	  
apex	   of	   the	   heart	   and	   into	   the	   left	   ventricle.	   A	   solution	   of	   cold	   (4°C)	   4%	  
paraformaldehyde	   in	   0.1M	   phosphate	   buffer	   (PFA/PB,	   pH	   7.4)	   was	   pumped	  
through	  the	  heart	   for	  2.5min	  at	  a	  constant	   flow	  rate	  of	  0.02L/min.	  Brains	  were	  
extracted	  and	  post-­‐fixed	   in	  4%	  PFA/PB	  on	  a	  rotator	  (8	  rpm)	  for	  1h,	  followed	  by	  
overnight	  rotation	  immersion	  in	  30%	  sucrose	  (Fluka,	  UK)	  for	  cryoprotection.	  The	  
forebrains	  were	  frozen	  on	  dry	  ice	  (BOC,	  UK)	  for	  further	  use	  (Möller	  et	  al.,	  1996).	  	  
	  
Cryostat	  sectioning	  
Frozen	  forebrain	  sections	  were	  fixed	  onto	  a	  Leica	  CM	  1900	  cryostat	  chuck	  using	  
optimal	   cutting	   temperature	   (OCT)	   compound	   (Tissue	   Tek,	   Netherlands).	   The	  
chuck	  temperature	  was	  set	  at	  -­‐15°C	  whereas	  the	  chamber	  temperature	  was	  set	  
at	   -­‐20°C.	   A	   small	   circular	   whole	   was	   punctured	   through	   the	   lower	   half	   of	   the	  
contralateral	  hemisphere	  using	  a	  26-­‐gauge	  needle	  to	  allow	  distinction	  between	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the	   ipsilateral	   and	   contralateral	   brain	   hemispheres.	   50	   sequential	   coronal	  
sections	   of	   40µm	   thickness,	   starting	   from	   the	   fusion	   point	   of	   the	   corpus	  
callosum,	   were	   collected	   onto	   labelled	   0.5%	   gelatinised	   glass	   slides	   (Thermo	  
Scientific,	  UK)	  and	  stored	  at	  -­‐80°C.	  
	  
Immunohistochemistry	  
Brain	   sections	  were	   retrieved	   from	   -­‐80°C,	   rehydrated	   in	   double	   distilled	  water	  
(ddH2O)	  and	  spread	  flat	  onto	  the	  slide	  under	  a	  dissection	  microscope	  using	  fine	  
brushes.	   After	   fan	   drying	   for	   40min	   at	   room	   temperature	   (RT),	   sections	   were	  
circled	  with	  PAP	  pen	  (DAKO,	  Cambridgeshire),	  then	  incubated	  for	  5min	  in	  4%	  PFA	  
and	  transferred	  into	  0.1M	  PB.	  For	  antigen	  retrieval,	  sections	  were	  immersed	  for	  
2min	  each	   in	  50%	  acetone,	  100%	  acetone,	  50%	  acetone,	  twice	   in	  0.1M	  PB,	  and	  
once	  in	  0.1%	  bovine	  serum	  albumin/0.1M	  PB	  (PB/BSA)	  (Sigma,	  UK).	  The	  sections	  
were	  then	  blocked	  in	  5%	  goat	  serum	  (Sigma,	  UK)	  in	  PB	  for	  30min	  at	  RT	  to	  match	  
the	  source	  of	  the	  secondary	  antibody.	  The	  block	  was	  removed	  and	  the	  sections	  
were	   incubated	   with	   primary	   antibody	   O/N	   at	   4°C	   using	   dilutions	   obtained	  
through	  previous	  titration.	  
	  
On	  day	  2,	  the	  primary	  antibody	  was	  washed	  from	  the	  slides	  by	  serial	  immersions	  
in	  PB/BSA,	  PB,	  PB	  and	  PB/BSA.	  The	  appropriate	  biotinylated	  secondary	  antibody	  
was	   pre-­‐incubated	   with	   mouse	   serum	   (1:50;	   Serotec,	   UK)	   for	   30min	   at	   37°C	  
before	   diluted	   to	   1:100	   in	   PB/BSA.	   The	   sections	  were	   then	   incubated	  with	   the	  
secondary	  antibody	  for	  1h	  at	  RT	   (see	  table	  2.3	   for	   list	  and	  source	  of	  antibodies	  
used).	  Sections	  were	  washed	  by	  consecutive	   immersion	   in	  PB/BSA,	  PB/BSA,	  PB,	  
PB	  and	   incubated	  for	  1h	  at	  RT	  with	  Avidin-­‐Biotinylated	  horse	  radish	  peroxidase	  
Complex	   (ABC;	   1:100;	   Vector,	   UK).	   The	   sections	   were	   washed	   in	   4	   changes	   of	  
10mM	  PB	  and	   the	   reaction	  was	   visualized	  with	  diaminobenzidine	   (DAB;	   Sigma,	  
UK)	  and	  hydrogen	  peroxide	  (H2O2;	  Sigma,	  UK).	  This	  reaction	  mixture	  consisted	  of	  
0.5	  g/l	  DAB,	  1:3000	  dilution	  of	  30%	  H2O2	  in	  PB,	  and	  allowed	  to	  react	  for	  3-­‐4min	  at	  
RT.	  The	  intensity	  of	  the	  staining	  was	  monitored	  under	  a	  light	  microscope	  (Zeiss).	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DAB	  reaction	  was	  stopped	  by	  immersing	  the	  slides	  once	  in	  10mM	  PB,	  and	  twice	  
in	  ddH2O.	  After	  re-­‐spreading	  and	  drying	  at	  RT,	  the	  sections	  were	  immersed	  3x	  in	  
xylene	  and	  mounted	  on	  a	  glass	  cover	  slip	  using	  Depex	  (BDH,	  UK).	  
	  
Antigen	   Antibody	   Dilution	   Manufacturer	  
	   Primary	   	   	  
Alpha	  M	  
(αmβ2	  integrin)	  
Monoclonal	   Rat	   Anti	   Mouse	  
CD11b	  
1:5000	   Serotec,	  UK	  
Glial	   fibrillary	   acidic	  
protein	  (GFAP)	  
Polyclonal	  Rabbit	  Anti	  GFAP	   1:6000	   Dako,	  UK	  
	   Secondary	   	   	  
Rabbit	  Ig	   Biot.	  anti-­‐rabbit	  IgG,	  	  
goat	  polyclonal	  
1:100	   Vector,	  UK	  
Rat	  Ig	   Biot.	  anti-­‐rat	  IgG,	  	  
goat	  polyclonal	  
1:100	   Vector,	  UK	  
Table	  2.3:	  List	  of	  antibodies	  used	  for	  immunohistochemistry.	  
	  
Antibody	  specificity	  
The	  specificity	  raised	  against	  αMβ2	  integrin	  has	  been	  previously	  confirmed	  in	  our	  
laboratory	   using	   appropriate	   KO	   mice,	   where	   homozygous	   mutants	  
demonstrated	   a	   lack	   of	   microglial	   αM	   immunoreactivity	   throughout	   the	   brain	  
(Makawana	  et	  al.,	  2009).	  The	  GFAP	  antibody	  used	  in	  the	  current	  study	  is	  also	  well	  
defined	  with	  long	  established	  functional	  characterization	  (Eng	  et	  al.,	  2000).	  
	  
Terminal	  Transferase-­‐Mediated	  d-­‐UTP	  Nick	  End-­‐Labelling	  (TUNEL)	  
Sections	   were	   rehydrated,	   spread	   and	   fixed	   as	   described	   in	   the	   above	  
immunohistochemistry	   protocol.	   The	   slides	   were	   then	   incubated	   in	   3%	   H2O2in	  
methanol	   (15min),	   and	  washed	   in	   0.1M	  PB.	   The	   antigen	   retrieval	   followed	   the	  
IHC	   protocol.	   Slides	   were	   incubated	   with	   terminal	   deoxytransferase	   (TdT)	   and	  
deoxyuridine	  triphosphate	  (dUTP)	  solution	  (0.1%	  TdT,	  0.15%dUTP,	  1%	  cacodylate	  
buffer;	   Roche,	   UK)	   for	   2h	   at	   37°C.	   The	   reaction	   was	   stopped	   in	   TUNEL	   stop	  
solution	  (300mM	  NaCl,	  300mM	  Sodium	  Citrate)	  for	  10min.	  Slides	  were	  washed	  in	  
3x	   0.1M	   PB	   and	   incubated	   for	   1h	   at	   RT	   in	   ABC	   solution.	   Sections	   were	   then	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washed	  4	  times	  in	  10mM	  PB	  and	  the	  reaction	  was	  visualized	  using	  DAB	  prepared	  
with	  cobalt	  nickel	  in	  the	  presence	  of	  H2O2	  for	  3-­‐4min.	  Reaction	  was	  stopped	  and	  
slides	  covered	  as	  described	  previously.	  
	  
Nissl	  staining	  
Sections	  were	  rehydrated	  in	  ddH2O,	  spread	  and	  allowed	  to	  dry	  completely.	  Slides	  
were	  then	  fixed	  in	  4%	  FA	  (BDH,	  UK)	  O/N	  followed	  by	  70%	  EtOH	  O/N.	  Cresyl	  violet	  
solution	   (1%)	   was	   prepared	   using	   4g	   cresyl	   violet	   powder	   (BDH,	   UK)	   in	   40ml	  
100%	   EtOH,	   shaken	   and	   inverted	   for	   15min.	   This	  mixture	  was	   added	   to	  warm	  
360ml	   ddH2O	   and	  mixed	   on	   a	  warmed	  magnetic	   stirrer	   plate	   for	   20min.	   Once	  
cooled,	  the	  solution	  was	  filtered	  O/N	  using	  Whatman	  size	  4	  filter	  paper.	  On	  day	  
3,	  slides	  were	   immersed	   in	  the	  1%	  cresyl	  violet	  solution	  for	  3min.	  Excess	  cresyl	  
violet	  solution	  was	  removed	  by	  washing	  twice	  in	  running	  water.	  The	  slides	  were	  
then	   dehydrated	   by	   consecutive	   immersion	   (2min	   each)	   in	   increasing	  
concentrations	  of	  EtOH	  (70%,	  90%,	  96%,	  96%	  with	  glacial	  acetic	  acid	  (10	  drops,	  
de-­‐stain),	   100%),	   isopropanol,	   and	   three	   washes	   in	   xylene.	   Slides	   were	   then	  





From	  each	   forebrain,	  5	  Nissl	   stained	  sections	  400µm	  apart	  were	  photographed	  
using	   x1	  magnification	   and	   imported	   into	  Optimas	   6.5	   image	   analysis	   software	  
(MediaCybernetics,	  Bothwell,	  WA).	  As	  cresyl	  violet	  labels	  both	  extra	  nuclear	  RNA	  
granules	   and	   cell	   nuclei,	   the	   intact	   areas	   of	   the	   dorsoparietal	   cortex,	   pyriform	  
cortex,	   hippocampus,	   striatum,	   thalamus	   and	   external	   capsule	   regions	   were	  
delineated	   bilaterally	   using	   the	   free-­‐hand	   tool.	   The	   area	   in	   pixel	  was	   obtained	  
using	  the	  histogram	  tool	  (see	  Figure	  2.3),	  and	  converted	  into	  mm2	  in	  Excel.	  The	  
volume	  was	  calculated	  by	  multiplying	  the	  area	  in	  mm2	  by	  400µm.	  These	  volumes	  
were	   used	   to	   calculate	   the	   percentage	   of	   intact	   forebrain	   tissue	   as	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ipsilateral/contralateral	   volume	   x	   100,	   or	   infarct	   size	   using	   the	  
contralateral/ipsilateral	  volume	  x	  100	  formula.	  	  
	  
	  
Figure	   2.3:	   Nissl	   staining	   infarct	   volume	   measurement.	   The	   represented	   region	   of	   interest,	  
ipsilateral	  hippocampus	  was	  delineated	  using	  the	  free	  hand	  tool	  (green	  delineation	  indicated	  by	  
black	   arrow).	   Luminance	   histogram	   was	   reviewed	   to	   ensure	   a	   0-­‐255	   range	   (blue	   box).	   Count	  
values	   (red	   box)	   were	   transferred	   into	   an	   Excel	   spread	   sheet	   for	   conversion	   and	   assessment.	  
Contralateral	   hemisphere	   (right)	   appears	   intact	   following	   LPS-­‐sensitization	   to	   subsequent	  
hypoxic-­‐ischemic	  insult	  (C57BL/6	  wild	  type	  animal).	  
	  
Injury	  score	  
Microglial	   activation	   (αM	   immunoreactivity)	   and	   neuronal	   cell	   loss	   (Nissl	   stain)	  
were	   scored	   using	   a	   scoring	   system	   previously	   established	   in	   our	   laboratory	  
(Kendall	  et	  al.,	  2006)	  on	  a	  light	  microscope	  at	  x10	  magnification	  (see	  Figure	  2.4).	  
The	  semi-­‐quantitative	  scoring	  system,	  as	  well	  as	  the	   infarct	  volume	  assessment	  
was	   performed	   blindly	   in	   the	   dorsoparietal	   cortex,	   pyriform	   cortex,	  
hippocampus,	  striatum	  and	  thalamus	  for	  both	  αM	  and	  Nissl	  stains.	  The	  external	  
capsule	  was	  assessed	  only	  for	  the	  αM	  stain	  but	  not	  for	  Nissl	  due	  to	  lack	  of	  Nissl	  
bodies	   outside	   neuronal	   soma.	  A	   scale	   of	   0-­‐4	  was	   used	   for	   both	  αM	  and	  Nissl	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individually,	  as	  described	  on	  table	  2.4,	  and	  the	  two	  score	  were	  combined	  to	  give	  
a	  total	  of	  0-­‐8	  point	  injury	  score.	  	  
	  
Score	   alphaM	  immunoreactivity	  
0	   No	  microglial	  activation	  
1	   Focal	  activation	  
2	   Mild	  diffuse	  activation,	  occasional	  amoeboid	  macrophages	  present	  
3	   Widespread	   activation,	   predominant	   amoeboid	   macrophages	  
present	  
4	   Tissue	  loss	  
Score	   Nissl	  (Cresyl	  Violet)	  Staining	  
0	   No	  damage	  
1	   Minimal	  evidence	  of	  damage	  with	  no	  discernible	  infarct	  
2	   Small	  infarct	  (<50%)	  of	  the	  affected	  brain	  region	  
3	   Large	  infarct	  (	  >50%)	  of	  the	  affected	  brain	  region	  
4	   Total	  neuronal	  cell	  loss	  
Table	   2.4:	   Brain	   Injury	   Score.	   There	   is	   a	   direct	   correlation	   between	   the	   level	   of	   microglial	  
activation	  and	  neuronal	  cell	  loss	  (adapted	  from	  Kendall	  et	  al.,	  2006).	  
	  
	  
Figure	   2.4:	   αM	   and	   Nissl	   immunoreactivity	   grades	   in	   the	   dorsoparietal	   cortex.	   Brain	   regions	  
were	  scored	   for	  αM	   immunoreactivity	  based	  on	  different	  appearance	  and	  morphology	  as	  none	  
(A),	   focal	   ramified	   (B),	   mild	   diffuse	   predominantly	   ramified	   (C),	   widespread	   predominantly	  
amoeboid	  (D)	  and	  total	  activation,	  predominantly	  amoeboid	  and	  accompanied	  by	  tissue	  loss	  (E).	  
Nissl	   scoring	  was	   distinguished	   as	   no	   damage	   (F),	  minimal	   damage	   (G),	   small	   infarct	   (H),	   large	  
infarct	  (I)	  and	  total	  neuronal	  cell	  loss	  along	  with	  tissue	  loss	  (J).	  	  
	  
Cell	  death	  
The	  presence	  of	   cell	   death	   involving	  DNA	   fragmentation	  was	  detected	   through	  
quantification	  of	   the	  number	  of	  TUNEL	  positive	  nuclei	   in	  3	   separate	   fields	   (x20	  
magnification)	   for	   each	   of	   the	   six	   brain	   regions	   (dorsoparietal	   cortex,	   pyriform	  
cortex,	   hippocampus,	   striatum,	   thalamus	   and	   external	   capsule),	   on	   both	   the	  
ipsilateral	  and	  contralateral	  brain	  hemispheres.	  Subsequently,	  for	  each	  region,	  an	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average	   for	   the	   3	   separate	   fields	   was	   taken,	   as	   well	   as	   for	   the	   5	   sections	   per	  
brain,	  representing	  the	  number	  of	  TUNEL	  positive	  cells	  per	  region	  within	  a	  group.	  
	  
Figure	  2.5:	  TUNEL	  staining	  of	  an	  LPS-­‐treated	  mouse	  
brain.	  LPS	  treatment	  (0.6µg/g)	  followed	  by	  neonatal	  
hypoxia-­‐ischemia	   leads	   a	   substantial	   increase	   in	  
DNA	   fragmentation-­‐associated	   cell	   death	   in	   the	  
ipsilateral	   brain	   region	   (left).	   There	   are	   evident	  
TUNEL+	   cells	   in	   the	   ipsilateral	   dorsoparietal	   cortex,	  
hippocampus	   (highlighted),	   striatum,	   thalamus	   and	  
external	   capsule.	   Close-­‐up	   of	   the	   hippocampal	  





A	   Sony	   3CCD	   colour	   video	   camera	   (AVT-­‐Horn;	   Aachen,	   Germany)	   was	   used	   to	  
assess	  3	  fields	  at	  x20	  magnification	  for	  each	  of	  the	  dorsoparietal	  cortex,	  pyriform	  
cortex,	   hippocampus,	   striatum,	   thalamus	   and	   external	   capsule	   brain	   regions	   of	  
brain	   sections	   stained	   for	   the	   presence	   of	   the	   GFAP	   marker	   of	   astrogliosis.	  
Images	   of	   both	   ipsilateral	   and	   contralateral	   regions	   and	   for	   the	   glass	   were	  
captured	   at	   x20	   magnification,	   using	   Optimas	   6.5	   software.	   The	   individual	  
regions	   of	   the	   captured	   images	   were	   delineated	   using	   the	   free-­‐hand	   tool	   and	  
mean	  and	  standard	  deviation	  values	   for	  optical	   luminosity	  were	  obtained	  using	  
the	  histogram	  tool.	  The	  luminance	  histogram	  was	  consistently	  checked	  to	  ensure	  





Figure	  2.6:	  GFAP	  staining	  optical	  luminosity	  measurement.	  A:	  The	  represented	  region	  of	  interest,	  
ipsilateral	  white	  matter	  was	  delineated	  using	  the	  free	  hand	  tool	  (green	  delineation	  indicated	  by	  
black	  arrow),	  with	  luminance	  histogram	  reviewed	  at	  0-­‐255	  range	  (blue	  box).	  Mean	  and	  standard	  
deviation	   values	   (red	   box)	  were	   transferred	   into	   an	   Excel	   spread	   sheet	   for	   assessment.	  B:	   Full	  
brain	   section	  of	  wild	   type	  C57BL/6	  animal	   treated	  with	   LPS	   (0.6µg/g)	  prior	   to	  hypoxic-­‐ischemic	  
insult,	   with	   close	   up	   of	   region	   of	   interest.	   Denote	   that	   contralateral	   hemisphere	   (B,	   right)	  
demonstrates	   minimal	   GFAP	   synthesis	   following	   LPS-­‐sensitization	   to	   subsequent	   hypoxic-­‐
ischaemic	  insult.	  
	  
The	   regional	   raw	   intensity	   of	   the	   stain	   was	   determined	   using	   the	   mean	   –	  
standard	   deviation	   algorithm	   (Möller	   et	   al.,	   1996;	   Kloss	   et	   al.,	   2001)	   in	   both	  
ipsilateral	   and	   contralateral	   brain	   hemispheres.	   The	   background	   staining	  
intensity	  was	  also	  measured	  for	  each	  slide	  using	  the	  same	  algorithm.	  Final	  stain	  
intensity	   for	   each	   brain	   region	   was	   calculated	   by	   the	   difference	   between	   raw	  
staining	  and	  background	  staining	  intensities.	  Average	  values	  for	  each	  region	  were	  




The	   average	   ±	   standard	   error	   of	   the	   mean	   (SEM)	   was	   recorded	   for	   all	   data.	  
Statistical	   analysis	   for	   infarct	   size,	   alphaM	   immunoreactivity	   and	  neuronal	   loss,	  
TUNEL+	   counts	   and	   GFAP	   luminosity	   between	   all	   groups,	   and	   between	   the	  
ipsilateral	   and	   contralateral	   brain	   hemispheres,	   was	   initially	   tested	   for	   normal	  
distribution	   using	   PRISM	   GraphPad	   5.	   As	   none	   of	   the	   data	   appeared	   to	   be	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normally	  distributed,	  the	  Mann	  Whitney	  test	  was	  used.	  P<5%	  was	  considered	  to	  





























CHAPTER	   3:	   THE	   ROLE	   OF	   DIFFERENT	   STRAIN	   BACKGROUNDS	   IN	  
BACTERIAL	   ENDOTOXIN-­‐MEDIATED	   SENSITIZATION	   TO	  
SUBSEQUENT	  HYPOXIC-­‐ISCHAEMIC	  NEONATAL	  BRAIN	  DAMAGE	  	  
	  
Abstract	  
The	  development	  of	  transgenic	  mouse	  strains	  led	  to	  their	  application	  in	  models	  
that	  mimic	  human	  disease.	   Studies	   showed	  variability	   in	   the	  hypoxic-­‐ischaemic	  
mouse	   model	   as	   well	   as	   varying	   responses	   to	   the	   hypoxic-­‐ischaemic	   insult	   in	  
difference	  mouse	   strains.	   To	   address	   this	   variability,	   we	   compared	   five	   strains	  
commonly	  used	  (C57BL/6,	  129SVJ,	  BALB/c,	  CD1	  and	  FVB).	  	  
	  
P7	  pups	  were	   subjected	   to	   unilateral	   carotid	   occlusion	   followed	  by	   continuous	  
30min	   8%	   O2	   exposure	   at	   36°C.	   12h	   prior,	   2/3	   of	   the	   pups	   received	   a	   single	  
intraperitoneal	  LPS	   injection	  (0.6µg/g)	   (HI	  LPS)	  or	  saline	  (HI	  saline)	  as	  a	  control.	  
1/3	  of	  the	  pups	  underwent	  hypoxia-­‐ischaemia	  alone	  (controls)	  (HI	  alone).	  	  
	  
Both	  C57BL/6	  and	  129SVJ	  strains	  were	  non-­‐responsive	   to	  HI	  alone	  or	  HI	   saline,	  
whereas	   BALB/c	   demonstrated	   a	   moderate	   response,	   and	   both	   CD1	   and	   FVB	  
revealed	   the	   highest	   brain	   damage.	   LPS	   pre-­‐sensitization	   led	   to	   a	   substantial	  
increase	   in	   overall	   brain	   infarction,	   immune	   response	   and	   cell	   death	   in	   all	   five	  
strains.	   Interestingly,	   saline	   treatment	  also	   led	   to	  an	   increase	   in	  brain	  damage,	  
particularly	  in	  the	  FVB	  background	  strain.	  
	  
	  
Individual	  Strain	  Results	  
	  
C57BL/6	  
C57BL/6	   is	   the	  most	   widely	   used	   inbred	   strain,	   not	   only	   as	   a	   general-­‐purpose	  
strain	  but	  also	  for	  the	  generation	  of	  transgenic	  mice	  carrying	  both	  spontaneous	  
and	   induced	  mutations.	   For	   this	   study	   wild	   type	   C57BL/6	   breeding	   pairs	   were	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used	  and	  the	  experimental	   litters	  were	  split	   into	  three	  groups:	  HI	  alone	  (n=10),	  
combined	  saline	  and	  HI	  (HI	  saline,	  n=11)	  and	  combined	  endotoxin	  and	  HI	   insult	  
(HI	  LPS,	  n=11).	  
	  
Infarct	  Volume	  
Extent	   of	   brain	   damage	  was	   assessed	   as	   percentage	  of	   ipsilateral/contralateral	  
surviving	  tissue.	  The	  results	  obtained	  demonstrated	  minimal	  tissue	  damage	  in	  HI	  
alone	  and	  HI	  saline	  animals,	  with	  no	  difference	  in	  total	  infarct	  size	  (15±7%;	  8±4%)	  
between	   both	   groups.	   However,	   when	   comparing	   the	   HI	   saline	   control	   group	  
with	  LPS	  pre-­‐treated	  animals	  there	  was	  a	  significant	  increase	  in	  total	  tissue	  loss	  
from	   8±4%	   to	   39±8%	   (p<1%)	   in	   the	   latter.	   Observation	   of	   the	   different	   brain	  
regions	  demonstrated	  that	  LPS	  pre-­‐treated	  animals	  had	  significantly	  higher	  tissue	  
loss	  in	  all	  six	  ipsilateral	  brain	  regions	  when	  compared	  to	  their	  HI	  saline	  littermate	  
controls:	   The	   dorsoparietal	   cortex	   showed	   an	   increase	   in	   infarct	   from	  5±5%	   to	  
40±8%	  (p<1%),	  pyriform	  cortex	  from	  7±5%	  to	  31±9%	  (p<5%),	  hippocampus	  from	  
23±6%	  to	  66±11%	  (p<1%),	  striatum	  from	  10±5%	  to	  34±9%	  (p<5%),	  thalamus	  from	  




Combined	  histological	  assessment	  of	  alphaM	  staining	  and	  Nissl	  neuronal	  cell	  loss	  
showed	  minimal	  brain	   injury	   in	  both	   ipsilateral	  HI	  alone	   (1.5±0.9)	  and	  HI	   saline	  
(1.2±0.4)	  animals.	  However,	  ipsilateral	  comparison	  between	  HI	  saline	  and	  HI	  LPS	  
littermates	   revealed	  a	   significant	   increase	   in	  microglial	   activation	  and	  neuronal	  
cell	   loss	   in	   the	   latter	   (4.9±0.9,	  p<1%).	   Furthermore,	   this	   surge	   in	  brain	  damage	  
was	  evident	   in	  all	  assessed	  forebrain	  regions.	  The	  dorsoparietal	  cortex	  revealed	  
an	   increase	   in	   injury	   score	   from	   0.5±0.4	   to	   5.1±1.0	   (p<0.1%),	   pyriform	   cortex	  
from	  0.3±0.2	   to	   3.6±0.9	   (p<1%),	   hippocampus	   from	  1.7±0.8	   to	   6.3±1.0	   (p<1%),	  
striatum	   from	   0.9±0.4	   to	   4.9±0.9	   (p<5%),	   thalamus	   from	   0.3±0.1	   to	   3.5±1.0	  
(p<5%)	  and	  external	   capsule	   from	  3.2±0.8	   to	  6.2±1.0	   (p<5%)	   (see	   figure	  3.1.B).	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Observation	  of	  the	  contralateral	  brain	  hemisphere	  revealed	  a	  lack	  of	  brain	  injury	  
in	   all	   three	   groups:	   Hi	   alone	   (0.0±0.0),	   HI	   saline	   (0.1±0.0)	   and	  HI	   LPS	   (0.2±0.1)	  
(see	  figure	  3.1.C).	  	  
	  
TUNEL+	  Cells	  
Quantification	   of	   DNA	   fragmentation-­‐associated	   cell	   death	   has	   shown	  minimal	  
TUNEL+	   cells	   in	   the	   contralateral	   brain	   hemisphere	   of	   all	   three	   experimental	  
groups:	   HI	   alone	   (0.0±0.0),	   HI	   saline	   (0.0±0.0)	   and	   HI	   LPS	   (0.3±0.2)	   (see	   figure	  
3.1E).	  Minimal	   numbers	   of	   TUNEL+	   cells	   were	   also	   observed	   on	   the	   ipsilateral	  
brain	  hemisphere	   for	  HI	   alone	   (2.7±1.2)	   and	  HI	   saline	   (6.9±2.7)	   control	   groups.	  
Conversely,	  LPS	  pre-­‐sensitization	  has	  led	  to	  a	  significant	  increase	  in	  the	  number	  
of	   cells	   undergoing	   fragmentation	   when	   compared	   to	   HI	   saline	   littermate	  
controls	  (37.4±17.5,	  p<5%).	  This	  decrease	  in	  cell	  survival	  was	  also	  evident	  in	  the	  
ipsilateral	   dorsoparietal	   cortex,	   where	   the	   number	   of	   TUNEL+	   cells	   increased	  
from	   3.7±0.6	   to	   64.5±26.3	   (p<1%),	   hippocampus	   from	   22.4±8.6	   to	   58.7±17.1	  
(p<5%)	  and	  external	  capsule	  from	  2.1±0.6	  to	  17.6±6.0	  (p<5%)	  (see	  figure	  3.1.D).	  
	  
GFAP	  Immunoreactivity	  
Optical	   luminosity	   assessment	   showed	   that	   stress	   of	   saline	   injection	   had	   an	  
effect	  on	  astrogliosis	  in	  the	  contralateral	  brain	  hemisphere,	  where	  there	  was	  an	  
overall	   significant	   increase	   in	   astrocyte	   immunoreactivity	   from	   13.5±1.0	   to	  
28.1±3.2	   (p<0.1%).	   This	   saline-­‐associated	   increase	   in	   GFAP	   synthesis	   was	   also	  
significant	  in	  the	  dorsoparietal	  (from	  12.4±0.6	  to	  23.9±3.1,	  p<0.1%)	  and	  pyriform	  
cortex	   (from	   11.4±0.8	   to	   25.2±3.3,	   p<1%),	   hippocampus	   (from	   19.2±1.8	   to	  
42.0±3.2,	   p<0.1%),	   striatum	   (from	   10.6±0.7	   to	   22.9±3.7,	   p<0.1%)	   and	   external	  
capsule	  (from	  19.4±1.3	  to	  44.2±4.2,	  p<0.1%).	  LPS-­‐treated	  animals	  did	  not	  appear	  
overall	  more	   affected	   than	   saline	   littermate	   controls	   (33.4±3.8),	   with	   the	   only	  
exception	   being	   the	   thalamus,	   where	   there	   was	   an	   LPS-­‐associated	   increase	   in	  
astrocytic	   activation	   from	   10.4±1.5	   to	   18.8±3.1	   (p<5%)	   (see	   figure	   3.1.G).	  
Observation	   of	   the	   ipsilateral	   hemisphere	   has	   also	   shown	   an	   overall	   saline-­‐
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mediated	  increase	  in	  GFAP	  immunoreactivity	  (from	  22.3±4.2	  to	  40.5±4.8,	  p<1%).	  
This	   was	   seen	   in	   most	   regions,	   with	   the	   exception	   of	   thalamus:	   Dorsoparietal	  
(from	   19.9±4.4	   to	   33.3±4.3,	   p<5%)	   and	   pyriform	   cortex	   (from	   17.8±2.2	   to	  
36.6±4.4,	   p<1%),	   hippocampus	   (from	   36.3±6.7	   to	   64.6±6.9,	   p<5%),	   striatum	  
(from	   18.0±4.4	   to	   33.0±4.1,	   p<1%)	   and	   external	   capsule	   (from	   32.2±6.4	   to	  
61.9±5.7,	  p<1%)	  brain	  regions.	  Further	  assessment	  of	  the	  ipsilateral	  hemisphere	  
showed	   an	   overall	   significant	   LPS-­‐sensitization	   effect	   (62.4±8.3,	   p<5%)	   when	  
compared	   to	   saline	   pre-­‐treatment.	   This	   increase	   was	   also	   significant	   in	   most	  
ipsilateral	   brain	   regions,	   where	   the	   dorsoparietal	   cortex	   demonstrated	   an	  
increase	   to	   59.1±8.1	   (p<5%),	   hippocampus	   to	   89.4±13.4	   (p<5%),	   striatum	   to	  




Figure	  3.1:	  Effects	  of	  LPS	  endotoxin	  treatment	  (0.6µg/g)	   in	  wild	  type	  C57BL/6	  mice	  followed	  by	  
neonatal	   hypoxic-­‐ischemic	   brain.	   Animals	   injected	   with	   saline	   served	   as	   controls.	   A:	   Infarct	  
volume	  assessment	  of	  individual	  forebrain	  regions	  and	  total	  ipsilateral	  hemisphere	  infarction,	  as	  
percent	   of	   contralateral	   hemisphere,	   showed	   that	   compared	   to	   saline-­‐treated	   littermates,	   LPS	  
sensitization	  (LPS)	  led	  to	  a	  total	  significant	  increase	  in	  tissue	  infarction,	  which	  was	  significant	  in	  all	  
assessed	  ipsilateral	  brain	  regions.	  Minimal	  tissue	  loss	  was	  observed	  in	  both	  HI	  alone	  (HI)	  and	  HI	  
saline	   (SAL)	   groups.	   B:	   Ipsilateral	   brain	   injury	   score	   assessment	   revealed	   minimal	   microglial	  
inflammatory	  response	  and	  neuronal	  cell	  death	  in	  both	  HI	  alone	  and	  HI	  saline	  groups.	  LPS-­‐treated	  
animals	   had	   demonstrably	   higher	   overall	   brain	   injury,	   which	   was	   also	   evident	   in	   all	   assessed	  
ipsilateral	   brain	   regions.	   C:	   Contralateral	   brain	   injury	   assessment	   demonstrated	   no	   microglial	  
inflammation	  or	  tissue	  loss	  in	  any	  of	  the	  three	  groups.	  D:	  DNA	  fragmentation	  cell	  death	  was	  only	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associated	  with	  LPS-­‐treatment.	  Overall	  TUNEL+	  cell	  quantification	  was	  significantly	  higher	  than	  in	  
HI	   saline	   littermate	   controls;	   this	   was	   also	   significant	   in	   50%	   of	   assessed	   brain	   regions	   E:	  
However,	  none	  of	  the	  three	  treatments	  elicited	  DNA	  fragmentation-­‐associated	  cell	  death	  in	  the	  
contralateral	   brain	   hemisphere.	   F:	   Astroglial	   immunoreactivity	   assessment	   using	   optical	  
luminosity	  values	   showed	  a	   saline-­‐associated	   increase	   in	  GFAP	  synthesis	   in	   the	   ipsilateral	  brain	  
hemisphere.	   	   This	   reached	   significance	   in	   most	   brain	   regions	   (significance	   not	   shown).	   LPS-­‐
treated	   further	   exacerbated	   astrogliosis.	   HI	   LPS	   group	   showed	   a	   significant	   overall	   increase	   in	  
astroglial	   activity,	   which	   was	   also	   significant	   in	  most	   ipsilateral	   brain	   regions.	  G:	   Contralateral	  
astroglial	  immunoreactivity	  assessment	  also	  demonstrated	  a	  significant	  overall	  saline-­‐associated	  
stress,	   which	   was	   significant	   for	  most	   contralateral	   brain	   regions.	   LPS-­‐treated	   animals	   did	   not	  
appear	   more	   affected,	   with	   only	   thalamus	   showing	   a	   significant	   increase	   in	   astrogliosis	   when	  
compared	   to	  HI	   saline	   controls.	   *p<5%	   in	  Mann	  Whitney	   test	   for	   the	   LPS-­‐treated	  wild	   type	   vs.	  
knockout	  groups,	  n=10	  for	  HI	  alone,	  n=11	  for	  HI	  saline	  and	  n=11	  for	  HI	  LPS.	  Abbreviations:	  CTX-­‐	  
dorsoparietal	  and	  PYR	  –	  pyriform	  cortex,	  HIP	  –	  hippocampus,	  STR	  –	  striatum,	  THL	  –	  thalamus,	  EXC	  




The	   129SVJ	   strain	   is	   widely	   used	   in	   the	   production	   of	   targeted	   mutation,	   as	  
multiple	  embryonic	  stem	  cell	  lines	  are	  derived	  from	  129SVJ	  mice.	  In	  this	  study	  a	  
wild	  type	  129SVJ	  breeding	  strategy	  was	  used,	  and	  the	  offspring	  were	  separated	  
into	  three	  groups:	  HI	  alone	  (n=10),	  HI	  saline	  (n=10)	  and	  HI	  LPS	  (n=10).	  
	  
Infarct	  Volume	  
Results	  looking	  at	  infarction	  revealed	  minimal	  tissue	  loss	  in	  both	  HI	  alone	  and	  HI	  
saline	  groups	   (3±2%	  and	  4±1%	  respectively).	  However,	   comparison	  between	  HI	  
saline	  and	  HI	  LPS	  animals	  demonstrated	  that	  the	  latter	  were	  highly	  sensitized	  to	  
LPS	   treatment	   prior	   to	   HI	   injury	  with	   a	   total	   increase	   in	   tissue	   infarction	   from	  
4±1%	  to	  29±9%	  (p<1%).	  Assessment	  of	  the	  individual	  brain	  regions	  showed	  that	  
this	   increase	  was	   also	   significant	   in	   the	  dorsoparietal	   (3±1%	   to	  32±10%,	  p<5%)	  
and	  pyriform	  cortex	  (3±2%	  to	  32±10%,	  p<1%),	  striatum	  (1±5%	  to	  31±11%,	  p<5%)	  
and	  external	  capsule	  (3±2%	  to	  27±10%,	  p<5%)	  (see	  figure	  3.2.A).	  	  
	  
Injury	  Score	  
Brain	   injury	   score	   assessment	   showed	  no	  microglial	   activation	   or	   neuronal	   cell	  
loss	  in	  the	  ipsilateral	  brain	  hemisphere	  of	  HI	  alone	  and	  HI	  saline	  animals	  (0.1±0.1	  
and	   0.7±0.7	   respectively).	   Conversely,	   HI	   LPS	   animals	   not	   only	   showed	   a	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significant	   overall	   increase	   in	   alphaM	  and	  neuronal	   cell	   death	   (2.7±1.1,	   p<5%),	  
but	   also,	   this	   increase	   in	   brain	   injury	   reached	   statistical	   significance	   in	   the	  
dorsoparietal	   (from	   0.8±0.5	   to	   3.7±1.1,	   p<5%)	   (see	   figure	   3.2.B).	   None	   of	   the	  
three	  experimental	  groups	  –	  HI	  alone,	  HI	  saline	  and	  HI	  LPS	  –	  demonstrated	  brain	  
injury	   in	   the	   contralateral	   brain	   hemisphere	   (0.0±0.0,	   0.0±0.0	   and	   0.1±0.1	  
respectively)	  (see	  figure	  3.2C).	  	  
	  
TUNEL+	  Cells	  
Average	   quantification	   of	   TUNEL+	   cells	   showed	   minimal	   counts	   for	   HI	   alone	  
(0.0±0.0),	   HI	   saline	   (0.2±0.2)	   and	   HI	   LPS	   (2.1±1.2)	   in	   the	   contralateral	   brain	  
hemisphere	  (see	  figure	  3.2.E).	  Assessment	  of	  the	  ipsilateral	  hemisphere	  revealed	  
that	   HI	   (0.0±0.0)	   and	  HI	   saline	   (1.5±1.5)	   insults	   also	   elicit	  minimal	   TUNEL+	   cell	  
death.	   Ipsilateral	   observation	   of	   the	   HI	   LPS	   group	   demonstrated	   that	   LPS	   pre-­‐
treatment	   led	   to	   a	   visible	   increase	   in	  DNA	   fragmentation-­‐associated	   cell	   death	  
when	  compared	  with	  HI	  saline	  controls	  (from	  1.3±1.3	  to	  15.0±7.6).	  However,	  this	  
never	  reached	  significance	  (see	  figure	  3.2.D).	  
	  
GFAP	  Immunoreactivity	  
Astrogliosis	   assessment	   revealed	   minimal	   astrocytic	   immunoreactivity	   in	   the	  
contralateral	   brain	   hemisphere	   of	   the	   three	   experimental	   groups:	   HI	   alone	  
(18.9±1.5),	  HI	  saline	  (27.3±4.4)	  and	  HI	  LPS	  (29.9±4.4)	  .Despite	  both	  HI	  saline	  and	  
HI	   LPS	   showing	   a	   small	   trend	   towards	   increased	   astrogliosis,	   this	   was	   never	  
significant	   (see	   figure	   3.2.G).	   Furthermore,	   ipsilateral	   comparison	   between	   HI	  
alone	   and	   HI	   saline	   animals	   once	   again	   demonstrated	   minimal	   astrocytic	  
activation	   and	   no	   difference	   between	   both	   groups	   (21.9±1.9	   and	   30.1±6.2	  
respectively).	   Ipsilateral	   assessment	  of	  HI	   LPS	   animals	  demonstrated	  an	  overall	  
substantial	   increase	   in	   GFAP	   immunoreactivity	   when	   compared	   to	   HI	   saline	  
littermate	  controls	  (from	  3.01±6.2	  to	  47.3±8.8,	  p<5%).	  This	  was	  further	  evident	  in	  
the	  dorsoparietal	   (from	  21.6±4.6	   to	  45.3±9.1,	  p<5%)	  and	  pyriform	  cortex	   (from	  





Figure	   3.2:	  Effects	   of	   LPS	   endotoxin	   treatment	   (0.6µg/g)	   in	  wild	   type	   129SVJ	  mice	   followed	  by	  
neonatal	   hypoxic-­‐ischemic	   brain.	   Animals	   injected	   with	   saline	   served	   as	   controls.	   A:	   Infarct	  
volume	  assessment	  of	  individual	  forebrain	  regions	  and	  total	  ipsilateral	  hemisphere	  infarction,	  as	  
percent	   of	   contralateral	   hemisphere,	   showed	   that	   compared	   to	   saline-­‐treated	   littermates,	   LPS	  
sensitization	  (LPS)	   led	  to	  a	  total	  significant	   increase	   in	  tissue	   infarction,	  which	  was	  significant	   in	  
most	   assessed	   ipsilateral	   brain	   regions,	   with	   only	   exception	   being	   the	   thalamus,	   which	   only	  
reached	  a	  trend	  towards	  increased	  infarction.	  Minimal	  tissue	  loss	  was	  observed	  in	  both	  HI	  alone	  
(HI)	   and	   HI	   saline	   (SAL)	   groups.	   B:	   Ipsilateral	   brain	   injury	   score	   assessment	   revealed	   minimal	  
microglial	  inflammatory	  response	  and	  neuronal	  cell	  death	  in	  both	  HI	  alone	  and	  HI	  saline	  groups.	  
LPS-­‐treated	  animals	  had	  demonstrably	  higher	  overall	  brain	  injury	  that	  was	  also	  significant	  in	  both	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dorsoparietal	   and	   pyriform	   cortex	   brain	   regions.	   C:	   Contralateral	   brain	   injury	   assessment	  
demonstrated	   no	   microglial	   inflammation	   or	   tissue	   loss	   in	   any	   of	   the	   three	   groups.	   D:	   DNA	  
fragmentation	  cell	  death	  was	  only	  associated	  with	  LPS-­‐treatment.	  TUNEL+	  cell	  quantification	  was	  
visibly	  higher	  than	  in	  HI	  saline	  littermate	  controls;	  this	  increase	  in	  cell	  death	  was	  significant	  in	  the	  
dorsoparietal	   cortex	   and	   hippocampus	   ipsilateral	   brain	   regions	   E:	   None	   of	   the	   three	   injuries	  
elicited	   DNA	   fragmentation-­‐associated	   cell	   death	   in	   the	   contralateral	   brain	   hemisphere.	   F:	  
Ipsilateral	   astroglial	   immunoreactivity	   assessment	   using	   optical	   luminosity	   values	   showed	  
minimal	   increase	   in	   GFAP	   synthesis	   in	   both	   HI	   alone	   and	   HI	   saline	   groups.	   Conversely,	   LPS	  
administration	  led	  to	  a	  significant	  overall	  increase	  in	  astrogliosis.	  This	  increase	  in	  GFAP	  synthesis	  
was	   significant	   in	   both	   dorsoparietal	   and	   pyriform	   cortex.	   G:	   Contralateral	   astroglial	  
immunoreactivity	  assessment	  showed	  minimal	  astrogliosis	  in	  the	  HI	  alone	  group	  with	  only	  a	  small	  
increase	  for	  both	  HI	  saline	  and	  HI	  LPS	  groups.	  *p<5%	  in	  in	  Mann	  Whitney	  test	  for	  the	  LPS-­‐treated	  
wild	   type	   vs.	   knockout	   groups,	   n=10	   per	   group.	   Abbreviations:	   CTX-­‐	   dorsoparietal	   and	   PYR	   –	  




BALB/c,	   another	   commonly	  used	   inbred	   strain	  was	   also	   studied	   in	   this	   project.	  
Once	  again,	  littermate	  offspring	  of	  wild	  type	  BALB/c	  breeding	  pairs	  were	  divided	  




Infarct	   volume	   assessment	   showed	   moderate	   tissue	   loss	   with	   no	   difference	  
between	   total	   HI	   alone	   (21±8%)	   and	   total	   HI	   saline	   (36±11%)	   animals.	  
Interestingly,	  assessment	  of	  the	  HI	  LPS	  group	  revealed	  only	  a	  trend	  in	  increased	  
tissue	   necrosis	   when	   compared	   to	   HI	   saline	   controls	   (47±9%	   and	   36±11%	  
respectively)	  (see	  figure	  3.3.A).	  
	  
Injury	  Score	  
Ipsilateral	  combined	  brain	   injury	  score	  demonstrated	  overall	  minimal	  microglial	  
activation	  and	  neuronal	  cell	  loss	  in	  the	  HI	  alone	  group	  (2.3±0.9).	  Despite	  a	  small	  
increase	   in	   overall	   injury	   score	   in	   the	   HI	   saline	   group,	   this	   was	   still	   minimal	  
(3.8±1.2).	   Pre-­‐treatment	   with	   LPS	   revealed	   only	   a	   trend	   towards	   increased	  
microglial	  activation	  and	  neuronal	  cell	  loss	  when	  compared	  to	  HI	  saline	  controls	  
(from	   3.8±1.2	   to	   5.4±1.0)	   (see	   figure	   3.3.B).	   Furthermore,	   none	   of	   the	   three	  
insults	   (HI	  alone,	  HI	   saline	  and	  HI	  LPS)	  were	  enough	  to	  elicit	  brain	   injury	   in	   the	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Results	   for	   HI	   alone	   (0.0±0.0),	   HI	   saline	   (0.0±0.0)	   and	   HI	   LPS	   (0.2±0.1)	   animals	  
have	   demonstrated	   that	   none	   of	   these	   insults	   were	   enough	   to	   cause	   DNA	  
fragmentation-­‐associated	   cell	   death	   in	   the	   contralateral	   brain	   hemisphere	   (see	  
figure	  3.3.E).	  Ipsilateral	  quantification	  of	  TUNEL+	  cells	  showed	  minimal	  counts	  for	  
both	   HI	   alone	   (21.0±11.6)	   and	   HI	   saline	   (35.3±15.0)	   animals.	   Comparison	  
between	   HI	   saline	   control	   group	   and	   HI	   LPS	   animals	   revealed	   an	   average	  
significant	   increase	   in	   TUNEL+	   cells	   on	   the	   latter	   from	   35.3±15.0	   to	   96.8±31.3	  
(p<5%).	  Closer	  observation	  of	  the	  assessed	  ipsilateral	  brain	  regions	  showed	  that	  
significance	   was	   also	   reached	   in	   the	   striatum	   (from	   31.3±20.7	   to	   132.2±52.2,	  




In	   terms	   of	   GFAP	   immunoreactivity,	   optical	   luminosity	   values	   revealed	   no	  
difference	   between	   HI	   alone	   (35.7±5.1),	   HI	   saline	   (25.7±2.8)	   and	   HI	   LPS	  
(28.0±3.6)	   in	   the	   contralateral	   brain	  hemisphere	   (see	   figure	  3.3.G).	  HI	   LPS	  pre-­‐
treatment	   (57.1±8.0)	   also	   failed	   to	   elicit	   an	   increase	   in	   astrogliosis	   in	   the	  







Figure	   3.3:	  Effects	   of	   LPS	   endotoxin	   treatment	   (0.6µg/g)	   in	  wild	   type	  BALB/c	  mice	   followed	  by	  
neonatal	   hypoxic-­‐ischemic	   brain.	   Animals	   injected	   with	   saline	   served	   as	   controls.	   A:	   Infarct	  
volume	  assessment	  of	  individual	  forebrain	  regions	  and	  total	  ipsilateral	  hemisphere	  infarction,	  as	  
percent	  of	  contralateral	  hemisphere,	  showed	  that	  both	  Hi	  alone	  (HI)	  and	  HI	  saline	  (SAL)	  groups	  
had	  moderate	  tissue	   loss,	  with	  no	  significant	  difference	  between	  both	  groups.	  LPS	  sensitization	  
(LPS)	   led	   to	  a	   further	   increase	   in	   tissue	   infarction;	  however,	   this	  never	   reached	   significance.	  B:	  
Ipsilateral	  brain	  injury	  score	  assessment	  revealed	  minimal	  microglial	  inflammatory	  response	  and	  
neuronal	   cell	   death	   in	   both	  HI	   alone	   and	  HI	   saline	   groups.	   LPS-­‐treated	   animals	   showed	   only	   a	  
small	   increase	   in	  overall	  brain	   injury.	  C:	  Contralateral	  brain	   injury	  assessment	  demonstrated	  no	  
microglial	  inflammation	  or	  tissue	  loss	  in	  any	  of	  the	  three	  groups.	  D:	  DNA	  fragmentation	  cell	  death	  
was	   only	   associated	   with	   LPS-­‐treatment.	   Overall	   TUNEL+	   cell	   quantification	   was	   significantly	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higher	  than	  in	  HI	  saline	  littermate	  controls;	  this	  was	  also	  significant	  in	  the	  striatum	  and	  external	  
capsule	   ipsilateral	  brain	  regions.	  E:	  None	  of	   the	  three	  groups	  –	  HI	  alone,	  HI	  saline	  and	  HI	  LPS	  –	  
had	   demonstrable	   DNA	   fragmentation-­‐associated	   cell	   death	   in	   the	   contralateral	   brain	  
hemisphere.	   F:	   Ipsilateral	   astroglial	   immunoreactivity	   assessment	   demonstrated	   equally	  
moderate	  astrogliosis	  in	  all	  the	  groups	  (HI	  alone,	  HI	  saline	  and	  HI	  LPS).	  G:	  Contralateral	  astroglial	  
immunoreactivity	   assessment	   demonstrated	   equally	   reduced	   GFAP	   synthesis.	   *p<5%	   in	   Mann	  
Whitney	   test	   for	   the	  LPS-­‐treated	  wild	   type	  vs.	   knockout	  groups,	  n=11	   for	  HI	  alone,	  n=19	   for	  HI	  
saline	  and	  n=10	   for	  HI	  LPS.	  Abbreviations:	  CTX-­‐	  dorsoparietal	  and	  PYR	  –	  pyriform	  cortex,	  HIP	  –	  




The	   CD1	   mouse	   is	   a	   strain	   that,	   unlike	   C57Bl/6,	   129SvJ,	   BALB/c	   or	   FVB,	   is	  
outbred.	   It	   is	   commonly	   used	   in	   research,	   including	   hypoxic-­‐ischaemic	   insult	  
studies,	  where	   importance	   is	   laid	  on	  having	  a	  background	   that	  may	  generate	  a	  
more	  diverse	  response.	  Offspring	  of	  wild	   type	  CD1	  breeding	  pairs	  were	  divided	  
into	  HI	  alone	  (n=10),	  HI	  saline	  (n=12)	  and	  HI	  LPS	  (n=10).	  
	  
Infarct	  Volume	  
Infarct	  measurements	  showed	  moderate	  tissue	  loss	  of	  46±12%	  in	  HI	  alone	  and	  of	  
39±9%	  in	  HI	  saline	  animals.	  This	  tissue	  necrosis	  was	  further	  increased	  in	  animals	  
pre-­‐treated	  with	  LPS.	  LPS	  sensitization	  led	  to	  a	  total	  increase	  in	  tissue	  infarction	  
to	  86±5%	  when	  compared	  to	  HI	  saline	  controls	  (p<1%).	  This	  was	  also	  evident	  in	  
all	   assessed	   brain	   regions:	   Dorsoparietal	   (from	   38±9%	   to	   83±4%,	   p<1%)	   and	  
pyriform	  cortex	  (from	  30±13%	  to	  89±11%,	  p<1%),	  hippocampus	  (from	  55±9%	  to	  
90±6%,	  p<5%),	  striatum	  (from	  46±14%	  to	  93±5%,	  p<5%),	  thalamus	  (from	  30±11%	  




Average	   ipsilateral	   injury	   score	   of	   HI	   alone	   and	   HI	   saline	   littermates	  
demonstrated	   similarly	  high	  microglial	   activation	  and	  neuronal	   cell	   loss	   in	  both	  
groups	   (4.7±1.0	   and	   4.9±0.9	   respectively).	   There	   was	   a	   significant	   overall	  
increase	   in	   ipsilateral	   brain	   injury	   in	   HI	   LPS	   animals	   (from	   4.9±0.9	   to	   6.8±0.8,	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p<5%),	   this	   was	   also	   significant	   most	   ipsilateral	   brain	   regions:	   Pyriform	   cortex	  
(from	  3.6±0.8	  to	  6.6±0.6,	  p<5%),	  hippocampus	  (from	  4.9±0.7	  to	  6.7±0.5,	  p<5%),	  
striatum	  (from	  5.0±0.9	  to	  6.8±0.5,	  p<5%)	  and	  thalamus	  (from	  3.0±0.7	  to	  6.5±0.6,	  
p<5%)	  when	  compared	  to	  HI	  saline	  controls	  (see	  figure	  3.4.B).	  Observation	  of	  the	  
contralateral	   brain	   hemisphere	   showed	   no	   microglial	   activation	   or	   neuronal	  
cellular	   loss	   in	  any	  of	  the	  three	  experimental	  groups	  (HI	  alone,	  HI	  saline	  and	  HI	  
LPS)	  (see	  figure	  3.4.C).	  
	  
TUNEL+	  Cells	  
Observation	  of	  the	  contralateral	  brain	  hemisphere	  revealed	  a	  reduced	  number	  of	  
TUNEL+	   cells	   for	   all	   three	   experimental	   groups.	   HI	   alone	   had	   an	   average	   of	  
0.0±0.0,	   HI	   saline	   0.0±0.0	   and	   HI	   LPS	   1.0±0.5	   TUNEL+	   cells	   (see	   figure	   3.4.E).	  
Assessment	  of	  the	  ipsilateral	  brain	  hemisphere	  showed	  a	  small	  similar	  increase	  in	  
DNA	   fragmentation-­‐associated	  cell	  death	  staining	   for	  both	  HI	  alone	   (27.6±15.1)	  
and	  HI	  saline	  (19.3±9.1)	  animals.	  Comparison	  between	  ipsilateral	  HI	  saline	  and	  HI	  
LPS	  animals	   revealed	  an	  LPS-­‐mediated	  sensitization	  effect,	  where	   there	  was	  an	  
average	  increase	  to	  84.6±27.7	  (p<5%)	  in	  TUNEL+	  cells	  in	  the	  latter.	  Furthermore,	  
this	   increase	  was	   also	   evident	   in	   hippocampus	   (from	   17.6±11.3	   to	   101.8±29.2,	  
p<5%),	   striatum	   (from	   28.0±15.1	   to	   126.7±52.6,	   p<5%)	   and	   thalamus	   (from	  
0.0±0.0	  to	  126.9±33.2,	  p<0.1%)	  ipsilateral	  brain	  regions	  (see	  figure	  3.4.D).	  
	  
GFAP	  Immunoreactivity	  
Direct	  quantification	  of	  GFAP	  immunoreactivity	  revealed	  no	  difference	  in	  optical	  
luminosity	   values	   between	   contralateral	   HI	   alone	   (28.9±3.0)	   and	   HI	   saline	  
(29.7±3.9)	   animals.	   HI	   LPS	   group	   showed	   an	   overall	   significant	   increase	   in	  
astrogliosis	   (48.3±5.2,	   p<5%),	   which	   was	   also	   significant	   in	   the	   dorsoparietal	  
cortex	   (from	  20.7±1.9	  to	  36.1±5.2,	  p<1%),	  striatum	  (from	  20.1±2.3	  to	  36.5±4.2,	  
p<5%),	   thalamus	   (from	  15.7±2.2	   to	  41.6±5.2,	  p<1%)	  and	  external	  capsule	   (from	  
15.7±2.2	  to	  41.6±5.2,	  p<5%)	  contralateral	  regions	  when	  compared	  to	  littermate	  
saline	  controls	  (see	  figure	  3.4.G).	  Assessment	  of	  the	  occluded	  brain	  hemisphere	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has	  shown	  no	  difference	  in	  overall	  astrocyte	  immunoreactivity	  between	  HI	  alone	  
(57.2±10.6)	  and	  HI	  saline	  (56.8±7.9)	  animals.	  Comparison	  between	  the	  latter	  and	  
littermate	   HI	   LPS	   animals	   revealed	   a	   significant	   increase	   in	   GFAP	   synthesis	   to	  
86.1±11.6	   (p<1%)	   in	   the	   LPs	   treated	   animals.	   This	   was	   also	   significant	   in	   the	  
dorsoparietal	   cortex	   (from	   45.0±6.5	   to	   89.6±16.9,	   p<1%),	   striatum	   (from	  
56.2±7.3	   to	  82.9±15.4,	  p<5%)	  and	   thalamus	   (from	  31.0±6.0	   to	  75.0±9.4,	  p<1%)	  





Figure	   3.4:	   Effects	   of	   LPS	   endotoxin	   treatment	   (0.6µg/g)	   in	   wild	   type	   CD1	   mice	   followed	   by	  
neonatal	   hypoxic-­‐ischemic	   brain.	   Animals	   injected	   with	   saline	   served	   as	   controls.	   A:	   Infarct	  
volume	  assessment	  of	  individual	  forebrain	  regions	  and	  total	  ipsilateral	  hemisphere	  infarction,	  as	  
percent	   of	   contralateral	   hemisphere,	   showed	   that	   compared	   to	   saline-­‐treated	   littermates,	   LPS	  
sensitization	  (LPS)	  led	  to	  a	  total	  significant	  increase	  in	  tissue	  infarction,	  which	  was	  significant	  in	  all	  
assessed	  ipsilateral	  brain	  regions.	  Moderate	  tissue	  loss	  was	  observed	  in	  both	  HI	  alone	  (HI)	  and	  HI	  
saline	   (SAL)	  groups.	  B:	   Ipsilateral	  brain	   injury	  score	  assessment	   revealed	  equally	  high	  microglial	  
inflammatory	  response	  and	  neuronal	  cell	  death	  in	  both	  HI	  alone	  and	  HI	  saline	  groups.	  LPS-­‐treated	  
animals	   demonstrated	   a	   further	   increase	   in	   brain	   injury.	   This	   LPS-­‐associated	   increase	   reached	  
significance	   in	   the	   ipsilateral	   thalamus	   brain	   region.	   C:	   Contralateral	   brain	   injury	   assessment	  
demonstrated	  no	  microglial	  inflammation	  or	  tissue	  loss	  in	  any	  of	  the	  three	  groups.	  D:	  There	  was	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minimal	   DNA	   fragmentation	   cell	   death	   in	   both	   ipsilateral	   HI	   alone	   and	   HI	   saline	   groups.	   DNA	  
fragmentation	  cell	  death	  was	  significantly	  increased	  with	  LPS-­‐treatment,	  this	  was	  also	  significant	  
in	  50%	  of	  assessed	  brain	  regions	  E:	  However,	  none	  of	  the	  three	  insults	  (HI	  alone,	  HI	  saline	  and	  HI	  
LPS)	  elicited	  DNA	   fragmentation-­‐associated	   cell	   death	   in	   the	   contralateral	  brain	  hemisphere.	  F:	  
Ipsilateral	   astroglial	   immunoreactivity	   assessment	   using	   optical	   luminosity	   values	   showed	   no	  
difference	  in	  GFAP	  synthesis	  between	  HI	  alone	  and	  HI	  saline	  groups.	  LPS	  treatment	  however,	  led	  
to	   an	  overall	   increase	   in	   astrogliosis,	  which	   reached	   significance	   in	   the	   ipsilateral	   dorsoparietal	  
cortex	   and	   thalamus	   brain	   regions.	   G:	   Contralateral	   astroglial	   immunoreactivity	   assessment	  
showed	  minimal	  astroglial	  activation	  on	  both	  HI	  alone	  and	  HI	  saline	  groups.	  LPS-­‐treated	  animals	  
showed	   a	   trend	   towards	   increased	   GFAP	   synthesis	   which	   reached	   significance	   in	   the	  
dorsoparietal	   cortex	   and	   thalamus	   brain	   regions.	   *p<5%	   in	   Mann	   Whitney	   test	   for	   the	   LPS-­‐
treated	  wild	  type	  vs.	  knockout	  groups,	  n=10	  for	  HI	  alone,	  n=12	  for	  HI	  saline	  and	  n=10	  for	  HI	  LPS.	  
Abbreviations:	  CTX-­‐	  dorsoparietal	  and	  PYR	  –	  pyriform	  cortex,	  HIP	  –	  hippocampus,	  STR	  –	  striatum,	  




FVB	  mice	   are	   another	   suitable	   background	   strain	   used	   in	   transgenic	   research.	  
Similarly	   to	  the	  previous	  background	  strains	  studied,	  offspring	  of	  wild	   type	  FVB	  
animals	  were	  divided	   into	   three	  experimental	   groups:	  HI	   alone	   (n=9),	  HI	   saline	  
(n=11)	  and	  HI	  LPS	  (n=11).	  
	  
Infarct	  Volume	  
Ipsilateral	  brain	  hemisphere	  of	  HI	  alone	  and	  HI	  saline	  animals	  had	  considerable	  
tissue	  infarction	  of	  around	  50%	  over	  the	  contralateral	  hemisphere	  (41±10%	  and	  
50±9%	   respectively).	   LPS	   sensitization	   led	   to	   a	   further	   substantial	   increase	   in	  
tissue	   infarction	  to	  87±3%	  (p<1%).	  Further	  comparison	  between	  HI	  LPS	  animals	  
and	  HI	   saline	   littermate	   controls	   demonstrated	   that	   this	   exacerbation	   in	   tissue	  
necrosis	  was	  evident	  in	  all	  six	  assessed	  brain	  regions:	  Dorsoparietal	  (from	  52±7%	  
to	   83±4%,	   p<1%)	   and	   pyriform	   cortex	   (from	   55±14%	   to	   99±1%,	   p<5%),	  
hippocampus	  (from	  59±10%	  to	  90±5%,	  p<5%),	  striatum	  (from	  57±11%	  to	  95±2%,	  
p<1%),	   thalamus	   (from	   27±13%	   to	   74±10%,	   p<1%)	   and	   external	   capsule	   (from	  
36±9%	  to	  82±4%,	  p<0.1%)	  (see	  figure	  3.5.A).	  
	  
Injury	  Score	  
Results	  showed	  no	  alphaM	  staining	  or	  Nissl	  neuronal	  cell	  loss	  in	  the	  contralateral	  
brain	  hemispheres	  of	  mice	  in	  any	  of	  the	  three	  experimental	  groups:	  HI	  alone,	  HI	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saline	  and	  HI	  LPS	  (see	  figure	  3.5.C).	  However,	  comparison	  between	  ipsilateral	  HI	  
alone	   and	   HI	   saline,	   revealed	   a	   saline	   injection-­‐associated	   stress	   for	   the	   latter	  
group,	  with	  a	   significant	   increase	   in	  average	  brain	   injury	   score	   from	  2.5±0.6	   to	  
5.7±1.0	   (p<5%).	   The	   pyriform	   cortex	   (from	   2.0±0.5	   to	   5.7±0.9,	   p<5%),	  
hippocampus	  (from	  1.8±0.5	  to	  5.8±1.0,	  p<5%),	  striatum	  (from	  2.1±0.5	  to	  5.9±0.9,	  
p<5%)	   and	  external	   capsule	   (from	  2.8±0.6	   to	   6.5±1.0,	   p<5%)	   regions	  were	   also	  
significantly	  more	   affected	   in	   the	   HI	   saline	   group	  when	   compared	   to	   HI	   alone	  
controls.	   Ipsilateral	   comparison	   of	   saline	   and	   LPS	   treatment	   revealed	   a	   further	  
significant	   increase	   in	  overall	  brain	   injury	   score	   to	  8.0±0.0	   (p<1%)	   in	   the	   latter.	  
The	   most	   significantly	   affected	   ipsilateral	   brain	   regions	   to	   LPS	   administration	  
were	   the	   dorsoparietal	   (from	   6.3±1.0	   to	   8.0±0.0,	   p<5%)	   and	   pyriform	   cortex	  
(from	  5.7±0.9	  to	  8.0±0.0,	  p<5%),	  hippocampus	  (from	  5.8±1.0	  to	  8.0±0.0,	  p<5%),	  
striatum	  (from	  5.9±0.9	  to	  8.0±0.0,	  p<5%)	  and	  thalamus	  (from	  4.1±1.0	  to	  7.8±0.2,	  
p<5%)	  (see	  figure	  3.5.B).	  
	  
TUNEL+	  Cells	  
None	  of	  the	  three	  experimental	  insults	  led	  to	  DNA-­‐fragmentation-­‐associated	  cell	  
death	  in	  the	  contralateral	  brain	  hemisphere.	  HI	  alone	  revealed	  minimal	  average	  
TUNEL+	  counts	  of	  1.6±1.6,	  HI	  saline	  2.8±2.8	  and	  HI	  LPS	  3.7±2.3	  (see	  figure	  3.5.E).	  
However,	  observation	  of	  the	  occluded	  brain	  hemisphere	  revealed	  an	  increase	  in	  
TUNEL+	   cells	   for	   both	   HI	   alone	   (70.5±35.8)	   and	   HI	   saline	   (82.1±22.7),	   with	   no	  
difference	  between	   the	   two	  groups.	  Further	  assessment	  of	   the	   ipsilateral	  brain	  
hemisphere	  revealed	  a	  substantial	  overall	  increase	  in	  TUNEL+	  cells	  to	  194.1±31.2	  
in	   the	   LPS	   group	  when	   compared	   to	   HI	   saline	   littermate	   controls	   (p<5%).	   This	  
increase	   in	   DNA	   fragmentation	  was	   significant	   in	  most	   brain	   regions,	   with	   the	  
dorsoparietal	   cortex	   showing	   an	   increase	   in	   TUNEL+	   cells	   from	   163.0±38.1	   to	  
376.5±55.6	   (p<1%),	   pyriform	   cortex	   from	   54.3±12.7	   to	   132.2±21.1	   (p<1%),	  
hippocampus	  from	  101.4±23.1	  to	  248.3±22.3	  (p<0.1%),	  thalamus	  from	  61.4±32.2	  
to	   158.1±33.3	   (p<5%)	   and	   external	   capsule	   from	  16.8±6.3	   to	   51.1±12.1	   (p<5%)	  





Contralateral	   optical	   luminosity	   assessments	   showed	   similar	   moderate	   optical	  
luminosity	   values	   between	   HI	   LPS	   and	   both	   HI	   alone	   (58.5±3.6)	   and	   HI	   saline	  
(58.5±2.6)	  animals	   (see	   figure	  3.5.G).	  LPS	  pre-­‐treatment	   (59.2±3.3)	  did	  not	   lead	  
to	   an	   increase	   in	   astrocytic	   activation	   in	   the	   contralateral	   brain	   hemisphere.	  
However,	   results	   in	   the	   ipsilateral	   hemisphere	   showed	   that	   both	   HI	   alone	  
(90.2±8.1)	   and	   HI	   saline	   (82.7±5.7)	   had	   a	   similar	   and	   strong	   astrocytic	  
immunoreactivity.	   Furthermore,	   comparison	  between	  HI	   saline	   controls	   and	  HI	  
LPS	  animals	  demonstrated	  a	  significant	  overall	  increase	  in	  GFAP	  synthesis	  in	  the	  
latter	  (99.3±6.8,	  p<5%),	  this	  was	  also	  evident	  in	  the	  dorsoparietal	  cortex,	  where	  
there	  was	  a	  significant	  increase	  in	  astrogliosis	  from	  77.7±5.5	  to	  98.4±8.3	  (p<5%),	  
hippocampus	   from	   89.8±4.3	   to	   111.2±4.7	   (p<1%),	   thalamus	   from	   62.3±6.6	   to	  
94.3±6.6	  (p<1%)	  and	  external	  capsule	  from	  100.3±5.0	  to	  118.2±7.2	  (p<5%)	  brain	  







Figure	   3.5:	   Effects	   of	   LPS	   endotoxin	   treatment	   (0.6µg/g)	   in	   wild	   type	   FVB	   mice	   followed	   by	  
neonatal	   hypoxic-­‐ischemic	   brain.	   Animals	   injected	   with	   saline	   served	   as	   controls.	   A:	   Infarct	  
volume	  assessment	  of	  individual	  forebrain	  regions	  and	  total	  ipsilateral	  hemisphere	  infarction,	  as	  
percent	  of	  contralateral	  hemisphere,	  showed	  that	  both	  HI	  alone	  (HI)	  and	  HI	  saline	  (HI	  SAL)	  groups	  
had	  substantial	  tissue	  loss.	  Compared	  to	  saline-­‐treated	  littermates,	  LPS	  sensitization	  (LPS)	  led	  to	  a	  
further	   total	   significant	   increase	   in	   tissue	   infarction,	   which	   was	   significant	   in	   all	   assessed	  
ipsilateral	  brain	  regions.	  B:	   Ipsilateral	  brain	   injury	  score	  assessment	  revealed	  minimal	  microglial	  
inflammatory	   response	   and	   neuronal	   cell	   death	   in	   the	   HI	   alone.	   However,	   there	   was	   a	  
significantly	   visible	   saline	   stress-­‐associated	   increase	   in	  brain	   injury.	  This	  was	   significant	   in	  most	  
ipsilateral	  brain	  regions,	  with	  only	  exception	  being	  the	  dorsoparietal	  cortex,	  where	  only	  a	  trend	  
was	  visible.	  LPS-­‐treated	  animals	  had	  an	  even	  higher	  overall	  brain	  injury	  which	  was	  also	  significant	  
in	  all	  assessed	  ipsilateral	  brain	  regions.	  C:	  Contralateral	  brain	  injury	  assessment	  demonstrated	  no	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microglial	   inflammation	   or	   tissue	   loss	   in	   any	   of	   the	   three	   groups.	  D:	   There	   was	  minimal	   DNA	  
fragmentation	   cell	   death	   in	   both	   ipsilateral	   HI	   alone	   and	   HI	   saline	   groups.	   However,	   LPS	  
treatment	   led	   to	   an	   overall	   significant	   increase	   in	   TUNEL+	   cell	   quantification,	   which	   was	  
significant	   in	  most	   ipsilateral	   brain	   regions,	  with	   pyriform	   cortex	   as	   the	   only	   exception,	  where	  
only	   a	   trend	   towards	   increased	   TUNEL+	   cell	   death	  was	   visible.	  E:	   However,	   none	   of	   the	   three	  
treatments	  elicit	  DNA	  fragmentation-­‐associated	  cell	  death	  in	  the	  contralateral	  brain	  hemisphere.	  
F:	   Ipsilateral	   astroglial	   immunoreactivity	   assessment	   using	   optical	   luminosity	   values	   showed	  
similar	  and	  visible	  GFAP	   synthesis	   in	  both	   ipsilateral	  Hi	   alone	  and	  HI	   saline	  groups.	   LPS-­‐treated	  
further	  exacerbated	  astrogliosis.	  HI	  LPS	  group	  showed	  a	  significant	  overall	   increase	   in	  astroglial	  
activity,	   which	   was	   also	   significant	   in	   50%	   of	   the	   assessed	   ipsilateral	   brain	   regions.	   G:	  
Contralateral	   astroglial	   immunoreactivity	   assessment	   demonstrated	   no	   difference	   in	   GFAP	  
synthesis	  between	  HI	   alone,	  HI	   saline	  and	  HI	   LPS	   groups.	   *p<5%	   in	  Mann	  Whitney	   test	   for	   the	  
LPS-­‐treated	  wild	  type	  vs.	  knockout	  groups,	  n=9	  for	  HI	  alone,	  n=11	  for	  HI	  saline	  and	  n=11	  for	  HI	  
LPS.	  Abbreviations:	   CTX-­‐	   dorsoparietal	   and	   PYR	   –	   pyriform	   cortex,	   HIP	   –	   hippocampus,	   STR	   –	  
striatum,	  THL	  –	  thalamus,	  EXC	  –	  external	  capsule.	  
	  
	  
Differences	  between	  C57BL/6,	  129SVJ,	  BALB/c,	  CD1	  and	  FVB	  in	  combined	  
inflammation	  and	  hypoxia-­‐ischemia	  injury	  
	  
Infarct	  Volume	  
All	   five	   strains	   showed	   a	   robust	   LPS-­‐mediated	   sensitization	   to	   subsequent	   HI	  
injury	   in	   the	   ipsilateral	   brain	   hemisphere,	   with	   higher	   tissue	   necrosis	   in	   LPS-­‐
treated	  animals	  when	  compared	  to	  saline	  littermate	  controls.	  C57BL/6,	  CD1	  and	  
FVB	  strains	  showed	  the	  highest	  level	  of	  LPS-­‐mediated	  sensitization,	  with	  not	  only	  
an	  overall	  significant	  increase	  in	  tissue	  infarction,	  but	  also,	  this	  increase	  in	  tissue	  
necrosis	  was	  still	  evident	   in	  all	  assessed	  brain	   regions.	  129SVJ	  strain	  also	  had	  a	  
total	  significant	  increase	  in	  tissue	  loss	  in	  LPS-­‐treated	  animals	  when	  compared	  to	  
HI	  saline	  littermates;	  this	  significance	  was	  evident	  in	  almost	  all	  regions	  with	  the	  
exception	   of	   thalamus.	   Interestingly,	   BALB/c	   LPS-­‐treated	   animals,	   despite	  
showing	  a	  visible	  trend	  towards	  increased	  tissue	  infarction,	  this	  increase	  failed	  to	  
reach	  significance	  when	  compared	  to	  HI	  saline	  littermates.	  Overall	  comparison	  of	  
saline	   treated	   groups	   over	   the	   five	   different	   strains	   has	   shown	   that	   saline	  
administration	  prior	  to	  HI	  injury	  demonstrated	  leads	  to	  minimal	  or	  no	  increase	  in	  





In	  terms	  of	  brain	  injury	  assessment,	  again	  LPS	  pre-­‐treatment	  led	  to	  a	  significant	  
increase	  in	  microglial	  activation	  and	  neuronal	  cell	  loss	  in	  all	  five	  strains.	  C57BL/6	  
showed	   the	   highest	   overall	   increase	   as	   well	   as	   significant	   increase	   for	   all	  
ipsilateral	  brain	   regions	  when	   compared	   to	   saline-­‐treated	   controls.	   129SVJ	   and	  
BALB/c	  demonstrated	  only	  moderate	  significant	  LPS-­‐sensitization.	  In	  the	  129SVJ	  
study	  only	  the	  dorsoparietal	  cortex	  was	  particularly	  affected.	  However,	  this	  was	  
significant	   enough	   to	   lead	   to	   an	   overall	   significant	   increase	   in	   combined	   injury	  
score	   for	   this	   strain.	   BALB/c	   background	   strain	   revealed	   only	   a	   trend	   towards	  
increased	  brain	  injury	  associated	  with	  LPS	  pre-­‐sensitization.	  Similarly	  to	  C57BL/6	  
animals,	  the	  CD1	  and	  FVB	  strains	  were	  particularly	  affected	  by	  LPS	  administration	  
prior	   to	  HI	   insult.	  Not	  only	   there	  was	  a	   significant	  overall	   increase	   in	   ipsilateral	  
brain	   injury	   score	   in	   HI	   LPS	   animals,	   this	  was	   also	   significant	   in	  most	   assessed	  
brain	  regions,	  with	  only	  exception	  being	  the	  dorsoparietal	  cortex	  in	  the	  CD1	  LPS	  
animals	   and	   external	   capsule	   white	   matter	   in	   FVB	   LPS	   animals,	   where	   only	   a	  
trend	   towards	   increased	   brain	   injury	   was	   reached	   in	   the	   LPS	   treated	   animals	  
when	   compared	   to	   saline	   littermate	   controls.	   Interestingly,	   saline-­‐associated	  
increase	   in	   brain	   damage	  was	   seen	   in	   FVB	   saline-­‐treated	   animals,	  where	   there	  
was	  a	  significant	  overall	  increase	  in	  alphaM	  staining	  and	  Nissl	  neuronal	  cell	  loss,	  
when	  compared	  with	  HI	  alone	  controls.	  This	  saline	  damaging	  effect	  was	  also	  seen	  
in	   most	   ipsilateral	   brain	   regions:	   pyriform	   cortex,	   striatum,	   thalamus	   and	  
external	  capsule.	  All	   five	  background	  strains	  demonstrated	  minimal	  brain	   injury	  
in	  the	  contralateral	  brain	  regions	  irrespective	  of	  type	  of	  insult	  (HI	  alone,	  HI	  saline	  
and	  HI	  LPS).	  	  
	  
TUNEL+	  Cells	  
Once	   again,	   LPS	   administration	   prior	   to	   HI	   insult	   demonstrated	   a	   significant	  
damaging	   effect.	   Quantification	   of	   DNA	   fragmentation-­‐associated	   cell	   death	  
using	   TUNEL+	   cell	   assessment	   has	   shown	   that	   LPS	   pre-­‐treatment	   led	   to	   a	  
substantial	  increase	  in	  TUNEL+	  cells	  in	  the	  ipsilateral	  brain	  hemisphere	  of	  all	  five	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different	   background	   strains.	   Despite	   not	   reaching	   significance,	   129SVJ	   LPS	  
animals	   showed	  a	   visible	   trend	   in	   increased	  DNA	   fragmentation-­‐associated	   cell	  
death.	   At	   least	   three	   of	   the	   seven	   assessments	   (overall,	   dorsoparietal	   and	  
pyriform	   cortex,	   hippocampus,	   striatum,	   thalamus	   and	   external	   capsule)	   were	  
significantly	  more	  affected	  in	  BALB/c	  background	  strain,	  with	  four	  regions	  in	  both	  
C57BL/6	   and	   CD1	   studies	   being	   particularly	   affected.	   The	   FVB	   strain	  
demonstrated	   the	   most	   significant	   increase	   in	   TUNEL+	   cells,	   where	   six	   of	   the	  
seven	  different	  comparisons	  had	  significant	  increase	  in	  HI	  LPS-­‐associated	  TUNEL+	  
cell	  death	  when	  compared	  to	  HI	  saline	  controls.	  Saline	  stress-­‐associated	  effect	  is	  
not	   seen	   in	   the	   TUNEL+	   cell	   assessment.	   Contralateral	   brain	   hemisphere	  
observation	  demonstrated	  no	  HI,	  HI	  saline	  or	  HI	  LPS-­‐induced	  DNA	  fragmentation-­‐
associated	  cell	  death.	  
	  
GFAP	  Immunoreactivity	  
Optical	  luminosity	  values	  also	  revealed	  LPS-­‐mediated	  sensitization	  as	  causal	  to	  an	  
increase	  in	  astrocytic	  activation.	  Both	  C57BL/6	  and	  FVB	  background	  strains	  were	  
overall	   particularly	   affected,	  with	   five	   out	   of	   the	   six	   individual	   ipsilateral	   brain	  
regions	   also	   being	   significantly	   affected.	   This	   LPS-­‐induced	   astrogliosis	   was	   also	  
overall	   strongly	   evident	   in	   the	   CD1	   and	   129SVJ	   with	   three	   and	   four	   of	   the	  
assessed	   brain	   regions	   being	   significantly	   affected	   respectively.	   Conversely,	  
BALB/c	   animals	   revealed	   no	   LPS-­‐mediated	   sensitization	   effect	   in	   astrocytic	  
activation	  in	  the	  ipsilateral	  brain	  hemisphere	  when	  compared	  to	  saline	  controls.	  
Assessment	   of	   the	   contralateral	   brain	   hemisphere	   revealed	   an	   LPS-­‐mediated	  
increase	  in	  astrogliosis	  only	  on	  the	  thalamus	  of	  C57BL/6	  animals,	  and	  on	  four	  out	  
of	   seven	   assessments	   in	   the	   contralateral	   brain	   regions	   of	   CD1	  HI	   LPS	   animals	  
when	  compared	  to	  saline	  littermate	  controls.	  	  
	  
Ipsilateral	   saline-­‐associated	   increase	   in	   astrogliosis	   only	   occurred	   in	   C57BL/6	  
animals.	  This	  was	  significant	  in	  most	  brain	  regions	  as	  well	  as	  overall.	  Observation	  
of	   the	   contralateral	   brain	   hemisphere	   in	   all	   five	   strains	   showed	   no	   significant	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difference	   between	   HI	   alone	   and	   HI	   saline	   littermates	   most	   strains,	   with	   only	  
exception	  being	  C57BL/6	  animals.	   In	  a	  similar	  manner	  to	  what	  was	  observed	   in	  
the	  ipsilateral	  hemisphere,	  the	  same	  brain	  regions	  appeared	  to	  be	  detrimentally	  
affected	   by	   saline	   administration:	   dorsoparietal	   and	   pyriform	   cortex,	  





The	   P7	  mouse	  model	   of	   hypoxic-­‐ischaemic	   insult	   is	  widely	   used	   as	   a	  model	   of	  
neuropathology	   that	   mimics,	   to	   a	   certain	   degree	   of	   fidelity	   the	   pathology	   of	  
hypoxic-­‐ischaemic	  injury	  occurring	  in	  human	  term	  neonates.	  With	  the	  addition	  of	  
transgenic	  mice,	   this	  model	   has	   become	   particularly	   relevant	   in	   attempting	   to	  
establish	   the	   pattern	   of	   injury	   evolution	   and	   assessing	   efficacy	   of	   particular	  
treatments.	   As	   advance	   in	   science	   and	  medicine	   have	   shown	   the	   aetiology	   of	  
perinatal	   brain	   damage	   to	   be	   multifactorial	   and	   not	   only	   a	   result	   of	   hypoxic-­‐
ischaemic	   insult,	   the	   neonatal	   mouse	   model	   of	   hypoxic-­‐ischaemic	  
encephalopathy	   has	   been	   modified	   to	   include	   an	   inflammatory	   sensitizing	  
element,	  known	  to	  occur	  in	  some	  human	  cases	  of	  perinatal	  brain	  damage.	  	  
	  
Previous	  research	  have	  shown	  that	  genetic	  strain	  influences	  the	  degree	  of	  brain	  
damage	  in	  neonatal	  mouse	  models	  of	  hypoxic	  (Li	  et	  al.,	  2008;	  Li	  et	  al.,	  2009;	  Li	  et	  
al,	   2013),	   ischaemic	   (Comi	   et	   al.,	   2013)	   and	   hypoxic-­‐ischaemic	   (Sheldon	   et	   al.,	  
1998)	  insults.	  Additionally,	  studies	  looking	  at	  inflammatory	  response	  in	  different	  
mouse	  strains,	  once	  again	  demonstrated	  that	  genetic	  background	  plays	  a	  role	  in	  
cytokine	  synthesis	  (Lambertsen	  et	  al.,	  2002;	  Hoover-­‐Plow	  et	  al.,	  2008;	  Gibb	  et	  al.,	  
2011;	  Browne	  et	  al.,	  2012)	  as	  well	  as	  inflammatory	  cell	  recruitment	  (White	  et	  al.,	  
2002;	   Hoover-­‐Plow	   et	   al.,	   2008).	   However,	   no	   study	   to	   date	   has	   investigated	  
whether	   this	   variation	   in	   response	   is	   also	   seen	   in	   the	   synergistic	   model	   of	  
inflammation	  and	  neonatal	  hypoxic-­‐ischaemic	   insult.	   The	  current	   study	  has	  not	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only	   been	   able	   to	   replicate	   previous	   research	   in	   regards	   to	   the	   differences	   in	  
hypoxic-­‐ischaemic	   response	  by	  different	   isogenic	   strains	   (Sheldon	  et	   al.,	   1998),	  
but	  also	  to	  demonstrate	  that	  despite	  the	  consistent	  occurrence	  of	  LPS-­‐mediated	  
sensitization	  across	  the	  multiple	  strains	  used,	  the	  level	  of	  sensitization-­‐mediated	  
exacerbation	   in	   brain	   damage	   also	   differs	   between	   different	   genetic	   strains.	  
Interestingly,	   some	   of	   the	   strains	   appeared	   to	   be	   affected	   by	   intraperitoneal	  
administration	   of	   sterile	   0.9%	   saline	   as	   a	   control.	   This	   novel	   finding	   can	   be	   of	  
relevance,	  as	  saline	  treatment	  may	  not	  always	  represent	  a	  true	  control.	  
	  
Hypoxia-­‐ischaemia	  differs	  significantly	  between	  different	  mouse	  strains	  
Several	   ischaemia	  studies	  have	  demonstrated	  that	  cerebrovascular	  architecture	  
differs	   not	   only	   between	   different	   mouse	   background	   strains	   (Barone	   et	   al.,	  
1993;	  Fujii	  et	  al.,	  1997;	  Maeda	  et	  al.,	  1998;	  Maeda	  et	  al.,	  1999;	  Beckmann,	  2000),	  
but	   also	   within	   the	   same	   strain	   (Beckmann,	   2000).	   Particularly,	   a	   study	   by	  
Nicolau	   Beckmann	   (2000)	   using	   non-­‐invasive	   magnetic	   resonance	   angiography	  
(MRA)	   to	   detect	   differences	   in	   cerebrovascular	   anatomy	   in	   adult	   mice,	   has	  
demonstrated	   not	   only	   a	   difference	   in	   arterial	   architecture	   between	   C57BL/6,	  
CD1,	  CBA	  and	  129SVJ	  mouse	  strains,	  but	  also	  within	  the	  CD1	  strain	  (Beckmann,	  
2000).	  	  Both	   Fujii	   et	   al.,	   1997	   and	  Maeda	   et	   al.,	   1998	   have	   used	   intravascular	  
perfusion	  of	  carbon	  black	  ink	  to	  describe	  cerebrovascular	  anatomical	  differences	  
between	  C57BL/6	  and	  129SVJ	  inbred	  strains,	  where	  the	  former	  also	  described	  an	  
incompletely	  formed	  circle	  of	  Willis	  in	  C57BL/6	  mice	  (Fujii	  et	  al.,	  1997;	  Maeda	  et	  
al.,	   1998).	   These	   studies	   suggested	   that	   this	   difference	   in	   cerebrovascular	  
anatomy	   could	   explain,	   in	   part,	   the	   larger	   brain	   infarction	   seen	   in	   C57BL/6	  
compared	   to	   129SVJ	   mice	   following	   both	   transient	   and	   permanent	   middle	  
cerebral	  artery	  occlusion,	  as	  this	  artery	  supplies	  a	  significantly	  larger	  territory	  in	  
C57BL/6	  animals	  (Connolly	  et	  al.,	  1996).	  Another	  study	  comparing	  BDF,	  CFW	  and	  
BALB/c	   strains’	   response	   to	   focal	   cerebral	   ischaemia,	   showed	   a	   difference	   in	  
response	   between	   each	   of	   these	   strains.	   Furthermore,	   BALB/c	   mice	   were	  
significantly	  more	  affected,	  not	  only	   in	   terms	  of	   cerebral	   infarction,	  but	  also	   in	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increased	   mortality	   when	   compared	   to	   the	   other	   two	   (Barone	   et	   al.,	   1993).	  
However,	  all	  aforementioned	  studies	  were	  performed	   in	  adult	  mice	  and	  used	  a	  
different	   ischaemic	   insult	  methodology.	   Comi	   et	   al.,	   2009,	   used	   a	  more	   similar	  
approach	  to	  the	  study	  performed	  in	  this	  project,	  where	  unilateral	  carotid	  ligation	  
was	  performed	  in	  P12	  CD1	  and	  C57BL/6	  mice.	  This	  group	  had	  previously	  shown	  
that	   CD1	   mice	   exhibited	   moderate	   to	   severe	   brain	   injury	   in	   the	   cortex,	  
hippocampus,	   striatum	   and	   thalamus	   brain	   regions	   as	   well	   as	   seizure-­‐related	  
behaviour	   (Comi	   et	   al.,	   2004).	   In	   the	   more	   recent	   comparison	   study,	   it	   was	  
observed	   that	   the	   C57BL/6	  were	  much	   less	   vulnerable	   than	   CD1	  mice	   to	   both	  
brain	   injury	   and	   seizures	   (Comi	   et	   al.,	   2009).	   Similarly,	   a	   study	   looking	   at	   the	  
different	  responses	  of	  adult	  C57BL/6	  and	  CD1	  mice	  in	  acute	  hypoxia	  has	  shown	  a	  
strain-­‐related	  difference	   in	  response	  to	   insult.	  Zwemer	  et	  al.,	  2006,	  described	  a	  
higher	  tolerance	  and	  survival	  to	  acute	  hypoxic	  insult	  in	  the	  C57BL/6	  strain	  when	  
compared	  to	  CD1	  mice.	  Indirect	  calorimetry	  as	  well	  as	  respiratory	  exchange	  ratio	  
and	   fluorometric	   assay	  of	   plasma	   ketones	   showed	   that	   C57BL/6	   and	  CD1	  mice	  
respond	  differently	  to	  hypoxic	  insult.	  Whereas	  CD1	  animals	  lowered	  their	  mass-­‐
specific	   oxygen	   consumption	   and	   carbon	   dioxide	   production,	   C57BL/6	   mice	  
maintained	   both	   oxygen	   consumption	   and	   carbon	   dioxide	   production,	   but	  
switched	  rapidly	  fuel	  to	  ketone	  metabolism.	  Despite	  lowering	  metabolic	  demand	  
being	   considered	   generally	   more	   efficient,	   it	   appears	   that	   maximizing	   oxygen	  
usage	   may	   be	   more	   advantageous	   in	   an	   episode	   of	   acute	   severe	   hypoxia	  
(Zwemer	  et	  al.,	  2006).	  	  
	  
The	  only	  other	  study	  to	  date	  to	  have	  looked	  at	  the	  effects	  of	  hypoxia-­‐ischaemia	  
in	   multiple	   mouse	   strains	   was	   conducted	   by	   Sheldon	   and	   colleagues,	   where	  
histological	   assessment	   conducted	   five	   days	   after	   P7	   hypoxic-­‐ischaemic	   insult	  
revealed	   that	   129SVJ	  mice	  had	  minimal	   brain	   injury,	   in	   both	  30min	   and	  60min	  
set-­‐ups.	   The	   same	   study	   showed	   that	   C57BL/6	   animals	   had	   moderate	   brain	  
damage	  following	  30min	  hypoxia,	  which	  was	  increased	  when	  animals	  underwent	  
60min	  hypoxia	  (Sheldon	  et	  al.,	  1998).	  This	  C57BL/6	   increased	  susceptibility	  to	  a	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more	  severe	  hypoxia	  was	  also	  seen	  in	  a	  study	  by	  Kendall	  et	  al.	  2006	  where	  48h	  
post-­‐HI	  insult,	  animals	  that	  underwent	  60min	  hypoxia	  following	  unilateral	  carotid	  
occlusion,	  had	   substantially	  more	  brain	  damage	   than	   the	  30min	  hypoxia	   group	  
(Kendall	   et	   al.,	   2006).	   Sheldon	   et	   al.	   1998	   also	   showed	   that	   out	   of	   the	   three	  
assessed	   strains,	   C57BL/6,	   129SVJ	   and	   CD1,	   the	   latter	   was	   the	   most	   sensitive	  
strain	   to	   30min	   hypoxic-­‐ischaemic	   insult.	   Interestingly,	   CD1	   mice	   showed	   no	  
increase	  in	  brain	  damage	  after	  60min	  hypoxia;	  however	  this	  strain	  displayed	  an	  
increase	  in	  death	  post	  hypoxic-­‐ischaemic	  insult	  (Sheldon	  et	  al.,	  1998).	  
	  
Similarly	   to	  what	  was	   seen	   in	   both	   neonatal	   and	   adult	   ischaemic	   insults,	   adult	  
hypoxic	  and	  neonatal	  hypoxic-­‐ischaemic	  studies,	  this	  study	  has	  shown	  that	  there	  
is	  a	  strain-­‐dependent	  variation	  response	  to	  hypoxic-­‐ischaemic	  insult.	  This	  project	  
has	   shown	   that	   48h	   post-­‐HI,	   the	   most	   sensitive	   strain	   appears	   to	   be	   the	   FVB	  
strain.	  	  Furthermore,	  the	  same	  trend	  is	  seen	  between	  this	  and	  previous	  studies,	  
where	  CD1	  animals	  appeared	  to	  be	  the	  second	  most	  affected	  strain,	  with	  higher	  
degree	   of	   infarction,	   followed	   by	   BALB/c,	   C57BL/6	   and	   lastly	   129SVJ.	   In	   this	  
particular	   study,	   histological	   assessment	   of	   brain	   damage	   looking	   at	   tissue	  
infarction,	   combined	   injury	   score,	   TUNEL-­‐associated	   cell	   death	   and	   astrogliosis	  
has	   shown	   that	   both	   inbred	   strains	   C57BL/6	   and	   129SVJ	   have	   the	   least	   brain	  
damage	   in	   response	   to	   hypoxic-­‐ischaemic	   insult	   alone.	   In	   respect	   to	   individual	  
assessments,	   C57BL/6	   animals	   had	   an	   average	   of	   15%	   tissue	   infarction,	   1.5	  
combined	  injury	  score,	  2.7	  TUNEL+	  cell	  counts	  and	  a	  minimal	  optical	   luminosity	  
value	  (OLV;	  GFAP	   immunoreactivity)	  of	  22.3.	  129SVJ	  animals	  were	  even	  further	  
resistant	   to	   hypoxia-­‐ischaemia	   alone,	   with	   3%,	   0.1,	   0.0	   and	   21.9	   respectively.	  
However,	   this	   response	   was	   moderately	   increased	   in	   BALB/c	   animals,	   where	  
there	  was	  an	  overall	   increase	   in	   infarction	   to	  21%,	  combined	  alphaM	  and	  Nissl	  
injury	  score	  to	  2.3,	  21	  TUNEL+	  cells	  and	  53.6	  OLV.	  There	  was	  a	  further	  increase	  in	  
brain	  damage	  seen	  in	  the	  CD1	  and	  FVB	  outbred	  strains.	  	  CD1	  mice	  demonstrated	  
an	  infarct	  volume	  of	  46%,	  injury	  score	  of	  4.7;	  TUNEL+	  counts	  of	  27.3	  and	  OLV	  of	  
63.9.	   Similarly,	   FVB	   animals	   demonstrated	   an	   elevated	   increase	   in	   infarction	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(41%),	   combined	   injury	   (2.5),	   TUNEL+	   cells	   (70.5)	   and	   GFAP	   immunoreactivity	  
(90.2).	   Interestingly,	   contrary	   to	  what	  was	   observed	  previously	   (Sheldon	   et	   al.,	  
1998)	  and	  despite	  this	  varying	  degree	  of	  brain	  damage,	  none	  of	  the	  animals	  used	  
in	   this	   study	   succumbed	   to	   the	   experimental	   design,	   irrespective	   of	   strain	  
background.	  
	  
Saline-­‐stressor	  effect	  in	  the	  different	  strain	  backgrounds	  
Interestingly,	  different	  assessments	  performed	  in	  this	  study	  have	  shown	  a	  saline	  
injection-­‐associated	   susceptibility	   in	   different	   strains	   as	   seen	   in	   the	   C57BL/6	  
GFAP	   immunoreactivity	  assessment,	  where	  this	  effect	  was	  also	  observed	   in	  the	  
contralateral	  hemisphere.	  Combined	  microglial	  activation	  and	  neuronal	  cell	   loss	  
injury	  score	  assessment	  in	  FVB	  mice	  also	  showed	  a	  saline-­‐associated	  increase	  in	  
damage.	  As	   the	   saline	  used	   in	   the	   experimental	   design	  was	  obtained	   from	   the	  
BSU	   veterinary	   specifically	   as	   an	   intravenous	   infusion,	   therefore	   removing	   the	  
risk	  of	  endotoxin	  contamination,	  it	  was	  concluded	  that	  other	  stress	  factors	  were	  
causing	  this	  sensitivity	  to	  sterile	  saline	  administration.	  
	  
Stressful	  events	  are	  known	  to	  cause	  short	  and/or	  long-­‐term	  adverse	  effects	  both	  
in	   terms	   of	   behavioural	   but	   also	   in	   neurochemical	   outcomes,	   including	  
influencing	  circulating	  and	  brain	  cytokine	  activity	  (Gibb	  et	  al.,	  2008;	  Audet	  et	  al.,	  
2010).	   Furthermore,	   individual	   animas	   are	   known	   to	   demonstrate	   different	  
sensitivity	   to	   stress,	   and	   this	  difference	   in	   response	   is	   also	  noticeable	  between	  
different	   animal	   strains,	   where	   BALB/c	   animals	   are	   know	   to	   be	   highly	   stress	  
reactive	   in	  comparison	  to	  the	  C57BL/6	  strain	  (Anisman	  et	  al.,	  2001;	  Anisman	  et	  
al.,	  2008).	  In	  a	  study	  where	  exposure	  to	  a	  dominant	  mouse	  was	  used	  as	  a	  social	  
stress	   alone	   or	   in	   combination	   with	   different	   acute	   immune	   challenges	   to	  
investigate	   immune	   response,	   it	  was	   shown	   that	   social	   stressor	   combined	  with	  
saline	   administration	   led	   to	   an	   increase	   in	   the	   production	   of	   plasma	  
corticosterone	   in	   both	   C57BL/6	   and	   BALB/c	   animals	   when	   compared	   to	  
respective	  no	  stress	  groups.	  	  Assessment	  of	  hippocampal	  expression	  of	  IL-­‐1,	  IL-­‐6	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and	   TNFα	   cytokines	   showed	   a	   trend	   in	   increased	   IL-­‐6	   expression	   in	   C57BL/6	  
animals	   that	   again	   underwent	   stress	   challenge	   combined	   with	   saline	  
administration	  (vehicle).	  Furthermore,	  both	  no	  stress	  and	  stress	  C57BL/6	  groups	  
had	   a	   higher	   level	   of	   IL-­‐6	   cytokine	   production	   when	   compared	   to	   respective	  
BALB/c	   groups.	   As	   expected,	   the	   increase	   in	   corticosterone	   and	   cytokines	  was	  
visibly-­‐significantly	  higher	   in	  animals,	  both	  C57BL/6	  and	  BALB/c,	   that	  were	  also	  
subjected	   to	   LPS	   administration	   instead	   of	   saline	   (Gibb	   et	   al.,	   2011).	   Another	  
study	  used	  forced	  swim-­‐stress	  combined	  with	  peripheral	  administration	  of	  either	  
LPS	  or	  saline	  as	  a	  control.	  C57BL/6	  and	  BALB/c	  mice	  were	  forced	  to	  swim	  15min	  
instead	  of	  the	  usual	  6min,	  thus	  leading	  to	  an	  effective	  physical	  and	  psychological	  
stressor	   in	   rodents	   (Connor	  et	  al.,	   1997).	   It	  was	  demonstrated	   that	   the	   forced-­‐
swim	  stressor	  alone	  (plus	  saline)	  significantly	  raised	  corticosterone	  levels	  in	  both	  
C57BL/6	  and	  BALB/c	  mice.	  There	  was	  also	  a	  small	  increase	  in	  hippocampal	  IL-­‐1β	  
mRNA	  expression	   in	  BALB/c	   swim-­‐stress	  animals.	  This	   study	  also	  demonstrated	  
LPS-­‐mediated	   upregulation	   of	   IL-­‐1β	   and	   TNFα	   in	   both	   strains,	   but	   to	   a	   greater	  
extent	  in	  the	  BALB/c	  animals,	  which	  interestingly	  was	  attenuated	  in	  the	  presence	  
of	  swim-­‐stressor,	  thus	  indicating	  an	  altered	  immune	  activation	  in	  BALB/c	  animals	  
when	   compared	   to	   the	   more	   normo-­‐sensititve	   C57BL/6	   strain	   (Browne	   et	   al.,	  
2012).	   Therefore,	   it	   is	   possible	   that	   in	   the	   current	   study,	   the	   stress	   associated	  
with	   night-­‐time	   separation	   from	   the	   dam	   together	   with	   intraperitoneal	  
administration	  of	  saline	  could	  have	  an	  effect	   in	   the	   immune	  response,	  which	   is	  
seen	   in	   the	   assessment	   of	   immune-­‐associated	   markers	   for	   astrogliosis	   and	  
microglial	  activation	  of	  C57BL/6	  and	  FVB	  strains.	  
	  
Interestingly,	   the	   psychological	   and/or	   physical	   stress	   studies	   aforementioned	  
have	   demonstrated	   that	   great	   care	   is	   required	  when	   creating	   an	   experimental	  
design	   involving	   an	   immune	   response	   (Gibb	   et	   al.,	   2011;	   Brown	   et	   al.,	   2012).	  	  
These	  studies	  have	  demonstrated	  that	  multiple	  factors,	  including	  environmental	  
changes	   can	   lead	   to	   an	   upregulation	   of	   the	   immune	   system,	   which	   can	   then	  
sensitize	  the	  organism	  to	  subsequent	  insults	  such	  as	  LPS	  and	  hypoxia-­‐ischaemia.	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It	  was	  also	  shown	  that	  a	  same	  stress-­‐factor	  that	  could	  exacerbate	  the	  response	  
to	   a	   subsequent	   immune	   challenge	   could	   instead	  dampen	   it	   depending	  on	   the	  
background	  strain	  used	  (Browne	  et	  al.,	  2012).	   	  Subsequently,	  the	  present	  study	  
has	  also	  shown	  how	  relevant	  it	  is	  to	  understand	  the	  importance	  of	  using	  a	  proper	  
control,	   and	   also	   to	   understand,	   that	   the	   use	   of	   saline,	   or	   possibly	   any	   other	  
vehicle	  does	  not	  always	  equate	  to	  a	  controlled	  unadulterated	  response.	  
	  
Strain	  impact	  on	  combined	  inflammation	  and	  hypoxic-­‐ischaemic	  insults	  
As	  the	  principal	  aim	  of	  this	  study	  was	  to	  understand	  the	  role	  of	  inflammation	  and	  
the	  individual	  members	  of	  the	  TNF	  cluster	  of	  cytokines	  using	  multiple	  single	  gene	  
knockout	  strains,	  it	  was	  decided	  to	  first	  address	  if	  the	  variability	  seen	  in	  hypoxic,	  
ischaemic	   and	   hypoxic-­‐ischaemic	   models	   would	   also	   occur	   in	   the	   combined	  
inflammation	  and	  hypoxia-­‐ischaemia	  model,	  and	   if	  so,	  could	  this	  have	  an	  effect	  
in	  the	  interpretation	  of	  results.	  
	  
This	   study,	   as	   well	   as	   previous	   research	   (Hagberg	   et	   al.,	   2002;	   Mallard	   et	   al.,	  
2003;	  Kendall	  et	  al.,	  2011b;	  van	  de	  Looij	  et	  al.,	  2012),	  has	  shown	  that	  bacterial	  
endotoxin	   successfully	   sensitizes	   the	   neonatal	   brain	   to	   subsequent	   hypoxic-­‐
ischaemic	   injury,	   as	   all	   five	   strains,	   C57BL/6,	   129SVJ,	   BALB/c,	   CD1	   and	   FVB	  
demonstrated	   strong	   LPS-­‐mediated	   sensitization	   to	   subsequent	   hypoxic-­‐
ischaemic	   insult.	   Additionally,	   it	   was	   shown	   that	   the	  mouse	   strain	   background	  
used	  has	  an	  effect	  in	  the	  degree	  of	  brain	  damage.	  LPS	  pre-­‐treatment	  significantly	  
increased	  tissue	  infarction,	  microglial	  activation,	  cell	  death	  and	  astrogliosis	  in	  the	  
C57BL/6	  strain.	  129SVJ	  also	  demonstrated	  an	  overall	  significant	  increase	  in	  tissue	  
infarction,	   microglial	   activation	   and	   neuronal	   cell	   death	   injury	   score,	   and	  
astrogliosis;	   with	   also	   a	   visible	   trend	   towards	   increased	   TUNEL+	   cell	  
quantification	   after	   LPS	   treatment.	   BALB/c	   mice	   also	   showed	   an	   overall	   trend	  
towards	   increased	   brain	   damage	   in	   the	   LPS	   group;	   however	   this	   was	   only	  
significant	  in	  the	  TUNEL	  assessment.	  CD1	  mice	  also	  showed	  substantial	  increase	  
in	  brain	  damage	  associated	  with	  LPS	  administration;	  this	  was	  particularly	  evident	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in	   terms	   of	   tissue	   infarction	   and	   TUNEL+	   cell	   quantification.	   Finally,	   FVB	   LPS-­‐
treated	  mice	   showed	  maximal	  brain	  damage,	  with	   significant	   increase	   in	   tissue	  
loss,	   microglial	   activation	   and	   neuronal	   cell	   loss	   brain	   injury	   and	   DNA	  
fragmentation-­‐associated	  cell	  death.	  Despite	  LPS-­‐associated	  increase	  in	  astrocyte	  
activation	  only	  demonstrating	  an	  overall	  trend,	  astrogliosis	  was	  still	  significantly	  
increased	  in	  50%	  of	  the	  assessed	  brain	  regions	  for	  the	  FVB	  strain.	  
	  
After	   initial	   observation	   of	   strain-­‐mediated	   variation	   in	   response	   to	   insult	   and	  
correlating	   these	   observed	   differences,	   at	   least	   partially,	   with	   anatomical	  
differences,	   particularly	   in	   cerebrovascular	   architecture,	   further	   studies	   looked	  
also	   at	   inflammatory	   effect	   and	   variation	   between	   different	   genetic	   mouse	  
strains.	   Cytokines	   are	   an	   integral	   part	   of	   the	   inflammatory	   response	   and	   are	  
upregulated	   following	  both	  neonatal	   and	   adult	   insult.	   In	   an	   adult	  mouse	   study	  
looking	   at	   the	   difference	   between	  C57BL/6	   and	  BALB/c	   in	   the	   synthesis	   of	   the	  
pleitropic	  cytokine	  TNFα	  within	  the	  focal	  and	  border	  zone	  of	  cerebral	  infarction	  
has	  demonstrated	  that	  degree	  of	  TNFα	  synthesized	  by	  microglia-­‐macrophages	  is	  
strain	   dependent.	   However,	   this	   variation	   in	   cellular	   TNFα	   production	   is	   not	  
present	  in	  terms	  of	  time-­‐related	  response	  and	  cellular	  source.	  Interestingly,	  this	  
group	  has	  shown	  that	  BALB/c	  mice	  had	  larger	  infarct	  area	  with	  significantly	  fewer	  
TNFα-­‐producing	  microglia	   (Lambertsen	  et	  al.,	  2002).	  TNFα	   is	  a	  known	  activator	  
of	   the	   vascular	   endothelium,	   T	   cells,	   B	   cells	   (Ettinger	   et	   al.,	   1998),	   as	   well	   as	  
stimulator	  of	   adhesion	  molecules	   and	   chemokines	   culminating	   in	   infiltration	  of	  
blood-­‐borne	   leukocytes	   into	   the	   CNS	   (Sedwig	   et	   al.,	   2000).	   Additionally,	   this	  
cytokine	   is	   an	   endogenous	  pyrogen,	   inducer	   of	   cell	   death	   (Gaur	   and	  Aggarwal,	  
2003)	  and	   further	  activates	  microglia	  and	  macrophages	  stimulating	  not	  only	   its	  
own	  production,	  but	  also	  that	  of	  other	  pro-­‐inflammatory	  cytokines	  such	  as	  IL-­‐1β	  
and	   IL-­‐6,	   as	  well	   as	   nitric	   oxide	   (Kendall	   et	   al.,	   2011b),	   all	   known	  mediators	   of	  
cerebral	   ischaemia.	  This	  finding	  could	  potentially	  explain	  the	  results	  seen	  in	  the	  
current	   project	   where,	   despite	   an	   obvious	   increase	   in	   brain	   damage	   in	   the	  
BALB/c	   strain,	   the	   immune	   profile,	   as	   seen	   through	   the	   combined	   injury	   score	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and	   astrogliosis	   assessments,	   never	   reached	   significance	   in	   the	   animals	   pre-­‐
treated	  with	  LPS	  when	  compared	  to	  saline-­‐treated	  controls,	  as	  opposed	  to	  what	  
was	  seen	   in	  the	  C57BL/6,	  CD1	  and	  FVB	  strains.	  Genetic	  differences	  can	  cause	  a	  
variation	   in	   the	   sensitivity	   to	   insult	   and	   inflammation	   and	   alteration	   in	   the	  
balance	  between	  pro-­‐	  and	  anti-­‐inflammatory	  cytokines,	  and	  consequently	  affect	  
the	   microglial	   and	   astroglial	   immune	   response,	   activation	   and	   recruitment	   of	  
inflammatory	  cells.	  	  
	  
However,	   both	   this	   current	   (48h)	   and	   the	   Lambertsen	   et	   al.,	   (12h	   and	   24h)	  
studies	   have	   only	   looked	   at	   assessments	   post-­‐insult.	   A	   study	  where	   TNFα	   was	  
inhibited	  prior	  to	  1h	  middle	  cerebral	  artery	  occlusion	  in	  CD1	  mice,	  showed	  that	  
23h	   later	   the	   infarct	  are	  of	  mice	  pre-­‐treated	  with	  monoclonal	  neutralizing	  anti-­‐
murine	   TNFα	   antibody	   was	   significantly	   smaller	   than	   that	   of	   vehicle-­‐treated	  
mice.	  Additionally,	  expression	  of	  intracellular	  adhesion	  molecule-­‐1	  (ICAM-­‐1)	  was	  
also	   significantly	   reduced	   in	   the	   inhibited	   group	   (Yang	   et	   al.,	   1998).	   The	   same	  
reduction	   in	   infarction	   was	   observed	   in	   BALB/c	   mice	   pre-­‐treated	   with	   TNF	  
receptor	  linked	  to	  polyethylene	  glycol	  -­‐	  which	  binds	  to	  and	  inhibits	  TNFα	  -­‐	  prior	  
to	   permanent	   middle	   cerebral	   artery	   occlusion	   (Nawashiro	   et	   al.,	   1997).	  
Conversely,	   hybrid	   C57BL/6x129	   mice,	   which	   were	   deficient	   in	   TNF	   receptors,	  
demonstrated	   higher	   focal	   cerebral	   infarction,	   and	   epileptic	   seizures	   following	  
focal	   cerebral	   ischaemia	   (Bruce	  et	   al.,	   1996;	  Gary	   et	   al.,	   1998).	   These	  different	  
studies	   show	   a	   TNFα	   modulatory	   effect	   on	   ischaemic-­‐induced	   brain	   damage	  
irrespective	  of	  strain	  background.	  Therefore,	  despite	  a	  reduced	  number	  of	  TNFα	  
synthesizing	  microglia	  seen	  in	  BALB/c	  animals	  after	  ischaemic	  insult	  (Lambertsen	  
et	   al.,	   2002)	   correlating	   to	   a	   less	   significant	   increase	   inflammatory	   response	   in	  
the	   current	   combined	   inflammation	   and	   hypoxic-­‐ischaemic	   study,	   it	   has	   been	  
shown	  that	  this	  does	  not	  equate	  to	  a	  correlation	  in	  reduced	  infarct	  size,	  as	  albeit	  
not	   significant,	   there	  was	  a	   substantial	   infarction	   in	   the	  BALB/c	   LPS	  group.	  The	  
same	   substantial	   increase	   in	   tissue	   necrosis	   was	   also	   observed	   in	   the	   other	  
assessed	  strains,	  which	  could	  be	  an	  indicative	  that	  if	  the	  different	  strains	  have	  a	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genetic	   varying	   effect	   on	   TNFα	   synthesis,	   this	   occurs	   only	   hours	   later	   and	   not	  
immediately	  after	  insult.	  
	  
Of	  all	  five	  strains	  assessed	  (C57BL/6,	  129SVJ.	  BALB/c,	  CD1	  and	  FVB),	  the	  one	  that	  
appears	  to	  be	  the	  least	  affected	  is	  the	  129SVJ.	  In	  the	  current	  study,	  both	  HI	  alone	  
and	   HI+SAL	   groups	   have	   demonstrated	   minimal	   response,	   and	   despite	   a	  
substantial	   to	   significant	   increase	   in	   damage-­‐associated	   markers,	   this	   increase	  
was	   generally	   smaller	   than	   what	   was	   observed	   in	   the	   other	   four	   strains.	   This	  
reduced	   response	   has	   been	   explained	   in	   part	   due	   to	   the	   cerebrovascular	  
anatomical	  differences	  observed	  in	  129SVJ	  mice	  (Fujii	  et	  al.,	  1997;	  Maeda	  et	  al.,	  
1998;	   Beckmann,	   2000).	  However,	  more	   recent	   studies	   looking	   at	   the	   immune	  
profile	  of	  different	  mouse	  strains	  have	  shown	  that	  129SVJ	  strain	  has	  a	  defect	  in	  
inflammatory	   cell	   recruitment	   (White	   et	   al.,	   2002;	   Hoover-­‐Plow	   et	   al.,	   2008).	  
White	   et	   al.	   2002,	   administered	   thioglycollate	  medium	   into	   the	   peritoneum	  of	  
both	   male	   and	   female	   C57BL/6,	   129SVJ,	   BALB/c	   and	   CD1	   mice	   to	   test	  
inflammatory	   cell	   recruitment	   4	   days	   after	   injection.	   All	   four	   strains	   revealed	  
different	  total	  cell	  recruitment,	  where	  the	  C57BL/6	  demonstrated	  to	  be	  the	  most	  
responsive,	   followed	  by	  BALB/c	  and	  CD1,	  and	  129SVJ	  mice	  appeared	   to	  be	   the	  
least	   affected.	   Further	   assessment	   on	   both	   C57BL/6	   and	   129SVJ	   mice	   using	  
multiple	   time	  points	   (4h,	  1d,	  2d,	  3d,	  4d	  and	  5d)	   revealed	   that	  both	  strains	  had	  
similar	   neutrophil	   recruitment	   at	   4h	   post-­‐inject,	   with	   significant	   macrophage	  
recruitment	  appearing	  only	  24h	  after	  injection.	  Interestingly,	  129SVJ	  had	  highest	  
cell	   count	   4h	   post-­‐injection	   with	   numbers	   falling	   progressively	   at	   later	   time	  
points.	   The	   opposite	   effect	   was	   seen	   in	   the	   C57BL/6	   strain,	   where	   the	   total	  
number	   of	   cell	   counts	   rose	   steadily	   up	   to	   48h	   following	   injection,	   where	   it	  
reached	  a	  plateau	  up	  to	  4d	  post-­‐injection	  with	  gradual	  reduction	  started	  at	  day	  5	  
(White	  et	  al.,	   2002).	   	   In	  a	   study	  by	  Hoover-­‐Plow	  et	  al.	   2008,	   thioglycollate	  was	  
also	  used	  as	  an	  inflammatory	  stimulus	  in	  A/J,	  C57BL/6	  and	  129SVJ	  animals.	  In	  this	  
study,	   A/J	   animals	   had	   the	   lowest	   number	   of	   recruited	   leucocytes	   and	  
macrophages,	   followed	   by	   129SVJ	   animals,	   when	   compared	   to	   C57BL/6	   mice	  
117	  
	  
(Hoover-­‐Plow	  et	  al.,	  2008).	  A	  study	  by	  Medina	  and	  North,	   further	  confirms	  this	  
reduced	   129SVJ	   ability	   to	   recruit	   macrophages	   in	   a	   model	   of	  Mycobacterium	  
tuberculosis,	   where	   129SVJ	   mice	   were	   significantly	   more	   susceptible	   than	  
C57BL/6	   animals	   (Medina	   and	   North	   1998).	   Therefore,	   this	   observed	   reduced	  
macrophage	  recruitment	  and	  resistance	  to	  M.	  tuberculosis	  further	  demonstrates	  
defective	  macrophage	  recruitment	  and/or	  function,	  which	  could	  further	  explain	  
it’s	   diminished	   response	   not	   only	   to	   HI	   alone	   and	   HI+SAL,	   but	   also	   in	   the	   LPS	  
ability	  to	   induce	  as	  robust	  an	  immune	  response	  when	  compared	  the	  other	  four	  
strains.	  	  
	  
C57BL/6	  as	  the	  optimal	  strain	   in	  combined	   inflammation	  and	  hypoxic-­‐ischaemic	  
insult	  	  
C57BL/6	  and	  129SVJ	  are	  the	  most	  commonly	  used	  parent	  strains	  in	  the	  creation	  
of	   transgenic	  mice.	  As	  explained	  above,	  both	  C57BL/6	  and	  129SVJ	  had	  minimal	  
response	   to	   either	   HI	   alone	   or	   combine	   HI	   and	   saline	   treatments.	   However,	  
C57BL/6	   showed	   a	   higher	   degree	   of	   LPS-­‐mediated	   brain	   injury.	   This	   is	   in	  
concordance	   with	   previous	   findings.	   A	   study	   by	   Maeda	   et	   al.	   has	   shown	  
anatomical	  differences	   in	   adult	  C57BL/6	  and	  129SVJ	   inbred	   strains.	   Location	  of	  
anastomoses	   was	   determined	   using	   carbon	   black	   stained	   latex	   showed	   that	  
C57BL/6	  animals	  had	  a	   larger	  vascularised	  area	  supplied	  by	  the	  middle	  cerebral	  
artery,	  which	  could	  potentially	  explain	  the	  larger	  infarct	  volume	  in	  these	  animals	  
when	  compared	  to	  129SVJ	  after	  middle	  cerebral	  artery	  occlusion	  (Maeda	  et	  al.,	  
1998).	  Furthermore,	  inflammation	  cell	  recruitment	  studies	  have	  demonstrated	  a	  
reduced	  129SVJ	  strain	  ability	  to	  recruit	  immune	  cells	  (White	  et	  al.,	  2002;	  Hoover-­‐
Plow	   et	   al.,	   2008)	   and	   produce	   TNFα	   (Lambertsen	   et	   al.,	   2002),	   a	   pro-­‐
inflammatory	  cytokine	  that	  is	  well	  established	  as	  playing	  a	  role	  in	  this	  particular	  
type	  of	  insult.	  This	  makes	  the	  use	  of	  the	  129SVJ	  strain	  less	  than	  desirable	  in	  this	  
particular	   study,	   where	   the	   objective	   is	   to	   further	   understand	   the	   role	   of	   the	  
individual	  members	  of	   the	  TNF	  cluster	  of	   cytokines	   in	   sensitizing	   the	   immature	  




BALB/c	  animals,	   although	   responsive	   to	   LPS	   sensitization,	  only	  had	  a	  moderate	  
increase	  in	  the	  studied	  damage-­‐associated	  markers	  when	  compared	  to	  HI	  alone	  
and	   HI+SAL.	   Additionally,	   its	   baseline	   response	   to	   both	   controls	   was	   relatively	  
high,	  thus	  again	  making	  this	  strain	   less	  than	  ideal	  for	  the	  current	  project	  as	  the	  
purpose	  is	  to	  require	  LPS	  administration	  in	  order	  to	  elicit	  a	  response.	  This	  same	  
principle	   excludes	   both	   CD1	   and	   FVB	   animals,	   as	   their	   baseline	   response	   (HI	  
alone	  and	  HI+SAL)	  were	  too	  high.	  Furthermore,	  C57BL/6	  strain	  appears	  to	  be	  the	  
most	  well	  characterised	  isogenic	  strain,	  which	  allows	  for	  better	  understanding	  of	  
its	   response	   to	   different	   types	   of	   insult.	   Therefore,	   for	   the	   purpose	   of	   this	  
research,	   it	   was	   decided	   to	  maintain	   animals	   whenever	   possible	   in	   a	   C57BL/6	  
background,	   as	   this	   particular	   background	   demonstrated	   a	   sufficiently	   high	  
response	   to	   LPS	   sensitization,	   not	  only	   across	   all	   four	  histological	   assessments,	  
but	   also	   within	   the	   six	   different	   forebrain	   regions	   being	   assessed.	   This	   choice	  
thus	  would	  allow	  clear	  comparison	  between	  LPS	  and	  saline	  (control)	  groups,	  with	  
the	  added	  benefit	   that	   the	  chosen	  strain	   -­‐	  C57Bl/6	   -­‐	   is	  not	   sensitive	  enough	   to	  
have	   a	   baseline	   response	   to	   the	   moderate	   30min	   hypoxic-­‐ischaemic	   insult.	  
Furthermore,	   keeping	   the	   strains	   in	   this	   background	   would	   avoid	   unnecessary	  
rebreeding	  and	  crossing	  of	  animals	  to	  a	  new	  background,	  thus	  improving	  our	  use	  
of	   the	  3Rs	  as,	  with	   the	  exception	  of	  NUDE	  animals,	   all	   other	   transgenic	   strains	  
were	  obtained	  in	  the	  C57BL/6	  background.	  
	  
Conclusion	  
This	  study	  not	  only	  has	  been	  able	  to	  reproduce	  similar	  results	  to	  previous	  work	  
looking	  at	  the	  effects	  of	  using	  different	  mice	  strains	  in	  different	  insults,	  it	  has	  also	  
further	   consolidated	   that	   genetic	   background	   influences	   response	   to	   both	   a	  
hypoxic-­‐ischaemic	  as	  well	  as	  an	  immune-­‐sensitized	  hypoxic-­‐ischaemic	  injury.	  The	  
observed	   differences	   in	   response	   to	   such	   insults	   could	   assist	   in	   future	   studies	  
attempting	   to	   explain	   the	   high	   variation	   in	   the	   neonatal	   mouse	   model	   of	  
hypoxia-­‐ischaemia	   as	   well	   as	   foetal/neonatal	   response	   to	   inflammation	   and	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reduced	  oxygen-­‐blood	  supply,	  as	  it	  has	  been	  established	  that	  careful	  selection	  of	  
the	   experimental	   strain	   is	   required.	   Cerebral	   blood	   vascularity	   and	   immune	  
sensitivity	  are	  known	  factors	  involved	  in	  response	  to	  insult,	  which	  appear	  to	  also	  
play	  a	  role	  in	  this	  synergistic	  model.	  However,	  other	  factors	  such	  as	  activation	  of	  
early	   transcription	   factors	   such	   not	   be	   excluded	   as	   possible	   denominators	   in	  
perinatal	   brain	   damage	   resulting	   from	   both	   hypoxia-­‐ischaemia	   and	   combined	  
inflammation	  and	  hypoxia-­‐ischaemia	  injury,	  and	  therefore	  should	  be	  investigated	  
in	   future	   studies.	   Furthermore,	   great	   care	   is	   required	   when	   considering	   the	  
control	   groups,	   as	   this	   study	   has	   shown	   that	   saline,	   a	   commonly	   used	   vehicle,	  
may	  also	  elicit	  an	  immune	  response,	  possibly	  due	  to	  stress-­‐associated	  activation	  




















CHAPTER	   4:	   THE	   ROLE	   OF	   TNFα ,	   LTα 	   AND	   LTβ 	   CYTOKINES	   IN	  




Infection	   and	   hypoxic-­‐ischaemic	   (HI)	   insult	   share	   inflammatory	   mechanisms.	  
However,	  because	  live	  infection	  is	  frequently	  a	  too	  rapid	  and	  catastrophic	  event,	  
the	   pathophysiological	   effects	   of	   infection	   are	   normally	   modelled	   using	   some	  
standard	  pathogen	  such	  as	  endotoxins,	  particularly	  the	  E.	  coli	  lipopolysaccharide	  
(LPS).	  Systemic	  injection	  of	  LPS	  up-­‐regulates	  inflammation-­‐associated	  molecules,	  
including	  the	  TNF	  cluster	  of	  pro-­‐inflammatory	  cytokines.	  Our	  group	  has	  explored	  
the	  role	  of	  this	  cluster	  In	  terms	  of	  the	  LPS	  signalling	  pathway,	  and	  shown	  that	  its	  
deletion	  abolishes	  LPS	  sensitization	  to	  HI.	  
	  
In	   this	   study,	  we	  wanted	   to	   investigate	   individual	  effects	  of	   the	  TNFα,	   LTα	  and	  
LTβ	  cluster	  members,	  using	  either	  global	  gene	  deletion,	  or	  macrophage-­‐specific	  
deletion	   of	   TNFα	   with	   MLys::Cre.	   P7	   littermate	   wild	   type	   and	   homozygous	  
knockout	   offspring	   of	   heterozygous	   mice	   underwent	   HI	   insult,	   consisting	   of	  
carotid	  occlusion	  followed	  by	  30min	  8%	  oxygen	  exposure.	  12h	  prior,	  0.6µg/g	  LPS	  
or	  saline	  was	  administered	  intraperitoneally.	  
	  
LPS	   pre-­‐treatment	   resulted	   in	   significant	   neuronal	   injury	   and	   infarct,	  
inflammation,	   cell	   death	   and	   astrogliosis	   in	   wild	   type	   littermates	   of	   all	   four	  
experimental	   groups.	   LTα	   homozygous	   mutants	   revealed	   a	   clear	   reduction	   in	  
LPS-­‐mediated	   sensitization.	   Conversely,	   global	   LTβ	   deletion	   had	   a	   detrimental	  
effect,	   with	   significantly	   increased	   brain	   damage.	   TNFα-­‐/-­‐	   showed	   a	   trend	  
towards	  greater	  damage,	  but	  deletion	   just	   in	  MLys+	  macrophages	  was	  strongly	  
protective,	  pointing	   to	  a	  dual	   role	   for	   the	  TNFα	  gene	  depending	  on	  which	  cell-­‐
type	  it	  is	  expressed.	  
121	  
	  
Lymphotoxin	  α 	  deletion	   results	   in	  a	  marked	   reduction	   in	  brain	  damage	  
following	  combined	  endotoxin	  and	  hypoxic-­‐ischaemic	  insult	  
	  
Generation	  of	  mutants	  lacking	  LTα	  gene	  	  
Animals	  homozygous	  for	  the	  deletion	  of	  the	  LTα	  gene	  were	  bred	  against	  animals	  
that	   were	   WT	   with	   a	   C57BL/6	   background.	   F1	   generation	   obtained	   from	   this	  
breeding	   allowed	   setting	   up	   of	   heterozygous	   breeding	   pairs.	   F2	   offspring	  mice	  
received	   a	   single	   intraperitoneal	   injection	   of	   either	   0.6µg/g	   LPS,	   or	   saline	   as	   a	  
control,	  12h	  prior	  HI	  insult.	  48h	  post	  HI	  insult,	  mice	  were	  transcardially	  perfused,	  
and	   after	   PCR	   genotyping	   (see	   figure	   4.1),	   only	  WT	   and	   homozygotes	   for	   LTα	  
gene	  deletion	  were	  used	  for	  further	  investigation.	  
	  
	   	  
Figure	   4.1:	  Generation	  of	   LTα+/+,	   LTα+/-­‐	   and	   LTα-­‐/-­‐mice.	  Global	   deletion	  of	   the	   LTα	   gene	  was	  
achieved	   using	   a	   heterozygous	   breeding	   strategy.	   Agarose	   gel	   electrophoresis	   following	   PCR	  
reaction	  allowed	   identification	  of	   the	  different	  genotypes	  through	  visualization	  of	   the	   fragment	  
band	  sizes:	  LTα	  wild	  type	  allele	  at	  229bp	  (A)	  and	  LTα	  mutant	  allele	  at	  280bp	  (B).	  If	  an	  animal	  had	  
both	  wild	  type	  (+/+)	  and	  knock	  out	  alleles	  (-­‐/-­‐)	  PCR	  product	  present,	  then	  it	  was	  a	  heterozygote	  
(+/-­‐)	  for	  the	  mutation.	  
	  
LTα	  global	  gene	  deletion	  decreases	  tissue	  loss	  	  
As	   demonstrated	   by	   other	   studies	   (Kendall	   et	   al.,	   2011b)	   as	   well	   as	   in	   the	  
previous	   study	   (chapter	   3),	   LPS	   sensitization	   prior	   to	   HI	   insult	   leads	   to	   a	  
significant	  overall	   increase	   in	  brain	   tissue	  damage	   in	  WT	  animals,	   including	   the	  
C57BL/6	   strain.	   Comparison	   between	   WT	   saline	   (n=10)	   and	   WT	   LPS	   (n=10)	  
treated	   animals	   using	   total	   and	   regional	   measurements	   of	   infarct	   size	   as	  
percentage	   of	   forebrain	   as	   ipsilateral/contralateral	   volume	   has	   shown	   a	   total	  
A	   B	  
LTα	  WT	   LTα	  KO	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increase	   in	   tissue	   loss	   from	  5±2%	   to	   23±5%	   (p<1%).	   This	  was	   significant	   in	   the	  
dorsoparietal	  cortex	  (from	  5±1%	  to	  25±6%,	  p<5%),	  hippocampus	  (from	  12±4%	  to	  
43±7%,	  p<1%),	  striatum	  (from	  7±3%	  to	  22±5%,	  p<5%),	  thalamus	  (from	  -­‐2±2%	  to	  
7±3%,	  p<5%)	  and	  external	  capsule	  white	  matter	   (from	  1±2%	  to	  33±10%,	  p<1%)	  
brain	   regions.	   Furthermore,	   WT	   animals	   pre-­‐sensitized	   with	   LPS	   endotoxin	  
demonstrated	   the	   highest	   infarct	   volume	   of	   all	   four	   experimental	   groups:	  WT	  
saline,	  WT	  LPS,	  LTα	  KO	  saline	  and	  LTα	  KO	  LPS,	  with	  a	  total	  tissue	  loss	  of	  23±5%.	  
There	   was	  minimal	   tissue	   damage	   in	   LTα	   KO	  mice	   injected	   with	   saline	   (4±2%,	  
n=10),	  with	  trend	  towards	   increase	   in	  KO	  animals	  pre-­‐treated	  with	  LPS	  (15±5%,	  
n=10).	  However,	  this	  difference	  did	  not	  reach	  significance.	  Comparison	  between	  
the	  two	  LPS	  groups	  –	  LTα	  WT	  and	  LTα	  KO	  –	  revealed	  that	  the	  mutants	  had	  less	  
necrotic	   tissue,	   with	   significant	   decrease	   in	   infarct	   size	   from	   25±6%	   to	   17±7%	  
(p<5%)	  in	  the	  dorsoparietal	  cortex	  brain	  region	  (see	  figure	  4.2.A).	  
	  
LTα-­‐/-­‐	  animals	  have	  reduced	  injury	  response	  to	  combined	  LPS	  and	  HI	  insults	  
Once	  again,	  histological	  analysis	  confirmed	  the	  results	  previously	  observed	  in	  the	  
WT	  C57BL/6	  mice	  where	  pre-­‐sensitization	  with	  bacterial	  endotoxin	  resulted	  in	  a	  
marked	   increase	   in	   injury	   response	   on	   the	   ipsilateral	   brain	   hemisphere.	   WT	  
animals	  pre-­‐treated	  with	  LPS	  displayed	  a	  significant	   increase	   in	  brain	   injury	  and	  
cell	   loss	   in	   comparison	   to	   WT	   saline-­‐treated	   littermates	   (2.1±0.5	   vs.	   0.4±0.1,	  
p<1%).	  This	  was	  also	  significant	  in	  most	  brain	  regions:	  dorsoparietal	  (3.5±0.9	  vs.	  
0.2±0.1,	   p<1%)	   and	   pyriform	   cortex	   (0.6±0.2	   vs.	   0.1±0.1,	   p<5%),	   hippocampus	  
(3.8±0.5	  vs.	  0.9±0.2,	  p<0.1%),	  striatum	  (1.3±0.4	  vs.	  0.4±0.2,	  p<5%)	  and	  external	  
capsule	  (2.4±0.5	  vs.	  0.4±.3,	  p<1%).	  Likewise,	  when	  LPS	  was	  administered	  to	  mice	  
lacking	   both	   copies	   of	   the	   LTα	   gene,	   these	   showed	   a	   clear	   up-­‐regulation	   in	  
inflammation	  when	  compared	  to	  saline-­‐treated	  KO	  animals	  (1.4±0.4	  vs.	  0.4±0.2,	  
p<5%).	  Additionally,	   LTα	  mutants	   showed	  a	   clear	  decrease	   in	   LPS	   sensitization-­‐
mediated	   response	   to	   HI	   in	   comparison	   to	   LTα	   WT	   animals.	   Microglial	  
inflammation	  and	  cell	  death	  was	  markedly	  reduced	  in	  the	  pyriform	  cortex	  (from	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0.6±0.2	   to	   0.1±0.1,	   p<5%)	   and	   in	   the	   hippocampus	   (from	   3.8±0.5	   to	   2.5±0.6,	  
p<5%)	  (see	  figure	  4.2.B).	  	  
	  
Ltα	  deletion	  reduces	  TUNEL+	  cells	  
Neural	  cell	  death	  associated	  with	  nuclear	  DNA	  fragmentation	  was	  also	  studied	  in	  
this	   project.	   	   The	   dorsoparietal	   and	   pyriform	   cortex,	   hippocampus,	   striatum,	  
thalamus	   and	   external	   capsule	   white	   matter	   regions	   on	   both	   ipsilateral	   and	  
contralateral	  brain	  regions	  were	  quantified	  for	  TUNEL	  positive	  cells.	  As	  previously	  
demonstrated	   (see	   chapter	   3)	   WT	   littermate	   animals	   pre-­‐sensitized	   with	   LPS	  
demonstrated	   higher	   TUNEL	   counts	   in	   the	   ipsilateral	   brain	   hemisphere	   when	  
compared	   to	   WT	   saline-­‐treated	   littermates.	   This	   increase	   was	   particularly	  
significant	   in	   the	   dorsoparietal	   and	   pyriform	   cortex	   brain	   regions,	   with	   the	  
number	   of	   TUNEL	   positive	   cells	   increasing	   from	   12.8±2.8	   to	   152.4	   (p<1%)	   and	  
from	  5.3±0.8	  to	  24.6±13.1	  (p<5%)	  respectively.	  Comparison	  between	  the	  mutant	  
groups	   revealed	   that	   LPS	   LTα	   KO	   animals	   were	   also	   more	   affected	   than	   KO	  
littermates	   pre-­‐treated	   with	   saline.	   This	   was	   principally	   evident	   in	   the	  
hippocampus,	  where	  the	  number	  of	  TUNEL	  positive	  cells	  increased	  from	  30.2±7.4	  
to	   185.9±56.5	   (p<1%).	  With	   the	   exception	   of	   the	   hippocampus	   and	   thalamus,	  
there	  were	  generally	  less	  TUNEL+	  cells	  in	  the	  LPS	  LTα	  mutants	  in	  comparison	  to	  
WT	  LPS	  littermate	  controls.	  However,	  significance	  reduction	  was	  only	  reached	  in	  
the	   pyriform	   cortex,	   where	   the	   number	   of	   TUNEL-­‐associated	   cell	   death	  
decreased	  from	  24.6±13.1	  to	  5.0±1.7	  (p<5%)	  (see	  figure	  4.2.C).	  
	  
Astrogliosis	  response	  to	  LPS	  pre-­‐sensitization	  is	  not	  altered	  in	  LTα	  mutants	  
The	   final	   assessment	   perfomed	   in	   this	   study	   was	   observation	   of	   the	   levels	   of	  
astrogliosis	   using	   optical	   luminosity	   measurement,	   48h	   after	   combined	  
inflammation	  and	  HI	  injury.	  In	  a	  manner	  similar	  to	  what	  was	  shown	  in	  the	  strain	  
comparison	   study	   (chapter	   3),	   bacterial	   endotoxin	   pre-­‐sensitization	   of	   the	  WT	  
littermates	  led	  to	  a	  clear	  increase	  in	  astrocyte	  immunoreactivity	  when	  compared	  
to	  WT	  saline	  controls,	  with	  an	  average	  luminosity	  intensity	  of	  26.0±3.1	  in	  the	  WT	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saline	  versus	  39.8±5.4	  in	  the	  WT	  LPS	  group	  (p<1%).	  Separate	  analysis	  of	  the	  brain	  
regions	   revealed	   that	   this	   increase	   was	   also	   significant	   in	   the	   dorsopratietal	  
(from	   19.8±1.3	   to	   39.8±5.9,	   p<1%)	   and	   pyriform	   cortex	   (from	   19.8±2.1	   to	  
26.6±54.8,	   p<5%),	   striatum	   (from	   18.2±2.3	   to	   41.1±12.0,	   p<5%)	   and	   external	  
capsule	   (from	   40.2±4.3	   to	   54.3±4.2,	   <5%).	   Similarly,	   observation	   fo	   the	   LTα	  
mutant	   groups	   revealed	   a	   significant	   increase	   in	   astrogilosis	   in	   the	   external	  
capsule	   (from	  44.4±3.8	   to	  57.0±4.9,	  P<5%)	  as	  well	   as	  overall	   (from	  27.8±2.6	   to	  
39.5±6.0,	  p<5%)	  on	  the	  LTα	  LPS	  KO	  animals.	  However,	  global	  deletion	  of	  the	  LTα	  
gene	  did	  not	  alter	  astrocytic	  activation	  in	  the	  presence	  of	  LPS	  sensitization	  when	  





Figure	   4.2:	  Effects	   of	   LTα	   global	   gene	   deletion	   on	   neonatal	   hypoxic-­‐ischemic	   brain	   injury	   after	  
pre-­‐exposure	   to	   0.6µg/g	   LPS	   endotoxin	   (LPS).	   Animals	   injected	   with	   saline	   (SAL)	   served	   as	  
controls.	   A:	   Infarct	   volume	   assessment	   of	   individual	   forebrain	   regions	   and	   total	   ipsilateral	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hemisphere	   infarction	   as	   percent	   of	   contralateral	   hemisphere,	   showed	   that	   compared	   to	   wild	  
type	   LPS-­‐treated	   littermates,	   global	   deletion	   of	   LTα	   gene	   led	   to	   a	   50%	   reduction	   in	   tissue	  
infarction,	   which	   reached	   significance	   in	   the	   dorsoparietal	   cortex.	   B:	   Brain	   injury	   score	  
assessment	  of	   LTα	  gene	  deletion	   revealed	  an	  overall	   50%	   reduction	   in	  microglial	   inflammatory	  
response	  and	  neuronal	   cell	   death	   in	   the	   LPS	   knockouts	   compared	   to	  wild	   type	   LPS	   littermates.	  
This	  reduction	  in	  brain	  injury	  score	  reached	  significance	  in	  the	  pyriform	  cortex	  and	  hippocampus	  
ipsilateral	   brain	   regions.	   C:	   DNA	   fragmentation	   cell	   death	   assessment	   using	   TUNEL+	   cell	  
quantification	   demonstrated	   an	   overall	   decrease	   in	   LPS-­‐mediated	   cell	   death	   in	   the	   LTα	   gene	  
deficient	   mice	   with	   significant	   reduction	   reached	   in	   the	   pyriform	   cortex.	   D:	   Astroglial	  
immunoreactivity	  assessment	  using	  optical	   luminosity	  values	  showed	  a	  minor	  decrease	   in	  GFAP	  
synthesis	   in	   the	   LPS	   LTα	   knockouts	  when	   compared	   to	   LPS	  wild	   type	   littermates.	   Contralateral	  
hemisphere	  not	  shown.	  *p<5%	  in	  Mann	  Whitney	  test	  for	  the	  LPS-­‐treated	  wild	  type	  vs.	  knockout	  
groups,	  n=10	  per	  group.	  Abbreviations:	  WT	  –	  wild	  type,	  KO	  –	  knockout,	  CTX-­‐	  dorsoparietal	  and	  
PYR	   –	   pyriform	   cortex,	   HIP	   –	   hippocampus,	   STR	   –	   striatum,	   THL	   –	   thalamus,	   EXC	   –	   external	  
capsule.	  	  
	  
Lymphotoxin	   β 	   gene	   deletion	   has	   a	   detrimental	   role	   in	   the	   neonatal	  
synergy	  model	  of	  endotoxin	  and	  hypoxia-­‐ischaemia	  brain	  injury	  
It	  was	  originally	  believed	  that	   the	  animals	  received	  from	  Jackson	   laboratory	   for	  
this	  study	  were	  homozygous	  for	  the	  global	  deletion	  of	  the	  LTβ	  gene,	  as	  well	  as	  on	  
the	  C57Bl/6	  background.	  The	  P6	  offspring	  of	  the	  homozygous	  breeder	  pairs	  were	  
randomly	  allocated	  to	  receive	  LPS	  endotoxin	  and	  saline	  followed	  by	  HI	  insult	  12h	  
later,	  and	  allowed	  48h	  survival.	  Their	  response	  to	  combined	  LPS	  and	  HI	  insult	  was	  
compared	   to	   offspring	   of	   commercially	   provided	   C57BL/6	   non-­‐littermate	   mice	  
that	   underwent	   the	   same	   type	   of	   injury.	   Previous	   studies	   established	   that	  
C57BL/6	   LPS-­‐treated	   mice	   (n=13)	   showed	   endotoxin-­‐sensitization	   and	   up-­‐
regulation	  of	  brain	  injury,	  whereas	  C57BL/6	  saline	  animals	  (n=13)	  demonstrated	  
minimal	  brain	  injury	  (3.1±0.4	  vs.	  1.0±0.2,	  p<5%)	  (see	  figure	  4.3.A).	  	  
	  
However,	   in	   depth	   assessment	   of	   the	   LTβ	   strain	   through	   PCR	   genotyping	  
revealed	   that	   some	   of	   the	   animals	   used	   as	   breeding	   pairs	   were	   in	   fact	  
heterozygous	  for	  the	  LTβ	  gene.	  Therefore	  all	  three	  genotypes	  –	  WT,	  HET	  and	  KO	  
–	   were	   inadvertently	   present	   in	   the	   F1	   generation	   used	   in	   this	   first	   study.	  
Comparison	   of	   all	   three	   different	   LTβ	   genotypes	   showed	   that	   LPS-­‐sensitization	  
was	  lost	  in	  all	  three	  LPS	  groups	  (see	  figure	  4.3.B).	  This	  preliminary	  study	  onto	  the	  
LTβ	   cytokine	   role	   in	   combined	   LPS+HI	   injury	   was	   performed	   by	   Drs	   Mariya	  





Figure	   4.3:	   Overall	   and	   mean	   combined	   injury	   score	   of	   LTβ	   homozygous	   and	   heterozygous	  
breeding.	  Overall	  brain	  injury	  scores	  (A)	  and	  combined	  injury	  score	  across	  the	  different	  forebrain	  
regions	  (B).	  LPS	  administration	  in	  WT	  mice	  (n=13)	  led	  to	  sensitization	  of	  the	  neonatal	  brain	  to	  HI	  
insult	   with	   significant	   increase	   in	   brain	   injury,	   whereas	  WT	   saline	   animals	   (n=13)	   had	  minimal	  
brain	  injury	  (A).	  LTβ	  null	  animals	  did	  not	  show	  significant	  difference	  in	  the	  mean	  combined	  injury	  
score	  in	  comparison	  to	  littermate	  saline-­‐treated	  animals	  (B).	  *p<5%	  in	  one	  way	  ANOVA	  followed	  
by	  post-­‐hoc	  Tukey.	  Abbreviations:	  WT	  –	  wild-­‐type,	  HET	  –	  heterozygous,	  KO	  –	   knockout.	  Graph	  
reproduced	  with	  permission.	  
	  
Heterozygous	  LTβ	  (+/-­‐)	  breeding	  strategy	  
After	  observing	  that	  WT	  mice	  obtained	  in	  LTβ	  heterozygous	  breeding	  were	  non-­‐
responsive	   to	   endotoxin	   sensitization	   for	   HI	   injury,	   we	   turned	   to	   the	   working	  
hypothesis	   that	   some	   strains	   can	  be	  more	   resistant	   to	   this	   combined	   insult,	   as	  
seen	  on	  chapter	  3.	  We	  first	  repeated	  the	  experiment	  by	  re-­‐crossing	  only	  the	  LTβ	  
heterozygote	   animals	   and	   used	   the	   F1	   offspring	   containing	   both	  WT	   (controls)	  
and	  KO	  littermates.	  
	  
Figure	   4.4:	   Generation	   of	   LTβ+/+,	  
LTβ+/-­‐	   and	   LTβ-­‐/-­‐mice.	   LTβ	   mice	  
were	  bred	  in	  a	  heterozygous	  fashion	  
in	  order	  to	  obtain	  LTβ+/+	  and	  LTβ-­‐/-­‐	  
littermates.	   PCR	   reaction	   products	  
were	   run	   on	   an	   agarose	   gel	  
electrophoresis	  apparatus	  to	  detect	  
the	   different	   band	   sizes.	   LTB	   wild	  
type	   allele	   has	   120bp,	  whereas	   the	  
LTβ	  mutant	  allele	  has	  a	  product	  size	  
of	  330bp.	  LTβ+/-­‐	  genotype	  had	  both	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For	   this	   experiment,	   a	   new	   batch	   of	   LPS	   was	   required,	   with	   an	   optimal	  
sensitization	  dose	  of	  0.6µg/g	  (see	  chapter	  2).	  Combined	  assessment	  of	  microglia	  
activation	  and	  neuronal	   cell	   loss	   in	  animals	   that	  had	  undergone	  HI	   insult	   at	  P7	  
with	  pre-­‐treatment	  of	  LPS	  and	  saline	  12h	  prior	  revealed	  again	  a	  resistance	  in	  LPS	  
sensitization	  on	  the	  WT	  group.	  The	  KO	  animals	  showed	  a	  trend	  towards	  increase	  
in	  injury	  in	  some	  of	  the	  ipsilateral	  brain	  regions	  upon	  application	  of	  LPS,	  but	  this	  
never	  reached	  statistical	  significance	  (see	  figure	  4.5).	  
	  
Figure	  4.5:	  Combined	  injury	  
score	   in	   WT	   and	   LTβ	   KO	  
littermates	   pre-­‐sensitized	  
with	   saline	   and	   LPS	  
(0.6µg/g)	   12h	   before	  
neonatal	   HI	   injury.	   LPS	  
administration	   in	   WT	   mice	  
(n=10)	  did	  not	  sensitize	  the	  
neonatal	   brain	   to	   HI	   in	  
comparison	   to	   WT	   saline-­‐
treated	  animals	  (n=10).	  LTβ	  
KO	   animals	   (n=10)	   showed	   a	   trend	   towards	   increase	   in	   the	   mean	   combined	   injury	   score	   in	  
comparison	   to	   their	  WT	  LPS	   littermates.	   Saline	  KO	  animals	   (n=10)	  demonstrated	  minimal	  brain	  
injury.	   The	   Y-­‐axis	   shows	   brain	   injury	   score	   based	   on	   extent	   of	   infarction	   and	   microglial	  
macrophage	   response.	  One	  way	  ANOVA	   test	   followed	  by	   post-­‐hoc	   Tukey.	  Abbreviations:	  WT	   –	  
wild-­‐type,	  CTX	  -­‐	  dorsoparietal	  and	  PYR	  -­‐	  pyriform	  (PYR)	  cortex,	  HIP	  -­‐	  hippocampus,	  STR	  -­‐	  striatum,	  
THL	  -­‐	  thalamus	  (THL),	  EXC	  -­‐	  external	  capsule.	  
	  
Crossing	  of	  heterozygous	  LTβ-­‐KO	  with	  commercially-­‐provided	  C57BL/6	  
To	   address	   the	   issue	  with	   the	   non-­‐responsiveness	   to	   LPS	   administration	   in	   the	  
wild	  type	  littermates	  produced	  through	  heterozygous	  LTβ-­‐breeding,	  the	  current	  
LPS	  batch	  was	  tested	  to	  check	  whether	  or	  not	  it	  had	  lost	  its	  sensitizing	  property.	  
AlphaM	   assessment	   demonstrated	   that	   this	   was	   not	   the	   case	   as	   there	   was	  
significant	  microglial	  activation	  in	  all	  assessed	  brain	  regions	  (see	  figure	  4.6).	  This	  
finding	   raised	   two	  main	   concerns.	  Was	   this	   reduction	   caused	   by	   difference	   in	  
strain	  background	  or	  due	  to	  gene	  deletion?	  If	  non-­‐responsiveness	  was	  a	  result	  of	  
strain	   background	   differences,	   this	   change	   in	   response	   is	   probably	   a	   dominant	  
trait,	   as	   further	   crossing	   of	   the	   animals	   did	   not	   remove	   this	   lack	   of	   endotoxin	  
sensitization.	   In	   an	   attempt	   to	   address	   this	   new	   hypothesis,	   F2	   heterozygous	  
mice	  were	   re-­‐crossed	  with	   commercially	   provided	   C57BL/6	  mice,	   shown	   to	   be	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strong	  responders	  to	  endotoxin	  sensitization	  (see	  chapter	  3	  as	  well	  as	  figure	  4.6).	  
This	   procedure	   introduced	   a	   50%	   C57BL/6	   background	   into	   the	   strain.	   F1	  
offspring	   heterozygotes	   were	   crossed	   and	   the	   F2	   generation	   mice	   that	   were	  
either	  WT	  or	  homozygous	  for	  LTβ	  gene	  deletion	  were	  used	  in	  the	  LPS	  (0.6µg/g)	  +	  
HI	  synergy	  murine	  model	  of	  perinatal	  brain	  damage.	  
	  
	  Figure	   4.6:	   AlphaM	   injury	   score	  
assessment	   of	   wild-­‐type	   C57BL/6	  
animals	   treated	   with	   either	   LPS	  
(0.6µg/g)	   or	   saline	   as	   a	   control.	   Saline-­‐
treated	   animals	   (n=5)	   demonstrated	  
minimal	   microglial	   activation.	  
Conversely,	   LPS	   administration	   in	   wild-­‐
type	  littermate	  mice	  (n=4)	  resulted	  in	  a	  
significant	   upregulation	   in	   microglial	  
activation	   across	   all	   six	   assessed	   brain	  
region	  (p<5%).	  	  
	  
Global	  deletion	  of	  the	  LTβ	  gene	  significantly	  increases	  cerebral	  tissue	  loss	  
As	  shown	  in	  figure	  4.7.A,	  there	  was	  an	  overall	   increase	   in	   infarct	  volume	  in	  WT	  
LPS	   animals	   (n=10)	   in	   comparison	   to	   the	   WT	   saline	   control	   group	   (n=10).	  
However,	  this	  was	  only	  significant	  in	  the	  pyriform	  cortex	  (from	  7±4%	  to	  21±7%,	  
p<5%)	  and	  hippocampus	  (from	  18±5%	  to	  45±9%,	  p<5%)	  ipsilateral	  brain	  regions.	  
Observation	  of	   the	  mutant	  groups	  revealed	  a	  statistically	  significant	   increase	   in	  
total	  infarct	  volume	  from	  5±3%	  to	  51±10%	  (p<0.1%)	  in	  LTβ	  KO	  mice	  treated	  with	  
LPS	   (n=10)	   when	   compared	   to	   saline	   controls	   (n=10).	   This	   was	   apparent	   in	   all	  
brain	  regions:	  Dorsoparietal	  from	  3±5%	  to	  52±10%	  (p<0.1%)	  and	  pyriform	  cortex	  
from	   1±6%	   to	   43±12%	   (p<1%),	   hippocampus	   from	   17±6%	   to	   60±12%	   (p<1%),	  
striatum	   from	   11±5%	   to	   60±11%	   (p<1%),	   thalamus	   from	   -­‐41±3%	   to	   31±10%	  
(p<1%)	   and	   external	   capsule	   from	   4±4%	   to	   53±13%	   (p<1%).	   Additionally,	   LPS	  
treated	  LTβ	  KO	  animals	  demonstrated	  a	  significant	  overall	  increase	  in	  tissue	  loss	  
relating	   to	  WT	   LPS	  mice	   (from	   23±7%	   to	   53±13%,	   p<5%).	  When	   the	   ipsilateral	  
forebrain	  regions	  of	  both	  WT	  and	  KO	  LPS	  groups	  were	  assessed	  separately,	  this	  
significance	   was	   also	   evident	   in	   the	   dorsoparietal	   cortex	   (25±7%	   vs.	   52±10%,	  
p<5%),	   striatum	   (23±9%	   vs.	   60±11%,	   p<1%),	   thalamus	   (110±6%	   vs.	   31±10%,	  







CTX	   PYR	   HIP	   STR	   THL	   EXC	  












CTX	   PYR	   HIP	   STR	   THL	   EXC	  




LTβ	  mutants	  have	  higher	  neonatal	  brain	  injury	  when	  treated	  with	  LPS	  
Analysis	   of	   WT	   LTβ	   animals	   showed	   reduced	   brain	   injury	   when	   treated	   with	  
saline.	   Conversely,	  WT	   littermate	   animals	   revealed	   significant	   sensitization	   and	  
increase	   in	   inflammation	  when	  treated	  with	  LPS.	  This	  was	  particularly	  visible	   in	  
the	   dorsoparietal	   cortex	   (1.4±0.8	   vs.	   3.4±1.1,	   p<1%)	   and	   external	   capsule	  
(2.5±0.8	   vs.	   4.5±1.1,	   p<5%).	   Comparison	   between	   the	   two	   LTβ	   KO	   groups	  
demonstrated	  a	  significant	  increase	  from	  0.9±0.6	  in	  the	  saline	  group	  to	  5.6±1.2	  in	  
the	   endotoxin	   group	   (p<1%).	   This	   overall	   increase	   in	   inflammation	   and	   cellular	  
loss	  was	  also	  noticeable	  in	  all	  six	  brain	  regions	  when	  assessed	  individually.	  In	  the	  
dorsoparietal	  cortex	   there	  was	  an	   increase	   from	  0.7±.7	   to	  5.6	   (p<1%),	  pyriform	  
cortex	   from	   0.7±0.7	   to	   5.4±1.2	   (p<1%),	   hippocampus	   from	   1.2±0.8	   to	   5.9±1.1	  
(p<1%),	   striatum	   from	   0.5±0.4	   to	   5.5±1.2	   (p<0.1%),	   thalamus	   from	   0.4±0.4	   to	  
5.5±1.1	   (p<0.1%)	   and	   external	   capsule	   white	   matter	   from	   1.6±0.8	   to	   6.0±1.1	  
(p<1%).	  Evaluation	  of	  WT	  and	  LTβ	  KO	  animals	  pre-­‐treated	  with	  LPS	  established	  
that	  homozygous	  deletion	  of	  LTβ	  gene	  led	  to	  an	  overall	  increase	  in	  sensitization	  
and	  inflammation	  in	  the	  ipsilateral	  brain	  hemisphere	  (3.1±1.0	  vs.	  5.6±1.2,	  p<5%).	  
This	   was	   particularly	   significant	   on	   the	   pyriform	   cortex	   (2.2±0.9	   vs.	   5.4±1.2,	  
p<5%),	   striatum	   (2.5±8	   vs.	   5.5±1.2,	   p<0.1%)	   and	   thalamus	   (2.2±0.9	   vs.	   5.5±1.1,	  
p<5%)	  (see	  figure	  4.7.B).	  	  	  
	  
LTβ-­‐/-­‐	  mice	  have	  a	  marked	  increase	  in	  TUNEL	  positive	  cells	  following	  LPS+HI	  insult	  
Quantification	  of	  TUNEL+	  cells	  revealed	  only	  a	  small	  trend	  in	  increased	  cell	  death	  
in	  the	  WT	  LPS	  group	  when	  compared	  to	  WT	  saline	  littermate	  controls.	  LTβ-­‐/-­‐	  LPS	  
treated	   animals	   revealed	   the	   highest	   number	   of	   cells	   undergoing	   DNA	  
fragmentation.	  Comparison	  with	  the	  LTβ-­‐/-­‐	  saline	  controls,	  which	  had	  an	  overall	  
count	   of	   0.8±0.5,	   the	   number	   of	   TUNEL+	   cells	   was	   significantly	   increased	   to	  
43.5±15.5	  (p<0.1%).	  The	  same	  level	  of	  significance	  was	  also	  found	  in	  all	  ipsilateral	  
brain	   regions	   assessed.	   The	   dorsoparietal	   cortex	   showed	   an	   increase	   from	  
1.1±0.5	   to	   70.8±21.7	   (p<0.11%),	   pyriform	   cortex	   from	   0.0±0.0	   to	   29.8±12.3	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(p<1%),	  hippocampus	   from	  2.3±1.5	   to	  42.1±14.3	   (p<1%),	   striatum	   from	  0.5±0.5	  
to	   52.9±19.7	   (p<1%),	   thalamus	   from	   0.0±0.0	   to	   24.4±12.3	   (p<5%)	   and	   external	  
capsule	  from	  0.8±0.7	  to	  41.0±12.6	  (p<0.1%).	  Furthermore,	  analysis	  between	  LTβ	  
WT	   and	   LTβ	   KO	  endotoxin	   groups	   also	   showed	   a	   significant	   overall	   increase	   in	  
TUNEL+	  counts	   in	   the	   later,	  as	  well	  as	   in	  most	  assessed	  brain	   regions,	  with	   the	  
exception	   of	   the	   hippocampus,	   which	   only	   showed	   a	   trend	   towards	   increased	  
DNA	   fragmentation-­‐associated	   cell	   death.	   The	   dorsoparietal	   cortex	   showed	   an	  
average	   increase	   in	   TUNEL+	   cells	   from	   10.0±5.8	   to	   70.8±21.7	   (p<1%),	   pyriform	  
cortex	   from	   2.7±2.6	   to	   29.8±12.3	   (p<1%),	   striatum	   from	   5.7±3.0	   to	   52.9±19.7	  
(p<1%),	   thalamus	   from	   1.5±1.0	   to	   24.4±12.3	   (p<5)	   and	   external	   capsule	   from	  
11.0±5.2	  to	  41.0±12.6	  (p<1%)	  	  (see	  figure	  4.7.C).	  
	  
Astrocyte	  immunoreactivity	  is	  unaffected	  by	  global	  deletion	  of	  the	  LTβ	  gene	  
GFAP	  immunoreactivity	  assessment	  showed	  an	  overall	  increase	  in	  astrogliosis	  in	  
WT	  animals	  treated	  with	  LPS	  versus	  their	  WT	  saline	  littermate	  controls.	  The	  LTβ	  
KO	   LPS	   group	   revealed	   the	   highest	   levels	   of	   immunoreactivity,	   and	   when	  
compared	   with	   LTβ	   KO	   saline	   animals,	   this	   difference	   reached	   statistical	  
significance	   in	   the	   dorsoparietal	   cortex	   (34.3±4.7	   vs.	   58.0±7.0,	   p<1%),	  
hippocampus	   (53.6±6.4	   vs.	   75.4±6.9,	   p<5%),	   external	   capsule	   (60.0±5.2	   vs.	  
83.1±6.9,	   p<15),	   as	   well	   as	   overall	   (45.3±7.9	   vs.	   65.5±8.0,	   p<5%).	   However,	  
observation	  of	  the	  two	  LPS	  groups	  –	  WT	  and	  LTβ	  KO	  –	  demonstrated	  only	  a	  small	  





Figure	   4.7:	  Effects	   of	   LTβ	   global	   gene	   deletion	   on	   neonatal	   hypoxic-­‐ischemic	   brain	   injury	   after	  
pre-­‐exposure	   to	   0.6µg/g	   LPS	   endotoxin	   (LPS).	   Animals	   injected	   with	   saline	   (SAL)	   served	   as	  
controls.	   A:	   Infarct	   volume	   assessment	   of	   individual	   forebrain	   regions	   and	   total	   ipsilateral	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hemisphere	   infarction	   as	   percent	   of	   contralateral	   hemisphere	   revealed	   substantial	   increase	   in	  
tissue	  necrosis	  on	   the	  LPS	  LTβ	  mutants,	  which	   reached	  significance	   in	   the	  dorsoparietal	   cortex,	  
striatum,	   thalamus	   and	   external	   capsule	   ipsilateral	   brain	   regions,	   as	   well	   as	   in	   total	   tissue	  
infarction.	  B:	  LTβ	  brain	  injury	  score	  also	  demonstrated	  an	  increased	  detrimental	  effect	  in	  the	  LPS	  
LTβ	  knockouts,	  with	  an	  overall	  significant	  increase	  in	  microglial	  activation	  and	  neuronal	  cell	  loss,	  
which	  was	  also	  significant	  in	  the	  ipsilateral	  pyriform	  cortex,	  striatum	  and	  thalamus	  brain	  regions.	  
C:	   DNA	   fragmentation	   cell	   death	   assessment	   using	   TUNEL+	   cell	   quantification	   demonstrated	   a	  
significant	   overall	   increase	   in	   cell	   death	   in	   the	   LPS-­‐treated	   LTβ	   gene	   deficient	   mice.	   This	  
detrimental	  effect	  was	  also	  significant	  in	  most	  ipsilateral	  brain	  regions,	  with	  only	  exception	  being	  
the	   hippocampus,	   where	   only	   a	   trend	   towards	   increased	   TUNEL+	   associated	   cell	   death	   was	  
visible.	   D:	   Astroglial	   immunoreactivity	   assessment	   using	   optical	   luminosity	   values	   showed	   an	  
overall	   trend	   towards	   increased	  astrocyte	  activation	   in	   the	   LTβ	  deficient	  mice	   treated	  with	   LPS	  
when	   compared	   to	   LPS	   wild	   type	   littermates.	   Contralateral	   hemisphere	   not	   shown.	   *p<5%	   in	  
Mann	   Whitney	   test	   for	   the	   LPS-­‐treated	   wild	   type	   vs.	   knockout	   groups,	   n=10	   per	   group.	  
Abbreviations:	  WT	  –	  wild	  type,	  KO	  –	  knockout,	  CTX-­‐	  dorsoparietal	  and	  PYR	  –	  pyriform	  cortex,	  HIP	  
–	  hippocampus,	  STR	  –	  striatum,	  THL	  –	  thalamus,	  EXC	  –	  external	  capsule.	  	  
	  
Tumour	  necrosis	   factor	  α :	  dual	   role	   in	   the	  sensitization	  of	   the	  neonatal	  
brain	  to	  hypoxic-­‐ischemic	  insult?	  
Effects	   of	   TNFα	   gene	   on	   endotoxin-­‐mediated	   sensitization	   to	   HI	   insult	   and	  
subsequent	  perinatal	  brain	  damage	  were	  assessed	  by	  global	  gene	  deletion,	  and	  
by	   analysing	   cell-­‐type	   specific	   deletion	   of	   this	   cytokine	   using	   the	   Cre-­‐Lox	  
recombination	  technique.	  The	  latter	  used	  the	  MLys::CRE	  promoter,	  where	  TNFα	  
was	  deleted	  in	  granulocytes/macrophages	  expressing	  MLys	  promoter,	  therefore	  
excluding	  brain	  microglia.	  
	  
Homozygous	  breeding	  of	  TNFα	  mutants	  (TNFα-­‐/-­‐)	  
Similarly	   to	   the	   initial	   LTβ-­‐/-­‐	   study,	   TNFα-­‐/-­‐	   mice	   were	   compared	   with	   WT	  
C57BL/6	  non-­‐littermate	  animals.	  This	  initial	  TNFα	  study,	  like	  the	  preliminary	  LTβ	  
work	  was	  performed	  by	  Drs	  Mariya	  Hristova,	  Giles	  Kendall	  and	  Sigrun	  Lange.	  The	  
same	  WT	  C57BL/6	  animals	  were	  again	  used	  as	  non-­‐littermate	  controls.	  Both	  P6	  
WT	  and	  P6	  TNFα	  (KO)	  mice	  were	  pre-­‐treated	  with	  either	  0.3µg/g	  LPS	  or	  saline.	  
12h	   after	   endotoxin/vehicle	   administration,	   all	   experimental	   animals	   were	  
exposed	  to	  HI	  insult	  and	  allowed	  48h	  survival.	  	  
	  
The	   results	   indicated	   that	   WT	   animals	   injected	   with	   saline	   showed	   negligible	  
brain	  injury.	  Conversely,	  when	  treated	  with	  LPS,	  there	  was	  a	  significant	  increase	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in	   mean	   combined	   injury	   score	   in	   the	   cortex	   (p<1%),	   hippocampus	   (p<0.1%),	  
striatum	   (p<55),	   thalamus	   (p<5%)	   and	   ipsilateral	   white	   matter	   (p<5%)	   brain	  
regions.	   This	   significance	   was	   also	   present	   in	   the	   overall	   injury	   score	   (p<5%).	  
Subjective	   comparison	  between	   the	  WT	  and	  TNFα	  KO	  saline	  groups	   revealed	  a	  
significant	  increase	  in	  combined	  injury	  score	  in	  the	  latter.	  Statistical	  significance	  
was	  reached	   in	   the	  dorsoparietal	  cortex	   (p<5%),	  hippocampus	   (p<1%),	  striatum	  
(p<5%),	  thalamus	  (p<5%)	  and	  ipsilateral	  white	  matter	  (p<5%)	  regions,	  and	  also	  in	  
the	   overall	   injury	   score	   (p<5%).	   In	   contrast,	   LPS	   treated	   TNFα	   KO	   animals	  
demonstrated	   little	   further	   increase	   in	   damage	   in	   comparison	   to	   their	   saline	  
littermate	  controls	  (see	  figure	  4.8).	  	  
	  
	  
Figure	   4.8:	   Combined	   injury	   score	   in	   WT	   C57BL/6	   and	   homozygous	   TNFα	   null	   animals	   pre-­‐
treated	  with	  saline	  and	  LPS	  (0.3µg/g)	  12h	  before	  neonatal	  HI	  injury.	  
Brain	   injury	   score	   across	   the	   different	   forebrain	   regions	   (left)	   and	   overall	   brain	   injury	   score	  
(right).	  LPS	  administration	  in	  WT	  mice	  (n=13)	  led	  to	  sensitization	  of	  the	  neonatal	  brain	  to	  HI	  insult	  
with	   significant	   increase	   in	   brain	   injury,	   whereas	  WT	   saline	   animals	   (n=13)	   had	  minimal	   brain	  
injury.	  TNFα	  null	  animals	  (n=14)	  before	  HI	  insult	  did	  not	  show	  significant	  difference	  in	  the	  mean	  
combined	  injury	  score	  in	  comparison	  to	  their	  saline	  treated	  littermate	  animals	  (n=13).	  *p<5%	  in	  
one	  way	  ANOVA	  followed	  by	  post-­‐hoc	  Tukey.	  Abbreviations:	  CTX	  –	  cortex,	  HIP	  –	  hippocampus,	  
STR	  –	   striatum,	  THLM	  –	   thalamus,	   IpWM	  –	   ipsilateral	   and	  CoWM	  –	  contralateral	  white	  matter.	  
Graph	  reproduced	  with	  permission.	  
	  
Crossing	  of	  homozygous	  TNFα	  KO	  with	  WT	  C57BL/6	  mice	  
Homozygous	  breeding	  of	  TNFα	  null	  animals	   thus	  provided	  two	  separate	  sets	  of	  
results.	  	  Compared	  to	  WT	  C57BL/6	  non-­‐littermate	  mice,	  TNFα	  KO	  exhibited	  more	  
severe	  injury	  at	  baseline,	  as	  well	  as	  a	  considerable	  reduction	  in	  LPS	  sensitization	  
prior	   to	   HI.	   This	   latter	   finding	   raised	   two	   main	   questions.	   Was	   this	   reduction	  
caused	  by	  difference	  in	  strain	  background	  or	  due	  to	  global	  deletion	  of	  the	  TNFα	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gene?	   This	   issue	   led	   to	   a	   second	   experimental	   approach	   where	   homozygous	  
TNFα	  KO	  mice	  were	   crossed	  with	   commercially	  provided	  C57BL/6	  animals.	   The	  
F1	  heterozygous	  offspring	  were	  set	  up	  as	  the	  new	  breeding	  pairs	  with	  F2	  progeny	  
used	  in	  the	  LPS	  +	  HI	  experiment.	  In	  this	  second	  approach	  a	  new	  batch	  of	  LPS	  was	  
required	  with	   a	   new	   optimal	   sensitization	   dose	   of	   0.6µg/g	   (see	   chapter	   2).	   All	  
animals	   were	   injected	   randomly	   with	   LPS	   or	   saline,	   followed	   12h	   later	   by	   HI	  
insult,	  and	  once	  again	  allowed	  to	  survive	  for	  48h.	  PCR	  genotyping	  allowed	  use	  of	  
WT	  littermates	  as	  control	  (see	  figure	  4.9.A).	  The	  new	  results	  showed	  that	  the	  LPS	  
sensitivity	   previously	   seen	   on	   the	   WT	   C57BL/6	   (see	   chapter	   3)	   had	   now	  
disappeared	   on	   the	   new	   experimental	   LPS	  WT	   littermate	   animals.	   In	   addition,	  
there	  was	  a	  trend	  towards	  increased	  inflammation	  and	  cell	  loss	  on	  the	  LPS	  TNFα	  




Figure	  4.	  9:	  TNFα	  gene	  deletion	  study	  using	  WT	  littermate	  controls.	   	  A:	  Generation	  of	  TNFα+/+,	  
TNFα	  +/-­‐	  and	  TNFα	  -­‐/-­‐	  mice.	  TNFα	  mice	  were	  bred	  in	  a	  homozygous	  knock	  out	  versus	  WT	  C57BL/6	  
manner	  in	  order	  to	  obtain	  TNFα+/+	  and	  TNFα	  -­‐/-­‐	  littermates.	  PCR	  reaction	  products	  were	  run	  on	  
an	  agarose	  gel	  electrophoresis	  apparatus	  to	  detect	  the	  different	  genotypes.	  TNFα	  wildtype	  allele	  
has	  180bp,	  whereas	  the	  TNFα	  mutant	  allele	  has	  a	  product	  size	  of	  318bp.	  TNFα+/-­‐	  genotype	  was	  
identified	  through	  the	  presence	  of	  both	  +/+	  and	  -­‐/-­‐	  alleles.	  B:	  Combined	  microglial	  activation	  and	  
cell	  death	  injury	  score	  in	  WT	  and	  TNFα	  KO	  littermates	  pre-­‐sensitized	  with	  saline	  and	  LPS	  (0.6µg/g)	  
12h	   before	   neonatal	   HI	   injury.	   LPS	   administration	   in	   WT	   mice	   (n=10)	   did	   not	   sensitize	   the	  
neonatal	  brain	  to	  HI	  in	  comparison	  to	  WT	  saline-­‐treated	  animals	  (n=10).	  TNFα	  KO	  animals	  (n=10)	  
showed	  a	  trend	  towards	  increase	  in	  the	  mean	  combined	  injury	  score	  in	  comparison	  to	  their	  WT	  
LPS	   littermates.	   Saline	  KO	  animals	   (n=10)	  demonstrated	  minimal	  brain	   injury.	   The	  Y-­‐axis	   shows	  
brain	  injury	  score	  based	  on	  extent	  of	  infarction	  and	  microglial	  macrophage	  response.	  *p<0.05	  in	  
one	   way	   ANOVA	   followed	   by	   post-­‐hoc	   Tukey.	   Abbreviations:	   CTX	   -­‐	   dorsoparietal	   and	   PYR	   -­‐	  





Crossing	  of	  heterozygous	  TNFα	  with	  WT	  C57BL/6	  mice	  
Once	  more,	   TNFα	   KO	  mice	   displayed	   no	   sensitization	   to	   HI	  when	   treated	  with	  
LPS.	  Moreover,	  introduction	  of	  C57BL/6	  background	  (by	  50%)	  appeared	  to	  not	  be	  
enough	   in	  terms	  of	  prompting	  endotoxin	  sensitization,	  as	  wild	  type	  LPS-­‐treated	  
littermates	  now	  demonstrated	  the	  same	  non-­‐responsiveness	  as	  the	  homozygous	  
mutants.	  Since	  it	  was	  shown	  that	  the	  current	  LPS	  batch	  had	  not	  lost	  its	  function	  
(see	   figure	   4.6),	   it	   was	   now	   assumed,	   just	   as	   with	   the	   LTβ	   study,	   that	   if	   non-­‐
responsiveness	   was	   a	   result	   of	   strain	   background	   differences,	   this	   change	   in	  
response	   is	   probably	   a	   dominant	   trait.	   In	   an	   attempt	   to	   address	   this	   new	  
hypothesis,	   F2	   heterozygous	   mice	   were	   re-­‐crossed	   with	   C57BL/6.	   F3	  
heterozygous	  offspring	  were	  now	  used	  as	  the	  new	  tentative	  breeding	  pairs.	  The	  
experimental	   design	   remained	   the	   same	   as	   the	   one	   described	   directly	   above,	  
where	  F4	  mice	  were	  injected	  with	  0.6µg/g	  LPS	  or	  saline	  12h	  before	  HI	  followed	  
by	   48h	   survival.	   Again,	   only	   WT	   and	   TNFα	   KO	   littermates	   were	   used	   for	  
histological	  assessment.	  
	  
TNFα	  gene	  ablation	   reveals	   tendency	   towards	   increased	   tissue	   infarction	   in	   LPS	  
treated	  animals	  
Re-­‐crossing	  homozygous	  TNFα	  null	  mice	  with	  WT	  C57BL/6	   for	   two	  generations	  
successfully	   re-­‐established	   the	   LPS-­‐mediated	   sensitization	   to	   subsequent	   HI,	  
initially	   observed	   in	   the	   C57BL/6	   animals.	   This	   effectively	   allowed	   further	  
histological	  assessment	  of	  the	  molecular	  components	  involved	  in	  this	  combined	  
model	  of	  neonatal	  brain	  injury.	  
	  
Infarct	   volume	   assessment	   of	   the	  WT	   groups	   showed	  minimal	   necrosis	   in	   the	  
saline	  group	  (n=9)	  and	  a	  trend	  towards	  increased	  tissue	  loss	  in	  animals	  that	  had	  
been	  administered	  LPS	  (n=9)	  prior	  to	  HI	  insult.	  This	  was	  visible	  in	  all	  brain	  regions	  
with	   significance	   reached	   in	   the	   hippocampus	   (26±8%	   vs.	   45±5%,	   p<5%).	   TNFα	  
KO	   saline	   treated	   animals	   (n=10)	   demonstrated	  minimal	   tissue	   loss,	   and	  when	  
compared	   with	   TNFα	   KO	   LPS	   administered	   littermates	   (n=10),	   the	   latter	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demonstrated	  a	  clear	  increase	  in	  brain	  injury.	  However,	  once	  again,	  this	  increase	  
in	  LPS-­‐sensitization	  did	  not	  reach	  significance.	  Furthermore,	  the	  results	  obtained	  
did	   not	   reveal	   statistical	   significant	   difference	   between	   the	   WT	   and	   KO	   LPS	  
groups,	   only	   a	   trend	   towards	   increase	   of	   tissue	   necrosis	   on	   the	   mutants	   (see	  
figure	  4.10.A).	  	  
	  
Global	  deletion	  of	  TNFα	  gene	  leads	  to	  increased	  immune	  response	  and	  cell	  loss	  
This	  second	  change	  in	  experimental	  strategy	  also	  revealed	  a	  clear	  up-­‐regulation	  
in	   LPS-­‐mediated	   sensitivity	   in	   WT	   LPS-­‐administered	   vs.	   WT	   saline	   animals.	  
Statistical	   significance	   was	   reached	   on	   the	   dorsoparietal	   cortex	   (1.0±0.9	   vs.	  
4.1±1.2,	   p<5%)	   and	   hippocampus	   (1.6±9	   vs.	   4.5±1.2,	   p<5%).	   Additionally,	   this	  
increase	   in	   endotoxin-­‐mediated	   sensitivity	   was	   also	   observed	   on	   the	   TNFα	   KO	  
LPS,	  when	  compared	  to	  TNFα	  KO	  saline	  controls.	  This	  was	  again	  apparent	  in	  brain	  
injury	  on	  the	  dorsoparietal	  cortex	  (0.7±0.6	  vs.	  5.2±1.1,	  p<1%)	  and	  hippocampus	  
(1.5±0.8	  vs.	  6.1±0.9,	  p<1%),	  as	  well	  as	  in	  the	  striatum	  (0.4±0.2	  vs.	  3.6±0.9,	  p<1%)	  
and	  external	  capsule	  (1.6±0.5	  vs.	  6.4±0.9,	  p<5%).	  Comparison	  between	  the	  two	  
LPS	  groups	  –	  WT	  vs.	  TNFα	  KO	  –	  demonstrated	  a	   trend	  towards	   increased	  brain	  
injury	  in	  the	  mutant	  animals.	  However,	  this	  did	  not	  reach	  significance	  (see	  figure	  
4.10.B).	  
	  
TNFα-­‐/-­‐	  animals	  have	  higher	  DNA	  fragmentation-­‐associated	  cell	  death	  
LPS	   sensitization	   prior	   to	   HI	   caused	   a	   marked	   increase	   in	   DNA	   fragmentation	  
positive	  cells	   in	  the	  WT	  group,	  with	  a	  significant	   increase	  in	  TUNEL+	  cells	   in	  the	  
hippocampus	   (65.7±20.6	   vs.	   25.5±12.5,	   p<1%)	  when	   compared	  with	  WT	   saline	  
littermate	   controls.	   Assessment	   of	   both	   mutant	   groups	   again	   demonstrated	   a	  
markedly	   higher	   number	   of	   TUNEL+	   cells	   in	   the	   TNFα	   KO	   LPS	   group,	   with	  
statistical	  significance	  reached	  in	  the	  dorsoparietal	  cortex	  (4.1±3.5	  vs.	  73.8±18.3,	  
p<0.1%)	   and	   hippocampus	   (29.8±8.3	   vs.	   84.0±19.1,	   p<0.1%)	   ipsilateral	   brain	  
regions.	  Global	  TNFα	  gene	  deletion	  led	  to	  a	  higher	  number	  of	  TUNEL+	  cells	  in	  the	  
LPS	   group	   when	   compared	   to	   WT	   LPS	   littermates.	   Furthermore,	   this	   was	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statistically	  significant	  in	  the	  dorsoparietal	  cortex,	  where	  the	  number	  of	  TUNEL+	  
cells	  rose	  from	  33.4±16.4	  (WT	  LPS)	  to	  73.8±18.3	  (TNFα-­‐/-­‐	  LPS,	  p<1%)	  (see	  figure	  
4.10.C).	  
	  
TNFα	  global	  gene	  deletion	  has	  a	  moderate	  effect	  on	  astrocytic	  activation	  
Similarly	   to	   what	   has	   been	   shown	   in	   the	   previous	   TNFα	   global	   gene	   deletion	  
assessments,	  LPS	  administration	  prior	   to	  HI	   insult	   led	  to	  an	   increase	   in	  reactive	  
astrogliosis	   in	   the	   WT	   group	   when	   compared	   to	   its	   control	   (WT	   saline).	  
Furthermore,	   this	   astrocytic	   activation	   was	   significantly	   higher	   in	   the	   striatum	  
(from	   23.5±6.0	   to	   37.9±4.3,	   p<5%)	   and	   external	   capsule	   (from	   42.5±4.3	   to	  
56.3±2.8,	   p<5%).	   Observation	   of	   the	   TNFα-­‐/-­‐	   saline	   and	   TNFα-­‐/-­‐	   LPS	   groups	  
revealed	   the	   same	   rise	   in	   GFAP	   synthesis	   in	   the	   later,	   and	   significantly	   more	  
astrocytic	   activation	   in	   the	   dorsoparietal	   cortex	   (from	   19.1±6.4	   to	   39.2±12.4,	  
p<1%),	  striatum	  (from	  23.4±7.8	  to	  36.2±11.5,	  p<5%)	  and	  external	  capsule	  (from	  
47.4±15.8	   to	  59.2±18.7,	  p<5%).	  Albeit	   the	  LPS	  mutants	  demonstrated	  a	   slightly	  
higher	  astrocytic	  reactivity,	  this	  was	  not	  significant	  when	  compared	  with	  the	  WT	  






Figure	  4.10:	  Effects	  of	  TNFα	  global	  gene	  deletion	  on	  neonatal	  hypoxic-­‐ischemic	  brain	  injury	  after	  
pre-­‐exposure	   to	   0.6µg/g	   LPS	   endotoxin	   (LPS).	   Animals	   injected	   with	   saline	   (SAL)	   served	   as	  
controls.	   A:	   Infarct	   volume	   assessment	   of	   individual	   forebrain	   regions	   and	   total	   ipsilateral	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hemisphere	   infarction	   as	   percent	   of	   contralateral	   hemisphere,	   showed	   that	   global	   deletion	   of	  
TNFα	   gene	   leads	   to	   an	   overall	   trend	   towards	   increased	   tissue	   infarction	   following	   LPS	  
administration.	  B:	  Brain	  injury	  score	  assessment	  of	  TNFα	  gene	  deletion	  revealed	  an	  overall	  trend	  
towards	  increased	  inflammatory	  microglial	  activation	  and	  neuronal	  cell	  loss	  in	  all	  ipsilateral	  brain	  
regions	  of	   LPS-­‐treated	  animals.	  C:	  DNA	   fragmentation	   cell	   death	  assessment	  using	  TUNEL+	   cell	  
quantification	  demonstrated	  an	  overall	  increase	  in	  cell	  death	  in	  global	  TNFα	  gene	  deficient	  mice	  
following	   LPS	   administration.	   This	   detrimental	   effect	   reached	   significance	   in	   the	   ipsilateral	  
dorsoparietal	   cortex	   brain	   region.	   D:	   Astroglial	   immunoreactivity	   assessment	   using	   optical	  
luminosity	   values	   showed	   an	   overall	   trend	   towards	   increase	   in	   GFAP	   synthesis	   in	   LPS-­‐treated	  
global	  TNFα	  mutants	  when	  compared	  to	   littermate	  LPS-­‐treated	  wild	  type	  animals.	  Contralateral	  
hemisphere	  not	  shown.	  *p<5%	  in	  Mann	  Whitney	  test	  for	  the	  LPS-­‐treated	  wild	  type	  vs.	  knockout	  
groups,	   n=9	   for	  WT	   SAL,	   n=9	   for	  WT	   LPS,	   n=10	   for	   TNFα	   KO	   SAL	   and	   n=10	   for	   TNFα	   KO	   LPS.	  
Abbreviations:	  WT	  –	  wild	  type,	  KO	  –	  knockout,	  CTX-­‐	  dorsoparietal	  and	  PYR	  –	  pyriform	  cortex,	  HIP	  
–	  hippocampus,	  STR	  –	  striatum,	  THL	  –	  thalamus,	  EXC	  –	  external	  capsule.	  	  
	  
Cell-­‐type	   specific	   deletion	  of	   TNFα	   gene:	  MLys-­‐expressing	  macrophages	  
have	  a	  detrimental	  effect	  in	  perinatal	  brain	  after	  LPS-­‐mediated	  HI	  
In	   order	   to	   further	   characterise	   the	   role	   of	   TNFα	   as	   a	  moderator	   of	   combined	  
endotoxin	   and	   HI	   insult,	   a	   more	   precise	   approach	   was	   required,	   as	   it	   is	   well	  
established	   that	   multiple	   cell-­‐types	   produce	   TNFα	   Knowing	   that	  
microglia/macrophage	  play	  a	  primary	  and	  significant	  role	  in	  brain	  inflammation,	  
the	  next	  aim	  was	  to	  target	  these	  cell-­‐types	  specifically.	  For	  this	  purpose,	  we	  were	  
able	  to	  obtain	  animals	  that	  were	  MLys::CRE.	  This	  promoter	   is	  expressed	  only	   in	  
mature	   hematopoietic	   granulomyelomonocytic	   cells,	   i.e.	   granulocytes	   and	  
macrophages,	  and	  not	  in	  microglia,	  as	  the	  latter	  originate	  from	  the	  yolk	  sac	  and	  
not	  from	  the	  bone	  marrow	  (Mawhinney	  et	  al.,	  2012;	  Prinz	  and	  Priller,	  2014).	  
	  
First,	  animals	   that	  had	  two	  copies	  of	   loxP-­‐tagged	  TNFα	  gene	   (TNFαf/f)	  and	  one	  
copy	   of	   Cre	   recombinase	   under	   the	   control	   of	   the	   MLys	   promoter	   (+/-­‐)	   were	  
crossed	  with	  WT	  C57BL/6	  animals.	  From	  the	  F1	  generation,	  only	  the	  animals	  that	  
had	  one	  copy	  of	  TNFαflox	  (flox/+)	  and	  were	  heterozygous	  for	  MLys::Cre	  were	  set	  
up	  as	   the	  next	  breeding	  pairs.	   F2	  offspring	   that	  had	  both	  MLys+/-­‐	  and	  TNFαf/f	  
were	  again	  crossed,	  and	  the	  F3	  progeny,	  consisting	  solely	  of	  WT	  f/f	  (controls)	  and	  
MLys+/-­‐	  TNFαf/f	  (mutants)	  was	  used	  in	  the	  LPS	  +	  HI	  study	  (see	  figure	  4.11).	  12H	  
prior	   to	   HI,	   P6	   mice	   received	   ip	   LPS	   (0.6µg/g)	   injection	   or	   saline.	   After	   48h	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survival,	   animals	   were	   sacrificed	   and	   brain	   tissue	   collected	   for	   histological	  
analysis.	  
	  
	   	  
Figure	  4.11:	  Generation	  of	  WT	  TNFαf/f	  and	  MLys+/-­‐	  TNFαf/f	  mutants.	  
WT	  TNFαf/f	  mice	  were	  bred	  with	  MLys+/-­‐	  TNFαf/f	   in	  order	   to	  obtain	   same	  genotype	  offspring.	  
Agarose	   gel	   electrophoresis	   following	   PCR	   reaction	   allowed	   distinguishing	   the	   different	  
genotypes	   through	  visualization	  of	   the	  different	  band	  sizes:	  MLys	  WT	  allele	  at	  345bp	  and	  MLys	  
KO	  allele	  near	  1kbp	  (A);	  TNFαflox	  allele	  at	  400bp	  and	  TNFα	  WT	  allele	  at	  350bp	  (B).	  
	  
Deletion	  of	  TNFα	  in	  MLys	  macrophages	  reduces	  tissue	  infarction	  
Assessment	   of	   neuronal	   cell	   loss	   by	   looking	   at	   infarct	   volume	   demonstrated	  
successful	   LPS-­‐sensitization	   in	   the	  WT	  group	   (n=10)	  with	  minimal	   tissue	   loss	   in	  
the	   WT	   saline	   controls	   (n=10)	   (39±7%	   and	   12±5%	   respectively,	   p<1%).	   This	  
increase	   in	   infarction	   was	   significant	   in	   most	   brain	   regions.	   The	   dorsoparietal	  
cortex	   showed	   a	   significant	   increase	   from	  10±5%	   to	   44±8%	   (p<0.1%),	   pyriform	  
cortex	  from	  12±9%	  to	  36±8%	  (p<5%),	  striatum	  from	  16±6%	  to	  35±6%	  (p<5%)	  and	  
external	   capsule	   from	   5±8%	   to	   48±11%	   (p<1%).	   Saline	   administered	   MLys+/-­‐	  
TNFαf/f	   animals	   had	  minimal	   tissue	   infarction	   (9±4%).	   Conversely,	   KO	   animals	  
treated	  with	  LPS	  had	  an	  increase	  in	  tissue	  loss	  when	  compared	  to	  the	  KO	  saline,	  
with	   significance	   in	   the	   external	   capsule	   (from	   1±5%	   to	   23±6%,	   p<1%).	  
Assessment	  between	  WT	  LPS	  and	  MLys+/-­‐	  TNFαf/f	  LPS	  groups	  clearly	   indicated	  
that	   deletion	   of	   TNFα	   in	   MLys-­‐expressing	   macrophages	   reduces	   tissue	   loss.	  
MLys+/-­‐	   TNFαf/f	   LPS	   animals	   had	   significantly	   less	   necrotic	   tissue	   in	   the	  
dorsoparietal	   (44±8%	   vs.	   25±8%,	   p<5%)	   and	   pyriform	   cortex	   (36±8%	   vs.	   9±6%,	  
p<5%),	   and	   striatum	   (35±6%	   vs.	   20±6%,	   p<5%)	   ipsilateral	   brain	   regions,	   with	  
B	  A	  
MLys	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significance	  also	  being	  reached	  in	  the	  overall	  (39±7%	  vs.	  23±6%,	  p<5%)	  tissue	  loss	  
assessment	  between	  both	  LPS	  groups	  (see	  figure	  4.12.A).	  
	  
MLys+/-­‐	  TNFαf/f	  animals	  have	  decrease	  brain	  injury	  following	  LPS+HI	  injury	  
Combined	   αM	   (activated	   macrophage/microglia)	   and	   Nissl	   (neuronal	   cell	   loss)	  
injury	   scoring	   (see	   chapter	  2)	   revealed	   successful	   LPS-­‐mediated	   sensitization	   in	  
the	  WT	  TNFαf/f	  group.	  The	   ipsilateral	  dorsoparietal	   (5.8±1.1	  vs.	  2.4±0.9,	  p<5%)	  
and	   pyriform	   cortex	   (5.2±1.0	   vs.	   1.6±0.8,	   p<5%),	   striatum	   (5.1±1.1	   vs.	   1.1±0.7,	  
p<1%)	  and	  thalamus	  (4.5±1.1	  vs.	  0.7±0.5,	  p<0.1%)	  brain	  regions	  had	  significantly	  
more	   brain	   injury	   in	   the	  WT	   LPS	   treated	   group	   when	   compared	   to	  WT	   saline	  
injected	  animals.	  The	  same	  increase	  in	  alphaM	  activation	  and	  neuronal	  loss	  was	  
seen	  in	  the	  MLys+/-­‐	  TNFαf/f	  LPS	  animals	  when	  compared	  to	  the	  MLys+/-­‐	  TNFαf/f	  
saline	  controls.	  In	  this	  assessment,	  LPS	  KO	  animals	  had	  significantly	  higher	  brain	  
injury	   in	   the	   dorsoparietal	   cortex	   (5.1±1.1	   vs.	   0.9±0.6,	   p<1%),	   hippocampus	  
(6.3±1.0	   vs.	   1.9±1.0,	   p<1%)	   and	   external	   capsule	   (5.7±1.0	   vs.	   2.2±0.8,	   p<5%).	  
Comparing	   both	   WT	   and	   MLys	   mutants	   after	   endotoxin	   administration	  
highlighted	   a	   trend	   towards	   reduction	   of	   LPS-­‐mediated	   sensitization	   to	  
subsequent	  HI	  in	  MLys-­‐expressing	  macrophages	  where	  the	  TNFα	  gene	  had	  been	  
deleted.	   This	   decrease	   in	   injury	   reached	   statistical	   significance	   in	   the	   pyriform	  
cortex	   (from	  5.2±1.0	   to	  2.7±0.9,	  p<5%)	  and	   thalamus	   (from	  4.5±1.1	   to	  1.9±0.7,	  
p<5%)	  brain	  regions	  (see	  figure	  4.12.B).	  
	  
TNFα-­‐/-­‐	  in	  MLys	  macrophages	  ameliorates	  DNA	  fragmentation	  and	  cell	  death	  
TUNEL+	   cell	   quantification	   comparison	   between	   the	   WT	   littermate	   groups	  
showed	  minimal	  number	  of	  DNA	  fragment-­‐associated	  cell	  death	  in	  the	  WT	  saline	  
controls	   (42.6±20.7).	   The	   average	   number	   of	   TUNEL+	   cells	   was	   significantly	  
increased	   to	   182.3±46.2	   in	   the	   WT	   LPS	   administered	   group	   (p<0.1%).	  
Observation	   of	   the	   individually	   assessed	   brain	   regions	   showed	   that	   this	  
significance	  was	  also	  present	  in	  the	  dorsoparietal	  (from	  49.7±30.4	  to	  363.9±82.1,	  
p<0.1%)	   and	   pyriform	   cortex	   (from	   24.8±20.0	   to	   105.1±40.1,	   p<5%),	   striatum	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(from	   36.6±24.1	   to	   253.9±65.1,	   p<1%),	   thalamus	   (from	   18.0±9.4	   to	   60.9±20.0,	  
p<5%)	   and	   external	   capsule	   (from	   22.9±11.0	   to	   129.3±30.4,	   p<0.1%)	   ipsilateral	  
brain	  regions.	  Subjective	  comparison	  between	  the	  KO	  groups	  –MLys+/-­‐	  TNFαf/f	  
saline	  and	  MLys+/-­‐	  TNFαf/f	  LPS	  –	  also	  revealed	  a	  trend	  towards	  higher	  average	  
number	   of	   TUNEL+	   cells	   in	   the	   latter,	   however	   this	   increase	   never	   reached	  
significance.	   Assessment	   of	   the	   LPS	   groups	   (WT	   and	   KO)	   demonstrated	   a	  
significant	   reduction	   not	   only	   in	   the	   dorsoparietal	   (from	   363.9±82.1	   to	  
158.3±44.6,	   p<0.1%)	   and	   pyriform	   cortex	   (from	   105.1±40.1	   to	   21.4±9.7,	   p<5%)	  
and	   external	   capsule	   (from	   129.3±30.4	   to	   46.2±16.6,	   p<1%),	   but	   also	   overall	  
(from	  182.3±46.2	  to	  87.3±25.8,	  p<5%)	  (see	  figure	  4.12.C).	  
	  
GFAP	  immunoreactivity	  is	  mildly	  reduced	  in	  MLys+/-­‐	  TNFαf/f	  LPS	  animals	  
Finally,	   comparison	   between	  WT	   saline	   and	  WT	   LPS	   animals	   in	   terms	   of	   GFAP	  
synthesis	  demonstrated	  an	  overall	  higher	  increase	  in	  astrocytic	  activation	  in	  the	  
WT	   LPS	   group	   from	  40.7±5.2	   to	   53.7±6.2	   (p<5%).	   Assessment	   of	   the	   individual	  
brain	   regions	   showed	   that	   this	   significance	   was	   also	   present	   in	   the	   pyriform	  
cortex	  from	  34.8±5.4	  to	  55.2±6.8	  (p<5%)	  and	  striatum	  from	  33.1±4.6	  to	  51.4±6.8	  
(p<5%).	  Comparison	  between	  the	  KO	  saline	  and	  KO	  LPS	  groups	  also	  showed	  the	  
same	  overall	  increase	  in	  astrocyte	  reactivity	  from	  38.1±5.4	  to	  49.8±5.8	  (p<5%),	  as	  
well	  as	   in	  the	  dorsoparietal	  cortex	  from	  30.7±5.8	  to	  50.9±6.5	  (p<5%).	  However,	  
comparison	  between	  WT	  LPS	  and	  MLys+/-­‐	  TNFαf/f	  LPS	  injected	  animals	  showed	  
that	  astrocyte	  activation	  was	  only	  moderately	  affected	  by	  deletion	  of	  TNFα	  gene	  
in	   MLys	   expressing	   macrophages,	   with	   the	   latter	   having	   slightly	   less	   GFAP	  





Figure	  4.12:	  Effects	  of	  TNFα	  gene	  deletion	  in	  MLys+	  macrophages	  on	  neonatal	  hypoxic-­‐ischemic	  
brain	  injury	  after	  pre-­‐exposure	  to	  0.6µg/g	  LPS	  endotoxin	  (LPS).	  Animals	  injected	  with	  saline	  (SAL)	  
served	   as	   controls.	   A:	   Infarct	   volume	   assessment	   of	   individual	   forebrain	   regions	   and	   total	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ipsilateral	   hemisphere	   infarction	   as	   percent	   of	   contralateral	   hemisphere,	   showed	   that	   this	   cell	  
specific	   deletion	   of	   the	   TNFα	   gene	  was	   not	   only	   significantly	   neuroprotective	   overall,	   but	   this	  
significant	  decrease	  in	  tissue	  necrosis	  was	  also	  observed	  in	  the	  dorsoparietal	  and	  pyriform	  cortex	  
and	  striatum	  ipsilateral	  brain	  regions	  of	  LPS-­‐treated	  knockout	  animals.	  B:	  Brain	  injury	  assessment	  
of	  TNFα-­‐/-­‐	  MLys+/-­‐	  animals	   revealed	  an	  overall	   trend	   towards	   reduced	  microglial	   inflammatory	  
response	   and	   neuronal	   cell	   loss	   following	   LPS	   administration.	   This	   becomes	   significant	   in	   the	  
pyriform	   cortex	   and	   thalamus	   ipsilateral	   brain	   regions.	   C:	   DNA	   fragmentation	   cell	   death	  
assessment	  using	  TUNEL+	  cell	  quantification	  demonstrated	  a	   significant	  overall	  decrease	   in	   cell	  
death	   in	   the	   LPS-­‐treated	   knockout	   group,	   with	   significant	   reduction	   also	   reached	   in	   the	  
dorsoparietal	   and	   pyriform	   cortex,	   and	   external	   capsule	   ipsilateral	   brain	   regions.	  D:	   Astroglial	  
immunoreactivity	   assessment	   using	   optical	   luminosity	   values	   showed	   a	   trend	   towards	   reduced	  
GFAP	   synthesis	   in	   the	   LPS	   TNFα-­‐/-­‐	   MLys+/-­‐	   animals	   when	   compared	   to	   wild	   type	   LPS-­‐treated	  
littermates.	   Contralateral	   hemisphere	   not	   shown.	   *p<5%	   in	   Mann	   Whitney	   test	   for	   the	   LPS-­‐
treated	   wild	   type	   vs.	   knockout	   groups,	   n=10	   per	   group.	  Abbreviations:	  WT	   –	   wild	   type,	   KO	   –	  
knockout,	  CTX-­‐	  dorsoparietal	  and	  PYR	  –	  pyriform	  cortex,	  HIP	  –	  hippocampus,	  STR	  –	  striatum,	  THL	  





Infection/inflammation	   and	   hypoxic-­‐ischaemic	   insult	   are	   widely	   accepted	   as	  
having	   a	   devastating	   impact	   on	   the	   neonatal	   brain.	   These	   types	   of	   injury	   can	  
cause	   severe	   brain	   damage	   alone,	   but	   when	   combined,	   work	   in	   a	   synergistic	  
manner	   augmenting	   significantly	   and	   irreversibly	   subsequent	   perinatal	   brain	  
damage,	   thus	   greatly	   enhancing	   the	   risk	   of	   cerebral	   palsy	   and/or	   other	  
neurological	  deficits	  such	  as	  cognitive	  impairment,	  schizophrenia	  and	  autism.	  
	  
Previous	   work	   performed	   in	   this	   laboratory	   has	   shown	   that	   LPS	   endotoxin,	   a	  
known	   inducer	   of	   inflammation	   requires	   the	   TNF	   cluster	   of	   pro-­‐inflammatory	  
cytokines	   in	   order	   to	   sensitize	   the	   immature	   brain	   to	   subsequent	   hypoxic-­‐
ischaemic	   insult	   (Kendall	   et	   al.,	   2011b).	   Therefore,	   the	   logical	   next	   step	  was	   to	  
study	  the	  individual	  TNF	  cluster	  members	  -­‐	  TNFα,	  LTα	  and	  LTβ	  –	  to	  see	  which	  one	  
or	  combination	  of	  is	  responsible	  for	  mediating	  the	  LPS	  sensitization.	  	  In	  order	  to	  
achieve	   this,	   in	   this	   study	   it	   was	   employed	   the	   use	   of	   transgenic	   mice	   with	  
individual	   global	   deletion	   of	   TNFα,	   LTα	   and	   LTβ	   genes,	   as	   well	   cell-­‐specific	  




Lack	  of	  LPS-­‐mediated	  sensitization	  can	  be	  resolved	  through	  serial	  introduction	  of	  
wild	  type	  C57BL/6	  background	  into	  the	  breeding	  	  
Pilot	  study	  performed	  by	  Drs	  Hristova,	  Kendal	  and	  Lange	  have	  shown	  a	  variation	  
in	   LPS-­‐mediated	   sensitization	   within	   different	   mouse	   strains,	   where	   TNFα	   and	  
LTβ	   animals	   were	   non-­‐responders	   to	   bacterial	   endotoxin	   pre-­‐treatment,	   only	  
showing	   a	   baseline	   reaction	   to	   hypoxic-­‐ischaemic	   insult.	   In	   their	   initial	  
experimental	  design,	  where	  TNFα	  and	  LTβ	  were	  used	  as	  homozygous	  breeding,	  
with	   the	   latter	   being	   uncovered	   as	   actually	   containing	   some	   heterozygous	  
animals,	   it	  was	  discovered	  that,	  unlike	   the	  separate	  wild	   type	  C57BL/6	  controls	  
(non-­‐littermates),	  the	  F1	  offspring	  of	  these	  two	  strains,	  displayed	  no	  sensitization	  
to	  LPS	  pre-­‐treatment	  (0.3µg/g)	  followed	  by	  hypoxic-­‐ischaemic	  insult.	  This	  lack	  of	  
sensitization	   appears	   to	   be	   novel,	   as	  multiple	   animal	   studies	   have	   successfully	  
demonstrated	  LPS	  sensitization	  prior	  to	  hypoxic-­‐ischaemic	  injury	  (Hagberg	  et	  al.,	  
2002;	   Mallard	   et	   al.,	   2003;	   Kendall	   et	   al.,	   2011b;	   van	   de	   Looij	   et	   al.,	   2012).	  
Additionally,	   In	   order	   to	   exclude	   the	   possibility	   that	   the	   new	   batch	   of	   LPS	  
bacterial	  endotoxin	  had	   lost	   its	   function,	  a	   test	  was	  performed	   in	  commercially	  
acquired	  C57BL/6	  mice	  (see	  figure	  4.6).	  This	   test	  revealed	  a	  significant	   increase	  
across	   all	   assessed	   brain	   regions,	   in	   microglial	   activation	   in	   the	   LPS-­‐treated	  
grouped	  when	  compared	  to	  their	  saline-­‐treated	  littermate	  controls.	  
	  
Interestingly,	   the	   strain	   study	   described	   in	   chapter	   3,	   revealed	   successful	   LPS-­‐
mediated	   sensitization	   to	   subsequent	   hypoxic-­‐ischaemic	   insult	   in	   five	   different	  
genetic	  background	  strains,	  including	  C57BL/6,	  the	  background	  strain	  used	  in	  this	  
study.	  However,	  the	  strain	  study	  also	  demonstrated,	  similarly	  to	  other	  research	  
looking	   at	   effects	   of	   strain	   differences	   in	   response	   to	   different	   stimuli,	   that	  
different	  genetic	  strains	  might	  respond	  differently	  to	  insult.	  Consequently,	  these	  
new	  findings	  regarding	  a	  lack	  of	  successful	  LPS-­‐mediated	  sensitization	  led	  to	  the	  
generation	  of	   two	  hypotheses,	  where	  non-­‐responsiveness	   to	  bacterial	   infection	  
could	   be	   a	   result	   of	   either	   strain	   differences,	   or	   due	   to	   gene	   deletion.	   In	   this	  
study,	  this	  issue	  was	  initially	  addressed	  from	  a	  strain	  difference	  perspective.	  The	  
147	  
	  
two	   mutant	   strains	   (TNFα	   and	   LTβ)	   were	   separately	   crossed	   with	   wild	   type	  
C57BL/6	   mice,	   which	   had	   already	   proven	   to	   be	   well-­‐responders	   to	   LPS	  
administration	   (see	   chapter	   3;	   figure	   4.6).	   This	   re-­‐crossing	   allowed	   obtaining	  
heterozygous	   breeding,	   which	   then	   permitted	   the	   use	   of	   wild	   type	   littermate	  
controls.	  However,	  one	  re-­‐crossing	  appeared	  to	  not	  be	  sufficient,	  indicating	  that	  
if	   this	  newly	   identified	  non-­‐responsiveness	  was	  caused	  by	  strain	  variations,	   this	  
must	   be	   due	   to	   an	   unknown	   dominant	   trait.	   A	   second	   attempt	   at	   crossing	  
heterozygotes	   for	   TNFα	   and	   LTβ	   animals	   with	   wild	   type	   C57BL/6	   mice	  
respectively,	  thus	  introducing	  75%	  of	  C57BL/6	  background	  into	  the	  strain,	  finally	  
generated	  positive	   results,	  where	  wild	   type	  LPS-­‐treated	   littermates	  successfully	  
revealed	  significant	  response	  to	  LPS	  pre-­‐sensitization.	  
	  
LTα,	  LTβ	  and	  TNFα	  genes	  play	  dissimilar	  roles	  in	  the	  synergistic	  model	  of	  infection	  and	  
neonatal	  hypoxic-­‐ischemic	  insult	  
Although	   numerous	   molecules,	   including	   the	   TNF	   family	   of	   pro-­‐inflammatory	  
cytokines	   consisting	   of	   TNFα,	   LTα	   and	   LTβ,	   are	   known	   to	   be	   up-­‐regulated	  
following	  antenatal,	  perinatal	  and	  early	  postnatal	   infection,	  the	  exact	  molecular	  
mechanisms	   that	   take	  part	   in	   the	  aetiology	  of	  perinatal	  brain	  damage	  are	  only	  
now	   beginning	   to	   be	   understood.	   Kendall	   et	   al.,	   (2011b)	   demonstrated	   that	  
deletion	   of	   the	   TNF	   cluster	   of	   pro-­‐inflammatory	   cytokines	   leads	   to	   an	  
abolishment	   in	   inflammation	   following	   LPS	   pre-­‐sensitization	   of	   the	   neonatal	  
mouse	  brain	   to	   subsequent	  hypoxic-­‐ischaemic	   insult.	   The	   current	   study	   further	  
investigated	   this	   effect,	   by	   looking	   at	   the	   individual	   role	   of	   each	   of	   the	   three	  
cluster	   members,	   using	   murine	   models	   of	   global	   and	   cell-­‐type	   specific	   gene	  
deletion.	  	  
	  
Removal	  of	  the	  LTα	  gene	  proved	  beneficial.	  Absence	  of	  LTα	   improved	  neuronal	  
cell	   survival,	   with	   an	   overall	   50%	   decrease	   in	   tissue	   infarction,	   microglia	  
activation	   and	   neuronal	   cell	   loss.	   Deletion	   of	   this	   gene	   showed	   an	   overall	  
reduction	  of	  32%	  in	  TUNEL	  positive	  cells.	  However,	  astroglial	  activation	  was	  only	  
minimally	   improved	   (8%)	   in	   the	   absence	   of	   LTα	   gene.	   A	   study	   performed	   by	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Nelson	  et	  al.,	  has	  also	  demonstrated	  LTα	  as	  a	  possible	  inducer	  of	  cerebral	  palsy,	  
where	   it	  was	   revealed	   that	   single	  nucleotide	  polymorphism	  of	   the	   LTα	  gene	   in	  
very	   preterm	   infants	   was	   associated	   with	   enhanced	   risk	   of	   CP	   (Nelson	   et	   al.,	  
2005).	   However,	   the	   LTα	   results	   in	   this	   study	   did	   not	   reproduce	   the	   same	  
abolishment	  effect	  seen	  in	  the	  TNF	  cluster	  knockout	  study	  (Kendall	  et	  al.,	  2011b).	  
Here,	  one	  can	  see	   that	  homozygous	  LTα	  mutants	  had	  a	  more	  moderate	  effect,	  
with	   an	   overall	   35%	   reduction	   on	   brain	   damage	   across	   the	   four	   different	  
assessments.	  These	  results	  therefore	  indicate	  that	  other	  genes	  or	  factors	  are	  at	  
play	  in	  this	  synergistic	  model	  of	  neonatal	  brain	  injury.	  
	  
Conversely	   to	   the	   LTα	   results,	   deletion	  of	   LTβ	   gene	   in	   animals	   that	   underwent	  
LPS	   pre-­‐sensitization	   had	   a	   detrimental	   effect	   across	   all	   four	   performed	  
assessments.	   Tissue	   infarction	   assessment	   showed	   a	   clear	   and	   significant	  
detrimental	   effect,	  with	   an	   overall	   130%	   increase	   in	   tissue	   necrosis	   of	   animals	  
that	  lacked	  LTβ	  gene.	  Overall	  injury	  score	  assessment	  once	  again	  demonstrated	  a	  
significant	  increase	  in	  microglial	  activation	  and	  neuronal	  cell	  loss	  of	  around	  42%.	  
This	  toxic	  effect	  was	  most	  evident	  in	  TUNEL+	  cell	  quantification	  where	  there	  was	  
nearly	  a	  fourfold	  increase	  in	  DNA	  fragmentation-­‐associated	  cell	  loss	  in	  the	  global	  
LTβ	   knockouts.	   However,	   this	   gene	   deletion	   had	   a	   less	   pronounced	   effect	   in	  
astrogliosis,	  where	  there	  was	  only	  a	  small	   increase	  of	  8%	  in	  astroglial	  activation	  
in	  LPS-­‐treated	  LTβ	  deficient	  mice.	  These	  results	  show	  a	  clear	  different	  effect	  from	  
what	  was	  observed	   in	   the	  TNF	  cluster	  deletion	  study	   (Kendall	  et	  al.,	  2011b).	   In	  
this	   particular	   model	   of	   perinatal	   brain	   damage,	   there	   appears	   to	   be	   a	   clear	  
significant	   neuroprotective	   role	   for	   the	   LTβ	   gene,	   where	   ablation	   of	   this	   gene	  
leads	  to	  an	  overall	  twofold	  increase	  in	  brain	  damage	  when	  taking	  into	  account	  all	  
four	  assessments	  performed.	  
	  
Of	   the	   three	   cluster	  members,	   the	   role	  of	   TNFα	  as	   a	  mediator	  of	  HI	   injury	  has	  
been	   the	  most	   extensively	   investigated.	   TNFα	   is	   produced	   by	   a	   variety	   of	   cell	  
types,	  but	  are	  predominantly	  expressed	  by	  activated	  macrophages.	  Studies	  using	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exogenous	  TNFα	  have	  shown	  its	  ability	  to	  increase	  permeability	  and	  to	  cross	  the	  
blood	   brain	   barrier.	   Up-­‐regulation	   of	   this	   protein	   activates	  NK	   cell	   toxicity	   and	  
generates	   T-­‐lymphocytes.	   There	   is	   also	   evidence	   of	   changes	   in	   endothelium,	  
which	   promote	   not	   only	   inflammation	   but	   also	   thrombosis	   (Uno	   et	   al.,	   1997).	  
However,	  in	  this	  particular	  study,	  the	  TNFα	  cytokine	  appears	  to	  have	  a	  beneficial	  
role	   in	   the	   synergistic	   mouse	   model	   of	   LPS	   infection	   and	   neonatal	   hypoxia-­‐
ischemia.	  Similarly	  to	  what	  was	  observed	  in	  the	  LTβ	  experiment,	  animals	  lacking	  
both	   copies	   of	   the	   TNFα	   gene	   demonstrated	   more	   susceptibility	   to	   brain	  
damage,	  with	  a	  53%	  increase	  in	  tissue	  infarction,	  and	  over	  60%	  increase	  in	  DNA	  
fragmentation-­‐associated	   cell	   death.	   Despite	   only	   a	   trend,	   there	   was	   also	   an	  
increase	   of	   8%	   in	   microglial	   activation	   and	   neuronal	   cell	   loss,	   with	   a	   further	  
increase	   of	   15%	   in	   astrogliosis	   in	   the	   brains	   of	   LPS-­‐treated	   TNFα	   global	  
knockouts.	  
	  
Interestingly,	   not	   only	   individual	   global	   deletion	   of	   LTα,	   Ltβ	   and	   TNFα	   did	   not	  
reproduce	  the	  abolishment	  of	  LPS-­‐mediated	  sensitization	  seen	  previously	  in	  the	  
TNF	   cluster	   study	   (Kendall	   et	   al.,	   2011b),	   this	   study	   has	   shown	   that	   these	  
cytokines	  have	  dissimilar	  roles	  in	  this	  combined	  form	  of	  injury,	  and	  that	  attempt	  
at	   acute	   neutralization	   of	   the	   individual	   cytokines	   would	   not	   be	   successful	   in	  
preventing	   and	   reducing	   perinatal	   brain	   damage	   following	   synergistic	   infection	  
and	  hypoxia-­‐ischaemic	  insults.	  
	  
Proximity	  of	  TNFα,	  LTα	  and	  LTβ	  genes	  could	  explain	  LTα-­‐/-­‐	  neuroprotective	  effect	  
TNFα,	   LTα	   and	   Ltβ	   genes	   are	   located	   within	   12kb	   of	   genomic	   DNA	   inside	   the	  
major	  histocompatibility	  complex	  locus	  (Muler	  et	  al.,	  1987;	  Kuprash	  et	  al.,	  2002;	  
Kendall	   et	   al.,	   2011b).	   These	   cytokines	   not	   only	   have	   overlapping	   activity	  
functions,	  but	  they	  are	  also	  involved	  in	  the	  functional	  development	  of	  peripheral	  
lymphoid	   organs	   and	   immune	   response	   (Kuprash	   et	   al.,	   2002;	   Liepinsh	   et	   al.,	  
2006).	  Therefore,	   it	   is	  possible	  that	  global	  deletion	  of	  one	  of	  these	  genes	  could	  
affect	  the	  expression	  of	  one	  or	  both	  other	  TNF	  cluster	  members.	  In	  fact,	  a	  study	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by	  Alexopoulou	  et	  al.,	  1998	  has	  shown	  that	  the	  more	  severe	  phenotypic	  defects	  
seen	  in	  LTα	  deficient	  mice	  when	  compared	  to	  TNFα	  and	  LTβ	  mutants	  is	  in	  fact	  a	  
consequence	   of	   partial	   TNFα	   production	   deficiency	   (Alexopoulou	   et	   al.,	   1998;	  
Kuprash	   et	   al.,	   2002).	   In	   this	   study,	   complementing	   LTα-­‐/-­‐	   animals	   with	   TNF-­‐
expressing	   transgenes	   led	   to	   partial	   restoration	   of	   primary	   B	   cell	   follicles,	  
follicular	  dendritic	  cells,	  germinal	  centers,	  as	  well	  as	  re-­‐establishment	  of	  B/T	  cell	  
segregation	  in	  a	  p55	  TNF	  receptor	  dependent	  manner.	  Furthermore,	  this	  reduced	  
TNFα	  function	  in	  LTα-­‐/-­‐	  mice	  is	  further	  evidenced	  when	  peritoneal	  macrophage	  
supernatants	  as	  well	  as	  serum	  of	  LTα	  knockout	  animals	  injected	  intraperitoneally	  
with	   LPS	   bacterial	   endotoxin	   failed	   to	   demonstrate	   production	   of	   TNFα	   at	  
physiological	  levels	  (Alexopoulou	  et	  al,	  1998).	  Therefore,	  it	  is	  possible	  to	  assume,	  
at	   least	   partially,	   that	   the	   neuroprotective	   effect	   seen	   in	   the	   current	   LTα-­‐/-­‐	  
results	   could	   be	   attributed	   to	   an	   addiction	   of	   reduction	   in	   TNFα	   synthesis	   by	  
peripheral	  macrophages	   as	  well	   as	   lack	   of	   the	   LTα	   pro-­‐inflammatory	   cytokine.	  	  
Considering	   how	   TNFα,	   LTα	   and	   Ltβ	   are	   known	   to	   have	   overlapping	   functions,	  
this	  added	  inhibition	  in	  inflammatory	  response	  could	  explain	  the	  different	  effect	  
global	   deletion	   of	   LTα	   gene	   has,	   i.e.	   neuroprotective,	   when	   global	   deletion	   of	  
either	  TNFα	  or	  Ltβ	  revealed	  a	  detrimental	  effect.	  
	  
The	  current	  study	  attempted	  to	  verify	  this	  theory	  by	  looking	  at	  mRNA	  expression	  
of	  TNFα,	  LTα	  and	  LTβ	  in	  the	  spleen	  of	  the	  different	  knockout	  mice.	  At	  P7,	  knock	  
out	   animals	   as	   well	   as	   littermate	   wild	   type	   controls	   for	   each	   of	   the	   3	   gene	  
mutations	  were	   injected	  with	   either	   LPS	   (n=4)	   or	   saline	   (n=4)	   and	   4h	   later	   the	  
spleen,	   liver,	  cortex,	  striatum	  and	  hippocampus	  were	  collected	  and	  snap	  frozen	  
before	  RNA	  was	  extracted.	  Following	  cDNA	  synthesis,	  the	  samples	  were	  run	  on	  a	  
qPCR	  machine,	  where	  each	  sample	  was	  checked	  for	  its	  own	  deleted	  gene,	  as	  well	  
as	   for	   the	  other	  2	  genes	  and	  a	  house	  keeping	  gene.	  Control	   samples	  were	  also	  
used,	   where	   commercially	   available	   wild	   type	   C57BL/6	   underwent	   the	   same	  
procedure.	   Unfortunately,	   the	   beta-­‐actin	   house	   keeping	   gene	   primers	   used	  
appear	  to	  have	  lost	  activity	  following	  the	  trial	  test,	  and	  did	  not	  give	  any	  readouts,	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thus	   impeding	   reading	   and	   comparison	   of	   expression	   levels	   of	   the	   three	  
cytokines	  of	  interest.	  Incorporation	  of	  such	  findings	  in	  future	  studies	  will	  benefit	  
not	  only	  the	  refinement	  of	  animal	  experimentation,	  but	  also	  the	  understanding	  
of	   how	   deletion	   of	   such	   closely	   related	   genes	   may	   affect	   function	   of	   the	  
remaining	  cluster	  members.	  	  
	  
Dual	  role	  for	  the	  TNFα	  gene	  depending	  on	  which	  cell-­‐type	  it	  is	  being	  expressed?	  
Several	   studies	   have	   shown	   differing	   effects	   associated	  with	   TNFα	   production.	  
Treatments	   blocking	   TNFα	   has	   demonstrated	   to	   improve	   outcome	   in	   patients	  
with	   autoimmune	   disorders	   such	   as	   Crohn’s	   disease,	   rheumatoid	   arthritis	   and	  
autoimmune	  psoriasis	  (Feldmann	  and	  Maini,	  2001).	  Conversely,	  deletion	  of	  TNFα	  
in	   mice	   has	   shown	   an	   increase	   in	   retention	   of	   T	   cells	   in	   secondary	   lymphoid	  
organs,	   causing	   exacerbation	   of	   animal	   models	   of	   multiple	   sclerosis	   (MS)	  
(Kassiotis	   and	   Kollias,	   2001).	   Additionally,	   therapeutic	   administration	   of	   TNFα	  
reduced	  MS	  severity	  in	  both	  TNFα	  knockout	  and	  wild	  type	  mice	  (Liu	  et	  al.,	  1998).	  
Furthermore,	  the	  current	  study	  suggests	  a	  positive	  role	  for	  TNFα	  in	  the	  combined	  
inflammation	  and	  neonatal	  hypoxia-­‐ischaemia	  model,	  as	   its	  deletion	  appears	  to	  
be	  detrimental.	  	  
	  
However,	   these	   studies	   only	   looked	   at	   global	   effects	   of	   TNFα	   gene	  expression,	  
not	  considering	  whether	  or	  not	  its	  source	  has	  an	  effect	  in	  this	  dual	  role.	  TNFα	  is	  
expressed	  by	  a	  multitude	  of	  cells,	  including	  macrophages,	  T	  and	  B	  cells,	  NK	  cells,	  
dendritic	  cells	  and	  neutrophils	  (Grivennikov	  et	  al.,	  2005).	  In	  this	  study	  we	  wanted	  
to	  further	  characterize	  the	  role	  of	  TNFα	  by	  looking	  at	  specific	  cellular	  sources,	  i.e.	  
granulocytes	  and	  macrophages	  -­‐	  excluding	  microglia	  -­‐	  and	  understand	  their	  role	  
in	  the	  synergistic	  model	  of	  inflammation	  and	  neonatal	  hypoxic-­‐ischaemic	  insult.	  	  
	  
Cell-­‐type	   specific	   deletion	   of	   TNFα	   in	   MLys-­‐expressing	   cells	   revealed	   a	   clear	  
neuroprotective	   effect,	   where	   deletion	   of	   TNFα	   gene	   in	   granulocytes	   and	  
macrophages	   of	   myeloid	   origin	   led	   to	   a	   significant	   reduction	   of	   70%	   in	   tissue	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infarction,	  and	  30%	  decrease	  in	  microglial	  activation	  and	  neuronal	  cell	   loss.	  The	  
overall	   presence	   of	   TUNEL+	   cells	   was	   halved	   and	   astrogliosis	   assessment	   also	  
showed	  a	  trend	  towards	  decreased	  astroglial	  activation.	  	  
	  
A	   study	   looking	   at	   different	   cell	   sources	   of	   TNFα	   in	   experimental	   autoimmune	  
encephalomyelitis	   (EAE)	   has	   also	   shown	   a	   detrimental	   effect	   for	   this	   cytokine	  
depending	   on	   which	   cell-­‐type	   it	   is	   expressed.	   TNFα	   MLys	   knockout	   mice	  
demonstrated	   a	   later	   disease	   onset	   when	   compared	   to	   wild	   type	   controls.	  
Additionally,	   animals	   that	   lacked	   TNFα	   in	   T	   cells	   demonstrated	   significantly	  
milder	   symptoms	   than	   wild	   type	   controls	   (Kurglov	   et	   al.,	   2011).	   This	   study	   by	  
Kurglov	  et	  al.,	  suggested	  that	  TNFα	  pathogenic	  activity	  seen	  in	  the	  EAE	  CNS	  is	  a	  
result	  of	  a	  distinct	  contribution	  of	  TNFα	  expression	  by	  T	  cells	  and	  myeloid	  cells.	  
This	   research	   group	   also	   suggested	   that	   TNFα	   mediation	   of	   pathogenesis	  
functions	  through	  an	   initial	  phase	  of	   recruitment	  of	   inflammatory	  cells	   into	  the	  
CNS.	  	  
	  
Several	  studies	  have	  suggested	  an	  increase	  in	  neonatal	  BBB	  permeability	  due	  to	  
inflammation.	  In-­‐vitro	  studies	  of	  the	  human	  BBB	  have	  shown	  both	  TNFα	  and	  LPS-­‐
associated	   increase	   in	  BBB	  permeability	   (Wong	  et	   al.,	   2004).	   Furthermore,	   it	   is	  
widely	  suggested	  that	  inflammatory	  cytokines	  not	  only	  affect	  the	  CNS	  increasing	  
inflammation	  after	  injury	  and	  infection,	  but	  may	  also	  induce	  a	  disruption	  in	  BBB	  
function	   (de	   Vries	   et	   al.,	   1997;	   Hagberg	   and	  Mallard,	   2005).	   Knowing	   that	   the	  
neonatal	   BBB	   is	   leaky	   following	   infection/inflammation,	   and	   considering	   the	  
possibility	  suggested	  by	  Kurglov	  et	  al.,	  where	  MLys+	  cells	  expressing	  TNFα	  lead	  to	  
the	   initial	   recruitment	   of	   inflammatory	   cells	   into	   the	   CNS,	   this	   could	   provide	   a	  
possible	  explanation	  to	  the	  results	  seen	  in	  this	  study,	  where	  animals	  which	  TNFα	  
was	  expressed	  in	  MLys+	  macrophages	  had	  substantially	  higher	  brain	  damage	  48h	  
post-­‐HI,	  when	  pre-­‐treated	  with	   LPS.	   This	   also	   coincides	  with	   the	   LTα	   results	   in	  
the	   current	   study,	   where	   global	   deletion	   of	   LTα	   gene,	   which	   also	   causes	   a	  
reduced	  ability	  of	  peripheral	  macrophages	  to	  produce	  TNFα,	  has	  demonstrated	  a	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neuroprotective	  effect.	  However,	  it	   is	   important	  to	  note	  that	  Alexopoulou	  et	  al,	  
1998,	  did	  not	   investigate	  TNFα	   production	  within	   the	  brain,	   and	   therefore	   it	   is	  
not	  known	  whether	  neuronal	  and/or	  glial	  TNFα	  synthesis	  is	  also	  affected	  in	  LTα	  
knockout	  animals.	  
	  
However,	   since	   global	   deletion	   of	   TNFα	   is	   detrimental	   in	   this	   particular	   injury	  
model,	  this	  gives	  rise	  to	  the	  question	  of	  which	  cells	  are	  producing	  the	  protective	  
TNFα	   effect	   that	   counteracts	   the	  MLys-­‐specific	   TNFα	  negative	   role.	   A	   study	   by	  
Uno	  et	  al.	  has	  looked	  specifically	  at	  TNFα	  expression	  following	  a	  mouse	  model	  of	  
transient	   forebrain	   ischaemia,	  where	   they	  have	   shown	   that	   TNFα	  expression	   is	  
evident	  as	  early	  as	  1h30min	   following	  30min	  global	   ischaemia.	  Through	  double	  
staining	   of	   TNFα	  with	  GFAP,	   they	   have	   also	   been	   able	   to	   suggest	   that	   TNFα	   is	  
being	   expressed	   by	   microglial	   cells	   rather	   than	   astrocytes	   (Uno	   et	   al.,	   1997).	  
Additionally,	   Kendall	   et	   al.,	   has	   successfully	   shown	   using	   in	   situ	   hybridization	  
TNFα	   mRNA	   in	   the	   P7	   mouse	   forebrain	   following	   systemic	   LPS	   administration	  
(Kendall	  et	  al.,	  2011b).	   	  Furthermore,	  a	  study	  by	  Hristova	  et	  al.	  has	  also	  used	   in	  
situ	  hybridization	  to	  show	  that	  TNFα	  is	  normally	  expressed	  at	  very	  low	  levels	   in	  
the	  P7	  mouse	  brain.	  However,	  following	  LPS-­‐treatment,	  TNFα	  immunoreactivity	  
is	   strongly	  upregulated	   (Hristova	  et	  al.,	  2010).	  Combining	  evidences	   from	  these	  
three	   studies	  demonstrating	  TNFα	  expression	   in	  microglia	   following	  either	   LPS-­‐
mediated	   inflammation	   or	   ischaemia,	   it	   is	   possible	   to	   suggest	   that	   brain	  
microglial	  expression	  of	  TNFα	  may	  have	  the	  protective	  effect	  seen	  in	  this	  study	  of	  
combined	  inflammation	  and	  hypoxic-­‐ischaemic	  injury.	  
	  
TNFα	   receptors	   within	   the	   brain	   are	   expressed	   in	   both	   glia	   and	   neurons.	  
However	  receptor	  activation	  and	  distribution	  vary	  depending	  on	  stressor	  marker,	  
cell	   activation	   level	   and	   downstream	   effectors.	   Therefore,	   this	   difference	   in	  
activation	   pattern	   could	   determine	   whether	   TNFα	   will	   play	   a	   detrimental	   or	  
protective	   role	   following	   insult.	   Microglia	   represent	   the	   CNS	   first	   and	   main	  
immune	   response	   to	   insult.	   It	   is	   known	   that	  microglia	   have	   a	   dual	   role,	  where	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alternative	  M2	   differentiation	   is	   neuroprotective	   as	  M2	  macrophages	   dampen	  
the	   immune	   response	   and	   promote	   tissue	   repair.	   Classical	   M1	   polarization	   is	  
believed	   to	   exert	   cytotoxic	   effects	   through	   release	   of	   pro-­‐inflammatory	  
cytokines.	   However,	   it	   is	   now	   accepted	   that	   both	  M1	   and	  M2	   phenotypes	   co-­‐
exist	  simultaneously	  (Prinz	  and	  Priller,	  2014)	  indicating	  a	  concept	  of	  co-­‐existence	  
where	   acute	   inflammation	   is	   required	   for	   production	   of	   pro-­‐inflammatory	  
cytokines	   (M1	   polarization)	   leading	   to	   recruitment	   of	   immune	   cells	   and	  
destruction/removal	   of	   pathogen	   (Huang	   and	   Feng,	   2013)	   and	   promotion	   of	  
regeneration	   (M2	  polarization)	   (Huang	  and	  Feng,	  2013;	  Prinz	  and	  Priller,	  2014).	  	  
Therefore	  it	  is	  entirely	  possible	  that	  microglial	  TNFα	  production,	  at	  least	  initially,	  
is	   neuroprotective	   in	   this	   combined	   model	   in	   inflammation	   and	   hypoxia-­‐
ischaemic	   insult.	  However,	  depending	  on	   the	  degree	  of	  homeostatic	   imbalance	  
caused	  by	   severity	   of	   insult	   combined	  with	  disruption	  of	   BBB,	   there	   can	  be	   an	  
extensive	   infiltration	   of	   immune	   cells	   into	   the	   brain,	   thus	   exacerbating	   the	  
inflammatory	   response	   and	   either	   greatly	   reducing	   the	   M2	   neuroprotective	  
effect	   or	   leading	  M2	  macrophages	   to	   switch	   into	   the	   classical	  M1	   detrimental	  
phenotype.	  	  
	  
TNF	   cluster	   deletion	   effect	   versus	   individual	   cytokines	   role	   in	   combined	  
infection/inflammation	  and	  neonatal	  hypoxic-­‐ischaemic	  insult	  
As	  aforementioned,	  individual	  deletion	  of	  TNFα,	  LTα	  and	  LTβ	  produced	  not	  only	  
moderate,	  but	  also	  diverse	  effects.	  In	  summary,	  global	  deletion	  of	  the	  LTα	  gene	  
provides	  a	  degree	  of	  neuroprotection	  to	  the	  brain.	  Conversely,	  global	  deletion	  of	  
LTβ	   induced	   a	   significant	   increase	   in	   brain	   damage.	   TNFα	   global	   deletion	   also	  
revealed	   a	   detrimental	   effect,	   albeit	   only	  moderately.	   The	   opposite	   effect	  was	  
seen	   when	   TNFα	   was	   deleted	   in	   all	   MLys-­‐expressing	   peripheral	   macrophages,	  
which	  proved	  to	  be	  rather	  beneficial.	  	  
	  
Initial	  studies,	  considering	  only	  the	  existence	  of	  TNFα	  and	  LTα	  cytokines,	  which	  
was	  widely	  known	  as	   lymphotoxin	   (LT),	  demonstrated	   that	  mice	  deficient	   in	   LT	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have	   normal	   thymus	   development,	   however,	   no	   morphologically	   detectable	  
lymph	  nodes	  or	  Peyer's	  patches.	  Additionally,	  white	  pulp	  of	  the	  spleen	  showed	  a	  
failure	  of	  normal	  segregation	  of	  B	  and	  T	  cells,	  suggesting	  an	  essential	  role	  for	  LT	  
in	  the	  normal	  development	  of	  peripheral	  lymphoid	  organs	  (De	  Togni	  et	  al.,	  1994).	  
Additionally,	  LTα	  knockout	  animals	  have	  suboptimal	  physiological	  production	  of	  
TNFα	  (Alexopoulou	  et	  al,	  1998).	  Discovery	  of	  LTβ	  (Browning	  et	  al.,	  1993)	  has	  led	  
to	   subsequent	   studies	   where	   all	   three	   cytokines	   TNFα,	   LTα	   and	   LTβ	   were	  
genetically	   removed.	  A	   study	  by	  Kuprash	  et	  al.,	   looking	  at	   lymphoid	   tissue,	  has	  
shown	   that	   individual	   inactivation	   of	   TNFα,	   LTα	   and	   LTβ	   showed	   significant	  
overlap	   in	  phenotypes,	  where	   splenic	  germinal	   centers	  were	  defective	   in	   these	  
knockout	   animals.	   The	   same	   study	   also	   looked	   at	   deletion	   of	   the	   entire	   TNF	  
cluster.	   This	   cluster	   deletion	   demonstrated	   an	   additive	   combination	   of	   the	  
individual	   cytokine	   deletion	   defects,	   with	   greater	   impairment	   in	   lymphoid	  
development	   and	   maintenance	   of	   lymphoid	   organs.	   Furthermore	   TNF	   cluster	  
knockout	  mice	  had	  a	  much	  more	  severe	  structural	  spleen	  defect	  than	  individual	  
TNFα,	  LTα	  and	  LTβ	  knockout	  mice	   (see	   table	  6.1).	  This	  more	  severe	  phenotype	  
seen	  in	  the	  cluster	  mutants	  is	  highly	  suggestive	  of	  non-­‐overlapping	  functions	  for	  
each	  of	   the	  cytokines	   in	  vivo	   (Kuprash	  et	  al.,	  2002).	  This	  assumption	  correlates	  
with	  the	  results	  obtained	  in	  this	  study,	  as	  each	  of	  the	  three	  individual	  cytokines	  
demonstrated	   different	   roles	   in	   the	   combined	   infection	   and	   hypoxia-­‐ischaemia	  














Structural	  architecture	  defect	  
TNFα	  -­‐/-­‐	   • Splenic	   defect	   leading	   to	   lack	   of	   primary	   B	   cell	   follicles,	  
follicular	  dendritic	  cells	  and	  germinal	  centers	  (Pasparakis	  et	  
al.,	  1996)	  .	  
LTα	  -­‐/-­‐	   • Disruption	   in	   development	   of	   lymph	   nodes	   and	   Peyer’s	  
patches	  and	  follicular	  dendritic	  cells	  (Kuprash	  et	  al.,	  2002);	  
• Reduced	   germinal	   center	   formation	   segregation	  
(Matsumoto	  et	  al.,	  1996);	  
• Splenic	   white	   pulp	   defect	   causing	   reduced	   B	   and	   T	   cells	  
segregation	  (de	  Togni	  et	  al.,	  1994);	  
• Impaired	   NK	   cell	   development	   and	   recruitment	   (Ito	   et	   al.,	  
1999);	  
• Lack	   of	  mesenteric	   and	   cervical	   lymph	   nodes	   (de	   Togni	   et	  
al.,	  1994).	  
LTβ	  -­‐/-­‐	   • Disruption	   in	   development	   of	   lymph	   nodes	   and	   Peyer’s	  
patches	  (Koni	  et	  al.,	  1997);	  
• Lack	  of	  germinal	  centers	  (Alimzhanov	  et	  al.,	  1997).	  
TNF	  cluster	  -­‐/-­‐	   • Combined	  defects	  in	  lymphoid	  organs	  development	  from	  all	  
three	   individual	   cytokines:	   no	   Peyer’s	   patch	   and	   no	  
mesenteric,	   brachial,	   axillary,	   inguinal	   or	   popliteal	   lymph	  
nodes	  (Kuprash	  et	  al.,	  2002);	  
• Quantitative	   defect	   of	   single	   TNFα,	   LTα	   and	   LTβ	   spleen	  
structural	   defects:	   no	   germinal	   center	   formation,	   lack	   of	  
follicular	  dendritic	  cells,	  reduced	  segregation	  of	  B	  and	  T	  cells	  
(Kuprash	  et	  al.,	  2002).	  
Table	  6.1:	  Structural	  defects	   in	  peripheral	   lymphoid	  organs	  and	  spleen	  of	  single	  TNFα,	  LTα,	  LTβ	  




In	   summary,	   it	   is	   known	   that	   there	   is	   a	   greater	   structural	   defect	   seen	   in	   the	  
spleen	  and	  peripheral	   lymphoid	  organs	  of	  TNF	  cluster	  deletion,	   compared	  with	  
individual	   TNFα,	   LTα	   and	   LTβ	   cytokine	   knockouts	   (Kuprash	   et	   al.,	   2002).	   It	   has	  
also	  been	   shown	   that	  deletion	  of	   the	  TNF	  cluster	  also	  abolished	   the	  endotoxin	  
sensitization	   prior	   to	   neonatal	   hypoxic-­‐ischaemic	   insult	   (Kendall	   et	   al.,	   2011b).	  
Additionally,	  this	  study	  has	  demonstrated	  that	  deletion	  of	  the	   individual	  cluster	  
members	   not	   only	   does	   not	   reproduce	   the	   same	   lack	   of	   LPS-­‐mediated	  
sensitization,	   but	   also	   shows	   dissimilar	   roles	   for	   the	   different	   cytokines	   with	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strong	  suggestion	  that	  peripheral	  immune	  cells	  play	  a	  significant	  detrimental	  role	  
in	   this	   particular	   model.	   Therefore,	   considering	   all	   these	   facts,	   it	   can	   be	  
suggested	   that	   the	   phenotypic	   structural	   defect	   of	   peripheral	   lymphoid	   organs	  
caused	  by	   the	   cluster	  deletion,	   rather	   than	   the	   cytokines	   functions	   is	   causal	   to	  
the	  lack	  of	  LPS-­‐mediated	  sensitization	  in	  the	  neonatal	  model	  of	  hypoxic-­‐ischemic	  
insult.	  This	  is	  a	  novel	  hypothesis	  where	  peripheral	  immunity	  response	  may	  play	  a	  
bigger	   detrimental	   role	   in	   perinatal	   hypoxia-­‐ischaemia	   encephalopathy	  
associated	   with	   endotoxin	   inflammation,	   rather	   than	   inflammatory	   cytokine	  
























CHAPTER	  5:	  THE	  ROLE	  OF	  ACQUIRED	  CELLULAR	  IMMUNE	  SYSTEM	  IN	  
LPS-­‐MEDIATED	  NEONATAL	  HYPOXIC-­‐ISCHAEMIC	  BRAIN	  DAMAGE	  
	  
Abstract	  
Bacterial	   endotoxin	   LPS	  and	  hypoxic-­‐ischaemic	   insults	  not	  only	   induce	  a	   robust	  
inflammatory	   response	   in	   the	   immature	   brain,	   but	   are	   also	   known	   to	   cause	  
strong	   activation	   of	   the	   immune	   system.	   The	   aim	   of	   this	   study	   was	   to	   use	  
athymic	  nude	  mice	  to	   investigate	  the	  role	  of	  T	  cell	   lymphocytes	   in	  a	  synergistic	  
model	  of	  neonatal	  inflammation	  and	  hypoxic-­‐ischaemic	  injury.	  
	  
P7	   offspring	   of	   homozygous	   Nude	   (no	   T	   cell)	   versus	   Nude	   heterozygotes	  
(controls)	  breeding	  underwent	  unilateral	  carotid	  occlusion	  followed	  by	  30min	  8%	  
O2	   exposure.	   12h	   prior,	   animals	   received	   a	   single	   intraperitoneal	   injection	   of	  
0.6µg/g	  LPS	  or	  saline	  as	  a	  control.	  Following	  48h	  survival	  post-­‐hypoxic-­‐ischaemic	  
insult,	  mice	  were	  sacrificed	  and	  their	  brains	  assessed	  histologically.	  
	  
LPS	  pre-­‐treatment	  resulted	  in	  significant	  microglial	  up	  regulation,	  neuronal	  injury	  
and	   infarct,	  DNA	   fragmentation	  and	  astrogliosis	   in	   the	  heterozygotes.	  This	   LPS-­‐
mediated	   effect	   was	   abolished	   in	   the	   Nude	   mice,	   where	   LPS	   sensitization	   to	  
subsequent	  hypoxic-­‐ischaemic	  insult	  was	  not	  present.	  These	  results	  suggest	  that	  
T	   cell	   function	   may	   be	   required	   for	   successful	   LPS-­‐mediated	   sensitization	   to	  
subsequent	  hypoxic-­‐ischaemic	  insult.	  
	  
	  
Heterozygous	  versus	  homozygous	  Nude	  breeding	  
As	   described	   in	   chapter	   2,	   genotyping	   of	   the	   recessive	   nude	   (nu)	   mutation	   is	  
rather	   difficult.	   Therefore,	  males	   homozygous	   for	   the	   nude	   gene	   (nu/nu)	  were	  
bred	  against	   females	  that	  were	  heterozygotes	  for	  this	  gene	  (nu/+).	  F1	  offspring	  
were	   either	   nu/+	   (controls)	   or	   nu/nu	   (mutants)	   in	   a	   50:50%	   ratio.	   All	   animals	  
used	   in	   this	   study	  were	   raised	   in	   the	   BALB/c	   background.	   As	   demonstrated	   in	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chapter	  3,	  this	  particular	  strain	  background	  is	  moderately	  sensitive	  to	  mild	  30min	  
hypoxic-­‐ischaemic	  insult	  alone	  or	  when	  combined	  with	  saline	  as	  a	  control.	  
	  
Figure	   5.1:	   Untyped	   athymic	   nude	  mice	   are	  macroscopically	  
differentiated	   at	   P9	   prior	   to	   transcardial	   perfusion.	   Mice	  
heterozygotes	   (nu/+)	   for	   the	   recessive	   nude	   mutation	   are	  
physically	   larger	   and	   covered	   with	   white	   fur,	   whereas	  






Nude	  phenotype	  abolishes	  LPS-­‐mediated	  brain	  infarction	  
Results	   on	   the	   effects	   of	   LPS-­‐sensitization	   in	   tissue	   infarction	   showed	   that	  
heterozygotes	  (controls)	  pre-­‐treated	  with	  saline	  (n=11)	  had	  moderate	  total	  tissue	  
infarction	   of	   31±8%.	   When	   compared	   to	   the	   nu/+	   LPS	   (n=14),	   there	   was	   a	  
significant	  increase	  in	  tissue	  infarction	  in	  the	  latter	  group	  to	  72±6%	  (p<1%).	  This	  
substantial	   cell	   death	   was	   evident	   in	   all	   six	   assessed	   forebrain	   regions.	   In	   the	  
dorsoparietal	   cortex	   there	  was	   an	   increase	   in	   ipsilateral	   brain	   tissue	   loss	   from	  
42±10%	   to	   82±7%	   (p<1%),	   pyriform	   cortex	   from	   26±11%	   to	   67±11%	   (p<1%),	  
hippocampus	   from	   26±11%	   to	   67±11%	   (5%),	   striatum	   from	   42±10%	   to	   82±7%	  
(p<5%),	   thalamus	   from	   5±65	   to	   48±11%	   (p<1%)	   and	   external	   capsule	   white	  
matter	  from	  30±8%	  to	  79±4%	  (p<0.1%).	  Nude	  animals	  treated	  with	  saline	  (n=11)	  
showed	  no	  difference	  when	  compared	  with	  heterozygotes	  saline	  group	  (38±11%,	  
31±8%	   respectively).	   Additionally,	   Nude	   LPS-­‐treated	   animals	   (n=13)	  
demonstrated	   no	   LPS-­‐sensitization	   to	   HI	   insult.	   When	   compared	   with	  
heterozygotes	   (nu/+)	   LPS-­‐administered	   animals,	   this	   lack	   of	   LPS-­‐mediated	  
sensitization	  was	   statistically	   significant,	   showing	  a	  decrease	   in	   total	   tissue	   loss	  
from	   72±6%	   to	   39±9%	   (p<5%).	   Individual	   assessment	   of	   the	   same	   ipsilateral	  
forebrain	   regions	   confirmed	   an	   abolition	   of	   LPS-­‐mediated	   sensitization,	   where	  
infarct	   volume	   in	   the	   dorsoparietal	   cortex	   decreased	   from	   82±7%	   to	   53±11%	  
(p<5%),	   pyriform	   cortex	   from	   67±11%	   to	   37±12%	   (p<5%),	   hippocampus	   from	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67±11%	   to	  37±12%	   (p<5%),	   striatum	   from	  82±7%	   to	  53±11%	   (p<5%),	   thalamus	  
from	   48±11%	   to	   17±10%	   (p<5%)	   and	   external	   capsule	   from	   79±4%	   to	   42±10%	  
(p<1%)	  (see	  figure	  5.2.A).	  
	  
Animals	  homozygous	  for	  the	  nude	  gene	  (nu/nu)	  do	  not	  show	  an	  increase	  in	  brain	  
injury	  when	  treated	  with	  LPS	  prior	  to	  HI-­‐injury	  
Assessment	  of	  brain	  injury	  using	  the	  combined	  injury	  score	  system	  described	  in	  
chapter	   2	   demonstrated	   that	   heterozygotes	   injected	   with	   saline	   had	  
considerable	   microglial	   activation	   and	   neuronal	   cell	   loss	   (3.8±1.0).	   This	   is	  
consisted	   to	  what	  was	  demonstrated	   in	   the	  assessment	  of	   the	  BALB/c	  strain	   in	  
chapter	   3	   (3.8±1.0).	   However,	   when	   compared	   with	   the	   nu/+	   LPS	   group,	   the	  
latter	   showed	  a	  maximal	   increase	   in	  combined	   injury	   score	  by	  a	   factor	  of	  2,	   to	  
7.6±0.3	   (p<1%).	   Similarly	   to	   what	   was	   shown	   in	   the	   infarct	   assessment,	   this	  
increase	  in	  brain	  damage	  also	  evident	  in	  most	  ipsilateral	  brain	  regions	  assessed,	  
with	   most	   regions	   almost	   reaching	   the	   maximal	   combined	   injury	   score	   of	   8:	  
dorsoparietal	  (3.9±1.1	  to	  7.9±0.1,	  p<1%)	  and	  pyriform	  cortex	  (2.7±1.1	  to	  7.2±0.5,	  
p<1%),	   hippocampus	   (3.3±1.0	   to	   7.9±0.1,	   p<1%),	   striatum	   (4.6±0.9	   to	   7.8±0.2,	  
p<5%)	   and	   thalamus	   (2.2±1.0	   to	   6.7±0.7,	   p<1%).	   Although	   not	   statistically	  
significant,	  there	  was	  also	  a	  visible	  trend	  in	  increased	  brain	  injury	  in	  the	  external	  
capsule	  of	  nu/+	  LPS	  from	  6.1±0.8	  (nu/+	  saline)	  to	  8.0±0.0.	  Again,	  observation	  of	  
the	  Nude	  saline	  and	  Nude	  LPS	  groups	  showed	  no	  difference	  in	  alphaM	  activation	  
and	  Nissl	  cell	  death	  when	  compared	  to	  each	  other	  and	  to	  nu/+	  saline	   (4.0±1.1,	  
4.5±1.1	  and	  3.8±1.0	  respectively).	  Consequently,	  comparison	  between	  both	  LPS	  
groups	  –	  nu/+	  and	  nu/nu	  –	  demonstrated	  once	  again	  that	  not	  only	  athymic	  nude	  
animals	  are	  non-­‐responsive	  to	  LPS	  sensitization,	  but	  also,	  this	  lack	  of	  sensitization	  
is	   statistically	   significant	   when	   compared	   to	   nu/+	   LPS	   littermates	   in	   terms	   of	  
brain	   injury	   (4.5±1.1	   vs.	   7.6±0.3,	   p<5%).	   Furthermore,	   individual	   scoring	   of	   the	  
assessed	  forebrain	  regions	  showed	  that	  this	  decrease	  was	  almost	  by	  a	  factor	  of	  
2.	  Dorsoparietal	  cortex	  of	  nu/nu	  LPS	  animals	  showed	  a	  decrease	   in	   injury	  score	  
to	   4.9±1.1	   (p<5%),	   pyriform	   cortex	   to	   3.8±1.1	   (p<5%),	   hippocampus	   to	   4.4±1.1	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(p<1%),	   striatum	   to	   5.0±1.0	   (p<5%),	   thalamus	   to	   3.9±1.0	   (p<5%)	   and	   external	  
capsule	  to	  5.2±1.0	  (p<5%)	  (see	  figure	  5.2.B).	  
	  
Nude	   mice	   have	   considerably	   less	   DNA	   fragmentation	   than	   heterozygotes	  
littermates	  
Quantification	  of	  TUNEL+	  cells	  showed	  minimal	  DNA	  fragmentation	  cell	  death	  in	  
the	   heterozygote	   saline,	  Nude	   saline	   and	  Nude	   LPS	   groups	   (9.5±5.2,	   27.0±13.8	  
and	  38.7±16.1	  respectively).	  Conversely,	  heterozygote	  animals	   treated	  with	  LPS	  
prior	   to	   HI	   insult	   demonstrated	   a	   significant	   increase	   in	   TUNEL+	   cells	  
(189.6±48.7)	  not	  only	  when	  compared	  to	  heterozygotes	  saline	  controls	  (p<0.1%),	  
but	   also	   when	   compared	   to	   Nude	   LPS	   animals	   (p<0.1%).	   Furthermore,	   this	  
substantial	   increase	   in	  DNA	   fragmentation-­‐associated	  cell	  death	  was	   significant	  
in	   all	   assessed	   forebrain	   regions	   of	   the	   ipsilateral	   brain	   hemisphere.	   The	  
dorsoparietal	   cortex	   of	   nu/+	   LPS	   animals	   had	   an	   average	   TNUEL+	   cell	   count	   of	  
40.1±92.9	  whereas	  nu/+	  saline	  had	  an	  average	  count	  of	  46.3±	  23.8	  (p<0.1%)	  and	  
nu/nu	   LPS	   animals	   114.4±38.1	   (p<1%).	   In	   the	   pyriform	   cortex	   average	   TUNEL+	  
counts	  of	  148.6±38.9	  were	  reduced	  to	  1.2±1.0	  and	  13.5±9.7	  (0.1%),	  hippocampus	  
from	  142±28.7	   to	   5.9±4.7	   and	   14.8±8.4	   (p<0.1%),	   striatum	   from	  180.6±46.1	   to	  
0.5±0.4	  and	  68.2±32.8	  (p<1%,	  p<5%),	  thalamus	  from	  172.6±52.4	  to	  0.2±0.1	  and	  
0.0±0.0	   (p<0.1%),	  and	  external	  capsule	   from	  91.7±33.4	  to	  2.8±1.3	  and	  21.1±7.8	  
(p<1%,	  p<5%)	  respectively	  (see	  figure	  5.2.C).	  
	  
GFAP	  immunoreactivity	  is	  significantly	  reduced	  in	  nu/nu	  LPS	  treated	  animals	  
Assessment	  of	  astrocytic	  activation	  demonstrated	  once	  again	  that	  LPS	  treatment	  
does	   not	   increase	   GFAP	   immunoreactivity	   in	   athymic	   nude	   mice.	   Optical	  
luminosity	  values	   for	  nu/nu	  LPS	  animals	   (53.5±7.1)	  showed	  no	  difference	  when	  
compared	   to	   nu/+	   saline	   (58.2±6.6)	   and	   nu/nu	   saline	   (55.8±8.3)	   animals.	  
However,	   GFAP	   synthesis	   was	   consistently	   and	   significantly	   higher	   in	   the	   nu/+	  
LPS	   group	   (91.0±9.3)	   when	   compared	   to	   nu/+	   saline	   controls	   (p<1%)	   and	   to	  
nu/nu	   LPS	   (p<0.1%)	   littermates.	   Closer	   observation	   of	   the	   individual	   forebrain	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regions	  showed	  the	  same	  significant	  up	  regulation	  in	  astrogliosis	  in	  the	  nu/+	  LPS	  
group	  when	  compared	  to	  nu/+	  saline	  and	  nu/nu	  LPS	  respectively.	  Assessment	  of	  
the	   dorsoparietal	   cortex	   showed	   a	   significant	   increase	   in	   astrocyte	  
immunoreactivity	   from	   53.9±6.5	   in	   the	   nu/+	   saline	   and	   from	   43.9±6.1	   in	   the	  
nu/nu	  LPS	  animals	  to	  94.8±10.9	  in	  the	  nu/+	  LPS	  group	  (p<0.1%).	  In	  the	  pyriform	  
cortex	   from	   51.3±8.0	   and	   47.4±6.7	   to	   82.2±11.7	   (p<5%),	   hippocampus	   from	  
60.4±5.9	  and	  64.0±5.7	  to	  97.5±7.0	  (p<1%),	  striatum	  from	  68.6±5.8	  and	  58.6±7.2	  
to	  90.0±7.7	  (p<5%	  and	  p<1%),	  thalamus	  from	  35.9±7.1	  and	  41.0±7.9	  to	  70.9±11.3	  
(p<5%),	   and	   external	   capsule	   from	   78.8±6.4	   and	   66.2±8.8	   to	   110.7±7.4	   (p<5%,	  





Figure	  5.2:	  Effects	  of	  the	  nude	  gene	  (nu/nu)	  on	  neonatal	  hypoxic-­‐ischemic	  brain	  injury	  after	  pre-­‐
exposure	  to	  0.6µg/g	  LPS	  endotoxin	  (LPS).	  Animals	  injected	  with	  saline	  (SAL)	  served	  as	  controls.	  A:	  
Infarct	   volume	   assessment	   of	   individual	   forebrain	   regions	   and	   total	   ipsilateral	   hemisphere	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infarction	   as	   percent	   of	   contralateral	   hemisphere	   showed	   that	   LPS-­‐mediated	   tissue	   loss	   was	  
abolished	   in	   the	   nu/nu	   animals.	   B:	   Brain	   injury	   assessment	   of	   nu/nu	   mice	   revealed	   again	   an	  
abolishment	  of	  LPS-­‐mediated	   increase	   in	   inflammatory	  response	  and	  neuronal	  cell	   loss.	  C:	  DNA	  
fragmentation	  cell	  death	  assessment	  using	  TUNEL+	  cell	  quantification	  demonstrated	  a	  significant	  
increase	   in	   TUNEL+	   cells	   in	   the	   LPS	  heterozygotes.	  However,	   LPS	  pre-­‐treatment	   in	   the	   athymic	  
nude	   mice	   failed	   to	   elicit	   this	   type	   of	   cell	   death	   beyond	   the	   baseline	   hypoxic-­‐ischemic	   saline	  
response.	  D:	  Astroglial	   immunoreactivity	   assessment	   using	   optical	   luminosity	   values	   showed	   a	  
significant	   increase	   in	   GFAP	   synthesis	   in	   the	   LPS	   heterozygotes.	   This	   LPS-­‐mediated	   effect	   was	  
absent	   in	   the	   LPS	  nu/nu	  mice.	   Contralateral	   hemisphere	  not	   shown.	  *	  p<5%	   in	  Mann	  Whitney	  
test	  for	  the	  LPS-­‐treated	  wild	  type	  vs.	  knockout	  groups,	  n=11	  for	  HET	  SAL,	  n=14	  for	  HET	  LPS,	  n=11	  
for	  NUDE	  SAL	  and	  n=13	   for	  NUDE	  LPS.	  Abbreviations:	  HET	  –	  heterozygotes,	  CTX-­‐	  dorsoparietal	  






The	   results	   obtained	   in	   the	   cytokines	   chapter	   (chapter	   4)	   of	   the	   current	   study	  
demonstrated	  moderate	  and	  differing	  roles	  for	  the	  TNF	  cluster	  members,	  TNFα,	  
LTα	  and	  LTβ,	  thus	  suggesting	  that	  endotoxin-­‐mediated	  sensitization	  seen	  on	  the	  
TNF	  cluster	  study	  (Kendall	  et	  al.,	  2011b)	  was	  not	  a	  result	  of	  a	  single	  action	  of	  one	  
of	   these	   three	   cytokines.	  Consequently,	  we	  were	  unable	   to	  answer,	   so	   far,	   the	  
original	  question	  of	  this	  study:	  Which,	  or	  combination	  of,	  these	  three	  cytokines	  is	  
responsible	  for	  mediating	  the	  LPS	  sensitization	  to	  subsequent	  neonatal	  hypoxia-­‐
ischaemia?	  	  
	  
Interestingly,	  studies	   looking	  at	  global	  deletion	  of	  these	  genes	  have	  also	  shown	  
that	   global	   deletion	   of	   TNFα,	   LTα	   or	   LTβ	   produce	   a	   defect	   in	   the	   acquired	  
immune	  system	  (Kuprash	  et	  al.,	  2002).	  Furthermore,	  deletion	  of	   the	  entire	  TNF	  
gene	  cluster	  causes	  more	  severe	  phenotypic	  defects,	  which	  appeared	  to	  be	  both	  
a	   combination	   and	   quantitative	   sum	   of	   the	   individual	   TNF	   cluster	   members’	  
defects,	   indicating	   these	  cytokines	  play	  an	   important	   role	   in	   the	   immunological	  
development	   (Kuprash	   et	   al.,	   2002).	   Therefore,	   in	   this	   study	   we	   wanted	   to	  
investigate	   the	   role	  of	   the	  acquired	   immune	  system	   in	   this	  combined	  model	  of	  




The	   athymic	   nude	   mouse	   was	   first	   described	   by	   Flanagan	   in	   1966,	   and	   was	  
characterized	  macroscopically	  by	  a	  lack	  of	  fur,	  increased	  postnatal	  mortality	  and	  
general	   susceptibility	   to	   systemic	   toxoplasmosis	   (Flanagan,	   1966).	   It	   was	   later	  
found	   that	   that	   homozygous	   nude	  mice	   (nu/nu)	   also	   lack	   a	   functional	   thymus	  
(Pantelouris,	  1968),	  thus	  leading	  to	  a	  profound	  T	  cell	  deficiency,	  with	  a	  severely	  
compromised	  cell-­‐mediated	   immune	  response	  and	  humoral	   immunity	   (Romano	  
et	   al.,	   2011).	  However,	   disturbed	  development	  of	   hair	   follicles	   and	   thymus	  are	  
independent	  phenotypic	  effects	  of	  nude	  mice,	   indicating	  a	  pleiotropic	  mutation	  
(Eaton,	   1976;	   Nehls	   et	   al.,	   1996).	   	   The	   ‘nude’	   phenotype	   is	   a	   spontaneous	  
autosomal	   recessive	   mutation	   of	   the	   Foxn1	   transcription	   factor	   gene	   of	   the	  
conserved	   winged-­‐helix	   domain	   family,	   and	   Foxn1	   gene	   is	   known	   to	   regulate	  
keratin	   gene	   expression	   (Nehls	   et	   al.,	   1994).	   Foxn1	   transcription	   in	   mammals	  
occurs	  mainly	  in	  the	  skin	  and	  thymus.	  However,	  there	  have	  been	  some	  cases	  of	  
expression	  in	  developing	  nails,	  tongue,	  teeth,	  palate	  and	  nasal	  passages	  (Nehls	  et	  
al.,	   1996;	   Lee	   et	   al.,	   1999).	   Foxn1	   protein	   is	   expressed	   exclusively	   in	   epithelial	  
cells,	   suggesting	   that	   Foxn1	   activity	   is	   specific	   to	   these	   cells,	   including	   thymus	  
epithelial	  cells	  (Brisette	  et	  al.,	  1996).	  Therefore,	  functional	  loss	  of	  Foxn1	  leads	  to	  
athymia	  where	  thymic	  epithelial	  cells	  cannot	  mature	  and	  attract	  hematopoietic	  
precursor	  cells.	  T	  cell	  development	  is	  dependent	  on	  these	  two	  events.	  However,	  
the	   exact	   signaling	   pathways	   that	   regulate	   Foxn1	   expression	   and	   the	  
microenvironment	   necessary	   for	   T	   cell	   development	   still	   remain	   unknown	  
(Balciunaite	  et	  al.,	  2002).	  
	  
Athymic	  nude	  mice	  do	  not	  respond	  to	  LPS	  sensitization	  prior	  to	  neonatal	  hypoxic-­‐
ischaemic	  insult	  
In	  this	  study,	  LPS	  treatment	  resulted	  in	  a	  significant	  increase	  in	  tissue	  infarction,	  
brain	   injury,	   DNA	   fragmentation-­‐associated	   cell	   death	   and	   astrogliosis	   in	   the	  
heterozygotes	   littermates	   (nu/+)	   of	   homozygous	   nude	  mice	   (nu/nu).	   However,	  
nude	   phenotype	   abolished	   the	   LPS-­‐sensitization	   effect	   to	   subsequent	   hypoxic-­‐




Both	   in	   vitro,	   in	   vivo	   and	   clinical	   studies	  have	  demonstrated	  up-­‐regulation	  of	  T	  
cell	   activation	   following	  bacterial	   infection.	   Vogel	   et	   al.,	   1983	  were	   the	   first	   to	  
suggest	   that	   endotoxin	   can	   stimulate	   T	   cells	   directly.	   In	   this	   study,	   a	   cloned	  
cytotoxic	  T	  cell	  line	  (IL-­‐2-­‐dependent	  CT	  6)	  which	  was	  free	  of	  other	  contaminating	  
lymphoid	   cell	   types,	   such	   as	   B	   lymphocytes	   and	  macrophage-­‐derived	   products	  
was	  used.	  The	  CT	  6	  cell	  line	  was	  shown	  to	  respond	  proliferative	  to	  LPS,	  and	  this	  
response	  was	  optimal	  at	  48h	  post-­‐stimulation,	   thus	   suggesting	   the	  presence	  of	  
an	  endotoxin-­‐responsive	  T	  cell	  population.	  (Vogel	  et	  al.,	  1983).	  In	  a	  mouse	  study,	  
LPS	  intravenous	  administration	  was	  assessed	  three	  days	  later	  in	  spleen	  tissue	  of	  
wild	  type	  C57BL/6	  mice.	  Results	  showed	  a	  substantial	  increase	  in	  CD8+	  cells,	  even	  
at	  minimal	  dose	  of	  10ng	  (Tough	  et	  al.,	  1997).	  A	  separate	  study	  using	  bacterial	  L.	  
monocytogenes	  as	  a	  means	  of	  infection,	  showed	  a	  substantial	  increase	  in	  T	  cells	  
within	  24h.	  Furthermore,	  this	  surge	  in	  T	  cell	  activation	  was	  not	  altered	  by	  use	  of	  
different	   concentrations	   of	   live	   L.	   monocytogenes	   (1,000	   to	   25,000),	   thus	  
indicating	   that	   even	   minimal	   doses	   of	   a	   pathogen	   can	   lead	   to	   an	   immediate	  
substantial	  activation	  and	  proliferation	  of	  T	  cells	   (Mercado	  et	  al.,	  2013).	   	  Blood	  
samples	   taken	   from	   patients	   with	   localized	   bacterial	   soft	   tissue	   infections	  
showed	  an	  increase	  in	  the	  presence	  of	  CD8+,	  and	  to	  a	  smaller	  extent,	  also	  CD4+	  
in	  the	  site	  of	  infection	  (Wagner	  et	  al.,	  2008).	  
	  
Furthermore,	   a	   study	   looking	   at	   acute	   hepatotoxicity	   using	   Pseudomonas	  
exotoxin	  (exotoxin	  A)	  showed	  that	  athymic	  BALB/c	  nu/nu	  mice	  –	  the	  same	  strain	  
as	   the	   one	   used	   in	   the	   current	   study	   –	  were	   resistant	   to	   endotoxin	   A-­‐induced	  
liver	   damage.	   Additionally	   there	   was	   a	   clear	   reduction	   in	   circulating	   cytokine	  
levels,	   including	   TNFα,	   a	   known	   mediator	   of	   hepatocellular	   apoptosis.	   BALB/c	  
control	   animals	   demonstrated	   TNFα	   to	   be	   locally	   produced	  within	   the	   liver	   by	  
Kupffer	  cells	  within	  3h	  after	  exotoxin	  A	  administration,	  and	  in	  the	  cytoplasm	  12h	  
after	  administration.	  These	  findings	  suggest	  that	  T	  cells	  play	  an	  essential	  role	  in	  
TNFα	   production	   by	   liver	   macrophages,	   as	   well	   as	   having	   an	   involvement	   in	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exotoxin	   A-­‐induced	   hepatotoxicity.	   (Schümann	   et	   al.,	   1998).	   These	   results	  
suggest	   a	   relevant	   sensitization	  mechanism	  by	  which	   T	   cells	   affect	   directly	   the	  
production	  of	  cytotoxic	  TNFα,	  other	  than	   its	  production	  by	  direct	  LPS-­‐mediated	  
stimulation	  of	  monocyte/macrophages,	  as	  seen	  on	  the	  MLys	  results	  (chapter	  4),	  
where	  there	  was	  a	  partial	  neuroprotective	  effect	  in	  TNFα-­‐deficient	  myeloid	  cells.	  
However,	   it	   is	   important	   to	   note	   that	   the	   current	   study	   did	   not	   look	   at	   TNFα	  
levels	   in	   the	   liver,	  as	  well	  as	  within	   the	  brain	  of	  nude	  mice	   in	  order	   to	  confirm	  
whether	  the	  effect	  seen	  in	  the	  Schümann	  et	  al.	  study	  is	  applicable	  in	  a	  neonatal	  
mouse	  model	  of	  combined	  inflammation	  and	  hypoxia-­‐ischaemia	  injury.	  
	  
T	   cell	   function	   may	   be	   required	   for	   LPS-­‐mediated	   sensitization	   to	   neonatal	  
hypoxic-­‐ischaemic	  insult	  
The	  nude	  phenotype	  is	  caused	  by	  a	  defect	  in	  the	  Foxn1	  gene,	  which	  has	  shown	  to	  
be	  essential	   for	   thymic	   epithelial	   cell	   to	  mature	   and	   support	   subsequent	   T	   cell	  
generation	   (Zhang	   et	   al.,	   2012).	   Additionally,	   LPS	   administration	   leads	   to	   T	   cell	  
activation	  and	  proliferation.	  Thus,	  the	  prevention	  of	  LPS-­‐sensitization	  seen	  in	  the	  
nude	  mice	   in	  this	  study	  could	  be	  caused	  by	  the	  absence	  of	  mature	  T	  cells.	  This	  
might	   suggest	   that	   LPS-­‐mediated	   sensitization	   of	   the	   neonatal	   brain	   to	  
subsequent	  hypoxic-­‐ischaemic	  insult	  requires	  T	  cell	  function.	  This	  could	  provide	  a	  
link	  to	  the	  results	  seen	  by	  Kendall	  et	  al.,	   looking	  at	  TNF	  cluster	  knockouts.	  Thus	  
suggesting	  that	  it	  is	  the	  structural	  defects	  in	  the	  peripheral	  immune	  system	  that	  
are	  causal	  to	  the	  lack	  of	  LPS-­‐mediated	  sensitization	  in	  the	  TNF	  cluster-­‐/-­‐	  animals,	  
rather	  than	  cytokine	  function.	  
	  
However,	   alternative	   explanations	   are	   possible	   –	   for	   example	   Foxn1	   might	   be	  
important	   for	   some	   aspect	   of	   LPS	   signal	   transduction	   directly	   involved	   in	  
endotoxin-­‐sensitization.	   Unfortunately,	   the	   precise	   target	   genes	   regulated	   by	  
Foxn1	   still	   remain	   largely	   unknown	   (Zhang	   et	   al.,	   2012).	   Furthermore,	   it	   is	  
important	   to	   note	   that	   the	   acquired	   cellular	   immune	   system	   is	   comprised	   of	  
other	   cells	   as	   well,	   such	   as	   B	   cells	   and	   NK	   cells,	   and	   that	   their	   role	   in	   the	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combined	  endotoxin	  and	  hypoxic-­‐ischaemic	  insult	  also	  need	  to	  be	  investigated	  in	  
order	  to	  further	  understand	  whether	  the	  Foxn1	  mutation	  is	  interfering	  with	  LPS-­‐
mediated	  sensitization	  through	  its	  immune	  defect,	  or	  if	  other	  factors	  could	  be	  at	  
play.	  
	  
Studies	   have	   looked	   at	   combined	   T	   and	   B	   cell	   deficiency	   using	   either	   Rag1	   or	  
Rag2	   recombination	   activation	   genes.	   These	   genes	   are	   involved	   in	   the	  
recognition	   and	   cleavage	   of	   signal	   specific	   sequences	   required	   for	   somatic	  
rearrangement	  of	  T	  cell	  receptors	  and	  immunoglobulin	  (Mombaerts	  et	  al.,	  1992;	  
Shinkai	  et	  al.,	  1992).	  A	  study	  looking	  at	  transient	  ischaemic	  stroke	  in	  adult	  mice	  
has	   shown	   that	   Rag1-­‐/-­‐,	   CD4+	   T	   cell-­‐/-­‐,	   CD8+	   T	   cell-­‐/-­‐	   and	   IFN-­‐γ-­‐/-­‐	   animals	  
demonstrated	   substantial	   reduction	   in	   ischaemia/reperfusion-­‐induced	   platelet	  
and	   leukocyte	   adhesion	   compared	   to	  wild	   type	   controls.	   Additionally,	   cerebral	  
infarction	  was	   also	   reduced	   in	   the	  Rag1	   knockout	  mice.	  When	  Rag1-­‐/-­‐	   animals	  
were	   reconstituted	  with	  wild	   type	  spleenocytes,	   this	  protective	  effect	  was	   lost.	  
Reconstitution	   with	   IFN-­‐γ-­‐/-­‐	   splenocytes	   led	   only	   to	   a	   partial	   improvement,	  
indicating	   that	   T	   lymphocytes	   may	   only	   be	   a	   small	   source	   for	   this	   cytokine.	  
Furthermore,	  mature	  B	  cell	  negative	  animals	  did	  not	  show	  an	  altered	  response	  to	  
ischaemic	   injury	  when	   compared	   to	  wild	   types.	   This	   study	  highly	   suggests	   that	  
CD4+	  together	  with	  CD8+	  T	  lymphocytes,	  and	  not	  B	  cells,	  play	  a	  relevant	  role	  in	  
inflammation	   and	   brain	   injury	   follwing	   an	   ischaemic	   episode	   	   (Yilmaz	   et	   al.,	  
2006).	   This	   study	   corroborates	   the	   results	   found	   in	   the	   current	   study,	   where	  
athymic	  nude	  mice	  demonstarted	  a	  lack	  of	  LPS-­‐mediated	  sensitization,	  therefore,	  
it	  is	  highly	  possible	  that	  Foxn1	  defect	  in	  the	  nude	  mice	  is	  in	  fact	  acting	  through	  its	  
T	  cell	  immune	  defect.	  
	  
Interestingly,	   there	   have	   been	   studies	   suggesting	   that	   nude	  mice	  may	  have	   an	  
elevated	   peritoneal	   macrophage	   activity.	   These	   macrophages	   have	   been	  
associated	   with	   releasing	   oxidising	   agents	   such	   as	   hydrogen	   peroxide	   and	  
superoxide	   anions	   following	   a	   burst	   of	   oxidative	   metabolism.	   Peritoneal	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macrophages	  from	  nude	  mice	  have	  shown	  a	  significantly	  higher	  release	  of	  these	  
agents	   following	   exposure	   to	   phorbol	   myristate	   acetate,	   thus	   confering	   a	  
resistance	  to	  L.	  	  monocytogenesis	  not	  seen	  in	  euthymic	  mice	  (Sharp	  and	  Colston,	  
1984).	  Also,	  T	  cell-­‐deprived	  C57BL/6	  mice	  have	  shown	  an	  increase	  in	  macrophage	  
activation	   following	  M.	   lepraemurium	   infection	   (Brett	   and	  Butler,	   1988).	   These	  
findings	  suggest	  that	  athymic	  nude	  mice	  might	  be	  either	  compensating	  for	  their	  
immunodefects	   by	   increased	   phagocytic	   activity	   and	   therefore	   systemic	  
macrophage	   activation	   may	   occur	   via	   T	   cell-­‐inidependent	   besides	   dependent	  
mechanims,	   or	   that	   peritoneal	   macrophage	   acitivity	   is	   suppressed	   in	   the	  
presence	  of	  T	  cells.	  Either	  hypothesis	  highlights	  a	  beneficial	  macrophage	  activity	  
effect	  that	  is	  either	  not	  present,	  or	  suppressed	  in	  the	  presence	  of	  mature	  T	  cells.	  
These	  findings	  suggest	  a	  potential	  beneficial	  effect	  for	  suppression	  of	  these	  cells,	  
which	  once	  again	   indicates	  that	  the	  beneficial	  effect	  seen	   in	  the	  current	  results	  
may	  be	  a	  result	  of	  lack	  of	  T	  cell	  activity.	  
	  
However,	  T	  cells	  are	  also	  an	   important	  component	  of	   the	   immune	  system.	   In	  a	  
mouse	  study	  of	  Coxiella	  burnetii	  infection,	  SCID	  (no	  T	  and	  B	  cells),	  SCIDbg	  (no	  T,	  B	  
and	  NK	  cells),	  nude	  (no	  T	  cells),	  muMT	  (no	  B	  cells),	  bg	  (no	  NK	  cells),	  TNFα-­‐/-­‐	  and	  
IFN-­‐γ-­‐/-­‐	  mice	  were	  infected	  with	  Nine	  Mile	  phase	  I	  (NM	  I)	  highly	  virulent	  bacteria	  
conatining	   a	   complete	   LPS,	   or	   avirulent	   NM	   II.	   This	   study	   showed	   that	   SCID,	  
SCIDbg,	  nude	  and	  IFN-­‐γ-­‐/-­‐	  animals	  showed	  the	  highest	  susceptibility	  to	  to	  NM	  I	  
infection.	  Furthermore,	  SCID,	  SCIDbg	  and	  nude	  mice	  showed	  the	  slowest	  disease	  
prgression.	   Additionally,	   muMT	   and	   bg	   mice	   mice	   did	   not	   demonstrate	   a	  
discernible	  difference	  in	   in	  bacterial	  clearance	  or	  disease	  progression,	  however,	  
there	  was	  a	  visible	   increase	   in	  severity	  of	  histopathological	   changes.	  This	   study	  
has	  shown	  an	  important	  role	  for	  T	  cell	  clearance	  of	  C.	  	  burnetii,	  whereas	  B	  cells	  





This	   study	   has	   demonstrated	   a	   robust	   LPS-­‐mediated	   sensitization	   in	   the	  
heterozygote	  littermates	  of	  athymic	  nude	  mice.	  Conversely,	  nu/nu	  animals	  failed	  
to	   respond	   to	   LPS-­‐sensitization.	   These	   results	   strongly	   suggest	   that	   the	   TNF	  
cluster	  abolishment	  of	  LPS	  sensitization	  seen	  by	  Kendall	  et	  al.,	  2011b,	  may	  be	  a	  
result	  of	   its	  severe	  effect	  on	  the	  structure	  of	  peripheral	   immune	  system,	  which	  
leads	   to	   a	   lack	   of	  mature	   T	   cells,	   rather	   than	   being	   a	   result	   of	   direct	   cytokine	  
function.	   These	   results	   are	   very	   novel	   and	   suggest	   that	  manipulation	   of	   T	   cell	  
function	   may	   be	   a	   useful	   strategy	   to	   block	   LPS-­‐mediated	   neonatal	   hypoxic-­‐
ischaemic	   injury.	   This	   novel	   hypothesis	   is	   highly	   attractive	   as	   T	   cell	  
immunosuppressants	   are	   already	   pharmacologically	   available.	   However,	   it	   is	  
important	   to	   note	   that	   T	   cells	   have	   an	   important	   physiological	   role	   in	   cell-­‐
mediated	   immunity.	   Therefore,	   inhibition	   of	   T	   cell	   activity	   should	   be	   carefully	  
monitored.	  Furthermore,	  it	  is	  still	  possible	  that	  the	  protective	  effect	  seen	  in	  this	  
study	   using	   nude	   mice	   may	   be	   caused	   by	   a	   Foxn1	   effect	   direct	   on	   LPS	   signal	  
transduction	  that	  is	  irrespective	  of	  T	  cell	  function,	  and	  therefore	  one	  should	  not	  
exclude	   further	   characterization	   of	   this	   combined	   model	   of	   inflammation	   and	  
hypoxia-­‐ischaemia	   injury	   by	   looking	   at	   the	   other	   components	   of	   the	   acquired	  














CHAPTER	  6:	  GENERAL	  DISCUSSION	  
	  
Infection/inflammation	   and	   hypoxic-­‐ischaemic	   insult	   are	   widely	   accepted	   as	  
having	   a	   devastating	   impact	   on	   the	   neonatal	   brain.	   These	   types	   of	   injury	   can	  
cause	   severe	   brain	   damage	   alone,	   but	   when	   combined,	   work	   in	   a	   synergistic	  
manner	   augmenting	   significantly	   and	   irreversibly	   subsequent	   perinatal	   brain	  
damage,	   thus	   greatly	   enhancing	   the	   risk	   of	   cerebral	   palsy	   and/or	   other	  
neurological	   deficits	   such	   as	   cognitive	   impairment,	   schizophrenia	   and	   autism	  
(Bax	   et	   al.,	   2005).	   Despite	   continuous	   advance	   in	   science,	   the	   mechanisms	  
involved	   in	   this	   synergistic	   form	   of	   brain	   damage	   remain	   largely	   unknown.	   To	  
better	  understand	  detrimental	   factors	   leading	   to	   impairment	   to	   the	  developing	  
brain,	  clinicians	  and	  scientists	  have	  not	  only	  relied	  on	  retrospective	  data,	  but	  also	  
on	  both	  large	  and	  small	  experimental	  animal	  models.	  Classic	  studies	  by	  Dobbing	  
and	   Sands,	   1979,	   and	   later	   Clancy	   et	   al.,	   2001,	   have	   further	   established	   the	  
relevance	   of	   using	   neonatal	   animal	   models	   to	   understand	   perinatal	   brain	  
damage.	  Dobbing	  and	  Sands	  have	  demonstrated	  the	  correlation	  of	  brain	  growth	  
across	   species	   (Dobbing	   and	   Sands,	   1979),	   whereas	   Clancy	   et	   al.	   have	   used	  
multivariate	   analysis	   from	   histological	   and	   functional	   maturity	   from	   multiple	  
brain	   regions	   and	   neural	   systems	   across	   multiple	   mammalian	   species	   and	  
provided	   comparison	   to	   both	   prenatal	   and	   early	   postnatal	   human	   brain	  
development.	   These	   findings	   have	   given	   credit	   to	   the	   continual	   use	   of	   the	   P7	  
mouse	   model	   of	   hypoxic-­‐ischaemic	   insult	   as	   they	   have	   demonstrated	   the	   P7	  
mouse	   to	   have	   an	   overall	   brain	   maturity	   equivalent	   to	   that	   of	   an	   early	   third	  
trimester	  human	  baby	  (Clancy	  et	  al.,	  2001;	  Clancy	  et	  al.,	  2007).	  Furthermore,	  the	  
availability	  of	   transgenic	  mice	  models	   represents	  a	  promising	   furthering	  step	   in	  
elucidating	  pathways	  and	  mechanisms	  of	  brain	  injury.	  Therefore,	  the	  use	  of	  wild	  
type	   and	   transgenic	   P7	  mouse	  model	   of	   combined	   infection/inflammation	   and	  
hypoxic-­‐ischaemic	  insult	  could	  provide	  invaluable	  new	  knowledge	  in	  attempting	  




However,	   despite	   the	   fact	   that	   the	   mouse	   is	   the	   most	   commonly	   used	  
mammalian	   model	   due	   to	   its	   close	   genetic	   relationship	   to	   humans	   and	  
availability	   for	   genome	   modification,	   the	   introduction	   of	   different	   mouse	  
backgrounds	  and	  genetically	  modified	  animals	  has	  also	  given	  rise	  to	  variability	  in	  
response	  to	  either	   insult	  or	   treatment	   (Beckmann,	  2000;	  Anisman	  et	  al.,	  2008).	  
As	   the	   current	   study	   required	  multiple	   genetically	  modified	   strains	   in	   order	   to	  
address	  the	  original	  question	  set	  out	  by	  this	  project	  –	  to	  determine	  which	  of	  the	  
three	   cytokines,	   TNFα,	   LTα	   and	   LTβ	   is	   responsible	   for	   the	   endotoxin-­‐mediated	  
sensitization	  seen	   in	  the	  TNF	  cluster	  study	  by	  Kendall	  et	  al.	  –	  and	  knowing	  that	  
there	  is	  a	  strain-­‐related	  response	  to	  neonatal	  hypoxia-­‐ischaemia	  insult	  (Sheldon	  
et	   al.,	   1998),	   we	   decided	   to	   first	   investigate	   the	   response	   to	   combined	  
inflammation	   and	   neonatal	   hypoxia-­‐ischaemia	   in	   five	   commonly	   used	  
background	  strains:	  129SVJ,	  C57BL/6,	  BALB/c,	  CD1	  and	  FVB.	  
	  
The	  results	  in	  this	  study	  are	  in	  line	  not	  only	  with	  Sheldon	  et	  al,	  showing	  a	  greater	  
sensitivity	   fro	   the	   CD1	   strain,	   followed	   by	   C57BL/6	   and	   129SVJ,	   they	   have	  
additionally	   shown	   that	  BALB/c	  has	   a	  moderate	   response	   to	  hypoxic-­‐ischaemic	  
insult,	  and	  FVB	  appears	  to	  be	  the	  most	  sensitive	  of	  all	  five	  strains.	  Addition	  of	  LPS	  
bacterial	   endotoxin	   pre-­‐treatment	   successfully	   sensitized	   all	   five	   strains,	  
revealing	  a	  substantial	  increase	  in	  tissue	  infarction,	  inflammation	  and	  cell	  death	  
in	   the	   already	   hypoxic-­‐ischaemic	   sensitive	   BALB/c,	   CD1	   and	   FVB	   strains.	  
Furthermore,	   both	   129SVJ	   and	   C57BL/6	   strains,	   which	   appeared	   resistant	   and	  
moderately	   resistant	   respectively,	   to	   30min	   hypoxic-­‐ischaemic	   insult,	   also	  
showed	   an	   extensive	   increase	   in	   damage	   in	   the	   presence	   of	   LPS-­‐induced	  
inflammation	   12h	   prior	   to	   hypoxic-­‐ischaemic	   surgery.	   This	   is	   a	   clear	   indication	  
that	  despite	  known	  anatomical	  and	  immunological	  variations	  between	  different	  
strains	  (Beckmann	  2000;	  Hoover-­‐Plow	  et	  al.,	  2008),	  immunodulatory	  role	  of	  LPS	  
is	  still	  present	  within	  all	  five	  strains.	  However,	  it	  is	  important	  to	  note	  that	  despite	  
successful	   LPS-­‐mediated	   sensitization,	   there	   is	   still	   noticable	   variation	   in	   brain	  




Interestingly,	  this	  study	  has	  shown	  a	  novel	  effect	  for	  the	  use	  of	  saline	  treatment	  
as	  a	  control,	  as	  some	  of	  the	  strains	  revealed	  a	  saline-­‐associated	  stress.	  FVB	  mice	  
demonstrated	  a	  saline-­‐associated	   increase	   in	  microglial	  activation	  and	  neuronal	  
cell	   loss.	   C57BL/6	   mice	   showed	   an	   increase	   in	   astrogliosis	   upon	   saline	  
administration	  12h	  prior	  to	  hypoxia-­‐ischaemia	  injury;	  this	  effect	  was	  also	  present	  
in	   the	   contralateral	   brain	   hemisphere.	   This	   is	   of	   great	   relevance,	   as	   this	   effect	  
may	   mask	   actual	   results,	   as	   different	   strains	   may	   have	   an	   altered	   immune	  
response,	  where	  they	  could	  be	  either	  more	  sensitive	  or	  resistant,	  and	  therefore	  
hinder	  more	  accurate	  interpretation	  of	  results.	  
	  
The	   results	   obtained	   in	   this	   strain	   study	   highlight	   the	   importance	   of	   careful	  
planning	  when	  choosing	  a	  background	  strain	  for	  use	  of	  genetically	  modified	  mice	  
in	  research.	  This	  study	  has	  shown	  that,	  what	  is	  considered	  a	  moderate	  hypoxic-­‐
ischaemic	   event	   (30	  min	   8%	   02)	   with	   negligible	   response	   in	   129SVJ	   mice,	   and	  
minimal	  response	  in	  C57BL/6	  animals,	  is	  in	  fact	  severe	  for	  CD1	  animals,	  and	  even	  
more	  so	  for	  FVB	  mice.	  This	  is	  interesting,	  as	  studies	  have	  shown	  that	  the	  longer	  
the	  duration	  of	  transient	  hypoxic	  insult,	  the	  higher	  the	  mortality	  rate	  (Kendall	  et	  
al.,	  2006).	  Also,	  studies	  using	  both	  C57BL/6	  and	  CD1	  mice	  have	  employed	  10%	  02	  
for	   longer	   periods	   of	   60-­‐90min	   in	   order	   to	   reproduce	   ipsilateral	   brain	   damage	  
(Hagberg	  et	  al.,	  2002;	  Kichev	  et	  al.,	  2014).	  In	  the	  current	  study,	  the	  30min	  8%	  O2	  
experimental	   design	   did	   not	   cause	   lethality	   during	   either	   insult,	   or	   throughout	  
the	  48h	  window	  before	  transcardial	  perfusion.	  Therefore,	  it	  is	  possible	  to	  suggest	  
using	  CD1	  and	  FVB	  animals	  for	  30	  min	  8%	  02	  neonatal	  hypoxia-­‐ischaemia	  alone	  as	  
a	   preferential	   approach.	   Furthermore,	   both	   CD1	   and	   FVB	   mice	   are	   known	   to	  
produce	  large	  litters	  and	  are	  not	  known	  to	  cannibalise	  first	  litters,	  unlike	  C57BL/6	  
mice.	  This	  provides	  not	  only	  a	  quicker	  experimental	  approach,	  with	  less	  stress	  to	  
animals	   due	   to	   reduced	   hypoxic	   period	   (30	   min),	   but	   also	   a	   refinement	   and	  




This	   study	  has	  also	   identified	   that	   the	  preferential	   strain	   for	  combined	  LPS	  and	  
hypoxic-­‐ischaemic	   insult	   is	   the	   C57BL/6	   inbred	   strain.	   C57BL/6	   animals	  
responded	   only	  mildly	   to	   hypoxia-­‐ischaemia	   alone,	   but	   damage	  was	   drastically	  
and	   significantly	   increased	   following	   LPS	   pre-­‐treatment.	   This	   effect	   was	  
consistent	   throughout	   all	   four	   different	   assessments.	   This	   provides	   an	   ideal	  
experimental	  approach,	  as	  a	  large	  number	  of	  transgenic	  mice	  are	  provided	  with	  
the	   C57BL/6	   background.	   Using	   the	   inbred	   C57BL/6	   background	   strain	   helps	  
avoid	   the	   need	   to	   re-­‐cross	   and	   backcross	   strains,	   once	   again	   providing	  
experimental	   refinement.	   Furthermore,	   this	   is	   a	   very	  well	   characterized	   inbred	  
strain,	  thus	  facilitating	  interpretation	  of	  results	  in	  the	  presence	  of	  variability.	  
	  
All	   animals	   obtained	   for	   the	   cytokine	   part	   of	   this	   study	   came	   in	   a	   C57BL/6	  
background,	   thus	   facilitating	   progression	   of	   this	   project.	   However,	   after	  
successful	  LPS-­‐senstitization	  on	  the	  LTα	  experiment,	  this	  response	  to	  endotoxin	  
pre-­‐treatment	   was	   lost	   in	   both	   TNFα	   and	   LTβ	   experiments.	   This	   was	   a	   novel	  
result,	  as	  both	  the	  strains	  experiments	  aforementioned,	  as	  well	  as	  multiple	  other	  
studies	  have	  shown	  successful	  LPS-­‐mediated	  sensitization	  (Hagberg	  et	  al.,	  2002;	  
Mallard	  et	  al.,	  2003;	  van	  de	  Looij	  et	  al.,	  2012).	  As	  a	  result,	  we	  decided	  to	  test	  the	  
LPS	  for	  loss	  of	  function,	  which	  proved	  to	  not	  be	  the	  case,	  as	  microglial	  activation	  
scoring	   following	  alphaM	   immunohistochemistry	   revealed	  a	   significant	   increase	  
in	   microglial	   activation.	   Subsequently,	   we	   hypothesised	   that	   this	   lack	   of	   LPS	  
sensitivity	  could	  be	  a	  result	  of	  either	  a	  gene	  mutation	  or	  due	  to	  strain	  variation.	  
As	  gene	  mutation	  would	  require	  a	  more	  complex	  approach,	  we	  decided	  to	  cross	  
each	   of	   the	   non-­‐responder	   strains,	   TNFα	   and	   LTβ,	   with	   wild	   type	   C57BL/6	  
animals.	   However,	   one	   re-­‐crossing	   was	   not	   sufficient	   to	   successfully	   induce	   a	  
LPS-­‐mediated	   response,	   and	   a	   second	   crossing	   against	  wild	   type	  C57BL/6	  mice	  
was	   required	   in	   order	   to	   successfully	   induce	   a	   robust	   endotoxin-­‐mediated	  
sensitization.	   This	   resulted	   in	   a	   75%	   genetic	   introduction	   of	   the	   new	   C57BL/6	  
animals,	   which	   suggests	   that	   whatever	   the	   cause	   of	   this	   reduced	   response	   to	  




Previous	   research	   has	   demonstrated	   that	   deletion	   of	   the	   TNF	   cluster	   of	   pro-­‐
inflammatory	   cytokines	   abolishes	   LPS-­‐mediated	   sensitization	   to	   subsequent	  
neonatal	  hypoxia-­‐ischaemia	  (Kendall	  et	  al.,	  2011b).	  This	  suggests	  that	  endotoxin	  
sensitization,	   in	   this	   particular	  model,	   occurs	   through	   a	  mechanism	  dependent	  
on	   the	   TNF	   cluster	   of	   pro-­‐inflammatory	   cytokines	   consisting	   of	   TNFα,	   LTα	   and	  
LTβ.	  The	  original	  aim	  of	  this	  study	  was	  to	  identify	  which	  of	  the	  three	  cytokines	  is	  
responsible	   for	   this	   sensitization,	  using	  single	  gene	  deletion	  models	   for	  each	  of	  
these	   cytokines,	   or	   cell-­‐specific	   deletion	   of	   TNFα	   gene	   under	   MLys::CRE	  
promoter.	  Unexpectedly,	   the	  results	  obtained	   in	  chapter	  4	  of	   the	  current	  study	  
demonstrated	  a	  diverging	  role	  for	  the	  TNFα,	  LTα	  and	  LTβ	  cytokines	  members	  of	  
the	   cluster,	   where	   only	   global	   deletion	   of	   the	   LTα	   gene	   was	   neuroprotective,	  
albeit	   only	   moderately	   when	   compared	   to	   the	   TNF	   cluster	   knockout	   results	  
(Kendall	  et	  al.,	  2011b).	  Furthermore,	  global	  deletion	  of	  the	  LTβ	  gene	  provided	  a	  
substantial	   increase	   in	   brain	   damage,	   whereas	   global	   TNα	   knockouts	   revealed	  
only	   a	   trend	   towards	   increased	   damage	   following	   combined	   inflammation	   and	  
hypoxia-­‐ischaemia	  injury.	  As	  TNFα	   is	  expressed	  by	  different	  cell-­‐types,	  we	  were	  
also	   able	   to	   look	   at	   animals	   that	   did	   not	   produce	   TNFα	   in	   myeloid	   cells	  
(MLys::CRE	  TNFα	  flox/flox).	  These	  animals	  revealed	  a	  neuroprotective	  effect	  for	  
this	  cell-­‐type	  specific	  deletion	  of	  the	  TNFα	  gene,	  thus	   indicating	  a	  possible	  dual	  
role	   for	  TNFα	  depending	  on	  which	  cell-­‐type	   it	   is	  being	  expressed.	   Interestingly,	  
these	   results	   were	   not	   able	   to	   successfully	   address	   and	   answer	   the	   original	  
question	  set	  by	   this	  project:	  which,	  or	  combination	  of,	   these	   three	  cytokines	   is	  
responsible	   for	   LPS-­‐mediated	   sensitization	   to	   subsequent	   hypoxic-­‐ischaemic	  
insult.	   Furthermore,	   these	   results	   suggest	   that	   individual	   pharmacological	  
inhibition	  of	   these	  cytokines	  would	  not	  be	  a	  desired	  approach	   for	   reduction	  of	  





A	   possible	   explanation	   for	   the	   opposing	   roles	   between	   LTα	   and	   TNFα	   and	   LTβ	  
could	   be	   their	   close	   proximity	   within	   12kb	   of	   genomic	   DNA	   within	   the	   major	  
histocompatibility	   complex	   locus	   (Kendall	   et	   al.,	   2011b).	   These	   cytokines	   are	  
known	   to	   have	   overlapping	   function,	   and	   to	   play	   an	   essential	   role	   in	   the	  
development	  of	  secondary	  lymphoid	  organs	  and	  immune	  response.	  Therefore,	  it	  
is	   entirely	   possible	   that	   deletion	   of	   one	   of	   these	   closely	   related	   genes	   could	  
affect	  expression	  of	  one	  or	  both	  other	  TNF	  cluster	  members.	  In	  fact,	  a	  study	  by	  
Alexopoulou	   et	   al.	   has	   demonstrated	   that	   LTα	   knockouts	   have	   a	  more	   severe	  
lymphoid	   organs	   phenotypic	   defect	   when	   compared	   to	   the	   other	   two	   cluster	  
members.	   Furthermore,	   this	   same	   study	   revealed	   that	   LTα	   mutants	   also	   had	  
reduced	  TNFα	  production	  by	  peritoneal	  macrophages	  (Alexopoulou	  et	  al.,	  1998).	  
These	   findings	   could	   explain	   the	   positive	   results	   seen	   both	   in	   the	   LTα	   and	  
MLys+/-­‐	  TNFα	  flox/flox	  (MLys)	  experiments.	  LTα	  knockout	  animals	  cause	  a	  more	  
severe	  defect	  on	  lymphoid	  organs,	  thus	  leading	  to	  a	  reduced	  immune	  response;	  
this	   is	   coupled	   with	   a	   reduction	   in	   TNFα	   synthesis	   by	   peripheral	   macrophage	  
cells.	  Additionally,	  it	  has	  been	  shown	  in	  the	  current	  study,	  that	  myeloid	  cells	  have	  
a	   detrimental	   effect	   when	   normally	   expressing	   TNFα	   cytokine	   (MLys	  
experiment).	   The	   protective	   deletion	   of	   TNFα	   gene	   in	  MLys+	   cells	   seen	   in	   the	  
current	  study	  is	  also	  in	  concordance	  with	  another	  study	  that	  showed	  that	  these	  
same	   knockout	   animals	   have	   a	   later	   onset	   of	   experimental	   autoimmune	  
encephalomyelitis.	  The	  same	  study	  also	  suggested	  that	  TNFα’s	  detrimental	  effect	  
in	   EAE	   could	   be	   a	   result	   of	   initial	   recruitment	   of	   immune	   cells	   into	   the	   brain	  
(Kurglov	  et	  al.,	  2011).	  	  
	  
A	   limitation	   of	   the	   current	   study	   is	   the	   fact	   that	   we	   were	   unable	   to	   verify	  
whether	   deletion	   of	   one	   of	   the	   TNF	   cluster	   members	   has	   an	   effect	   on	   the	  
expression	  of	  the	  other	  two	  members.	  qRT-­‐PCR	  was	  performed	  on	  tissue	  spleen	  
tissue	  from	  animals	  that	  had	  either	  TNFα,	  LTα	  or	  LT	  β	  gene	  globally	  removed,	  as	  
well	  as	  wild-­‐type	  mice.	  Unfortunately,	  the	  housekeeping	  gene	  βactin,	  which	  was	  
successfully	  used	  for	  a	  trial	  experiment	  for	  this	  mRNA	  expression	  protocol	  failed	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to	  work	   in	   this	   experiment,	   thus	   rendering	   impossible	   to	   do	   a	   correct	   readout	  
and	   comparison	   of	   expression	   levels	   of	   each	   of	   the	   three	   cytokines	   in	   the	  
different	   mutants.	   However,	   this	   experiment	   would	   be	   an	   invaluable	   future	  
addition	  to	  the	  understanding	  of	  these	  cytokines’	  role	   in	  this	  combined	  form	  of	  
injury.	  
	  
As	   previously	  mentioned,	   TNFα,	   LTα	   and	   LTβ	   global	   gene	   deletions	   leads	   to	   a	  
structural	   defect	   in	   the	   peripheral	   immune	   system,	   with	   a	  more	   severe	   effect	  
seen	   in	   the	   LTα	   mutants.	   Additionally,	   entire	   TNF	   cluster	   deletion	   leads	   to	   an	  
additive	   phenotype	   defect	   equivalent	   of	   a	   combination	   of	   all	   three	   individual	  
deletions	   in	   terms	   of	   impairment	   of	   lymphoid	   development	   and	   function	  
(Kuprash	  et	  al.,	  2002).	  Therefore,	   knowing	   that	   individual	   cytokine	  deletion	  did	  
not	   reproduce	   the	   abolition	   effect	   seen	   in	   Kendall	   et	   al,	   2011b,	   and	   that	  
impairment	  of	  TNFα	  expression	  in	  myeloid	  cells	  is	  rather	  beneficial,	  we	  decided	  
to	  approach	  this	  study	  from	  a	  new	  perspective.	  We	  now	  decided	  to	  investigate	  if	  
it	   was	   this	   defect	   in	   the	   acquired	   immune	   system	   that	   was	   causing	   the	   non-­‐
response	  to	  LPS	  sensitization	  seen	  in	  the	  TNF	  cluster	  study.	  To	  address	  this	  new	  
hypothesis	  we	  obtained	  BALB/c	  athymic	  nude	  mice.	  
	  
Bacterial	  administration,	  including	  LPS,	  lead	  to	  a	  substantial	  activation	  in	  T	  cells.	  
However,	  the	  current	  nude	  experiment	  showed	  an	  abolishment	  of	  LPS-­‐mediated	  
sensitization	  to	  subsequent	  hypoxic-­‐ischaemic	  injury	  in	  the	  nude	  group.	  This	  was	  
significant	   and	   consistent	   across	   all	   forebrain	   regions,	   as	   well	   as	   all	   four	  
assessments	   performed,	   thus	   suggesting	   the	   involvement	   of	   T	   cell	   in	   the	   LPS-­‐
mediated	   inflammation-­‐induction.	  An	   ischaemic	  study	  using	  Rag1	  animals	   (no	  T	  
and	   B	   cells)	   has	   shown	   similar	   effects,	   where	   Rag1	   animals	   demonstrated	   a	  
substantial	   decrease	   in	   tissue	   infarction.	   Furthermore,	   this	   protective	   effect	  
disappeared	  in	  animals	  that	  had	  been	  reconstituted	  with	  wild	  type	  splenocytes.	  
Additionally,	   the	   same	   study	   showed	   that	   lack	   of	  mature	   B	   cells	   did	   not	   alter	  
response	  to	  ischaemic	  injury	  (Yilmaz	  et	  al.,	  2006).	  These	  findings	  corroborate	  the	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theory	  generated	  in	  the	  current	  study,	  where	  it	  is	  the	  immune	  defect	  generated	  
by	   the	   TNF	   cluster	   mutants,	   which	   is	   causing	   the	   lack	   of	   LPS-­‐mediated	  
sensitization,	   rather	   than	   cytokine	   function.	   This	  hypothesis	   is	   strengthened	  by	  
the	   fact	   that	   the	   single	   gene	   knockout	   animals	   provided	   varying	   and	   differing	  
effects.	   The	   use	   of	   nude	   animals	   in	   this	   study,	   which	   further	   strengthens	   the	  
theory	   that	   the	   acquired	   immune	   system	   plays	   a	   bigger	   role	   than	   previously	  
expected	  in	  this	  combined	  form	  of	  injury,	  and	  that	  T	  cell	  physiological	  response	  
to	   LPS	   is	   what	   is	   causing	   the	   sensitization	   to	   subsequent	   hypoxic-­‐ischaemic	  
injury.	   These	   findings	   could	   also	   indicate	   that	   the	   stress	   affecting	   the	   immune	  
system,	  as	  seen	  in	  the	  C57BL/6	  and	  FVB	  strains	  response	  to	  saline	  administration	  
12h	  prior	  to	  hypoxia-­‐ischaemiaI	  could	  also	  occur	  thorugh	  the	  same	  pathway,	  as	  
peritoneal	   systemic	   saline	   injection	   led	   to	   a	   moderate	   increase	   in	   immune	  
response.	  
	  
However,	   the	   athymic	   nude	   mouse	   is	   a	   result	   of	   a	   spontaneous	   recessive	  
mutation	   on	   the	   Foxn1	   transcription	   factor	   gene.	   This	   transcription	   factor	   is	  
responsible	  for	  regulating	  keratin	  gene	  expression	  and	  occurs	  mainly	  in	  skin	  and	  
thymus	   epithelial	   cells	   (Brisette	   et	   al.,	   1996).	   The	   eaxct	   pathways	   involved	   in	  
Foxn1	  expressetion	  still	  remain	  unnown	  (Zhang	  et	  al.,	  2012),	  and	  therefore,	  one	  
cannot	  exclude	  the	  possibility	  that	  Foxn1	  may	  be	  involved	  in	  LPS	  signalling	  in	  a	  T	  
cell	   independent	   manner.	   Further	   clarification	   on	   whether	   it	   is	   the	   defective	  
acquired	   immune	   system	   that	   is	   causing	   the	   nude	   non-­‐responsivenes	   to	   LPS	  
sensitization	  or	  if	  this	  is	  a	  result	  of	  another	  function	  of	  Foxn1	  gene	  could	  possibly	  
be	  achieved	  by	   looking	   specifically	   at	  CD4+	  and	  CD8+	   subsets,	   as	  well	   as	  other	  
memebers	  of	  the	  acquired	  immune	  system,	  such	  as	  B	  cells	  and	  NK	  cells.	  
	  
Conclusion	  
In	   summary,	   this	   study	   has	   demonstrated	   a	   rather	   robust	   LPS-­‐mediated	  
sensitization	  of	  the	  neonatal	  brain	  to	  subsequent	  hypoxic-­‐ischaemic	  insult	  across	  
several	  inbred	  and	  outbred	  mouse	  strains.	  Even	  in	  cases	  where	  strains	  appeared	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to	   be	   non-­‐responsive	   to	   bacterial	   endotoxin,	   this	   could	   be	   reverted	   through	  
serial	  crossing	  with	  C57BL/6	  mice,	  shown	  to	  be	  high	  responders.	  This	  study	  has	  
also	  raised	  the	  question	  of	  whether	  or	  not	  saline	  administration	  as	  a	  control	  is	  in	  
fact	   representative	   of	   unchallenged	   animals,	   as	   some	   strains	   have	   shown	   a	  
saline-­‐associated	   increase	   in	   inflammatory	   markers.	   Another	   novel	   hypothesis	  
raised	   by	   this	   study	   is	   the	   suggestion	   that	   the	   peripheral	   immunity	   response	  
following	  combined	  endotoxin	  and	  neonatal	  hypoxia-­‐ischaemia	  injury	  may	  play	  a	  
bigger	   detrimental	   role	   in	   neonatal	   encephalopathy	   associated	   with	   bacterial	  
infection,	  rather	  than	   inflammatory	  cytokine	  activation	  having	  a	  direct	  effect	   in	  
neonatal	   brain	   damage.	   Furthermore,	   this	   study	   suggests	   that	   LPS-­‐mediated	  
sensitization	   may	   require	   T	   cell	   function.	   If	   correct,	   these	   findings	   provide	   an	  
easier	  and	  more	  readily	  available	  approach	  for	  therapeutic	  intervention,	  as	  there	  
are	   currently	   commercially	   available	   immunosuppressants	   that	   target	   T	   cell	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